Diseases

1: Acute Disease (544) 2: Pulmonary (39)

acut aml chronic clinic complic diseas group activ associ case clinic diagnos leukaemia leukemia manifest mds mild myeloid diagnosi diagnost factor incid men patient present sever sign mortal preval symptom syndrom transplant patient protein rate risk studi women year

3: Somnambulism (1) 4: Night Terrors (2)

adult conserv data depress disord care complex cost decreas famili elderli enhanc increas literatur mean old older peopl potenti releas stimul studi form format increas inform year young younger manag medic member particip person physician potenti practic report stimul target

5: Dog Diseases (124) 6: Myelodysplastic Syndromes (208)

asymmetri canin cat deform digit distal acut aml bcr-abl blast chronic cml flt3 hematolog imatinib leukaemia leukem dog foot hand later left leg limb proxim rabbit radial report right leukemia lymphoblast marrow mds myelodysplast myeloid patient relaps segment upper syndrom

7: Malformations (25) 8: Fetal Diseases (100) analysi associ brain cell control birth deliveri fetal fetu develop differ gestat infant matern mother express featur gene neonat newborn placent placenta pregnanc pregnant prenat human mechan mice preterm twin week women mutat normal number requir studi syndrom tissu

1 9: Kidney Diseases (109) 10: Muscular Dystrophies (65)

associ chronic clear creatinin develop dialysi diseas contract dmd dystrophi dystrophin exercis fiber gene

failur famili gene glomerular kidnei muscl muscular mutat myoblast myopathi perform role skelet smc smooth strength nephropathi patient progress rcc renal train weak studi tubul tubular

11: Carcinoma, Small Cell (135) 12: (1286) a549 adenocarcinoma alveolar associ a549 adenocarcinoma alveolar bronchial cancer

carcinoma case cell compar control lung cell compar includ lung non-smal non-smal non-small-cel nsclc patient pulmonari size non-small-cel nsclc observ patient pulmonari respect small studi tumor sclc small studi tumor

13: Chromosome Aberrations (688) 14: Asthma (240)

aberr abnorm analysi arm breakpoint case airwai allerg allergen allergi

chromosom cytogenet asthma cftr chronic conduct delet duplic gene genet karyotyp loss molecular mosaic rearrang region transloc trisomi copd cystic diseas eosinophil fibrosi ige obstruct pulmonari respiratori sever studi ventil

15: Bronchial Hyperreactivity (21) 16: Genetic Predisposition to Disease airwai allerg allergen associ (2191) allel associ diseas factor famili frequenc gene asthma cftr control cystic genet genotyp haplotyp diseas eosinophil fibrosi ige mice individu molecular mutat obstruct pulmonari respiratori polymorph popul risk snp suscept variant variat sever studi test ventil

2 17: Spherocytosis, Hereditary (9) 18: Hemophilia B (24) adult analysi caus cell child childhood analysi assai associ bleed detect

children clinic defici domin factor folat genet group increas famili genet mutat new parent pediatr phenotyp level mthfr plasma popul treatment year patient platelet risk sensit studi thrombosi venou

19: Cat Diseases (53) 20: Lymphoma (224)

canin cat clinic deform diagnosi diagnost b-cell case cell clinic cll diffus hodgkin human immunoglobulin larg leukemia lymphocyt lymphoid differ distal dog hand isol later left limb proxim rabbit report right lymphoma malign nhl non-hodgkin patient t-cell segment studi

21: Sphingolipidoses (1) 22: HIV Infections (534) activ basi biosynthesi catalyt conform crystal aids antiretrovir env envelop gag herp hiv enzym experi gener involv mechan molecular organ possibl process hiv-1 hsv hsv-1 human structur substrat underli immunodefici infect opn replic understand understood revers simplex viral viru virus

23: Acquired Immunodeficiency Syn- 24: Arenaviridae Infections (3) drome (123) adult care caus compar aids antiretrovir differ env envelop gag herp control frequenc health high hiv hiv-1 hsv hsv-1 human infect lead level low manag medic resist rna target viral viru year immunodefici infect new replic simplex viral viru virus

3 25: Hemophilia A (85) 26: Tooth Abnormalities (38) abnorm anomali case cleft clinic congenit defect associ bleed coagul factor fibrinogen dental develop facial famili increas lip palat folat folic homocystein leiden mthfr patient patient report respons sever plasma platelet reductas risk studi thrombin thrombosi venou vitamin syndrom teeth

27: Voice Disorders (4) 28: Tooth Loss (9) case data differ diseas follow gener incid loss caus data estim famili genet mean measur method multipl

patient persist predict state group higher incid life men studi subject valu variabl mortal patient popul preval

rate select studi subject women year

29: Mandibular Fractures (3) 30: Persistent Vegetative State (44) adapt case children complic condit argu articl concern conflict consent debat degre hospit patient period discuss ethic inform issu medic moral paper patient practic public question point region report select sequenc surgeri surgic temperatur research scientif social time tumour year

31: Osteosarcoma (109) 32: Syndrome (677)

abnorm anomali associ case caus clinic congenit activ analysi associ bone case cell children express gene group human kit line defect disord domin famili featur inherit malform patient protein respons sarcoma stromal studi tumor mutat patient report retard sever syndrom

4 33: Hepatitis C, Chronic (100) 34: Leukemia, Myelocytic, Acute (184)

aim bile biliari chronic cirrhosi duct fibrosi hbv hcv acut aml bcr-abl blast children chronic cml group imatinib leukaemia leukem hepat hepatocyt hepatoma infect liver methods patient replic viral viru virus leukemia lymphoblast marrow mds myelodysplast myeloid patient relaps syndrom

35: Intestinal Neoplasms (52) 36: Stomach Neoplasms (475)

analysi cancer cell chronic develop adenocarcinoma aim associ cancer erad examin diseas express gene human increas gastric gastrointestin helicobact intestin mice mous mutat number infect intestin methods mucin mucosa pylori relat respect stomach studi ulcer patient rate tissu tumor tumour

37: Adenocarcinoma (861) 38: Esophageal Neoplasms (202) adenocarcinoma analysi cancer associ carcinoma common carcinoma cell colon colorect express gastric gene esophag frequent includ investig italian mesothelioma observ possibl lesion lung pancreat patient prostat stain studi occur occurr probabl relat report studi transmiss surviv tissu tumor transmit tumor

39: Carcinoma, Signet Ring Cell (17) 40: Rhinitis (12) cancer case cell chang compar decreas assai asthma compar control delet develop express gastric gene correl detect effect fibrosi group increas phenotyp gener genet identifi patient pylori rate report studi tissu tumor requir screen sensit signific studi subject treatment year

5 41: Corneal Diseases (42) 42: Scleritis (3) aberr ablat case conclusions cornea biolog care caus conclusions corneal correct corneal correct develop diseas health hospit lead evalu examin mean measur methods method methods patient myopia ocular patient perform refract procedur protocol servic studi system techniqu studi thick visual

43: Eye Neoplasms (40) 44: Neoplasms, Multiple Primary (84) analysi case cell clinic diagnosi associ cancer case cell describ diagnos featur group lesion method patient popul diagnosi featur literatur man multipl patient phenotyp present rare report reveal risk tumor woman rate role specimen stain studi tissu treatment tumor tumour

45: Endophthalmitis (11) 46: Melanoma (541)

analysi case cataract clinic compar dai differ demonstr elong immun melanocyt melanoma microrna mirna nevi pol polymeras requir respons diseas glaucoma group higher ribozym rna rnase small transcript tumor uveal implant increas infect len measur popul vitro rate role studi

47: Adenocarcinoma, Sebaceous (3) 48: Sebaceous Gland Neoplasms (6) alpha approach carcinoma chines compar carcinoma case clinic express famili concentr control differ form format identifi individu member method frequenc method plai express normal patient phenotyp report receptor role signific strategi studi subtyp screen techniqu tissu tumor techniqu tumor

6 49: Glaucoma, Angle-Closure (18) 50: Glaucoma, Neovascular (6) activ anterior associ cataract adult case clinic conclusions differ diseas estim examin chamber conclusions disc examin famili implant method methods patient glaucoma implant includ pattern primari retin studi target techniqu visual year intraocular iop len methods perform studi surgeri visual

51: Conjunctival Neoplasms (13) 52: Denys-Drash Syndrome (7) aberr associ conclusions cornea abnorm anomali case chain congenit femal gene corneal correct develop examin high mean health includ individu male mutat patient measur methods ocular patient perform protein studi treatment visual year reaction report risk studi

syndrom target tumor

53: Liver Neoplasms (686) 54: Carcinoma, Hepatocellular (509) bile carcinoma case cell chronic carcinogenesi carcinoma case cirrhosi correl express hcc hepat hepatocellular cell chronic correl express gene hcc hepat hepatocellular hepatocyt immunohistochem invas liver hepatocyt invas liver methods patient progress methods progress scc squamou tumor scc squamou tumor

55: Vocal Cord Paralysis (9) 56: Branchioma (5) analysi case correl develop improv absenc case clinic diagnosi event experi featur genet initi intern manag origin patient increas life loss patient perform present presenc present process rare report second qualiti rare report reveal sever signific studi sever surgeri surgic

7 57: Colonic Polyps (35) 58: Genomic Instability (191)

analysi associ bac cancer cell chang colon colorect adenoma adenomat apc cancer compar complet damag differ dna express function colon colorect control crc differ effect mechan phenotyp repair instabl microsatellit mismatch mmr msi patient polyp genom sequenc polyposi risk studi

59: Colonic Neoplasms (560) 60: Astrocytoma (96)

adenocarcinoma adenoma adenomat apc arsen astrocytoma brain cell data examin gbm glioblastoma glioma grade includ indic malign cancer cell colon colorect crc hereditari hmlh1 hnpcc instabl microsatellit mismatch mlh1 mmr msi polyp polyposi meningioma primari secondari studi suggest tissu tumor

61: Brain Neoplasms (535) 62: Coronary Restenosis (14)

arsen astrocytoma brain central data gbm arteri coronari data glioblastoma glioma grade includ indic malign effect estim group meningioma patient primari progress hypertens infarct method new secondari studi suggest tumor patient pressur stroke studi therapi time treatment tumour vascular

63: Disease Progression (1032) 64: Sarcoma (114)

advanc cancer clinic develop diseas earli express c-kit case cell differenti gastrointestin giant

late median month outcom patient phase prognost progress recurr stage surviv gist hsp90 imatinib includ kit malign patient tumor year

sarcoma soft stromal sts studi

tissu tumor

8 65: Prostatic Hyperplasia (57) 66: Prostatic Neoplasms (917) activ analysi androgen cancer data androgen androgen-independ antigen benign bph estim function increas lncap men method pc-3 pca carcinogenesi du145 increas progress prostat psa risk sampl studi treatment cancer lncap men pc-3 pca progress prostat prostate-specif prostatectomi psa therapi tumor

67: Drug Eruptions (12) 68: Coronary Arteriosclerosis (90) caus chain clinic detect diagnosi experi follow initi intern new organ origin ace arteri associ blood cardiovascular coronari patient reaction respons role hypertens infarct ischem ischemia second sever skin studi level lipid myocardi patient pressur risk stroke vascular vein vessel

69: Myocardial Infarction (182) 70: Varicocele (11) associ cryopreserv dna fertil fresh genom ace angiotensin arteri blood cad germ hors infertil male motil normal risk cardiovascular coronari estim heart semen sperm spermatogenesi hypertens infarct ischem ischemia spermatozoa testi testicular treatment myocardi patient pressur stroke vascular vein vessel

71: Infertility, Male (132) 72: Cryptorchidism (26) cryopreserv femal fertil fresh germ hors associ case develop differ infertil male men motil normal reproduct germ group high sampl semen sperm spermatid human spermatogenesi spermatozoa testi testicular incid level male men mortal popul preval sperm studi syndrom women year

9 73: Lymphoma, T-Cell (72) 74: Fatigue (38) analysi associ b-cell case cell cll differ express assess associ case chang depress disord gene hodgkin immunoglobulin larg leukemia effect evalu follow increas measur multipl

lymphocyt lymphoma patient person score select studi malign nhl non-hodgkin rituximab tumor symptom time treatment

75: Syncope (26) 76: Soft Tissue Neoplasms (70) c-kit case gastrointestin giant gist cardiac cardiomyocyt cardiomyopathi case children differ failur hsp90 imatinib immunohistochem includ kit famili featur follow heart left mechan new patient respons sever time ventricular year malign pdgf report sarcoma soft

stromal sts studi tissu tumor

77: Neurilemmoma (30) 78: Alzheimer Disease (323) associ case cell clinic diagnosi ear accumul alzheimer amyloid autoimmun behavior caus express featur hair hear includ loss common dementia deposit diseas disord lysosom parkinson pathogenesi patholog precursor patient present rang rare report studi progress storag suggest tau tumor year

79: Substance-Related Disorders (83) 80: Leukemia, Promyelocytic, Acute (102) alcohol behavior consumpt depend differ disord drug effect ethanol examin acut aml associ blast cell chronic cml function gene genom imatinib leukaemia leukem increas model oral prefer research sampl lymphoblast mds signific studi substanc leukemia myelodysplast myeloid patient syndrom

10 81: Hepatolenticular Degeneration (50) 82: Hearing Loss, Conductive (16) bile biliari case chronic cirrhosi clinic diseas hepat adult auditori caus cochlear deaf ear famili hair

hear hospit impair inner middl hepatocyt hepatoma liver measur mutat loss number patient score sever studi treatment year normal number studi tissu vestibular year

83: Hearing Loss, Sensorineural (124) 84: Cleft Palate (142)

abnorm acoust auditori bilater canal caus cochlear cleft clinic craniofaci dental face deaf ear find hair hear impair inner loss gingiv mandibular maxillari middl normal patient sensorineur vestibular facial lip molar nasal oral palat periodont perman studi syndrom teeth tooth

85: Speech Disorders (16) 86: Velopharyngeal Insufficiency (12) analysi children cleft correl dental detect activ base behavior children determin effect facial lip method palat clinic cluster control develop patient sampl signific studi subject

famili hospit identifi syndrom teeth variabl member normal patient perform respons screen syndrom tissu year

87: Colorectal Neoplasms (912) 88: Muscular Dystrophy, Oculopharyn-

adenocarcinoma adenoma adenomat apc geal (10) cancer colon colorect crc abnorm ataxia atrophi caus clinic diseas hereditari hmlh1 hnpcc instabl microsatellit mismatch mlh1 mmr msi patient polyp polyposi disord dysfunct effect expand expans group huntington inclus motor onset patholog patient progress

11 89: Psychomotor Agitation (7) 90: Ovarian Neoplasms (531) ascit associ cancer compar endometri adult affect behavior case epitheli eralpha estrogen examin increas clinic cognit disord group health learn memori older perform product ovarian patient periton potenti risk serou studi suggest tumor uterin studi test treatment trial year young

91: Severe Acute Respiratory Syn- 92: Neoplasms (2522) drome (50) adjuv aromatas antivir capsid detect genom hbv hcv hepat host breast ductal estrogen factor gene human infect infecti influenza particl patient cancer hormon mcf-7 mda-mb-231 posit receptor risk statu tam tamoxifen therapi tumor women replic sequenc viral virion viru virus

93: Mouth Neoplasms (174) 94: Carcinoma, Squamous Cell (703)

abus alcohol carcinoma associ carcinogenesi carcinoma consumpt drink drug ethanol depend effect case correl differenti express hcc hepatocellular examin express hcc indic oral prefer immunohistochem invas malign patient progress scc signific squamou studi substanc tumor signific squamou surviv tissu tumor

95: Leukemia (275) 96: Heart Neoplasms (21) acut aml blast cell chronic cml data clinic develop gene imatinib leukaemia leukem cardiac case develop diagnosi examin extent leukemia lymphoblast mds famili find gene involv method model myeloid patient studi heart observ patient process report respons studi suggest survivin

12 97: Myxoma (9) 98: Sarcoidosis (25) area base cardiac case chang featur activ associ case cell chronic correl diseas famili gene inflamm inflammatori intestin gene heart larg mutat normal level mutat process posit protein rel report size patient patient report serum signific studi small time tissu

99: (64) 100: Neoplasms (2210)

advanc approach breast cancer clinic develop malign atrial cardiomyocyt new novel patient potenti prostat research strategi cardiac target therapeut therapi treatment cardiomyopathi caus death differ dilat failur tumor tumour gene heart hypertrophi left mice myocyt patient right sudden valv ventricular

101: Metastasis (649) 102: Neovascularization, Pathologic cancer carcinoma cell chemotherapi clinic (598) angiogen angiogenesi antiangiogen densiti

dissemin distant invas lymph metastas endostatin endotheli factor growth hif-1 hif-1alpha hypox hypoxia hypoxia-induc microvessel target tumor metastasi metastat node patient vascular vegf vessel vhl

primari progress recurr stage surviv tumor

103: Pulmonary Veno-Occlusive Dis- 104: Postoperative Complications ease (1) (290) chain control evalu healthi imag magnet abdomin aneurysm case complic manag oper measur methods mri patient pcr perform patient perform postop preoper reaction reson sever studi subject procedur resect studi surgeri treat volum treatment surgic techniqu transplant treatment underw year

13 105: Atrial Fibrillation (41) 106: Diseases in Twins (88) common compon contribut correl determin differ associ atrial cardiac cardiomyocyt effect environ environment factor cardiomyopathi failur famili group genet herit individu heart hypertrophi larg left patient right risk sampl size studi time ventricular influenc pair studi trait twin varianc variat

107: Recurrence (454) 108: Heart Defects, Congenital (168) case complet follow follow-up long-term mean median abnorm anomali associ cardiac caus children congenit defect develop disord featur group heart left malform patient report retard methods month patient rang receiv recurr relaps surviv therapi time treat syndrom ventricular treatment year

109: Carotid Artery (6) 110: Cerebrovascular Accident (133) arteri assess case clinic combin control effect follow function healthi initi level measur mice ace angiotensin arteri blood cad cardiovascular coronari health origin reduc score subject patient hypertens infarct ischem ischemia treatment myocardi patient pressur stroke vascular vein vessel year

111: Migraine Disorders (37) 112: Herpes Simplex (75) arthriti associ attack clinic diseas famili aids antiretrovir env envelop gag herp hiv gene group joint methods migrain hiv-1 hsv hsv-1 human objective patient rate report rheumatoid sever studi immunodefici infect opn replic revers simplex viral viru virus

14 113: Medulloblastoma (45) 114: Metaplasia (42) adenocarcinoma aim cancer carcinoma cell analysi associ brain cell central compar gastric gastrointestin gene cerebr cns cortex cortic differ express find gene helicobact higher mucosa posit pylori rate respect stomach studi time tissu involv matter nervou region role studi tumor

115: Craniofacial Abnormalities (118) 116: Leukemia, Myeloid (281)

abnorm anomali associ case chang children clinic acut aml bcr-abl blast chronic cml flt3 hematolog imatinib leukaemia leukem

lymphoblast marrow congenit defect disord featur malform mental leukemia mds myelodysplast myeloid patient relaps syndrom

patient phenotyp report retard sever studi syndrom

117: Angina Pectoris (21) 118: Brain Injuries (55) arteri blood cardiovascular chang clinic behavior brain central cluster coronari famili group hypertens cognit cord differ impair injuri infarct myocardi patient learn memori model nerv nervou pressur risk stroke studi support treatment patient perform spinal studi subject vascular task wound

119: Vertigo (15) 120: , Dilated (62) analysi auditori caus clinic control deaf ear atrial cardiac cardiomyocyt group hair hear high impair inner loss cardiomyopathi caus chang death dilat ecg failur

posit select sever studi patient heart hypertrophi left myocyt vestibular patient right studi sudden valv ventricular

15 121: Muscular Dystrophy, Emery- 122: Digestive System Neoplasms (8) Dreifuss (13) cancer carcinoma cell cluster associ caus cytoplasm develop diseas differ express femal male model function gene group isol local mechan mutat new number organ pattern mutant mutat nuclear nucleu phenotyp process protein rel number phenotyp protein report studi studi tumour

123: Coronary Stenosis (18) 124: Protein-Energy Malnutrition (7) area associ base bodi adult arteri blood cardiovascular cell coronari develop hypertens children control increas infarct level myocardi pressur develop differ evid femal high sampl stroke time tissu valu vascular male protein year level low popul provid risk studi support

125: Arthritis (39) 126: (82) adult chemotherapi chronic clinic dai arthriti associ attack clinic control differ diseas effect group inflammatori diseas fever group joint level intestin isol respons methods migrain objective patient pain strain studi time toxic treatment year patient report rheumatoid risk sever studi

127: Digestive System Diseases (7) 128: Inflammatory Bowel Diseases (66) clinic data diseas evid experi form function associ bowel chronic coliti colon crohn health initi intern origin genet diseas function genet ibd increas patient provid regul report popul second inflamm inflammatori mucos valu intestin studi number patient risk small ulcer

16 129: Pancreatitis (86) 130: Photosensitivity Disorders (12)

adenocarcinoma associ beta-cel demonstr determin analysi case children clinic cluster complex develop ductal endocrin includ increas indic islet diagnosi genet linkag loci locu map model

observ pancrea patient pancreat mutat patient sampl skin studi secret secretori studi suggest syndrom year

131: Ectodermal Dysplasia (38) 132: Leukemia, T-Cell (33) affect analysi associ autosom case caus cleft activ associ blood cell develop effect express gene group human identifi increas clinic congenit disord domin famili gene level lymphoma new normal patient protein provid tissu

genet inherit mutat patient recess

report syndrom

133: Genetic Diseases, Inborn (159) 134: Tuberculosis, Pulmonary (53)

approach data develop diseas estim ethic famili addit associ data defin demonstr gener includ indic lead mycobacterium new patient possibl gene genet health human identifi report repres result specif studi tuberculosi virtual inform method molecular mutat new provid research understand

135: Obesity (367) 136: Craniofacial Dysostosis (12) behavior compar congenit data develop bmi bodi consumpt diabet diet dietari differ group growth individu inform energi fat fed feed index intak leptin mass insight new patient provid rate report metabol nutrit obes supplement weight research size syndrom test

17 137: WAGR Syndrome (4) 138: Exostoses, Multiple Hereditary area case clinic diagnosi fish hybrid incid (12) affect analysi case caus delet men mortal patient plai popul detect form gene lead loss multipl preval probe rate role situ syndrom women year mutat patient report respons reveal segment singl studi syndrom

139: Ophthalmoplegia, Chronic Pro- 140: Trigeminal Neuralgia (5) gressive External (9) analysi case clinic compar control express famili gene group initi member mitochondri control data form format mutat new normal origin incid male men method mortal region second sequenc specif patient preval reveal risk studi tissu vector patient studi women year

141: Osteoarthritis (60) 142: Arthritis, Rheumatoid (231) arthriti associ attack clinic diseas arthriti associ attack chronic clinic fever gene identifi joint methods migrain diseas fever headach inflammatori joint objective pain patient knee methods migrain objective pain report rheumatoid sampl sever studi synovi patient report rheumatoid sever synovi

143: Asthenia (8) 144: Horse Diseases (37) approxim caus clinic dai earli factor famili growth analysi chain develop fertil germ health individu interact larg major increas infertil isol male motil patient patient phenotyp produc product reaction select semen sperm rel select size spermatozoa strain test testi testicular

18 145: Skin Diseases, Genetic (22) 146: Uterine Neoplasms (82) affect approach autosom basal cell cutan domin cancer compar differ endometri epiderm famili gene genet inherit keratinocyt epitheli eralpha estrogen examin express gene lesion model mutat number phenotyp group normal observ ovarian skin studi periton signific studi suggest tissu uterin

147: Hermaphroditism (30) 148: Leiomyoma (41) activ cancer develop differ endometri choic determin differ dimorph femal epitheli estrogen express gene genet group

function gender genet gonad male mate model number ovarian periton offspr patern ratio reproduct sex sexual sry steril report suggest tumor uterin success studi

149: (20) 150: Pain (168) associ breast cancer case develop arthriti associ care case clinic diseas ethic health human joint life pain particip differ femal increas male mate model normal phenotyp present report patient qualiti report research reproduct risk sex sexual tissu rheumatoid sever studi

151: Callosities (1) 152: Peripheral Nervous System Dis- eases (56) arabidopsi case clinic confirm criteria analysi clinic cord follow heal definit degrad diagnos diagnosi injuri multipl myelin nerv diagnost establish laboratori patient plant neuropathi oligodendrocyt patient peripher present protein root routin seed suspect regener sever spinal studi trauma wound

19 153: MELAS Syndrome (17) 154: MERRF Syndrome (4)

children cytochrom deplet dna featur imag indic combin control dai differ effect gener genet group identifi molecular involv membran mitochondri mitochondria mtdna oxidas patient popul potenti presenc reveal sever suggest mutat nucleotid patient region sequenc studi subject target time

155: Amyloid Neuropathies (4) 156: Brain Diseases (79) acid brain case differ earli effect evid featur group imag interact late abnorm activ area associ brain central cerebr cns cortex cortic find gene increas involv matter nervou region stress studi syndrom mutat patient phase popul reduc stage studi support

157: Parkinson Disease (205) 158: Anemia (117)

alpha-synuclein alzheimer autoimmun caus common abnorm anemia associ caus chemotherapi defect

dementia diseas disord fabri famili includ defici epo erythrocyt erythroid neurodegen onset parkin parkinson pathogenesi patholog erythropoietin g6pd hemoglobin normal patient progress symbol tau respons sever studi test treatment

159: Adrenoleukodystrophy (17) 160: Diabetic Nephropathies (60)

acid amino case caus clinic data domin associ develop diabet differ diseas famili fatti form high level mutat new fast glucos group high human insulin patient phenotyp present sever subject kidnei level mellitu metabol patient symptom polymorph renal risk studi

20 161: Dental Pulp Necrosis (2) 162: Oral Hemorrhage (2)

codon color composit concentr effect compar control cost differ factor group extract induc induct infect intens laser lesion light manag marker median medic month normal light prevent protect red reduc reduct patient respect signific structur studi tissu year respons substitut

163: Pulpitis (1) 164: Kidney Neoplasms (301) african american blue color composit differ effect ethnic associ cell chronic clear develop dialysi diseas failur group intens laser light popul red shed signific studi treat treatment white glomerular kidnei malign nephropathi patient

progress rcc renal studi tubul tubular tumor

165: Carcinoma, Renal Cell (198) 166: Leukorrhea (2)

associ cell chronic clear creatinin develop dialysi diseas absenc adolesc allel associ autism child failur glomerular kidnei nephropathi progress childhood children clinic genotyp parent patient pediatr phenotyp proteinuria proxim rcc renal studi tubul polymorph presenc sever studi symptom year tubular

167: Urination Disorders (15) 168: Dyspareunia (4) analysi associ bladder associ correl diseas factor femal form case children clinic group includ format health improv mobil multipl patient perform function

report reveal sever studi tract life male phenotyp popul qualiti requir treatment urinari year risk studi treat treatment

21 169: Trichomonas Vaginitis (3) 170: Hyperhomocysteinemia (39)

approxim clinic dai effect genet associ bleed coagul factor folat homocystein leiden measur mthfr new plasma platelet reductas risk score studi thrombin hybrid isol major patient thrombosi venou vitamin

popul rat reduc reduct rel sever

strain symptom therapi treat treatment

171: Fatty Liver (52) 172: Liver Cirrhosis (120)

afp aim bile biliari bodi chronic cirrhosi correl duct afp aim bile biliari chronic cirrhosi duct express fibrosi fibrosi hepat hepatocellular hepatocyt hepatoma hepat hepatocellular hepatocyt hepatoma hepg2

hepg2 increas level liver methods portal liver methods normal patient portal tissu

173: Carcinoma, Transitional Cell 174: Neoplasm Invasiveness (659) (112) activ breast cancer carcinoma cell

bladder data determin evalu express invas lymph matrix metalloproteinas metastas metastasi metastat examin excret high includ mobil perform mmp node patient primari surviv tissu tumor phone report signific studi suggest

tract transit upper urin urinari

175: Oligodendroglioma (36) 176: Vera (34) analysi arsen astrocytoma brain control data gene acut aml associ blast bone cell chronic glioblastoma glioma grade includ indic malign cml imatinib increas leukaemia leukem

meningioma number patient primari leukemia lymphoblast mds secondari studi tumor mutat myeloid normal patient tissu

22 177: (25) 178: Porphyria, Acute Intermittent adult associ case cell (19) arthriti associ attack clinic diseas children develop diseas fever function gene joint methods migrain

famili function group member objective pain patient mice mutat patient process protein report rheumatoid sever studi tissu report risk role studi year

179: Myelofibrosis (46) 180: (69) acut aml blast cell chronic cml human analysi associ bleed coagul defici imatinib leukaemia leukem factor folat homocystein leiden leukemia lymphoblast mds mthfr patient plasma platelet reductas risk measur myelodysplast myeloid number studi thrombin thrombosi venou vitamin patient score studi

181: Trisomy (129) 182: Hematologic Neoplasms (127)

aberr abnorm analysi aneuploidi arm breakpoint case acut allogen associ cell clinic control dai donor

centromer chromosom graft human leukemia patient cytogenet del duplic invers karyotyp molecular mosaic rearrang region transloc trisomi recipi stem studi target therapi transplant treatment tumour

183: Colitis, Ulcerative (79) 184: Crohn Disease (124)

associ bowel chronic coliti colon associ bowel card15 chronic coliti

crohn develop diseas enter group ibd colon crohn diseas enter gastrointestin increas inflamm inflammatori gut ibd increas inflamm inflammatori

intestin methods mucos patient small intestin methods mucos small ulcer ulcer

23 185: Glaucoma (99) 186: Lymphatic Metastasis (408) anterior cataract chamber conclusions cancer carcinoma clinic correl dissemin disc examin glaucoma distant invas lymph metastas implant includ intraocular iol iop len methods ocular par perform studi surgeri visual metastasi metastat

node patient primari prognosi

prognost progress stage surviv tumor

187: Neoplasm Recurrence, Local (483) 188: Liver Diseases (93)

cancer clinic factor follow-up median month activ bile biliari caus chronic cirrhosi clinic differ function gene hepat hepatocyt hepatoma increas outcom patient poor prognosi measur normal studi tissu valu prognost rang receiv recurr relaps stage surviv liver therapi treat year

189: Leukemia, Lymphocytic, Acute 190: Biliary Tract Neoplasms (11) (147) cancer carcinoma chemotherapi acut aml blast chronic cml data estim group imatinib leukaemia leukem combin dai effect increas

leukemia lymphoblast mds marker new normal method myelodysplast myeloid patient sampl level syndrom patient respons studi surviv tissu toxic trial tumor tumour

191: Pancreatic Neoplasms (405) 192: Cocarcinogenesis (23)

adenocarcinoma beta-cel demonstr determin develop activ combin develop effect gene genet human ductal endocrin includ increas indic investig islet incid increas mice mous new provid rat normal observ pancrea pancreat resist risk studi transgen tumor year secret secretori studi suggest

24 193: Skin Neoplasms (595) 194: Language Development Disorders

basal case cell cutan epiderm epidermi (25) keratinocyt lesion melanocyt melanoma abil attent behavior behaviour mirna patient polymeras report rna rnase children cognit deficit differ disabl impair languag learn memori particip skin studi tumor uvb perform social subject syndrom task test

195: Periodontal Attachment Loss (5) 196: Periodontal Diseases (23) approach clinic compar control correl data activ caus chang cleft compar dental develop facial function design develop effect flow initi method group interact lead lip palat patient new normal patient report posit rate risk studi tissu signific studi test tissu

197: Periodontitis (43) 198: Dementia, Vascular (12) associ behavior brain clinic cognit cell cleft clinic compar control dental differ facial human lip molar control data diseas effect palat patient periodont high level low mechan memori polymorph risk studi subject teeth number perform risk select studi tooth treatment

199: Atrophy (86) 200: Shock, Hemorrhagic (7) associ brain case caus central chang activ assess dai dose effect group high level children control differ diseas disord earli low measur model multipl patient famili imag increas patient retin rat regul role score studi treat treatment studi treatment visual

25 201: Necrosis (167) 202: Retinoblastoma (78)

activ apoptosi apoptot cell dai arrest case cell children cycl death differ effect increas induc ligand necrosi cyclin gene genom group identifi kinas p21 p27 patient respons studi surviv tissu trail treatment patient phase progress prolifer studi tumor year tumor

203: Diseases (9) 204: Hypogonadism (29) adren adult analysi case children complex assist associ clinic combin cycl develop

genom hormon mutat patient pituitari region renal report reveal sequenc studi femal follicl gene group high thyroid time year

hormon mutat ovarian patient

pregnanc reproduct steroid studi women

205: Hypertension, Pulmonary (41) 206: Abnormalities, Multiple (541)

abnorm anomali associ case caus children ace arteri blood cardiovascular coronari diseas gene genet group human chromosom clinic congenit defect disord featur hypertens infarct myocardi patient pressur role malform mental patient rare report retard sever stroke studi treatment vascular syndrom

207: Hand Deformities, Congenital (50) 208: Incontinentia Pigmenti (6)

abnorm anomali associ case clinic congenit anomali case clinic complex congenit dai

famili identifi member organ defect disord distal dog famili gene hand patient period presenc report screen sever studi syndrom time tumour malform member mutat report retard segment syndrom

26 209: Hypertension (326) 210: Gingival Hyperplasia (5)

cluster correl dai data differ dose enhanc estim ace angiotensin blood cad arteri follow group mechan multipl patient cardiovascular carotid coronari plai radiat remain role signific suggest treatment hypertens infarct ischem ischemia myocardi patient popul pressur stroke vascular vein vessel

211: Neoplasms, Radiation-Induced 212: Diabetes Mellitus, Type 1 (244) (180) adipocyt adiponectin associ diabet fast associ beam dose effect expos exposur fraction glucos impair increas insulin mellitu metabol nod obes patient peroxisom ppargamma resist studi gamma increas ioniz irradi radiat subject toler radiation-induc radiosensit radiotherapi risk studi surviv x-rai year

213: Puberty, Precocious (15) 214: Adenoviridae Infections (24) activ adult associ case caus child childhood adenovir adenoviru analysi deliveri effect effici express gene inject isol patient strain children control develop femal therapi transduc transduct transfer transgen life male parent patient pediatr report role studi year vector viru vivo

215: Cystitis (9) 216: Polyomavirus Infections (28) activ analysi cell function gene hbv hcv hepat associ bladder control determin human infect patient popul replic examin famili human includ mobil respons sampl studi tumor viral viru patient report sampl signific virus studi suggest tract transit treatment urin urinari

27 217: Hemorrhage (66) 218: Heart Septal Defects, Ventricular associ case cell chang clinic control differ effect (17) factor folat normal patient analysi cardiac case platelet report respons sever studi tissu treatment year children clinic data develop diagnosi failur heart left model number parent sampl studi syndrom time ventricular year

219: Down Syndrome (160) 220: Endocardial Cushion Defects (1) abnorm associ birth case chromosom african american asian black caucasian diseas congenit control fetal gestat group infant ethnic european follow-up median month matern mother neonat patient patient popul preval race rang pregnanc prenat syndrom recurr south white year week women

221: Ductus Arteriosus, Patent (15) 222: Heart Septal Defects, Atrial (25)

associ cardiac case clinic genet health heart associ atrial cardiac high left low patient phenotyp process cardiomyocyt cardiomyopathi case children dilat repeat sever studi suggest syndrom time ventricular failur heart high hypertrophi left patient report right studi syndrom valv ventricular

223: Adenocarcinoma, Papillary (18) 224: Foot Dermatoses (13) analysi associ carcinoma case analysi case clinic diagnosi distal dog effect gene group model mutat number cluster diagnosi differ express gene measur patient pattern posit protein report patient produc product protein respons studi time tumour valu segment size skin time

28 225: Paraneoplastic Syndromes (12) 226: Acanthosis Nigricans (9) antibodi associ cancer case cell clinic analysi basal carcinoma case cutan epiderm epidermi featur keratinocyt lesion patient present psoriasi rare report reveal sever control correl detect develop express skin studi uvb malign patient presenc process

respons risk role studi tumour

227: Glycogen Storage Disease Type I 228: Neutropenia (156) (8) advanc cell chemotherapi combin cycl dai diseas docetaxel grade median month accumul analysi associ case caus cell control diseas effect express model month mutat patient phase rate receiv regimen patient reduc report reveal specif respons surviv toxic treatment treatment year

229: Sex Cord-Gonadal Stromal Tu- 230: Aortic Aneurysm (16) mors (4) associ cardiac case chang associ case cell combin compar differ effect featur group higher earli form format group heart

patient present rare rate rel human increas level new patient report studi treatment tumor valu rate report studi surgeri syndrom treatment

231: Heart Aneurysm (5) 232: Ventricular Dysfunction, Right (3) cardiac case characterist approxim cardiac case clinic correl diseas heart imag left major mutant normal observ

common complic delet featur patient rel sever signific stimul tissu ventricular form format heart life oper patient perform postop procedur qualiti surgeri surgic test

29 233: Diverticulum (4) 234: Ventricular Outflow Obstruction cardiac case children complic (10) earli enhanc heart lesion marker atrial cardiomyocyt multipl oper patient repeat cardiac cardiomyopathi case caus death dilat failur report stage stain studi suggest surgeri surgic heart hypertrophi left patient rel right risk sudden treatment valv ventricular

235: Arrhythmia, Sinus (4) 236: Bradycardia (13) clinic compar concentr control associ cardiac caus diagnosi differ evolut factor follow chang decreas diseas form format mice model pattern persist presenc repeat test time transcript function heart increas new normal oral provid rat repeat select studi subject syndrom tissu

237: Long QT Syndrome (65) 238: Nasopharyngeal Neoplasms (79)

addit confirm consist data demonstr earlier fail associ atp ca2+ calcium cardiac find furthermor indic nasopharyng npc observ phenotyp previou recent report channel current failur heart ion left patient repeat risk studi suggest work sodium syndrom test time treatment ventricular

239: Carcinoma (410) 240: Thrombocytopenia (88) associ blood case chemotherapi clinic combin associ cancer carcinoma case control dai diseas factor famili gene group cell correl express hcc hepatocellular respons sampl studi immunohistochem invas malign metastasi patient patient surviv toxic treatment progress scc squamou surviv tissu tumor

30 241: Epidermolysis Bullosa Simplex 242: Inflammation (414) (12) activ associ bowel chronic cytokin affect analysi associ cutan diseas epiderm function gene genet individu keratinocyt lesion diseas express factor function gene increas induc inflamm inflammatori level normal phenotyp mutat intestin mice patient respons reveal skin studi tissu role small

243: Apnea (9) 244: Infant, Premature, Diseases (25) anim associ clinic data differ function birth caus children correl develop group imag increas level fetal function gestat group model popul posit patient infant matern mother remain sampl studi therapi neonat new patient treatment trial pregnanc prenat week women year

245: Gastroesophageal Reflux (43) 246: Neurocytoma (4) associ common esophag frequent adult assai clinic detect italian mesothelioma correl includ investig diagnosi index level mechan neg neuron posit observ occur occurr patient relat relationship report sampl sensit signific possibl probabl relat report studi year

studi suggest transmiss transmit

247: Glioma, Subependymal (1) 248: Glioma (267)

arsen astrocytoma brain data examin gbm cell chain compar control data glioblastoma glioma grade includ indic malign differ frequenc higher literatur neuron pcr polymeras publish report revers review search primari reaction meningioma multiform signific primari secondari studi suggest temozolomid tumor

31 249: Graves Disease (39) 250: Adenocarcinoma, Clear Cell (41) activ adren allel associ common control analysi cancer carcinoma cell diseas frequenc gene genotyp haplotyp compar differ express hormon normal patient pituitari polymorph respons snp thyroid tissu function increas kidnei normal ovarian patient pattern rate renal studi surviv tissu tumor

251: Aortic Coarctation (13) 252: Hepatitis B, Chronic (85)

associ cardiac cardiomyopathi children failur featur capsid carcinoma chronic differ gene genotyp group follow heart individu left model hbv hcv hepat hepatocyt host infect liver patient region rel sequenc surgeri patient polymorph replic viral surgic syndrom ventricular year viru virus

253: Myasthenia Gravis (19) 254: Glioblastoma (196)

associ barrier clinic compar contact correl earli arsen astrocytoma brain data examin gbm express gap group iron junction number glioblastoma glioma grade includ indic malign

patient rate sampl studi meningioma multiform primari suggest treatment valu secondari studi suggest temozolomid tumor

255: Pituitary Neoplasms (72) 256: Adenoma (224) activ adenoma adren braf carcinoma endocrin adenoma adren apc cancer factor gland growth hormon human increas neuroendocrin papillari patient pituitari ptc ret carcinoma colon colorect crc gene hormon human instabl microsatellit mismatch msi pituitari polyposi ret thyroid tumor thyroid tumor

32 257: Nerve Degeneration (85) 258: Uterine Cervical Neoplasms (294) activ associ ataxia atrophi caus cell control associ cancer case cervic cin develop diseas disord expand expans cytolog detect hpv human infect human mechan model mice motor intraepitheli lesion neoplasia papillomaviru neuron progress rat posit progress signific squamou studi type

259: Papillomavirus Infections (133) 260: Helicobacter Infections (107)

adenocarcinoma aim associ cancer children erad associ cancer case cervic cin cytolog detect high-grad hpv human infect examin gastric gastrointestin intraepitheli lesion neoplasia papillomaviru helicobact infect intestin methods mucin mucosa pylori respect stomach studi ulcer posit signific squamou studi type

261: Familial Mediterranean Fever (52) 262: Epstein-Barr Virus Infections (77)

associ character characterist contribut correl differ arthriti associ attack chronic clinic displai distinct ebv epstein-barr exhibit identifi includ diseas fever headach inflammatori joint indic lack latent observ phenotyp knee methods migrain objective pain similar suggest

patient report rheumatoid sever synovi

263: Biliary Atresia (11) 264: Head and Neck Neoplasms (242)

absenc absent addit complet confirm data determin approach caus adult associ children examin follow head hnscc indic investig lack neck develop differ group hepat observ presenc reveal studi suggest

hepatocyt level liver new patient provid risk studi time transplant year

33 265: Precancerous Conditions (211) 266: Arthritis, Reactive (4) benign biopsi cancer carcinoma case detect class clinic diseas distal dog find frequent genet dysplasia evalu histolog histopatholog infect occur occurr pain patient plai report immunohistochem immunohistochemistri role segment sever studi suggest immunoreact immunostain lesion methods section specimen stain tissu

267: Spondylitis, Ankylosing (23) 268: Dengue Hemorrhagic Fever (6) activ arthriti assess associ class clinic area associ children differ factor field control differ diseas joint measur methods function genet genom pain rheumatoid role patient infect level patient score sever studi subject group popul sampl serum studi test valu viru

269: Infertility, Female (87) 270: Wounds, Penetrating (13) assist control cycl estradiol follicl case control follow group human injuri method model fsh hormon ivf ovari ovarian nerv patient presenc produc product report respons sampl studi techniqu patient pregnanc progesteron time treatment

reproduct steroid stimul studi

testosteron women

271: Communicable Diseases (32) 272: Retroviridae Infections (34) care clinic compar control develop activ cell chain earli function gene high hiv diseas health incid increas medic hiv-1 human immunodefici increas model practic provid rate research risk infect mice number reaction specif time viral servic studi women year viru

34 273: Lupus Erythematosus, Systemic 274: Stress (97) (137) associ attempt condit control differ epilepsi function includ increas involv model addit biolog contribut demonstr determin develop gener report respons seizur select stress studi suggest suicid erythematosu evid includ involv lupu major observ

possibl provid pten relev sle studi system

275: Autoimmune Diseases (156) 276: Optic Atrophy, Hereditary, Leber

alzheimer antibodi associ autoimmun caus cell common (26) case control cytochrom develop dna famili diseas disord effect famili gene group function identifi includ parkinson pathogenesi patholog patient progress gene tau mitochondri mitochondria mtdna mutat patient report retin retina role suggest visual

277: Vomiting (39) 278: Neoplasm, Residual (70) analysi cancer case chemotherapi clinic dai acut aml associ cell chain clinic detect

effect month patient phase leukemia month myeloid patient random rate receiv report respons studi toxic pcr polymeras quantit reaction real-tim treatment trial year revers sampl treatment year

279: Leukemia, Lymphocytic, Acute, 280: Acidosis (11)

L1 (65) acid amino anim associ clinic concentr control develop effect express group isol model mutat acut aml blast cell children chronic clinic cml control group imatinib leukaemia leukem new patient product rate studi time leukemia lymphoblast mds myelodysplast myeloid new patient

35 281: Uremia (6) 282: Vitreoretinopathy, Proliferative (7) compar concentr control cone data degener find macular mice optic correl differ evid growth higher pigment previou regul report retin increas level normal process rate serum signific size subject retina state studi suggest target time treatment visual support time tissu

283: Bacterial Infections (85) 284: Peritonitis (18) antibiot aureu bacteri bacteria biofilm chang associ case clinic compar concentr clinic develop diseas effect host diagnosi differ follow group higher human level mice month infect new parasit pathogen patient salmonella strain treatment virul patient rate report studi time year

285: Liver Cirrhosis, Alcoholic (5) 286: Cardiovascular Diseases (244) analysi compar control data differ estim arteri assess associ care carrier develop diseas factor health hypertens incid increas level function higher identifi patient rate repeat reveal role screen subject test patient popul pressur preval risk studi treatment valu variabl year

287: Pseudohypoparathyroidism (9) 288: Adrenal Insufficiency (14) adren case children clinic earli famili activ autosom bone caus children delet domin express famili fractur gene genet function gene hormon mutat individu inherit loss miner mutat osteoblast time vitamin patient pituitari risk role sever stage symptom test thyroid time

36 289: Addison Disease (7) 290: Retinitis Pigmentosa (67) associ clinic common compar control acuiti age-rel amd cone degener detach examin

function gene macular mutat optic patient diseas form format frequenc function gene group haplotyp inhibit patient polymorph requir sever snp symptom photoreceptor pigment retin retina rod vision visual

291: Epilepsy (171) 292: Leukemia, Erythroblastic, Acute

associ attempt condit eeg epilepsi follow gener (21) idiopath includ involv onset patient report respons activ analysi cell develop differenti earli stress-induc studi suggest seizur stress effect enhanc express gene high identifi suicid inhibit mutat number prolifer rate region screen sequenc

293: Hypercholesterolemia (57) 294: Liver Neoplasms, Experimental activ apoe apolipoprotein associ (71) cholesterol diseas effect increas ldl anim cell compar control effect famili hepat human increas inject liver mice model level lipid lipoprotein metabol mous tissu treatment tumor vitro patient plasma risk studi total triglycerid rat year vivo

295: Gilbert Disease (6) 296: Hyperplasia (116) algorithm dai gene identifi individu level biopsi case cell chang develop epitheli express histolog human immunohistochem liver method mutat network patient popul predict product region screen immunohistochemistri lesion mice sequenc sever state subject mous normal section specimen stain tissu transgen

37 297: Gastrointestinal Stromal Tumors 298: HIV Seropositivity (40) (74) area gene genet group health herp high c-kit case gastrointestin giant gist histolog hiv hiv-1 human hsp90 imatinib immunohistochem includ kit immunodefici infect low malign pdgf sarcoma soft model research sampl simplex studi viral stromal sts studi tissu tumor viru

299: Temporomandibular Joint Disor- 300: Oligospermia (58) ders (17) cryopreserv fertil freez fresh germ hors infertil male men motil normal patient semen area assess cleft analysi sperm spermatid spermatogenesi clinic data dental earli evalu facial lip spermatozoa test testi testicular measur new palat patient reveal role score structur studi

301: Radiation Injuries (180) 302: Leukemia, Pre-B-Cell (7)

beam biolog damag dose effect expos exposur acut adult bind characterist children fraction gamma ion ioniz irradi particl differ earli express featur gene leukemia patient pattern radiat radiation-induc radiosensit radiotherapi rai surviv x-rai phenotyp process rel respons stage valu year

303: Cell Transformation, Neoplastic 304: Diseases (11) (665) activ analysi caus cell cluster data

differ c-myc cancer carcinoma cell cellular develop express growth human induc malign myc gene human oncogen overexpress function increas mutat number organ patient plai progress prolifer promot role role structur studi transform tumor tumorigenesi

38 305: alpha 1-Antitrypsin Deficiency 306: Pulmonary Emphysema (14) (24) cancer chang clinic effect famili abnorm activ analysi anemia caus defect function genet group increas defici differ diseas famili lung member mice mous mutat normal patient reduc studi target tissu function hemoglobin level member new normal number respons sever treatment

307: Escherichia coli Infections (37) 308: Ovarian Failure, Premature (17) associ clinic cycl develop differ follicl associ bacillu bacteri bacteria coli data escherichia express function gene fusion gene hormon larg group isol method model operon phage protein select strain toxin number ovarian patient reproduct size small steroid studi treatment women

309: Chromosomal Instability (104) 310: Heart Diseases (86)

aberr abnorm analysi cancer cell cardiac cardiomyocyt chromosom colon colorect cardiomyopathi clinic compar data failur cytogenet delet differ gene human karyotyp loss rearrang region role telomer transloc function heart left new normal patient rate research risk studi tissu ventricular year

311: Fibrosarcoma (66) 312: Fetal Alcohol Syndrome (9)

activ analysi cell differ effect express gene group human increas invas malign matrix rat respons studi alcohol birth cell chang control depend effect fetal target vitro vivo tumor identifi infant matern model neonat oral pregnanc prenat risk studi test women

39 313: Prenatal Exposure Delayed Effects 314: Paresis (18) (79) children clinic control high human includ increas injuri method mutat number activ associ birth deliveri differ femal rang respons segment male patient fetal gestat infant select sever studi time year matern mother neonat pregnanc prenat rat risk studi week women

315: Spinal Cord Injuries (35) 316: Retrograde Degeneration (1) axon control cord demyelin follow group heal approxim assess avail compar injuri model myelin nerv data databas diseas evalu inform neuropathi oligodendrocyt patient peripher major measur minor observ regener sensori spinal trauma wound program rel scale score suggest tool valid

317: Cochlear Diseases (5) 318: Otosclerosis (4) anim auditori correl dai deaf develop ear auditori deaf design ear enhanc genet hair experiment genet group hair hear identifi hear hospit impair inner larg loss main impair inner loss model resist screen studi medic objective patient size small studi

319: Nevus, Pigmented (35) 320: Macular , Cystoid (24)

associ control develop elong includ melanocyt acuiti age-rel amd chang cone degener detach melanoma mirna number patient examin function macular methods optic polymeras ribozym rna rnase skin studi transcript treat treatment year patient photoreceptor pigment retin retina rod vision visual

40 321: Choroid Neoplasms (16) 322: Sleep Apnea, Obstructive (19) cell degener incid macular new associ bipolar case chang clinic correl number optic popul rate depress disord express gene level retin retina rna sampl test treat patient person psychiatr report serotonin sleep studi symptom time treatment valu visual women year

323: Snoring (6) 324: Airway Obstruction (24) assess caus children cluster combin depress airwai allerg case cftr disord effect impact improv level asthma

life new patient physic cystic data differ evid qualiti repeat sever studi test fibrosi group health hypothesi ige

provid pulmonari rate

respiratori studi support

325: Cervical Intraepithelial Neoplasia 326: Papilloma (26) (70) carcinoma case cell cervic compar control develop effect express group associ cancer case cin cervic human increas mice mous number rat cytolog detect high-grad hpv human infect intraepitheli lesion neoplasia papillomaviru signific studi treatment tumor posit signific squamou studi type

327: Nervous System Diseases (89) 328: Neoplasms, Second Primary (112) care caus clinic current data develop discuss acut breast cancer case develop follow-up incid leukemia median men month mortal diseas effect health patient present provid recent research sever studi patient preval rang rate recurr symptom target time risk women year

41 329: Complications (134) 330: , Spontaneous (55)

birth case deliveri fetal fetu associ birth deliveri fetal gestat fetus gestat infant matern group infant matern mother mother neonat newborn placent placenta neonat newborn pregnanc pregnanc pregnant prenat pregnant prenat rate risk studi time week respons week women women

331: Abnormalities (87) 332: Melanoma, Experimental (109)

abnorm birth congenit fetal genet gestat activ antitumor cell effect express growth human human infant matern mother neonat immun inhibit inject mice model mous murin pregnanc prenat report risk studi nude tumor vaccin vitro vivo syndrom week women year xenograft

333: Leukemia, Plasmacytic (7) 334: (261)

addit bortezomib combin convent data demonstr highli associ blood case cell cluster concentr data decreas enhanc express function gene includ multipl myeloma novel includ potenti provid result simultan singl studi suggest increas level support thalidomid multipl myeloma plasma serum singl

335: Mammary Neoplasms, Animal 336: Rectal Neoplasms (89) (65) adenoma apc cancer case chang associ cancer cell control e-cadherin effect chemotherapi colon colorect crc dai dose effect instabl microsatellit msi patient rate studi surviv tumor epitheli epithelium express gland increas

mammari mice model normal number rat role

studi tumor

42 337: Substance Abuse, Intravenous 338: Critical Illness (35) (15) care center clinic conclusions design group health hospit inform main medic alcohol associ care chang effect femal genom group objective particip patient record retrospect sever studi unit univers health increas infect male new oral research risk studi treatment trial viru

339: Gastroparesis (2) 340: Birth Weight (79) alter cancer care chang densiti earli event birth deliveri fetal fetu fetus follow gastric health high initi involv gestat infant matern mother level low occur particip phase process stage neonat newborn patient placent placenta pregnanc pregnant prenat twin week women

341: Skin Abnormalities (20) 342: Dehydration (28) abnorm anomali clinic congenit develop famili chang compar function gene high human includ mice mutat condit degre differ phenotyp protein report skin studi effect gene genet group health heat increas number observ plant popul time syndrom respons studi temperatur time

343: Rosacea (4) 344: Psoriasis (86) approach associ care case clinic confid associ basal cutan epiderm epidermi examin hair includ involv keratin keratinocyt lesion patient diagnosi inform interv particip person ratio pigment psoriasi skin studi topic report requir risk skin smoke studi ultraviolet uvb therapi treatment

43 345: Acne Vulgaris (9) 346: Myeloproliferative Disorders (67)

acut aml associ blast chronic cml differ assess chain children gene imatinib leukaemia leukem control detect differ diseas month leukemia lymphoblast mds patient pcr polymeras quantit myelodysplast myeloid normal patient studi tissu reaction real-tim revers role skin studi subject year

347: Mouth Abnormalities (12) 348: Adhesions (9) associ children clinic compar data analysi cell data develop evid evid factor famili hypothesi function group high increas method patient identifi interact low patient protein provid screen specif stress studi support treatment provid rate ratio risk support syndrom time valu

349: Pheochromocytoma (45) 350: Paraganglioma (14) adenoma adren analysi braf endocrin famili adren approach case cell data delet famili function gene genet gland hormon mutat genet hormon identifi papillari patient pituitari ptc ret gene mutat patient pituitari popul report role thyroid tumor tumour screen thyroid year

351: Adrenal Gland Neoplasms (51) 352: Meningeal Neoplasms (56) adenoma adren braf carcinoma case cell clinic astrocytoma brain case develop glioblastoma glioma diagnosi endocrin gland hormon human grade includ local malign meningioma month patient normal papillari patient pituitari ptc ret primari rate secondari studi thyroid tumor therapi treatment tumor

44 353: Meningioma (59) 354: Pancytopenia (13)

arsen astrocytoma brain case data express gbm associ case cell clinic control defect defici glioblastoma glioma grade includ increas indic develop differ diseas effect famili gene malign meningioma patient primari member patient product report secondari studi suggest studi therapi transplant

355: Metabolic Syndrome X (71) 356: Cerebral Infarction (30)

associ bodi control data activ arteri blood cardiovascular control coronari develop function group diabet factor glucos incid increas insulin men metabol mortal hypertens infarct myocardi popul preval risk studi syndrom patient pressur risk role stroke women year treat treatment vascular

357: Arteriosclerosis (194) 358: Diabetes Mellitus, Type 2 (381) apoe apolipoprotein arteri associ adipocyt adiponectin associ diabet fast blood cardiovascular cholesterol glucos impair increas insulin level mellitu metabol nod obes peroxisom ppargamma resist studi coronari genet hypertens increas subject toler level lipid lipoprotein plasma pressur risk stroke studi vascular

359: Celiac Disease (52) 360: Fibroadenoma (18) associ bowel chronic coliti colon control breast cancer case correl detect express form format high normal crohn differ gene ibd inflamm diseas number patient product protein rate report sampl inflammatori intestin methods mucos tissu tumour women patient small studi ulcer

45 361: Peripheral Nervous System Neo- 362: Prostatic Intraepithelial Neoplasia plasms (12) (18) activ clinic detect develop diagnosi famili case acid androgen associ cancer cell combin genet human lesion level plai posit process product human injuri neg normal patient progress prostat psa role stain tumor posit present rare report specif time tissu tumor

363: Gingival Hemorrhage (3) 364: Jaw, Edentulous, Partially (4)

associ care case cleft clinic compar correl growth adult analysi associ children cluster differ effect genet high level health higher lower palat patient phenotyp rate ratio report risk studi treatment low phenotyp posit rate studi test time variabl variat year

365: Metabolism, Inborn Errors (59) 366: Hyperoxaluria, Primary (12)

acid amino approach candid clinic defect defici bladder clinic data determin detect gene identif identifi includ mutat new novel patient program sampl diagnosi evalu examin excret includ mobil screen sever mutat perform phenotyp signific studi

suggest tract transit urin urinari

367: Hypersensitivity (68) 368: Hepatitis B (104)

activ airwai allerg allergen antivir capsid control genom hbv hcv hepat host infect infecti influenza liver new particl replic asthma cftr cystic diseas respons viral virion viru virus effect fibrosi function group ige pulmonari respiratori respons sever studi test ventil

46 369: Kidney Failure, Chronic (142) 370: Pre- (58)

associ chronic clear creatinin develop dialysi diseas deliveri fetu fetus failur glomerular health kidnei level nephropathi birth fetal gestat infant matern mother patient progress rcc renal studi tubul tubular neonat newborn patient placent placenta pregnanc pregnant prenat twin week women

371: Carcinoma, Lewis Lung (40) 372: Bone Neoplasms (235)

activ antitumor bear cell control effect enhanc bone c-kit cancer case cell express kit growth human inhibit inject mice model mous murin nude tumor vitro vivo lymph malign metastas metastasi metastat xenograft

node patient primari sarcoma soft stromal

studi tumor

373: Endometrial Neoplasms (121) 374: Genital Neoplasms, Female (33) ascit associ cancer compar endometri assess associ cancer clinic compar control epitheli eralpha estrogen examin genistein observ develop differ human increas measur

ovarian patient periton potenti normal ovarian patient rate serou signific studi suggest uterin studi therapi tissu treatment tumor

375: Maxillary Neoplasms (3) 376: Mesothelioma (71) adolesc autism boi child childhood common esophag esophagu find

children effect evolut follow frequent includ investig italian function girl initi manag origin parent pediatr mesothelioma observ occur primari reduc studi year occurr possibl probabl relat report studi suggest transmiss transmit

47 377: Pleural Neoplasms (42) 378: Severe Combined Immunodefi- common esophag esophagu find ciency (46) cell clinic combin diseas effect express frequent includ investig italian human improv mice model mous mesothelioma observ occur gene occurr possibl probabl patient therapeut therapi transplant treatment vector vitro vivo relat report studi suggest transmiss transmit

379: Genetic Diseases, X-Linked (53) 380: Lymphopenia (22) affect analysi autosom case caus clinic diseas disord domin famili gene genet activ associ blood cell clinic dai develop differ differenti earli express gene hereditari inherit mutat patient gener increas lymphocyt mice patient regul stage year recess report studi syndrom

381: Leukemia, Myelomonocytic, 382: Anemia, Hemolytic, Congenital Acute (14) Nonspherocytic (5) acut aml cell chronic combin dai effect follow assess caus defect defici famili gene high leukemia level low myeloid genet identifi level mean measur mechan patient posit protein rel time member molecular mutant mutat score screen valu variabl transplant variabl

383: Lymphoma, Mantle-Cell (54) 384: Lymphoma, B-Cell (248)

b-cell case chronic cll differ diffus hodgkin b-cell case chronic cll diffus follicular hodgkin igh immunoglobulin larg leukemia lymphocyt lymphoid immunoglobulin larg leukemia lymphocyt lymphoid

lymphoma malign nhl lymphoma malign nhl non-hodgkin patient rearrang rituximab t-cell non-hodgkin rearrang rituximab t-cell

48 385: Leukemia, Lymphocytic, Chronic 386: Parvoviridae Infections (17) (108) assai associ clinic detect differ gene acut b-cell case chronic cll diffus hodgkin immunoglobulin larg leukemia lymphocyt lymphoid infect isol model popul product replic respons sampl sensit strain treatment viral lymphoma malign nhl non-hodgkin patient rituximab t-cell treatment viru virus

387: Cytomegalovirus Infections (89) 388: Lymphoproliferative Disorders address appear clear cmv controversi (53) cytomegaloviru despit evid exist issu known lack larg major possibl question rais activ analysi associ b-cell case cell diseas donor function group human larg lymphocyt remain unclear unknown lymphoma mutat

patient phenotyp t-cell transplant tumour

389: Pregnancy Complications, Cardio- 390: Sagittal Sinus Thrombosis (2) vascular (16) acid amino case cohort distal dog associ birth chang differ factor fetal factor incid increas men mortal popul gestat infant matern neonat normal preval rate report risk segment patient pregnanc prenat syndrom women year ratio risk tissu treatment week women

391: Polycystic Kidney, Autosomal 392: Hyperuricemia (12) Dominant (42) analysi caus clinic cluster combin data

chronic clear develop dialysi differ diseas failur diagnosi differ diseas failur genet incid kidnei famili glomerular group kidnei nephropathi mutat patient pattern renal repeat studi therapi patient progress rcc renal studi test tubul tubular

49 393: Intestinal Pseudo-Obstruction 394: Hirschsprung Disease (39) (10) bowel chronic clinic coliti crohn develop activ case chronic clinic control diseas distribut featur health inflammatori intestin diagnosi diseas genet group increas local model patient regul report inflamm inflammatori intestin mucos mutat patient small studi ulcer small studi test time

395: Enterocolitis (5) 396: Lyme Disease (16) biolog case chronic diseas effect analysi cluster complement control defin demonstr inflammatori inhibitor intestin involv detect determin gener genom highli identifi isol mechan molecular protein reduc report resist studi system treat major natur patient specif strain uniqu util treatment understand

397: Gastrointestinal Diseases (40) 398: Wound Infection (4) chain clinic compar control dai data diseas analysi assai base case chain clinic cluster effect genet improv patient detect diagnosi differ dog isol random reaction respons risk studi test treatment trial year model organ pcr reaction segment sensit specif target

399: Germinoma (34) 400: Testicular Neoplasms (100) associ compar develop differ fertil germ higher cryopreserv express fertil germ hors infertil male men motil normal patient semen infertil male motil rate patient sperm spermatogenesi semen spermatozoa studi testi sperm spermatozoa studi testi testicular tissu testicular tumor tumour tumor

50 401: (75) 402: Zoonoses (28) activ adult associ case detect diseas genet breast cancer carcinoma case cell detect differ hcc hpv cervic express health includ individu human lesion posit specimen squamou stain human infect isol model popul risk select strain studi studi tissu tumor year

403: Hemangiosarcoma (14) 404: Neoplasms, Vascular Tissue (1)

activ case cell chang data effect estim antibodi assai cancer cell clinic detect evalu limit

malign method methods monitor patient express form format high increas malign plant protein sampl sensit specif test tumor

number patient rat studi tissu

tumor tumour

405: (23) 406: Cholangiocarcinoma (36) analysi associ case congenit control bile carcinoma cell chronic correl differ express effect examin factor gene genet influenc hepat hepatocyt human increas level mutat number patient report studi liver patient posit respons role treatment syndrom tumor tumour year tumor tumour

407: Bile Duct Neoplasms (37) 408: Carcinoma, Ductal, Breast (148) analysi associ bile cell chronic differ express gene adjuv aromatas breast hepat hepatocyt increas level liver cancer dcis differ ductal estrogen model new patient posit studi surviv tumor express hormon mcf-7 mda-mb-231 posit progesteron receptor statu studi tam tamoxifen women

51 409: Neuroblastoma (222) 410: Breast Neoplasms, Male (33)

activ analysi associ cell cultur deriv effect associ breast cancer case differ estrogen famili femal high human level male mcf-7 establish express human immort investig line mutat patient rate tamoxifen time women year neuroblastoma panel parent primari studi tumor vitro

411: Hodgkin Disease (151) 412: Aging, Premature (10) b-cell case chronic clinic cll diffus follicular hodgkin caus cell dna event form format gene immunoglobulin larg leukemia lymphocyt lymphoid human initi involv lead model new occur plai requir respons role step lymphoma malign nhl process non-hodgkin patient rituximab t-cell

413: Hepatitis A (9) 414: Hepatitis C (118)

capsid control differ hbv hcv hepat hepatocyt host associ case compar dai diseas differ infect infecti liver patient popul rate replic hepat increas isol liver patient risk test viral viru virus pattern polymorph posit rate risk studi treat treatment type

415: Lymphocytic Choriomeningitis (4) 416: Rubulavirus Infections (1) cell densiti differenti enhanc gene genet cell correl develop development infect earli grade higher includ index infect invers paramet high human level posit relat relationship signific statist studi viral viru light low mice mous protein regul target transgen viral viru

52 417: Influenza, Human (51) 418: Swine Diseases (43) care children earli gene hbv hcv health host anim breed calv individu infect new provid replic bovin cattl cow differ effect farm goat herd research stage studi viral viru virus year hous isol lactat milk pig porcin respect sheep strain

419: Halitosis (1) 420: Leptospirosis (9) aggreg american assess coloni control convers amplifi analysi assai case clinic detect develop differ dna fragment function differ ethnic evalu form isol pcr primer restrict healthi measur popul patient format sampl sensit studi test region scale score sequenc studi subject

421: Tachycardia, Supraventricular (1) 422: Tachycardia, Ventricular (30)

electr action chromosom correl effect analysi atrial cardiomyocyt increas linkag loci locu map potenti puls cardiac cardiomyopathi death dilat ecg failur famili record relationship releas respons rest heart hypertroph hypertrophi left signific stimul threshold myocyt patient right sudden valv ventricular

423: Ventricular Fibrillation (16) 424: Simian Acquired Immunodefi- ciency Syndrome (23) acid associ base cardiac cell effect gener group herp hiv hiv-1 cardiomyocyt cardiomyopathi caus clinic failur human immun immunodefici infect increas left mean measur heart model rel sampl simplex studi tissu vaccin viral viru model patient phenotyp rate valu ventricular

53 425: Encephalitis, Viral (12) 426: Hearing Loss, Mixed Conductive- analysi chang clinic Sensorineural (5) activ analysi data deaf design ear evalu featur hair control dai diseas effect function infect larg new hear impair includ inner investig loss patient phenotyp rate patient perform presenc reveal studi sever size small stimul treatment viru

427: Hearing Disorders (26) 428: Hyperlipidemia, Familial Com- assess auditori care children clinic deaf ear earli bined (8)

hair health hear impair inner life loss analysi apoe approach associ bodi method patient qualiti score year cholesterol data error estim express level lipid lipoprotein map

method plasma popul statist studi test

429: Carcinoma, Lobular (49) 430: Cleft Lip (101)

analysi associ breast cleft clinic craniofaci dental face cancer carcinoma case correl facial gingiv lip maxillari molar nasal estrogen express gene hcc mcf-7 neg patient posit rate squamou tamoxifen tumor women oral palat patient periodont perman studi syndrom teeth tooth

431: Vasculitis (24) 432: Hepatitis, Viral, Animal (7) antibodi case cell clinic compar analysi blot cell children compar control detect differ effect control diagnosi differ diseas express group individu effect high higher human normal liver local posit protein select specif patient rate report studi tissu treatment viru western

54 433: Coronavirus Infections (10) 434: Carcinoma, Non-Small-Cell Lung (552) acid analys analysi data differ function a549 adenocarcinoma alveolar cancer cell gene genom group increas infect isol patient perform reveal role strain studi chemotherapi compar includ lung non-smal viral viru non-small-cel nsclc observ patient pulmonari respect respons sclc small studi

435: Chorea (12) 436: Athetosis (3)

case chang clinic differ associ develop earli epilepsi gener larg late diseas famili function gene gener mice mutant onset patient phase progress seizur sever size small stage stress studi model mutat patient protein subject suicid report stress studi subject test

437: Dis- 438: Sleep Apnea, Central (6) eases (17) adult case caus decreas develop disord essenti genet hospit associ clinic cluster combin compar control develop effect express increas measur mice mutat higher injuri measur nerv number organ patient rel requir score studi year patient phenotyp rate studi subject time

439: Nervous System Neoplasms (13) 440: Leukemia, Megakaryocytic, Acute (18) analys correl effect gene high cell acut aml blast children chronic high

higher incid leukaemia human increas level malign model new leukemia low lymphoblast mds myeloid patient rate respons studi treatment year

normal select studi test tissu treatment

tumor tumour

55 441: Anemia, Sickle Cell (58) 442: Sleep Initiation and Maintenance

abnorm anemia blood case caus cell defect Disorders (6) adult approxim assess data depress detect defici disord epo erythrocyt erythroid erythropoietin genet group hemoglobin normal disord famili group identifi patient report sever major measur member phenotyp rel report

score studi treatment year

443: Hypoplastic Left Heart Syndrome 444: Dyspepsia (14) (8) adult assai cancer clinic correl detect evalu assai cardiac care case children function gastric gastrointestin correl defect detect failur manag mucosa pylori health patient function heart respect sensit stomach studi therapi year left mutant particip report sensit syndrom ventricular year

445: Acinetobacter Infections (9) 446: Blindness (58) care caus clinic concentr correl famili gene case cone degener earli examin health improv life macular methods optic patient physic pigment group health host infect isol pathogen qualiti retin retina studi visual year provid recombin region respons sequenc servic strain

447: Influenza in Birds (14) 448: Hypersensitivity, Delayed (20) avian bird chicken control data detect determin differ antigen cell clinic compar control dai diagnosi examin health human imprint includ indic differ effect group immun induc individu japanes studi suggest test viru patient respons signific studi test time trial vaccin

56 449: Haemophilus Infections (9) 450: Meningitis, Meningococcal (4) adult clinic diagnosi distribut high infect associ biolog children clinic develop isol larg local low number pathogen patient function genom human

sampl select size studi type year strain isol method mice mous repeat specif state strain studi system techniqu vector

451: Cholera (7) 452: Plague (10) adult bacteri clinic host identifi american analys analysi antibiot infect isol method new bacteri cell chang differ genom host older pathogen patient protein screen infect isol pathogen popul strain studi system techniqu young product respons reveal select year strain studi

453: Pneumococcal Infections (20) 454: Neurofibromatosis 1 (67) associ case chang character clinic differ genet identifi broad common describ divers exist includ increas infect isol mutat patient phenotyp known larg limit major nf1 numer patient resist sequenc strain studi type year rang repres spectrum type vari varieti wide

455: Friedreich Ataxia (22) 456: (21) abnorm ataxia atrophi caus clinic case cell chang clinic develop gene human level lymphoma mice multipl new diseas disord dysfunct expand expans gene huntington increas motor patient posit product report respons studi time tumor neuron patholog patient progress repeat studi

57 457: Leukemia, Myeloid, Chronic (175) 458: Cerebral Palsy (20)

acut aml bcr-abl blast cell chronic cml flt3 imatinib leukaemia leukem activ children clinic compar leukemia lymphoblast marrow control differ function mds myelodysplast myeloid patient relaps syndrom group higher incid model number parent patient rate report studi time treatment year

459: Parasitic Diseases (12) 460: Multiple Sclerosis (123) adapt area associ chines clinic complex data differ gene genet heterogen infect appear contribut examin extent find indic investig involv later model popul research sampl lesser mark multipl observ patient possibl sclerosi signific studi suggest select subject subtyp studi survivin

461: Hematologic Diseases (51) 462: Porphyria, Variegate (5) associ cell chemotherapi clinic data develop area associ case clinic concentr diseas form diagnosi diseas donor effect increas mechan format gene genet imag mutat number patient studi surviv patient present ratio report risk therapi transplant treatment tumour sever studi symptom

463: beta-Thalassemia (61) 464: Paraparesis, Tropical Spastic (4)

abnorm anaemia anemia caus common defect allel analysi cell data develop differenti diseas genet

disord epo erythrocyt erythroid defici genotyp includ mass method erythropoietin g6pd hemoglobin mutat normal human patient sever sickl studi

patient polymorph popul protein sampl state studi

58 465: Leukemia-Lymphoma, T-Cell, 466: HTLV-I Infections (22) Acute, HTLV-I-Associated (23) american analysi cell control develop c-myc cell cellular content differ express differ ethnic express group flow human induc malign myc oncogen human infect oncogen overexpress prolifer overexpress popul region sampl sequenc studi promot role studi transform transform viru tumorigenesi year

467: Respiratory Syncytial Virus Infec- 468: Enterovirus Infections (9) tions (19) base cell children clinic cluster assai case children detect gene genet human induc induct infect isol replic report respond develop genet human respons sensit viral viru virus year infect isol patient phenotyp popul region role sequenc strain viral viru year

469: Thyroid Neoplasms (276) 470: Diverticulum, Esophageal (2)

acth adenoma adren adrenocort braf carcinoma adult case cell chain differenti imag occur occurr older pcr cortisol endocrin follicular gland hormon polymeras prolifer quantit reaction report revers segment hyperplasia hypothyroid neuroendocrin papillari studi year young

pheochromocytoma pituitari ptc ret thyroid

471: Wounds and Injuries (76) 472: Glucosephosphate Dehydrogenase axon care cord data famili heal health Deficiency (36) abnorm anemia associ caus defect hospit inform injuri manag medic nerv neuropathi particip defici differ epo erythrocyt erythroid patient erythropoietin genotyp group hemoglobin human practic spinal studi wound normal patient polymorph sever valu

59 473: AIDS Dementia Complex (10) 474: Neurodegenerative Diseases (118) case differ distribut earli effect genet hiv-1 ataxia atrophi autoimmun caus cell differ infect late local patient pattern diseas disord expand expans famili includ phase phenotyp resist role select sever stage motor neurodegen neuron onset parkinson pathogenesi patholog progress viru

475: Dermatitis (22) 476: Osteoporosis (98) activ associ cell differ diseas genet alkalin associ bmd bone calcium densiti group includ level mice format fractur health hip miner new osteoblast

osteoporosi phosphat risk skelet spine studi number patient phenotyp vitamin popul rat rate respons risk skin studi

477: CADASIL (18) 478: Hereditary Motor and Sensory Neuropathies (14) abnorm analysi brain case caus associ axon caus cord demyelin fibr gene heal central cerebr chang cns cortex cortic find matter mutat nervou number region reveal treatment white injuri myelin nerv neuropathi oligodendrocyt patient peripher regener sensori spinal trauma wound

479: Foot Deformities (9) 480: Quadriplegia (5) canin case cat clinic distal dog associ base behavior case hand health increas left limb clinic dai design hospit mechan model patient proxim rabbit report molecular patient presenc present rare report risk sever studi symptom right segment studi tissu treatment

60 481: Langer-Giedion Syndrome (3) 482: Bone Diseases, Developmental adult behavior case clinic diagnosi (37) abnorm anomali associ bone case children express gene gener function clinic congenit control defect develop differ function group mutat patient report studi human incid normal patient present report syndrom system tissu women syndrom variabl year

483: Anoxia (137) 484: Keratosis (21) activ angiogen angiogenesi cell develop basal clinic cluster cutan diagnosi diagnost epiderm epidermi featur gene includ individu differ effect endotheli factor keratinocyt lesion mutat new organ provid group growth hif-1alpha human hypox uvb hypoxia hypoxia-induc studi vascular skin vegf vessel

485: Epidermodysplasia Verruciformis 486: Fetal Death (55) (1) birth deliveri develop fetal fetu achiev approach carcinoma cervic activ fetus gestat group infant matern data design direct evid hypothesi limit literatur mother neonat newborn placent placenta pregnant prenat period point provid publish strategi success pregnanc week women support time

487: Vitiligo (22) 488: Enchondromatosis (4) basal caus children cutan data diseas epiderm analys analysi cell data genet improv keratinocyt lesion life new differ

patient popul provid qualiti time skin form format length line long malign treatment

pattern protein repeat reveal short

studi treatment tumor tumour

61 489: Xeroderma Pigmentosum (33) 490: (15)

analysi atm base break case cell combin control activ analysi damag differ dna damag dna double-strand dsb excis gene enhanc express function gene group male increas lesion mutat patient repair strand mechan mutat pattern phenotyp repair repeat report studi syndrom

491: Cicatrix, Hypertrophic (3) 492: Sunburn (7) adjust assess associ care confid effect factor area compar distribut effect control gene health identifi increas individu interv odd famili frequenc identifi local member plai presenc reduc regul requir respons ratio risk screen smoke studi system role screen suggest therapi

493: Alopecia (48) 494: Hallervorden-Spatz Syndrome (4) associ caus chemotherapi clinic cutan develop area ataxia case caus characterist clinic diseas human keratinocyt lesion loss mice common defect diagnosi diseas disord featur gene imag motor mutant mutat patient rate respons skin studi toxic treatment trial patient volum wild-typ

495: Carcinoma, Intraductal, Noninfil- 496: Neoplasms, -Dependent trating (62) (62) activ androgen breast cancer cell associ breast cancer chang correl express increas mcf-7 patient progress psa respons role tamoxifen therapi treatment carcinoma case cell correl earli estrogen express factor prostat women mcf-7 normal number posit risk tamoxifen tissu tumour women

62 497: Brucellosis (12) 498: Lymphoma, Mucosa-Associated Lymphoid Tissue (32) activ adult anim assai bovin detect b-cell case chain cll diffus hodgkin human larg leukemia lymphocyt effect gene human incid mice lymphoma malign nhl patient product respons sensit test non-hodgkin patient pcr polymeras reaction rituximab studi treat treatment women year

499: Phenylketonurias (30) 500: Candidiasis (35)

approach candid children confirm control detect albican bud candida cerevisia fission function

identif identifi includ known larg new newborn novel perform potenti program group growth human isol mutant new patient screen search test

requir respons saccharomyc select strain

treatment yeast

501: Gastrointestinal Neoplasms (81) 502: Fungemia (10) analysi associ cancer chang clinic develop associ chain clinic design detect hospit human hybrid

identifi isol patient phenotyp sampl differ function gastric gene group new strain studi target test treatment tumor yeast

patient protein respons studi

therapi tissu treatment tumor

503: Cryptococcosis (12) 504: Chronic Disease (384)

case clinic collect detect differ effect assess bowel care chronic clinic control diseas group health inflamm inflammatori intestin function fungal fungi increas isol pathogen patient popul reduc respons measur methods patient servic small studi transplant treatment sampl select strain test

63 505: Vitamin D Deficiency (17) 506: Tuberculosis (69)

addit data defin demonstr directli african american children gener bone includ indic lead mycobacterium new patient possibl control defici differ ethnic increas level report repres result specif studi tuberculosi virtual osteoblast popul preval respons risk serum studi vitamin white year

507: Chondromatosis, Synovial (2) 508: Leprosy, Lepromatous (8) adult carcinoma case effect follow-up allel control featur gene gener median month mutat older patient present genet genotyp includ isol number protect rare recurr reduc reduct report polymorph popul rang recombin region transcript year young repeat respons sequenc test wide

509: Histiocytoma, Benign Fibrous 510: Liposarcoma (12) (24) adult c-kit case characterist common activ c-kit case cell common differ delet express featur gene genom includ kit normal number patient featur gene gist kit malign marker patient rare

report sarcoma soft stromal studi tumor sarcoma stromal tissu tumor year

511: Ventricular Dysfunction, Left (28) 512: Heart Failure, Congestive (98)

atrial cardiac cardiomyocyt american atrial cardiac cardiomyopathi clinic death dilat failur cardiomyocyt cardiomyopathi caus death dilat

heart hypertrophi left model ecg failur heart hypertrophi left myocardi myocyt patient right sudden myocyt patient popul right sudden valv trial valv ventricular ventricular

64 513: Seminoma (23) 514: Cystadenoma, Serous (8) activ analysi develop express fertil gene cancer case cell correl endometri germ human male normal patient estrogen high lesion level low normal product sampl sperm ovarian posit risk stain spermatozoa testi testicular tissu studi tissu tumor tumour valu treatment tumor

515: Granulosa Cell Tumor (9) 516: Pneumonia, Bacterial (8) children chines clinic correl dai detect adult anim case caus cell differ heterogen infect children chromosom famili femal patient respons select signific specif studi subtyp male model patient provid transplant treat treatment report risk specif studi year tumor tumour year

517: Community-Acquired Infections 518: Pneumonia (42) (12) assess cancer clinic dai design assess chain clinic cluster dai develop differ diseas effect evalu evalu health host infect isol hospit lung measur mice measur new patient reaction patient popul respons risk studi respons risk sampl score treatment strain studi

519: Neuromuscular Diseases (22) 520: Vision Disorders (103) activ associ clinic correl develop diagnosi acuiti analysi case clinic conclusions cone differ diseas exercis famili gene genet degener examin macular methods optic group muscl number signific skelet smooth studi test patient phenotyp photoreceptor pigment

retin retina studi vision visual

65 521: Choroid Diseases (17) 522: Retinal Diseases (97) activ case clinic cone degener featur acuiti age-rel amd conclusions cone degener macular methods mutat optic detach examin macular methods optic patient photoreceptor pigment patient photoreceptor pigment retin region retin retina select sequenc retina rod rpe vision visual sever visual

523: Cushing Syndrome (10) 524: Sinus Thrombosis, Intracranial (4) adren associ cell enhanc hormon identifi acut associ case clinic diagnosi earli imag increas male normal number event involv occur phenotyp pituitari number patient patient present process respons screen specif thyroid tissu ratio risk sever stage step symptom tumour syndrom

525: Histiocytosis, Non-Langerhans- 526: , Systemic (42) Cell (30) analysi biolog case cell control acut allogen allograft autolog cluster condit diseas cultur develop differ effect examin factor fibroblast group growth observ

donor follow graft group hematopoiet patient studi suggest system tissu immunosuppress patient receiv recipi reject stem

surviv transplant

527: Lymphoma, Non-Hodgkin (207) 528: Cerebellar Ataxia (36)

b-cell case chronic cll diffus follicular hodgkin abnorm ataxia atrophi base case caus immunoglobulin larg leukemia lymphocyt lymphoid children clinic diseas disord lymphoma malign nhl expand expans gene motor mutat pair non-hodgkin patient rituximab t-cell treatment patient progress report role

66 529: Osteonecrosis (13) 530: Retinal Degeneration (81)

bone compar control differ follow gene acuiti age-rel amd blind cone degener detach health month multipl organ group examin famili macular methods optic patient process report signific singl studi time treatment year photoreceptor pigment retin retina rod rpe vision visual

531: MPTP Poisoning (3) 532: Parkinsonian Disorders (42)

assai compar control detect alzheimer autoimmun caus common diseas disord effect gene group motor mutat neuron onset parkinson pathogenesi patholog patient progress tau differ famili high human treatment larg level low member model popul receptor sensit size small studi subject

533: (54) 534: Bardet-Biedl Syndrome (12) acuiti age-rel amd blind cone degener detach abnorm caus correl diseas disord evid

differ examin macular methods optic form human identifi mechan photoreceptor pigment retin retina molecular motor mutat new rod rpe vision visual phenotyp provid repeat sequenc support syndrom

535: Canavan Disease (10) 536: Embolism (5) accumul activ analysi data diseas famili arteri assai case combin detect effect hypertens

larg method number gene hospit mice mutant new patient pressur rat reduc report select sensit size small studi patient perform report sampl

studi suggest test treat treatment

67 537: Dilatation, Pathologic (33) 538: Carotid Artery Injuries (5) associ case clinic control corneal correct control dai diagnosi differ imag mean measur methods case cell differenti express factor follow gener patient perform report sampl growth inhibit interact mice mous studi surgeri surgic syndrom point prolifer report subject time tumour

539: Myocardial Ischemia (65) 540: Pleural Effusion (17) clinic control detect esophag ace activ arteri blood cardiac cardiovascular coronari effect gene frequent includ investig italian heart hypertens incid infarct occur occurr ischem ischemia myocardi pressur patient possibl probabl relat stroke vascular year report studi transmiss transmit treatment valu

541: Esophageal and Gastric Varices 542: Gastrointestinal Hemorrhage (35) (3) case caus chain children clinic control dai differ effect factor gastric hospit increas mutat blood compar control dai differ group patient reaction report sever studi liver mean new number patient year provid ratio resist respect risk signific system treatment valu

543: Salivary Gland Neoplasms (42) 544: Jaundice, Obstructive (7)

basal carcinoma cell delet develop differ activ associ case caus combin e-cadherin epitheli epithelium hepat high includ lead level express gene gland loss mammari normal number patient role salivari tumor liver low mechan patient point rang select sever time wide

68 545: Common Bile Duct Neoplasms (8) 546: Neurofibroma (9) cancer carcinoma case clinic colorect broad case cell common describ divers

control delet express high level low featur includ larg limit major patient rang report repres size spectrum type patient posit prognost protein varieti wide report signific studi subject surviv

547: Abnormalities, Drug-Induced (34) 548: Waldenstrom associ birth chang children data develop (25) b-cell case cell cll cluster condit degre group hodgkin initi larg leukemia lymphocyt effect fetal function group matern lymphoma malign nhl number pregnanc process rat rate risk size non-hodgkin patient rituximab studi studi syndrom

549: Nausea (35) 550: Pleurisy (4) advanc chemotherapi combin cycl dai analysi assai blot cancer case cell dose grade group level median clinic detect diagnosi diagnost evid patient phase receiv regimen form format presenc present respons surviv toxic treatment trial week provid report respons sensit support

551: Lung Diseases (84) 552: Eosinophilia (20) asthma cancer case cell clinic data develop case chang clinic diagnosi enhanc famili fibrosi function health includ lung famili group leukemia member mutat number patient present report respons role new nsclc patient pulmonari sever studi studi subject system treatment treatment

69 553: Graft vs Host Disease (127) 554: Tenosynovitis (2)

acut allogen allograft autolog condit diseas donor adapt approach associ data event follow graft gvhd hematopoiet immunosuppress patient experi includ involv natur organ possibl

receiv recipi reject sct stem surviv process rang remain report select

transplant step studi treat treatment

555: Blood Group Incompatibility (13) 556: Carcinoma, Basal Cell (62) associ basal carcinoma cell control cutan blood circul cluster compar count differ epiderm epidermi human keratin keratinocyt donor group lymphocyt normal lesion pigment psoriasi studi peripher region respect sequenc signific studi skin treatment tumor ultraviolet uvb subtyp test tissu transplant

557: Adenovirus Infections, Human 558: Urologic Neoplasms (23) (29) adenovir adenoviru deliveri effici express activ bladder clinic data gene genom human inject isol number retrovir strain therapi transduc transduct determin diagnosi evalu examin high

transfer transgen vector vivo includ mobil mutat patient

signific studi tract transit treatment urin urinari

559: Gastritis (26) 560: (40)

adenocarcinoma aim cancer differ abnorm anomali associ case children clinic

gastric gastrointestin gene helicobact infect intestin methods mucin mucosa congenit control defect disord featur genet level patient pylori respect stomach studi subject ulcer

malform mental report retard studi subject syndrom

70 561: Coccidioidomycosis (3) 562: Hypoglycemia (39) associ case caus chang children clinic control assai clinic collect decreas detect diabet differ effect glucos insulin level diagnosi gene hybrid increas level mice mous mutant respons patient rat rate report sever studi year sampl sensit specif test transgen tumor

563: Carcinoma, Papillary (111) 564: Barrett Esophagus (45) adenoma adren braf carcinoma cortisol common esophag find differ endocrin express genom gland hormon neuroendocrin normal papillari pituitari ptc ret frequent group includ investig italian mesothelioma observ occur studi thyroid tumor occurr possibl probabl relat report studi suggest transmiss transmit

565: Amyotrophic Lateral Sclerosis 566: Neural Tube Defects (59) (80) case cell chang develop effect als appear contribut examin embryo embryon express factor gene extent find indic investig involv later genet increas mous neural pattern rate lesser mark observ possibl sclerosi risk studi test zebrafish signific sod1 studi suggest survivin

567: Meningomyelocele (6) 568: Wasting Disease, Chronic (4) allel anim bovin breed code codon dai gene behavior children defici genotyp human length milk model pig develop earli factor featur polymorph product repeat short individu larg mutant parent plai popul studi substitut risk role size small stage suggest valu

71 569: Myopathies, Nemaline (6) 570: Choreatic Disorders (11) distribut environment express factor ataxia atrophi caus differ diseas disord expand expans famili higher includ member motor gene genet influenc local muscl mutat progress protein mutat plai recombin role skelet structur patient rate stress treatment studi suggest time trait variat

571: Carcinoma, Pancreatic Ductal 572: Adenocarcinoma, Mucinous (31) (50) associ cancer carcinoma case cell correl

adenocarcinoma beta-cel demonstr determin develop develop differ express gastric high ductal endocrin includ increas indic investig islet increas level patient rate normal observ pancrea pancreat signific studi surviv tissu tumour secret secretori studi suggest

573: Pulmonary Disease, Chronic Ob- 574: Candidiasis, Vulvovaginal (9) structive (64) cerevisia chang clinic express genet airwai allerg allergen associ asthma cftr control cystic diseas effect fibrosi gene isol model patient period

genotyp human ige patient point posit produc product resist polymorph pulmonari respiratori studi saccharomyc strain studi time treatment yeast

575: Gram-Positive Bacterial Infections 576: Endocarditis, Bacterial (12) (17) activ adult antibiot bacteri combin group antibiot aureu bacteri bacteria case clinic gene high host infect level low measur model host infect isol model parasit parasit pathogen patient respons pathogen patient resist salmonella sequenc strain studi year strain treatment virul

72 577: Hypersensitivity, Immediate (26) 578: Keratoconus (19) aberr ablat conclusions cornea airwai allerg analysi associ corneal correct asthma cftr cystic develop evalu examin gene mean measur methods myopia ocular perform refract diseas develop famili fibrosi studi thick visual human ige includ number patient pulmonari respiratori risk studi

579: Huntington Disease (116) 580: Aortic Aneurysm, Abdominal (33) abnorm ataxia atrophi caus clinic degener abdomin aneurysm case complic flap diseas disord dysfunct expand manag oper patient perform expans genet huntington inclus motor postop preoper procedur reconstruct remov neuron onset patholog progress test resect surgeri surgic techniqu underw

581: Thromboembolism (38) 582: Chromosome Disorders (51) aberr abnorm analysi case associ bleed coagul factor folat homocystein leiden mthfr patient plasma chromosom cytogenet platelet protein rate reductas resist risk studi data delet differ domin famili gene genom increas karyotyp mutat number rearrang thrombin thrombosi venou syndrom transloc

583: Coronary Disease (130) 584: Lymphoma, AIDS-Related (23) arteri associ blood cardiovascular analysi associ b-cell case cell group hiv cholesterol coronari data estim genet hiv-1 infect lymphocyt hypertens increas level lipid method lymphoma patient patient pressur risk stroke phenotyp reveal risk studi therapi treatment studi vascular tumour viru

73 585: Sarcoma, Kaposi (46) 586: Fragile X Syndrome (69)

activ associ case cell develop differ abl addit chimer chimera complet consist construct contain demonstr fragil fuse

human increas infect kit fusion indic lack observ partial replac report result suggest patient rate replic sampl sarcoma stromal

studi tumor viral viru

587: Pemphigus (14) 588: DiGeorge Syndrome (27)

assai case children control cutan detect abnorm anomali associ behavior caus children develop factor gene genet growth high

keratinocyt lesion low role sensit skin congenit defect delet differ disord famili human studi test

malform mental patient report retard sampl syndrom

589: Behcet Syndrome (23) 590: Encephalopathy, Bovine Spongi- form (13) allel arthriti associ clinic compar control differ diseas frequenc gene genotyp increas anim bovin breed cattl joint level pain patient cow differ diseas effect includ lactat milk polymorph signific studi subject model normal patient pig porcin product sheep studi tissu

591: Connective Tissue Diseases (15) 592: Xanthogranuloma, Juvenile (5)

antibodi biolog case clinic cluster compar develop associ cell child children clinic cluster data develop diagnosi differ diseas express famili initi normal distribut famili femal includ local male parent rel therapi treatment year origin second studi subject system test tissu

74 593: Herpes Zoster (17) 594: (22) adult effect group hiv hiv-1 basal case children cutan differ epiderm epidermi follow gene group keratinocyt lesion immunodefici increas mutat number report skin studi treat incid infect treatment uvb

men mortal patient popul preval

studi subject viral viru women year

595: Lichen Sclerosus et Atrophicus (4) 596: Scleroderma, Localized (5) case characterist child childhood biolog case clinic data diagnosi featur includ inform literatur new organ present children common compar provid publish report respons review decreas featur genet higher increas lesion search system therapi mechan molecular mutat parent rate skin year

597: Lupus Erythematosus, Cutaneous 598: Uterine Hemorrhage (11) (6) associ biolog control correl develop cancer case clinic control diagnosi diagnost differ effect factor group increas method express femal function includ increas male ovarian patient report respons risk role studi women

patient pten respons role signific skin

specif studi system

599: Synovitis, Pigmented Villonodular 600: Malaria, Falciparum (68)

(5) carri compar comparison consid differ evalu exact analys analysi case cell

diagnosi differenti distribut fluid indic falciparum fisher hypothesi malaria parasit perform local morpholog number plai present prolifer rare report reveal role suggest

plasmodium posit signific standard statist studi test

75 601: Malaria (77) 602: Fever (77) carri compar control differ drosophila evalu exact blood case clinic condit dai data degre diagnosi dose effect model

falciparum fisher genet hypothesi malaria parasit patient present report sever studi symptom syndrom temperatur test

perform plasmodium popul signific statist studi test

603: Parasitemia (14) 604: Cataract (139) anim clinic data develop differ effect estim famili genet anterior capsul cataract chamber conclusions disc examin glaucoma

human hypothesi model patient perform sampl implant includ intraocular iol iop len methods par perform studi surgeri signific speci statist studi test visual

605: Amblyopia (15) 606: Vision, Low (11) assess caus data estim femal function analysi assess case children high higher male measur method correct evalu famili group high measur methods patient rate report respons particip patient popul rate respons retin score treatment visual retin risk studi treatment visual

607: , Bovine (22) 608: Malaria, Cerebral (4)

children differ distribut anim bovin breed calv associ cattl cow differ effect farm goat herd enhanc famili form format group local new polymorph popul respons hous lactat milk pig porcin respect select sheep signific select specif studi test time tumor

76 609: alpha-Thalassemia (34) 610: Tumor Virus Infections (65) abnorm anemia associ caus defect associ cancer case cell cervic control detect

defici disord epo erythrocyt erythroid express hbv hcv hpv human erythropoietin function g6pd hemoglobin identifi level patient replic studi tumor viral mutat normal sever studi infect viru virus

611: Mycosis Fungoides (13) 612: Lymphangitis (1) analysi b-cell base cell chang express famili gene level lymphoma member method care commun educ health includ inform medic need nurs particip practic profession program provid public rang servic normal patient product reveal student survei wide sampl sequenc studi tissu

613: Lymphedema (31) 614: Elephantiasis, Filarial (7) canin cat clinic deform develop distal dog area base care caus commun correl develop

hand later left life limb mutat educ express health increas infect need nurs program public region sequenc servic student patient proxim qualiti rabbit

rate right segment

615: Choroid Plexus Neoplasms (8) 616: Adrenal Hyperplasia, Congenital adult carcinoma case chromosom clinic (45) delet diagnosi earli famili high interact gene activ adenoma adren braf endocrin femal form low morpholog mutat primari protein report treatment year format gene hormon human male mutat

papillari patient pituitari ptc ret

sampl thyroid

77 617: West Nile Fever (23) 618: Dengue (12) detect differ gener hbv hcv health hepat host area develop differ drosophila individu infect number popul replic risk

select specif studi viral viru virus effect express gene genet identifi infect

level patient popul protein

replic serum speci studi viral viru

619: Arachnoid (8) 620: (51) associ case complic increas abnorm anomali associ case caus clinic congenit manag model oper patient perform

postop preoper procedur report resect defect disord featur malform mental patient rare studi surgeri surgic treatment underw year report retard sever surgeri surgic syndrom

621: Brain Edema (11) 622: Citrullinemia (2) acut associ brain case clinic dai bodi case control dai dose elev factor healthi develop effect human imag mice higher level measur plasma presenc risk serum studi subject treat treatment weight patient present report sever specif studi suggest symptom treatment

623: Hermanski-Pudlak Syndrome (15) 624: Breast Diseases (21) associ biolog develop differ function gene human includ involv mutat normal patient breast cancer chang product protein pten role studi syndrom clinic compar control correl diagnosi differ featur group high normal patient sampl signific tamoxifen tissu treatment women system tissu

78 625: Agammaglobulinemia (12) 626: Arthritis, Juvenile Rheumatoid

activ adult case cell chang gene genet mutat (22) arthriti associ clinic control diseas fever normal older organ patient gene genet group joint methods pain phenotyp popul protein role select tissu year young patient popul rate rheumatoid sever studi system year

627: Pericarditis (3) 628: Intracranial Arteriovenous Malfor- area cell chronic compar data differ differenti mations (12) diseas featur follow gene higher incid initi associ brain case clinic control lower number origin versu women rate develop effect find genet local model patient present report select studi suggest syndrom treatment valu

629: Insulin Resistance (191) 630: Glucose Intolerance (35)

adipocyt adiponectin associ bodi diabet associ compar control diabet fast fast glucos impair increas insulin mellitu glucos higher increas insulin level mellitu metabol nod obes peroxisom ppargamma resist studi metabol obes peroxisom rate ratio risk studi subject toler subject toler

631: Agricultural Workers’ Diseases (6) 632: Hypophosphatasia (10) area care caus clinic differ diseas exposur adult bmd case earli fractur group health lead normal number bone gene miner mutat normal osteoblast patient period point rate risk sampl patient popul report respons studi time tissu vitamin year time tissu

79 633: Sleep Apnea Syndromes (10) 634: Hypercapnia (7) activ analysi case data differ disord effect alter chang compar decreas earli function estim group method model new group increas larg level mice provid reveal signific studi therapi time number organ phenotyp rate respons treatment variabl sequenc size studi year

635: Muscular Dystrophy, Animal (17) 636: Hyperventilation (2)

compar contract control dystrophi effect exercis asthma cell children compar fiber gene higher human mice model control cystic differ dna fibrosi muscl muscular myopathi rate skelet fragment frequenc healthi higher muscl parent smc smooth target signific studi subject vitro vivo

637: Deafness (105) 638: Muscular Dystrophy, Duchenne

abnorm auditori bilater canal caus children cochlear (83)

contract dmd dystrophi dystrophin exercis fiber gene deaf ear find hair hear impair inner loss middl normal sensorineur syndrom vestibular muscl muscular myoblast myogen myopathi neuromuscular perform skelet smc smooth strength train weak

639: Vitamin B 12 Deficiency (13) 640: Mitochondrial Myopathies (22)

adult associ case control defici develop chang combin control cytochrom deplet dna indic factor famili function group increas involv membran mitochondri mitochondria mtdna mutat number oxidas level mutat new patient provid patient potenti reveal suggest treatment risk studi tissu year

80 641: Muscular Dystrophy, Facioscapu- 642: Arrhythmia (61) lohumeral (12) atrial cardiomyocyt clinic correl diagnosi diseas dystrophi earli exercis cardiac cardiomyopathi caus death dilat diseas failur famili featur fiber identifi muscl muscular protein role size skelet smooth studi function gene genet group heart test hypertrophi left right studi valv ventricular

643: Cardiomyopathy, Hypertrophic 644: Hyperandrogenism (10) (41) associ case caus chang combin

analysi atrial cardiac differ gene genet genom cardiomyocyt cardiomyopathi caus death dilat high hormon lead level mutat patient pattern popul steroid tissu women failur famili genet group heart hypertrophi left myocyt right sudden valv ventricular

645: Oligomenorrhea (1) 646: Reperfusion Injury (53)

acid affect amino associ autosom caus character activ blood chang disord domin ebv exhibit famili gene arteri coronari effect enhanc express identifi inherit mutat gene group hypertens phenotyp recess similar suggest increas infarct pressur rat sampl stroke studi time vascular

647: Ataxia (42) 648: Nystagmus, Pathologic (12) abnorm ataxia atrophi caus clinic degener case caus clinic control corneal correct data famili function gene group loss diseas disord dysfunct expand expans huntington includ inclus motor methods model patient sever mutat neuron onset patholog progress studi subject time treatment

81 649: Anuria (3) 650: Mitochondrial Encephalomy- opathies (10) blood case caus dai dose experi gene imag initi lead origin patient plai presenc autosom case clinic diagnosi diseas domin famili gene increas inherit mitochondri present rare renal report role second model mtdna mutat patient protein respons role state test

651: Spinocerebellar Ataxias (53) 652: Fanconi Anemia (45) abnorm ataxia atrophi caus clinic degener abnorm activ anemia associ caus control defect

diseas disord dysfunct expand defici differ erythroid group hemoglobin normal patient risk role sever studi expans huntington inclus motor transplant tumour neurodegen neurolog neuron onset patholog progress

653: Glaucoma, Open-Angle (63) 654: Retinal Neoplasms (71) anterior cataract chamber conclusions arrest associ case children clinic disc examin glaucoma group cell cycl cyclin express famili number p21 implant includ intraocular iol patient phase progress report retin studi treatment visual iop len methods par perform studi surgeri visual

655: Osteochondrodysplasias (59) 656: Macular Degeneration (149) acuiti age-rel amd conclusions cone degener bone case characterist children clinic common develop factor detach examin human macular methods optic featur gene growth human photoreceptor pigment retin retina individu mutat patient rod rpe vision visual

report studi syndrom vitamin year

82 657: Carcinoma, Mucoepidermoid (12) 658: Carcinoma, Acinar Cell (6) carcinoma case cell correl differ carcinoma cell differ epitheli express form format mechan method neg e-cadherin epitheli epithelium number pancreat pattern plai express gene gland high low mammari pattern phenotyp posit test tumor tumour posit role secret studi suggest tumor

659: Carcinoma, Adenoid Cystic (20) 660: Brain Ischemia (64)

analysi carcinoma case cell ace activ angiotensin arteri blood chang differ evid express famili featur genet cad cardiovascular cell coronari group hcc number patient posit squamou hypertens infarct ischem ischemia support tissu tumor myocardi pressur stroke studi vascular vein vessel

661: Anemia, Diamond-Blackfan (8) 662: Burkitt Lymphoma (57) abnorm anemia anim caus cell children defect activ analysi b-cell case cell cll express famili group larg lymphocyt defici differenti diseas earli hemoglobin mechan model normal produc lymphoma malign nhl product sever stage treatment non-hodgkin patient phenotyp rate respons studi

663: Neoplasm Circulating Cells (47) 664: Blood Coagulation Disorders (32) associ bleed case children differ effect assai blood cancer cell circul count detect determin donor evalu healthi human factor folat function group homocystein increas mthfr platelet lymphocyt multipl patient peripher patient report studi thrombosi venou sensit specif test tumor risk

83 665: Protein C Deficiency (13) 666: Thrombosis (85) associ base bleed case combin defect defici associ bleed case clinic coagul control factor folat form identifi mthfr mutat factor folat group homocystein patient platelet protein risk role screen venou mthfr patient plasma platelet risk studi thrombin thrombosi treatment venou

667: Protein S Deficiency (11) 668: Venous Thrombosis (98) activ approxim case combin differ factor associ bleed coagul famili identifi member factor famili group fibrinogen folat homocystein leiden mthfr patient plasma platelet reductas risk studi platelet protein rel respons risk role thrombin thrombosi venou vitamin state studi subject test

669: Hepatitis, Toxic (16) 670: Anemia, Sideroblastic (12)

area chang combin dai dose effect anemia caus defect defici diseas express follow group hepat earli gene high increas level low month mutat normal number patient stage liver model product rat respons structur subject treatment sampl specif studi time week

671: Blast Crisis (41) 672: Leukemia, Myeloid, Philadelphia- acut aml associ blast cell chronic cml Positive (43) combin correl imatinib leukaemia leukem acut aml bcr-abl blast chronic cml flt3 imatinib leukaemia leukem leukemia lymphoblast mds myelodysplast myeloid patient syndrom leukemia lymphoblast malign time marrow mds myelodysplast myeloid patient relaps syndrom

84 673: Herpesviridae Infections (47) 674: Sepsis (55) activ control detect differ genom group hbv hcv acut case caus clinic complic effect group hepat infect patient phenotyp protein region human infect manifest mild patient replic sequenc studi viral viru virus present role sampl select sever sign studi symptom

675: Oropharyngeal Neoplasms (12) 676: Coccidiosis (15) activ associ carcinoma case event function antibodi associ chicken clone control data involv mechan molecular detect differ estim gene human increas patient presenc process ratio individu isol method popul risk studi surviv tissu treatment tumour sequenc strain studi test valu

677: Poultry Diseases (56) 678: Dermatitis, Allergic Contact (15) appear avian bird chicken data determin differ examin blood clinic compar control detect high imprint includ indic individu investig isol japanes similar strain studi suggest diagnosi differ mean model

patient presenc produc product respons

select skin studi test time valu

679: Color Vision Defects (21) 680: Calcinosis (76) acuiti clinic cone degener famili function analysi arteri bone case children gene light macular model mutat number famili fractur gene hypertens imag miner model mutat osteoblast patient pressur report optic photoreceptor pigment retin studi vitamin year retina role vision visual

85 681: Pulmonary Valve Stenosis (5) 682: Cartilage Diseases (6) approxim base case chromosom clinic data diagnosi diseas domin famili featur mutat affect alter chang clinic diagnosi famili health increas interact loss mechan number observ pair patient rel risk select syndrom model mutat patient phenotyp region rel sequenc syndrom treatment

683: Dermatitis, Seborrheic (4) 684: Dermatitis, Occupational (3)

anim case core develop distribut drosophila establish experiment exposur indic keratinocyt local activ care character contain core encod frame health model open report requir skin effect structur studi syndrom identifi inform open orf particip person protein put read reduc relat

685: Growth Disorders (177) 686: Retinal Hemorrhage (11) abnorm adolesc anomali autism case child childhood case caus chang conclusions children congenit defect factor control design diseas high hospit growth igf-i insulin-lik parent pediatr low patient period report retin specif report retard syndrom year studi subject time visual year

687: Vitreous Hemorrhage (9) 688: Eyelid Diseases (21) adult case children conclusions control design aberr case children clinic conclusions diseas earli hospit main medic methods month corneal correct diagnosi evalu featur mean measur methods ocular patient present rare report studi year mutat objective patient retin studi visual year

86 689: Dry Eye Syndromes (10) 690: Lymphoma, Low-Grade (13) aberr conclusions cornea corneal correct associ b-cell case clinic cll dai detect diagnosi evalu examin mean measur methods ocular genet larg local lymphocyt

patient perform protein refract lymphoma model nhl studi thick time treatment visual non-hodgkin patient phenotyp rate score

691: Tendinopathy (4) 692: Diseases (9)

associ case caus character clinic data diseas gener assess avail data databas distal dog event hand inform measur includ literatur mutat patient process produc product report phenotyp process publish repeat report review syndrom treatment score segment splice state time variant

693: Exotropia (9) 694: Myopia (62) aberr ablat conclusions cornea case chang children cluster corneal correct equival evalu examin includ mean measur conclusions corneal correct data methods myopia ocular perform rang refract thick visual design evolut hospit incid mean

methods mortal patient studi

subject women year

695: Myositis (16) 696: Diplopia (8) associ case children clinic data estim increas adult area case experi initi injuri measur method muscl normal mean nerv origin present report resist second select stress studi syndrom test valu year patient score skelet smooth specif studi target tissu treatment

87 697: Orbital Diseases (11) 698: Myocardial Reperfusion Injury (16) case clinic correct correl diagnosi gener method patient perform posit present procedur protein rare report risk sampl ace arteri associ blood surgeri surgic syndrom cardiovascular concentr coronari group heart hypertens identifi infarct level myocardi pressur releas stimul stroke subject vascular

699: Smallpox (3) 700: Fibromyalgia (7) design hospit improv isol life medic novel clinic control diagnosi disord function objective organ pathwai patient potenti qualiti healthi human incid increas individu signal strain strategi studi target mortal patient preval risk role therapeut transplant studi subject treatment women year

701: Colorectal Neoplasms, Hereditary 702: Leukemia, B-Cell, Chronic (52)

Nonpolyposis (124) b-cell case cell cll diffus hodgkin immunoglobulin larg leukemia lymphocyt lymphoid adenocarcinoma adenoma adenomat apc cancer colon colorect crc lymphoma malign nhl famili genet hmlh1 hnpcc instabl microsatellit mismatch mmr msi particip polyp polyposi non-hodgkin patient rituximab sampl t-cell treatment

703: Leukemia, Hairy Cell (9) 704: Hamartoma (36) abil care case clinic combin compar diagnosi case describ develop diagnos diagnosi featur effect express health higher lymphoma function human literatur man new occur patient present rare report reveal syndrom unusu woman median month patient properti rate treat treatment year

88 705: Virus Diseases (71) 706: Neuralgia (16) cell data differ effect function genet genom adult arthriti care clinic dai diseas effect group health human identifi infect health injuri joint model pain number replic studi target test viral patient rate rheumatoid select sever studi treatment year viru virus

707: Viremia (41) 708: Hemochromatosis (97) associ control effect herp hiv hiv-1 human barrier c282y commun connexin contact coupl cx43 demonstr gap genet immunodefici increas infect level hemochromatosi hfe indic intercellular patient popul replic risk studi treatment iron junction overload virus viral viru studi suggest tight

709: Anemia, Iron-Deficiency (32) 710: Fish Diseases (33) anemia caus children control defect analysi assai data detect develop differ elegan group increas infect isol method defici differ group human iron model new region sensit sequenc junction level normal parent patient popul sever studi subject year speci strain studi

711: Enterobacteriaceae Infections (12) 712: Spinal Diseases (17) assai associ compar control analysi associ base bone care cluster compar data gene genet dai detect differ gene higher identifi number gener group host infect health patient rate rel studi isol mean pathogen role sensit treatment valu strain tissu valu

89 713: Low Back Pain (15) 714: Chondrosarcoma (18) assess care compar control differ c-kit case express gene gist group health high higher incid cell human kit line malign model new report increas level low measur patient rate sarcoma select soft stromal studi studi subject women year tumor tumour

715: Seizures, Febrile (20) 716: Pterygium (21) associ attempt chang condit differ eeg epilepsi aberr ablat conclusions cornea follow gener idiopath includ involv report respons corneal correct seizur stress studi suggest suicid year evalu examin group mean measur methods myopia ocular patient perform refract studi thick visual

717: (12) 718: Hyperkinesis (2) adult affect case children brain caus cell children classif cluster demonstr differ element find fusion inhibit lead popul clinic diagnosi diagnost previou report result site studi suggest diseas earli effect femal interact male patient repeat report stage

studi women year

719: Eye Abnormalities (53) 720: Blast Injuries (10) abnorm analysi anomali associ case children care commun educ famili health hospit manag medic need nurs patient practic program provid public research servic stimul congenit defect famili function genet includ structur year mutant mutat patient phenotyp report sampl

studi syndrom

90 721: Eye Injuries (19) 722: Maxillofacial Injuries (2) assess case clinic compar differ avail case data databas event involv mechan molecular neg occur group high imag increas injuri local measur method model nerv rate report phenotyp posit present sampl structur studi process random releas report stimul stress trial

723: Thalassemia (24) 724: Endocrine Gland Neoplasms (5) abnorm anemia caus concentr defect analysi cell chromosom clinic defici detect effect erythroid erythropoietin gene group hemoglobin human delet diagnosi diagnost normal patient sampl sever specif test differ form format gene genet human loss number patient pattern region sequenc tumor

725: Arthritis, Experimental (35) 726: Rheumatic Diseases (17) arthriti diagnosi arthriti attack chronic clinic develop associ clinic diseas effect famili gene genet joint diseas fever joint methods mice mechan molecular mutat new pain migrain objective pain patient rheumatoid risk sampl tissu patient rat report rheumatoid sever studi synovi

727: Pregnancy Complications, Neo- 728: Bundle-Branch Block (16) plastic (17) adult birth cancer case chang atrial cardiac cardiomyocyt children earli fetal human increas cardiomyopathi caus death differ effect failur infant matern neonat patient genet group heart hypertrophi left pregnanc report treatment tumor patient phenotyp right subject valu women year ventricular

91 729: Osteopetrosis (17) 730: Monosomy (45)

aberr abnorm analysi aneuploidi arm breakpoint case activ bone case caus cell effect famili function level marrow mechan mice centromer chromosom molecular patient phenotyp rate report respons cytogenet del duplic genet karyotyp mosaic patient rate rearrang transloc trisomi studi vitamin

731: Paraproteinemias (14) 732: Sarcoma, Clear Cell (8)

addit clinic convent diagnosi differ express famili analys analysi case cell higher includ level multipl

myeloma patient plasma protein rate chromosom cluster detect differenti fusion serum singl studi year

identifi larg method repeat report reveal

sarcoma screen size small tumor

733: Temporal Arteritis (13) 734: Central Nervous System Neo- adult african american associ clinic compar plasms (67)

control diagnosi differ ethnic brain cell central cerebr clinic cns cortex cortic diagnosi effect glioma matter frequenc pain patient polymorph nervou patient primari region secondari studi popul region role time tumour year treatment tumor

735: Aspergillosis (32) 736: Leukemia, B-Cell, Acute (20) analysi aspergillu caus children acut aml cell childhood children fungal fungi fungu group host enhanc express famili genet increas leukemia myeloid number parent increas inocul isol patient region respons sampl sequenc pathogen plant produc tissu product sampl speci spore wall

92 737: Bone Diseases (30) 738: Cranial Nerve Neoplasms (3) case clinic cultur includ injuri lesion loss analysi bone children control lymphoma nerv patient rang report sever decreas differ gene group health increas specimen spinal stain syndrom mutat number osteoblast patient requir studi system treatment tumour vitamin tumor varieti wide

739: Leukemic Infiltration (8) 740: Optic Nerve Diseases (36) cataract conclusions degener examin acut case cell chronic design differenti earli featur genet hospit leukemia level function glaucoma group implant len mous myeloid mice patient macular methods new number optic sampl stage studi treatment patient pigment retin retina studi visual

741: Skull Neoplasms (3) 742: Muscular Atrophy, Spinal (32) case examin lymph melanoma abnorm activ ataxia atrophi caus clinic diseas disord dysfunct expand metastas metastasi metastat node occur expans huntington inclus number patholog patient progress treatment

present primari rare report rna sarcoma segment state studi syndrom tumor

743: Dental Caries (42) 744: Exfoliation Syndrome (11) associ cataract compar conclusions children cleft clinic dental face facial group lip molar nasal oral control differ frequenc gene palat periodont perman popul studi glaucoma hospit implant increas len teeth time tooth variabl level methods model patient popul studi year

93 745: Leukemia, Lymphocytic, Acute, 746: Chordoma (10) L2 (10) analysi case chang clinic combin correl acut associ combin earli evid increas data effect express high low map new leukemia month myeloid patient reduc relationship signific patient phenotyp product studi surviv tumor respons studi support surviv therapi transplant treatment year

747: Pneumonia, Viral (9) 748: Diabetes Mellitus (161) analysi case clinic dai differ dose associ care data diabet differ estim featur group isol level measur fast glucos health incid increas insulin mellitu metabol method peroxisom risk studi toler model number patient select year sever strain studi test treatment

749: Pancreatitis, Alcoholic (6) 750: Distemper (3) adult alcohol clinic compar analysi base categori classif classifi

control depend differ cluster differ form format identifi increas interact new oral individu isol normal profil risk segment set pancreat patient secret strain subgroup tissu sever signific studi valu variabl year

751: Drug Hypersensitivity (26) 752: Amyloidosis (47) activ associ chain dai detect develop dose drug effect gener human identifi induc abeta accumul alzheimer amyloid biochem caus deposit diseas enzym patient product reaction group lead level lysosom number patholog patient precursor report storag suggest respons screen studi treatment

94 753: Amyloidosis, Familial (7) 754: Stomach Diseases (18) accumul analysi associ analysi associ cancer case cell data gastric gastrointestin gene mucosa differ diseas event gene normal patient pylori report respect risk genet involv level mechan month new stomach studi tissu treatment patient pattern popul process studi system year

755: Substance Withdrawal Syndrome 756: Acromegaly (28) (18) associ control differ factor famili associ consumpt alcohol depend growth hormon incid level life effect ethanol examin famili gene increas patient protein qualiti rate respons studi thyroid tumour women year member oral particip patient prefer respons signific studi substanc suggest

757: Hyperthyroidism (14) 758: Pseudoxanthoma Elasticum (21)

anim animal associ case demonstr develop differ adren associ chang children correl establish experiment gene human function hormon hospit human incid increas mortal patient pituitari preval rat model mutat potenti provid relev report serv studi util studi thyroid women year

759: Proteinuria (36) 760: Sex Chromosome Disorders (11)

activ associ case children control develop diseas cell chain chromosom clinic delet failur function kidnei normal patient rcc develop femal high larg male method renal respons sampl studi system tissu mutat patient role sampl sex tubular size small subject syndrom

95 761: Urologic Diseases (7) 762: Rectal Diseases (10) cancer case chronic clinic colon colorect approach case clinic combin data develop diseas dose design diagnosi diseas dose effect femal male normal patient radiat requir famili includ intestin member patient radiat report risk role sever size strategi studi tissu treatment

763: Placenta Diseases (9) 764: Abortion, Incomplete (1) associ confid develop earli fetal imag interv birth chang compar control fetal frequenc gestat infant level matern method mother neonat late normal odd peptid phase pregnanc pregnanc prenat role subject treatment week women progress ratio risk smoke stage studi tissu

765: Abortion, Threatened (1) 766: Albuminuria (32) associ concentr control detect develop caus clinic criteria diagnosi glucos increas diagnost discuss interact lead mean diabet insulin kidnei larg level number patient measur new produc product renal sampl size small studi test

ratio recent research respect technolog

understand valu

767: Kidney Failure (30) 768: Hypopituitarism (15) case control correl dai decreas differ diseas failur approach associ case caus chang clinic data factor group human increas kidnei mutat patient famili function gene growth method model

mutat report studi rcc renal signific studi subject tubular patient syndrom target

96 769: Diabetes Complications (65) 770: Strabismus (19)

associ case control diabet differ child childhood children compar diseas factor function gene genet glucos group conclusions corneal correct differ famili increas insulin metabol patient risk studi group mean measur methods parent subject year patient ratio respect studi valu year

771: Diabetic Retinopathy (56) 772: Werner Syndrome (18) associ cone correl data degener caus develop diseas dna gene diabet differ estim glucos group increas involv life mechan molecular mutat number phenotyp process qualiti repeat replic methods insulin macular optic patient requir respons role photoreceptor pigment retin retina visual

773: Erythema (11) 774: Amyloid Neuropathies, Familial (15) caus clinic combin diagnosi differ domin famili featur form genet group abeta accumul alzheimer inherit lesion level mutat pattern respons amyloid biochem caus deposit detect diseas skin studi time famili lead lysosom member mutat patholog precursor report storag subject suggest

775: Carpal Tunnel Syndrome (9) 776: Retinoschisis (9) area assess caus clinic correl dog associ cone degener distribut examin evalu health incid measur patient individu local macular optic posit scale score segment select sever famili patient phenotyp photoreceptor pigment studi women year process retin retina studi vision visual

97 777: Coloboma (37) 778: Ehlers-Danlos Syndrome (31)

abnorm anomali associ case caus clinic congenit abnorm anomali case clinic congenit defect disord famili gene genet malform model mutat normal patient report retard sampl

defect develop disord featur gene malform mental syndrom tissu

patient phenotyp report retard studi syndrom

779: Carcinoma, Skin Appendage (2) 780: Motor Neuron Disease (19)

addit approxim case convent data ataxia caus cell clinic differ diseas famili includ known major member disord examin expand expans famili find minor multipl mutat myeloma observ rel human mechan motor mutat neuron report singl suggest syndrom progress respons suggest

781: Infarction, Middle Cerebral Artery 782: Carotid Artery Diseases (27) (16) ace adult arteri associ blood activ analysi arteri blood cardiovascular coronari differ cardiovascular cell coronari gene group hypertens increas hypertens infarct model group infarct myocardi pressur risk stroke myocardi plai pressur protein role stroke studi subject vascular year treatment vascular

783: Rhabdomyosarcoma, Embryonal 784: Rhabdomyosarcoma (29) (7) base c-kit case cell control differ effect case dna featur femal gene identifi includ kit male methyl express gist kit malign number pair phenotyp promot region rel screen sequenc stromal sarcoma subject patient rat sarcoma soft stromal studi tumor tumor

98 785: Adenomatous Polyposis Coli (92) 786: Neoplasms, Muscle Tissue (7) adenoma adenomat apc cancer adult approxim base case cell colon colorect crc decreas develop famili increas instabl microsatellit mismatch mmr msi patient polyp polyposi treatment chromosom earli femal individu major male

mutat normal observ popul rel report tissu variant year

787: Muscle Neoplasms (5) 788: Keratitis (12) acid assai case children associ case cell clinic conclusions control corneal correct diagnosi differ chromosom control correl express genet group mean measur detect effect patient rat reduc regul sensit signific stimul studi subject target methods mutat patient studi tumor treatment

789: Iron Overload (30) 790: Eye Diseases, Hereditary (8) barrier commun connexin contact coupl associ character characterist children clinic cx43 demonstr gap gene hemochromatosi hfe combin common diseas distinct famili featur function gene human model mutat indic iron junction new patient studi syndrom mutat new studi suggest tight treatment

791: Ischemia (70) 792: (5) birth care decreas evid fetal arteri associ blood chang health hospit identifi coronari effect endotheli estim growth matern medic neonat human infarct method increas hypertens novel posit pregnanc provid model patient pressur stroke research screen support week studi time vascular

99 793: Birth Injuries (7) 794: Adrenal Cortex Neoplasms (31) activ adenoma adren analysi associ braf care develop development diseas carcinoma high hormon human increas level factor fetal health inform injuri matern method mutat papillari patient pituitari respons ret mice model mous nerv patient pregnanc research risk treatment thyroid tumor

795: Myasthenic Syndromes, Congeni- 796: Choroidal Neovascularization (46) tal (5) acuiti age-rel amd blind conclusions cone bind caus clinic cluster estim chang degener detach examin macular methods express genet high optic photoreceptor pigment retin lead low human level retina rod rpe vision visual mechan molecular mutat receptor rel repeat stimul

797: Uveitis, Intermediate (3) 798: Fibrosis (88) analysi associ blot caus control femal activ cell compar control develop differ effect gene impact improv life male mean express factor function gene group growth increas liver patient studi tgf-beta patient physic polymorph qualiti tissu transform studi subject treatment valu

799: Basal Cell Nevus Syndrome (14) 800: Cerebellar Neoplasms (43)

cell children clinic delet diagnosi earli adult associ brain case cell effect famili gene genet genom health central children cortex express gene group nervou patient report studi tissu new provid report skin patient treatment tumor tumour year stage studi syndrom

100 801: Microphthalmos (21) 802: Cough (18) abnorm case chromosom clinic congenit genet airwai area asthma case cftr chang children compar identifi increas local new number phenotyp control cystic differ rate region report respons sampl screen effect fibrosi group reduc respiratori risk role studi test sequenc syndrom

803: Prion Diseases (29) 804: Fetal Growth Retardation (60)

cellular data degrad diseas evid birth deliveri fetal fetu fetus finger ligas organ pathwai patient prion gestat infant matern mother neonat newborn patient proteasom protein prp regul pregnant stabil studi suggest ubiquitin zinc pregnanc prenat respons syndrom twin week women

805: (27) 806: Edema (42) abnorm anomali associ case clinic congenit case cell clinic distribut effect defect distal dog genet malform model mutat new patient report segment studi group increas induc local normal syndrom treatment patient present rat report respons sever studi tissu treat treatment

807: Hyperoxia (14) 808: Glycosuria (6) analysi cancer caus cell dai decreas analysi associ clinic combin data differ develop earli effect enhanc express earli gene incid increas mutat number patient pattern popul protein report sever group increas lead lung mice model number protein rat studi subject

101 809: Fanconi Syndrome (9) 810: Premature Birth (22) anim associ cell characterist clinic common control featur genet growth isol level birth deliveri fetal fetu fetus gestat infant matern mother model patient popul renal newborn patient placenta studi subject syndrom therapi neonat pregnanc pregnant prenat risk sampl week women

811: Sudden Infant Death (21) 812: Hydrothorax (1) associ cardiac children data adenovir adenoviru allel case cell deliveri effici disord gene health express gene genotyp muscl polymorph report therapi transduc transduct heart identifi mutat ratio transfect transfer transgen vector report risk screen studi test time tissu valu variabl

813: Bile Reflux (1) 814: Trachoma (2) analysi clinic cost diagnosi factor case correl densiti diabet extrem high genet includ influenc manag higher index level linkag low lower map pancreat relat relationship report secret signific studi map medic patient rang resist risk state variabl variat varieti wide

815: Lupus Nephritis (19) 816: Murine Acquired Immunodefi-

addit analysi biolog contribut control determin ciency Syndrome (2) develop group includ involv lupu mice patient analysi character clinic contain core dai provid pten relev sle studi system treatment diagnosi diseas encod evid frame

identifi open orf point provid put read

support time

102 817: Bovine Virus Diarrhea-Mucosal 818: Toxoplasmosis, Cerebral (2)

Disease (6) analys analysi brain copi data indic individu

bovin caus collect differ effect infect larg number perform plai presenc genet genom infect isol lead pattern pig prevent reduc reduct region sampl produc product reveal role studi sequenc strain viru suggest test

819: Encephalitis (20) 820: Streptococcal Infections (40)

activ analysi associ brain children clinic analysi antibiot bacteri bacteria caus differ gene compar control develop effect enhanc host infect isol model parasit level mice respons patient pathogen sequenc strain test treat treatment type virul sever studi subject tissu tumor

821: Herpes Genitalis (28) 822: Vaginal Diseases (3) activ aids assai associ detect develop differ adult assai associ caus cervic children confid detect interv older plai effect herp hiv hsv-1 hiv-1 ratio risk role sensit smoke studi tumor year young human immunodefici infect

posit sensit simplex viral viru

823: Neoplasms, Squamous Cell (15) 824: Sleep Disorders (19) cancer carcinoma cell chain adhd anxieti associ behavior bipolar children control differ effect factor clinic depress differ disord group gene growth increas life major person psychiatr sampl serotonin sleep studi symptom patient phenotyp presenc reaction risk sequenc studi tumour year

103 825: Trismus (3) 826: Arthrogryposis (18) abnorm affect analysi anomali associ autosom adult case characterist common compar control distinct elderli featur frequenc includ old older patient repeat case caus congenit defect disord domin famili report studi syndrom year young genet inherit mutat patient popul report syndrom

827: (21) 828: Orthomyxoviridae Infections (17) analysi case control data develop dog activ alter associ cell chang compar gene hcv higher human infect lower mice effect famili gene gener group rate replic select versu viral mutat new patient provid viru virus

report sampl segment studi syndrom

829: Thrombocytosis (17) 830: Mouth Diseases (12) acut aml chang cluster combin develop effect factor famili function includ leukemia care case clinic differ member mice mutat myeloid number diseas famili genet health patient risk treatment identifi includ larg model number patient report screen skin studi syndrom test

831: Blister (9) 832: Brain Infarction (8)

associ base case correl differ arteri associ brain dai detect differ effect hypertens identifi larg effect genet human model new mechan method patient

pressur rel screen normal observ pair protein report studi rate size small variabl

time tissu treat treatment

104 833: Multiple System Atrophy (12) 834: Cerebellar Diseases (11) cell ataxia atrophi caus clinic diseas adult assess brain disord expand expans express gene genotyp includ mice motor multipl neuron data diseas function patient polymorph progress singl gener increas level life measur mutat number phenotyp qualiti risk score time year

835: Retinal Neovascularization (18) 836: Burns (32) acuiti assai cone degener detect high level axon chang control cord develop effect heal macular normal number optic photoreceptor increas injuri myelin nerv neuropathi patient peripher regener select pigment retina sensit tissu retin spinal studi trauma wound treatment vision visual

837: Hand Injuries (5) 838: Nose Neoplasms (9) avail case caus clinic case clinic correl diagnosi effect function genom high low new patient data databas design earli evid present radiat rare report size subject treat health hospit inform lead lesion treatment year mechan patient process provid report support

839: Palatal Neoplasms (6) 840: Anus, Imperforate (16) area bind carcinoma case cleft associ case children chromosom clinic diagnosi diagnost diseas dose effect clinic complic diagnosi famili genet growth irradi oral patient radiat rang report influenc oper patient procedur rate studi tumor report studi surgeri surgic syndrom treatment

105 841: Cholelithiasis (7) 842: Hypertrophy (39)

clinic combin conclusions design diagnosi differ effect group hospit linkag liver locu map mean associ case children differ express function gene gener mice model methods patient ratio studi valu muscl normal parent patient report year studi tissu treatment tumour year

843: Muscular Diseases (70) 844: Sheep Diseases (25)

associ case contract differ dmd dystrophi exercis anim bovin breed calv fiber gene muscl muscular mutat cattl cow differ effect farm goat herd myoblast myopathi skelet smc smooth strength train weak hous isol lactat milk pig porcin respect sheep strain

845: Retinal Perforations (26) 846: Pemphigus, Benign Familial (7) acuiti age-rel amd cone degener detach case caus cell clinic common diseas develop earli examin macular methods optic enhanc famili featur gene increas inhibit larg member model report patient photoreceptor pigment retin risk size skin small retina rod vision visual

847: Keratosis Follicularis (10) 848: Exophthalmos (10) case chain detect diagnosi famili literatur affect chang develop diseas measur member patient pcr polymeras present quantit rare reaction real-tim report revers famili gene higher identifi incid keratinocyt treatment variabl men mortal mutat patient preval rate respons skin women year

106 849: Foreign-Body Migration (17) 850: Intestinal Fistula (7) case cataract chang complic case clinic complic diagnosi group glaucoma high implant len model oper patient postop present procedur process rare repeat report select subject surgeri normal oper patient surgic time year perform presenc procedur studi surgeri surgic tissu treatment

851: Surgical Wound Infection (15) 852: Retinopathy of Prematurity (16) analysi assess associ case complic caus correl develop group high data evid measur method oper identifi improv increas lead life method number optic qualiti retin retina screen patient perform procedur studi treatment visual provid score studi support surgeri surgic treatment

853: Epidermolysis Bullosa Dystroph- 854: Sjogren-Larsson Syndrome (1) ica (11) advanc applic caus clinic effici anim base caus clinic control develop differ gene improv lead new patient research gene genet genom group sever symptom syndrom technolog therapeut individu model mutat patient sampl skin specif studi tumor therapi transfer treatment vector

855: Keratoderma, Palmoplantar (20) 856: Hyperinsulinism (34) basal cutan epiderm epidermi express gene keratin keratinocyt lesion mutat new normal caus compar control diabet effect gene glucos group increas insulin level pigment psoriasi select studi tissu skin mellitu metabol mutat pancreat ultraviolet uvb patient secret studi subject variabl

107 857: Intestinal Diseases (14) 858: Uveal Neoplasms (40) bowel care chronic dai differ control demonstr elong malign melanocyt melanoma microrna mirna patient pol

polymeras rate ribozym rnase small function gastric rna diseas gene studi transcript vitro year

genom health inflamm inflammatori

intestin particip patient

small surgeri treat treatment

859: Ocular Hypertension (28) 860: Headache (41) cataract cell chamber children arthriti case clinic dai diseas effect conclusions effect examin glaucoma fever function group imag joint local methods group includ pain patient implant report rheumatoid sever studi symptom intraocular len level methods patient perform studi surgeri year

861: Urinary Incontinence (26) 862: Hydrocephalus, Normal Pressure assess bladder control data determin (1) evalu examin high includ mobil adult behavior clinic diseas elderli event imag involv isol occur old older patient perform report score patient perform process sever step strain signific studi tract transit urin urinari year young

863: Hydrocephalus (40) 864: Endometriosis (48) abnorm associ brain case central clinic activ assist cycl express follicl fsh gene congenit control develop differ gene group human method patient report studi hormon ivf ovari ovarian syndrom tumor year patient pregnanc progesteron

reproduct steroid stimul studi

testosteron women

108 865: Facial Asymmetry (14) 866: Leprosy (16) assess case chang cleft clinic activ data demonstr gener genet group human includ indic mycobacterium new particip dental facial function genom lip patient popul provid report specif studi time measur model palat patient periodont tuberculosi report score teeth tooth treatment

867: Zygomycosis (5) 868: Tonsillitis (9) absenc clinic compar concentr control data evid affect american approach case clinic ethnic high level low patient popul present rare regul genet influenc manag medic number report respons risk sever transplant white patient presenc provid rate sampl studi support treatment

869: Pigmentation Disorders (26) 870: Leukemia, Myeloid, Chronic- analysi caus cell clinic cutan data differ effect Phase (5)

gene group identifi includ keratinocyt lesion acut analysi bodi caus clinic correl dai data dose estim group lead leukemia mutat mutat patient sampl skin studi variabl patient resist reveal signific surviv therapi

871: Hemarthrosis (6) 872: Cystic Fibrosis (212) caus children clinic correl dai evid factor airwai allerg allergen asthma growth month organ rat patient cftr chronic conduct copd cystic diseas recombin risk select signific support treatment variabl year eosinophil fibrosi ige obstruct patient pulmonari respiratori sever test ventil

109 873: Priapism (5) 874: Demyelinating Diseases (43) associ case clinic decreas defect defici axon cord demyelin differ femal heal

male myelin nerv develop health increas individu level injuri neuropathi oligodendrocyt pattern peripher regener sensori spinal time trauma wound organ patient phenotyp presenc

protein repeat select sever studi

875: Lipoma (14) 876: Pupil Disorders (3) cancer case chain chang activ affect area cardiac caus cell chromosom clinic children clinic death diagnosi diagnost diseas examin heart implant lead diagnosi diagnost express human function gene new pcr phenotyp patient studi syndrom polymeras reaction report revers studi tissu

877: Echovirus Infections (3) 878: Uveitis (27) affect alter assai chain chang clinic detect diagnosi activ cataract chamber differ examin gene glaucoma group identifi implant differ function human isol mutat nucleotid region sensit sequenc strain studi intraocular iop len methods subtyp patient perform screen studi surgeri treatment

879: Campylobacter Infections (8) 880: Hand Dermatoses (17) base character cluster differ effect genet genotyp group activ base case diseas follow gene involv keratinocyt level model mutat particip human ident identifi individu isol origin patient random rate report patient pattern sequenc strain type valu segment skin studi trial

110 881: Acrodermatitis (6) 882: Hyperkeratosis, Epidermolytic (7) base case clinic analysi associ case caus clinic associ diagnosi diagnost genom high concentr diagnosi differ distribut genet keratinocyt level low mechan mutat high imag level local low organ phenotyp region sequenc report resist respons specif variabl sampl studi skin

883: Contracture (17) 884: Carcinoma, Ehrlich Tumor (11) activ analysi associ chang clinic combin effect associ cell compar control dai decreas effect gene famili featur identifi member muscl group mutat patient reveal screen studi increas inhibit level syndrom treat treatment mice model rat rate respons tumor tumour vivo

885: Lymphoma, Large-Cell (41) 886: Nail Diseases (15)

b-cell case cll diffus group hodgkin immunoglobulin larg leukemia lymphocyt lymphoid analysi case chain detect famili high identifi keratinocyt level member new lymphoma malign nhl non-hodgkin patient phenotyp rituximab t-cell number pcr polymeras product quantit transplant reaction revers screen skin

887: Fecal Incontinence (11) 888: Colitis (21) anim clinic diagnosi famili follow bowel case chronic clinic function genom group initi diseas effect increas inflamm member model number inflammatori intestin mice requir respons role patient mous patient rat role sampl score studi surgeri surgic year small treatment ulcer

111 889: Corneal Dystrophies, Hereditary 890: Hypotension (11) (37) assess case caus cell correl effect aberr ablat conclusions cornea function lead measur method corneal correct patient rat report respons score signific studi subject time treatment evalu examin famili gene includ mean measur methods ocular patient perform refract thick visual

891: Hypertriglyceridemia (21) 892: Facies (31) acid apoe apolipoprotein associ abnorm anomali assess children clinic congenit cholesterol develop famili gene defect develop evalu famili function group group increas ldl level lipid lipoprotein patient plasma measur mutat patient report score studi rate serum studi treatment

subject syndrom

893: Epidermolysis Bullosa (12) 894: Placenta Previa (2) anim children cutan earli famili femal gene identifi keratinocyt lesion male method model assess associ compar confid control

find interv level new parent role screen skin studi high low treatment measur odd previou ratio report risk score smoke studi variabl

895: Placenta Accreta (3) 896: Encephalitis, Tick-Borne (5) analys analysi birth case american analysi assai children detect

earli infect model patient develop earli fetal infant differ late matern neonat phase pregnanc prenat pattern popul protein region sequenc studi progress report reveal risk stage women subtyp variabl viral viru

112 897: Hemorrhagic Fever, Crimean (2) 898: Poliomyelitis (9) african american countri data differ ethnic case cell children develop incid european evid group medic nation pattern popul provid sampl speci state infect isol men mortal plai preval support type world rate region risk role sequenc strain viru women year

899: Rabies (19) 900: Hantavirus Infections (2) analysi area assai chain data detect hcv area chain detect discuss infect method popul reaction region repeat genom identifi individu replic sampl sequenc studi viral isol locat pcr polymeras reaction viru virus recent region revers risk screen sequenc strain studi

901: Yellow Fever (5) 902: Classical Swine Fever (10) area assai cell detect differ evolut anim approach control data famili genet individu isol member distribut gene mice phenotyp repeat sensit site strain differ estim studi valu viru high incid isol level local low method model pattern sampl strain women

903: Kartagener Syndrome (9) 904: Granulomatous Disease, Chronic (15) adult case caus clinic criteria chronic complex data diseas error estim function gene gener inflammatori intestin develop diagnos diagnosi diagnost function human laboratori method model patient respons risk role statist studi vector number organ patient report studi subject syndrom year

113 905: Trematode Infections (4) 906: Cryptosporidiosis (3) antibiot bacteri bacteria bind bodi children analysi base chromosom earli experi genet initi new normal origin conserv famili host infect popul region reveal second sequenc mammalian member mice mous new parasit pathogen patient provid site speci specif studi tissu year

907: Foot-and-Mouth Disease (17) 908: Anemia, Hemolytic (17) analysi assai compar control anemia associ case caus chain children clinic defect defici develop group detect develop diseas genom patient pcr polymeras protein reaction report risk sever studi infect isol method popul rate replic

role select sensit strain viral viru

909: Anophthalmos (11) 910: Neck Pain (4) abnorm case clinic congenit data defect affect approach assess associ data effect

disord evid famili gene member number femal group literatur male method organ patient present protein rare report

studi syndrom presenc rat repeat report score specif studi

treat treatment

911: Whiplash Injuries (5) 912: Hypocalcemia (22) approxim compar control differ effect form format group healthi high low mean area bmd bone case children clinic concentr diagnosi diagnost follow fractur gener model patient rel repeat studi genet level miner osteoblast respons studi syndrom vitamin subject suggest trial

114 913: Torsades de Pointes (6) 914: Pseudorabies (8) associ cardiac earli enhanc express featur bovin collect detect effect famili genom high femal heart identifi induc male period point increas larg level low model mutant pig posit process respons screen stage sampl select size small tissu target time valu

915: Angiofibroma (5) 916: Keratitis, Herpetic (13) area delet demonstr examin femal find genet acid control effect indic male neg observ plai posit enhanc event express gene hiv previou remain report role studi hiv-1 human infect mice model plai suggest tumour process reduc role specif treatment viru

917: Lymphoma, Large-Cell, Diffuse 918: Glomerulonephritis (32) (72) adult biolog develop diseas earli failur function b-cell case chronic cll diffus follicular hodgkin igh group kidnei mice model mous new immunoglobulin larg leukemia lymphocyt lymphoid patient product rcc renal studi lymphoma malign nhl system year non-hodgkin rearrang rituximab t-cell

919: Hyperparathyroidism (38) 920: Cadmium Poisoning (4) adren associ bone case clinic diagnosi chines cohort concentr data differ famili fractur gene hormon miner mutat health heterogen incid men osteoblast patient pituitari receptor sever thyroid treatment vitamin mortal popul preval rate respect

risk studi subject subtyp women year

115 921: Hypertension, Renal (13) 922: Situs Inversus (8) adult arteri compar control develop effect abnorm activ anomali associ case famili femal function group high increas children congenit defect patient produc product random region regul report sequenc kidnei male rat renal risk studi treatment year studi surgeri syndrom trial

923: Myotonic Dystrophy (47) 924: Anti-Glomerular Basement Mem- abnorm ataxia atrophi caus clinic control brane Disease (2) diseas disord dystrophi expand expans alter analysi blot care case chang decreas

famili motor muscl muscular diseas effect health method neuron patient progress skelet smooth model prevent protect reduc reduct report respons servic western

925: HTLV-II Infections (2) 926: Klinefelter Syndrome (21)

aberr abnorm analysi case associ blood combin effect event femal identifi includ initi male new chromosom clinic control origin process provid rang screen second sex cytogenet incid karyotyp level patient rearrang sexual speci report risk studi syndrom transloc women year

927: Niemann-Pick Diseases (25) 928: Tauopathies (4)

caus cell compar control differ abeta accumul activ alzheimer amyloid biochem caus deposit differ diseas effect express frequenc enzym lead lysosom patholog patient precursor diseas health identifi lead mice mutat protein reduc rate report storag suggest residu screen site variant

116 929: Epilepsy, Temporal Lobe (26) 930: Joint Instability (15) associ attempt condit control differ eeg epilepsi assess case high measur model month normal follow gener idiopath includ involv patient report patient period point rate score respons studi suggest seizur stress structur studi surgeri surgic time tissu suicid treatment year

931: Skull Base Neoplasms (9) 932: Orbital Neoplasms (15) associ base case clinic differ analysi associ case cell control delet function gener length long month design function hospit includ mechan patient repeat report patient perform present rare rate report studi treatment tumor select short size studi therapi tumor year

933: Neoplasms, Fibrous Tissue (5) 934: Genital Neoplasms, Male (4)

case children chromosom clinic diagnosi differ adult case diseas express method network patient posit predict produc product report risk structur studi featur malign normal occur parent pattern phenotyp treat treatment tumour young present process report select studi tissu year tumor

935: Abdominal Injuries (7) 936: Compartment Syndromes (4) care chang data design develop clinic diagnosi differ diseas effect genom health hospit inform femal hospit includ male medic model particip patient rat rate methyl muscl patient requir studi subject surgeri rang receptor region risk sequenc studi subtyp surgeri surgic

117 937: Pregnancy Complications, Infec- 938: Sarcoma, Ewing’s (53) tious (52) c-kit case cell famili gastrointestin gene giant

birth deliveri effect fetal gist hsp90 imatinib includ kit malign gestat incid infant infect male

soft stromal sts studi matern mother neonat sarcoma

newborn number patient tissu tumor pregnanc pregnant prenat week women

939: Bites and Stings (10) 940: Obstetric Labor, Premature (18) differ ethic form function genet analysi birth deliveri detect fetal genom group human fetu gestat infant level matern mother neonat newborn pregnant prenat includ initi isol light model origin pregnanc risk week women year patient popul research sequenc specif strain

941: Lymphatic Diseases (22) 942: Submandibular Gland Diseases (3) associ case children clinic dai diagnosi alter assai case cell chang correl detect epitheli earli featur includ lymph metastasi metastat initi origin patient present rare node number patient region remain report second sensit sequenc signific

phenotyp primari report studi tumor

943: Salivary Gland Calculi (2) 944: Lithiasis (5)

affect associ case clinic cluster data diagnosi earli area assai case clinic criteria dai genet incid measur new patient presenc preval report score studi women year detect diagnos diagnosi diagnost

effect laboratori patient rat region sensit

sequenc sever treat treatment

118 945: Respiratory Tract Infections (59) 946: Anodontia (32) analysi asthma case clinic cystic diagnosi clinic craniofaci face differ fibrosi genom human infect cleft dental facial famili gingiv lip mandibular isol patient rate report maxillari molar nasal oral palat respiratori sever strain studi viru periodont perman studi teeth tooth

947: Dental Enamel Hypoplasia (10) 948: Intestinal Polyps (16) associ cancer case caus colon analysi area children cleft dental facial gener lip normal palat parent colorect detect enhanc identifi predict regress report studi syndrom teeth increas larg model number patient tissu variabl variat respons risk screen size small specif

949: Peutz-Jeghers Syndrome (24) 950: Rubinstein-Taybi Syndrome (7)

abnorm analysi anomali associ cancer caus case congenit data dynam effect evid featur

hybrid male mechan model congenit defect diseas famili gene larg malform molecular mutat patient provid region report sequenc simul syndrom

mutat number report retard size small syndrom

951: Paranasal Sinus Neoplasms (11) 952: Occupational Diseases (66) area case correl develop featur area assess carcinogen care chemic control effect expos exposur frequenc incid men mortal neg patient genotox group health increas mutagen posit preval report sampl signific particip risk studi time toxic studi tissu tumor women year

119 953: Lichen Planus, Oral (5) 954: Dislocations (12) alcohol assess associ compar differ effect assess case clinic cluster combin compar factor higher incid larg number oral correl diagnosi effect evalu measur mutat patient popul rate ratio patient rate report sampl score segment syndrom treatment risk size studi subject

955: Lameness, Animal (11) 956: Tibial Fractures (6) allow appli applic bone chang correl develop accumul bovin case caus clinic effect method model procedur develop diagnosi protocol rapid simpl standard stimul studi techniqu treatment vitamin diagnost distal dog human identifi level mice muscl patient pig report segment structur

957: Xerostomia (11) 958: Stomatitis, Aphthous (5)

caus cell clinic compar control dai differ case children correl cours determin develop disord dose effect epitheli famili function genotyp level patient period point group high low patient radiat stimul treatment polymorph report signific time treatment studi tumor variabl year

959: Insect Bites and Stings (12) 960: Facial Paralysis (20) adult caus cluster control differ analysi case chang children control develop differ famili injuri method nerv drosophila famili fli host perform report reveal role studi insect larva melanogast model new provid role patient speci studi tumour wing test tumour year

120 961: Blepharoptosis (16) 962: Rinderpest (1) aberr associ case caus chang analysi cdna character clone contain encod est conclusions corneal correct evalu examin extract fraction identifi immun isol mean measur methods ocular gene librari novel sequenc strain tag tumor vaccin patient report risk studi syndrom tissu

963: Pituitary Diseases (10) 964: Activated Protein C Resistance adult associ case clinic differ (19) activ case clinic control correl diagnosi diseas factor genet growth factor famili genet group high mutat human normal patient patient platelet popul protein respons role specif therapi thyroid tissu resist respons studi test treatment year

965: Scrapie (16) 966: Malnutrition (15) adult analysi area associ bodi chang anim associ bovin control data differ factor genet breed cattl cow degrad differ group incid organ popul respons effect genotyp lactat mice milk risk studi weight year number pig polymorph porcin protein sheep test

967: Hippel-Lindau Disease (25) 968: Folic Acid Deficiency (17) angiogenesi case cell clinic develop bleed compar control correl decreas diagnosi differ diseas factor folat gene group increas endotheli factor gene model mthfr platelet risk signific studi subject thrombosi treatment venou growth hypoxia mechan studi treatment tumor vascular vegf year

121 969: Upper Extremity Deformities, 970: Smith-Lemli-Opitz Syndrome (13) Congenital (5) case caus clinic diagnosi environment factor famili gene genet high individu influenc lead adult alter analysi base chain level low mutant sampl chang differ dog exposur mechan patient syndrom time model mutat observ pair phenotyp predict reaction segment variabl year

971: Tooth Diseases (6) 972: Osteolysis, Essential (3)

care case caus chang children clinic area base case caus condit decreas degre differ famili featur gener imag increas lead loss diagnosi diseas earli famili featur health high level low member mutat member pair patient repeat report report studi treatment

973: Kidney Diseases, Cystic (6) 974: Polycystic Kidney Diseases (18) bind case cell diseas enhanc famili analysi case cell diseas express failur famili gener initi kidnei mechan member mice gene human identifi kidnei mutat

origin plai rcc renal report role progress rcc receptor renal reveal studi tubular variabl second tumor

975: Lipid Metabolism, Inborn Errors 976: Brain Diseases, Metabolic, Inborn (20) (8) acid amino anemia blood case caus clinic acid american amino area associ data defect defici famili gene genet brain clinic data diseas estim genet hospit human mutat normal patient report sever method patient popul product select valu specif studi year

122 977: Thyroiditis, Autoimmune (20) 978: Diabetic Neuropathies (28) associ case data detect develop differ diseas assess clinic combin compar control famili gene growth hormon human increas develop diabet effect glucos number report studi patient injuri insulin measur model nerv thyroid tissu year patient random score studi treatment trial

979: Muscle Spasticity (14) 980: Ameloblastoma (7) activ alter caus chang children clinic analysi biolog cell chain detect fish diagnosi differ diseas disord effect motor fluoresc high hybrid level low pcr probe normal patient stimul studi therapi tissu treat treatment reaction reveal situ studi subject system tumor

981: Mandibular Neoplasms (13) 982: Hyperacusis (4) case cell chromosom cleft clinic describ diagnos diagnosi earli featur literatur multipl new compar control differ earli high patient present rare report studi tumor woman individu level loss low method new patient pattern posit size small specif studi time type

983: Ear Diseases (10) 984: Tinnitus (20) associ case caus children clinic diagnosi auditori base canal caus cochlear deaf ear function diagnost earli gener identifi interact loss organ group hair hear impair inner loss middl rate risk sensorineur studi vestibular patient present process report risk screen studi

123 985: Fabry Disease (54) 986: Spinal Injuries (3)

alpha-synuclein alzheimer autoimmun caus common avail children clinic compar dementia diseas disord function human includ mutat onset parkinson pathogenesi patholog control criteria data patient progress tau tissu diagnosi diagnost genom inform literatur mechan molecular organ publish report review search subject

987: Acid-Base Imbalance (4) 988: Lafora Disease (8) combin correl determin differ anim clinic develop differ diseas earli epilepsi gene genet mechan model distribut energi estim famili molecular mutat patient process seizur sever stage stress studi hospit larg local measur predict

regress relationship signific size small valu variabl

989: Aphasia (5) 990: Epilepsy, Frontal Lobe (7) behavior case cognit differ disabl associ brain data effect enhanc epilepsi evid group method model mutat diseas famili impair learn mechan member memori mutat respons seizur stress studi suggest suicid support time variabl patient pattern perform syndrom target task tumour

991: Respiratory Distress Syndrome, 992: Movement Disorders (36) Adult (32) associ ataxia atrophi caus clinic develop asthma cancer clinic express fibrosi diseas disord evid expand expans function identifi increas lung express function health motor patient progress select support treatment patient plai posit protein role screen sever studi subject test treatment

124 993: Hemiplegia (8) 994: Neoplasms, Glandular and Epithe- activ analysi brain clinic lial (37) associ cancer cell differ effect estrogen develop diseas earli famili increas member mutant pain patient report reveal sever stage studi syndrom famili group human increas malign tumour

number ovarian patient posit respons role

studi tumor tumour

995: Rett Syndrome (36) 996: Intracranial Aneurysm (27)

abnorm analysi anomali associ case caus clinic abdomin activ analysi aneurysm case complic

manag oper patient perform congenit defect develop differ disord featur malform postop preoper procedur reconstruct resect surgeri surgic techniqu mental methyl report retard sever underw year syndrom

997: Epilepsies, Myoclonic (15) 998: Back Pain (6) associ attempt condit eeg epilepsi follow gener assess clinic combin compar control data genet idiopath includ increas mutat patient report differ group measur model respons seizur stress studi suggest patient score signific studi suicid popul subject therapi treatment trial variabl

999: Seizures (77) 1000: Epilepsy, Generalized (24) associ attempt condit eeg epilepsi follow gener absenc associ attempt children condit differ eeg idiopath includ involv patient report respons epilepsi follow gener idiopath includ presenc

seizur sever stress studi suggest report respons seizur stress studi suicid syndrom suggest suicid

125 1001: Abdominal Pain (47) 1002: Fascioliasis (4) arthriti case chain children chronic acid anim bovin breed case correl dai differ clinic diagnosi diseas group joint new pain high low patient present reaction report sever group level studi time year normal patient pig report serum signific tissu tumor

1003: Appendicitis (11) 1004: Taeniasis (4) assai case clinic complic detect case chain clinic diagnosi factor develop oper patient perform human incid infect level postop present procedur rate report resect select sensit surgeri surgic underw number phenotyp popul

posit preval reaction repeat risk subject women year

1005: Mitochondrial Diseases (57) 1006: Common Bile Duct Diseases (2) associ children clinic cytochrom deplet dna function affect diseas effect environment factor genet indic involv membran genet hepat influenc liver mitochondri method plai regul role mitochondria mtdna oxidas patient potenti studi suggest techniqu trait treat respiratori select suggest treatment variat

1007: Pseudolymphoma (4) 1008: Corneal Opacity (9) aberr analysi case clinic conclusions case clinic content criteria corneal correct design diagnosi determin develop diagnos diseas gene hospit mean measur diagnosi diagnost featur flow methods ocular patient method patient present process product perform studi subject sampl sever stain valu

126 1009: Conjunctival Diseases (19) 1010: Hyperemia (3) aberr activ case conclusions affect compar condit corneal correct degre differ evalu examin higher imag implant lower methods corneal correct differ famili group human mean measur perform rate respect studi test versu methods model ocular report respons sampl tissu visual

1011: Hyperaldosteronism (10) 1012: Leiomyosarcoma (23) adult analysi case clinic data analysi associ c-kit case develop differ gene mechan method normal organ perform report reveal size small studi genom gist includ kit malign patient thyroid tissu variabl year

rate respons sarcoma soft

stromal studi tissu tumor

1013: Carcinosarcoma (11) 1014: Histiocytosis, Sinus (2) associ cancer case cell combin associ biopsi case children clinic diseas effect correl differ gene high level low improv interact lesion mutat ovarian pattern posit process report

report specimen stain studi sarcoma size studi tumor patient

surviv therapi treat treatment

1015: Granular Cell Tumor (5) 1016: Leukemia, Prolymphocytic (7) adult base case cell electron featur layer analys analysi blood case characterist common featur includ lymphoma microscop microscopi model morpholog observ organ report reveal structur studi surfac patient perform posit protein rel tumor year report reveal sampl studi time transplant

127 1017: Cholangitis, Sclerosing (10) 1018: Constriction, Pathologic (14) approxim children compar control data differ children clinic compar control genet healthi high higher level month mutat diseas estim express function group hepat level liver patient rel risk role studi patient popul rate report studi year subject time treatment year

1019: Peptic Ulcer (12) 1020: Hypokalemic Periodic Paralysis cancer compar correl effect famili (6)

allel analysi case control diseas effect gastric gastrointestin group mucosa posit pylori rat reduc respect sampl famili gene genotyp histori hospit signific stomach studi test treatment identifi member mutat polymorph popul reveal studi subject time

1021: Carcinoma, Ductal (30) 1022: Microcephaly (44)

abnorm anomali case chang chromosom clinic analysi associ breast cancer carcinoma case compar control correl express group hybrid congenit defect evolut famili featur gene human increas method number patient signific studi surviv tumor malform mutat patient report retard select syndrom

1023: Tracheal Neoplasms (1) 1024: Steatorrhea (3) assai characterist clinic common absenc correl diseas dna fish case form format head hybrid indic detect develop featur gene lesion neck observ presenc probe relationship signific situ studi suggest genotyp mutat pancreat patient plasmid present rare recombin report sensit therapi

128 1025: Abetalipoproteinemia (3) 1026: (17) adult apoe case cholesterol clinic activ analysi associ case caus cell children clinic common diseas dna famili diagnosi diagnost effect gene featur genet group mutat pain lipid lipoprotein mean metabol mutat patient reduc reduct studi valu year patient studi time

1027: Cattle Diseases (78) 1028: Nematode Infections (7) anim bovin breed calv adapt adult cell cultur dai differ dose cattl cow differ effect farm goat herd femal group male popul rel hous isol lactat milk pig resist select sex speci test valu week porcin respect sheep strain year

1029: Intestinal Diseases, Parasitic (15) 1030: Tuberculosis, Multidrug- Resistant (14) area care cell chang children dai addit data defin demonstr gener health includ indic isol mutat mycobacterium popul rate report differ gener high dose health repres resist specif strain studi tuberculosi host human infect pathogen product sampl servic treatment week

1031: Carcinoma, Medullary (37) 1032: Lesch-Nyhan Syndrome (7) adenoma adren braf carcinoma control activ cell combin defici effect evid high level low mechan organ endocrin express gland hormon mutat patient plai provid respons

role support system variabl papillari patient pituitari ptc respons ret studi

studi subject surviv thyroid

129 1033: Neoplasms, Ductal, Lobular, and 1034: Rare Diseases (38) Medullary (6) case chang develop diagnos diagnosi diseas analysi associ breast cancer cluster data genet genom life literatur mice mutat patient present rare report research syndrom woman year famili gene length methyl patient protein ratio repeat reveal risk signal surviv

treat treatment

1035: Superinfection (2) 1036: Leukoplakia, Oral (11) analysi associ blot clinic combin effect incid alcohol analysi associ compar correl depend effect health higher increas interv isol mortal multipl patient preval ratio risk strain structur therapi western oral patient rate ratio risk women year signific studi tumour year

1037: Abortion, Veterinary (8) 1038: Teratoma (32) anim bovin breed caus data differ incid activ adult carcinoma case cell isol men method milk mortal children clinic diagnosi differenti featur gene number pig porcin preval strain group human patient progenitor remain studi women year stem studi tumor year

1039: Gaucher Disease (45) 1040: Heart Arrest (25)

activ alzheimer autoimmun caus common dementia area cardiac care dai differ differ diseas disord human includ mutat onset parkinson pathogenesi patholog patient progress ethic failur studi tau health heart left organ patient practic rate research respons studi test time ventricular

130 1041: Central Nervous System Diseases 1042: Constipation (20) (27) care case children chronic clinic clone dai analysi anim brain case central control diseas function gene health inflammatori develop differ effect experiment gene high intestin patient presenc report level model new patient protein sequenc sever studi treatment provid studi test

1043: Leukopenia (40) 1044: Aphakia (2) advanc cancer chemotherapi alter cataract chang compar conclusions differ children combin cycl dai group human glaucoma group higher hospit hybrid implant len lower method methods median month phase rate patient rate signific studi versu regimen respons studi surviv toxic treatment

1045: Gallbladder Neoplasms (30) 1046: Pleural Effusion, Malignant (15) cancer carcinoma cell chang compar assai case cell clinic detect diagnosi esophag correl develop differ express frequent genom investig occur occurr gastric gene group human patient probabl rate report resist sensit studi transmiss methyl patient rate respect signific studi tumor

1047: Cystadenocarcinoma, Serous 1048: Cleidocranial Dysplasia (5) (36) analysi blot bone case compar detect cancer compar differ endometri epitheli express gene gener higher lower marker estrogen express group high level low mutat organ rate report studi ovarian patient periton rate syndrom vitamin western signific studi suggest surviv uterin

131 1049: Periapical Abscess (2) 1050: Dens in Dente (3)

children cleft differ experi extract field follow associ case children cleft initi intern light manag mechan group clinic dental mechan molecular month molecular origin parent second studi subsequ syndrom multipl palat patient popul present rare report sever studi symptom year

1051: Maxillary Diseases (3) 1052: Tooth, Supernumerary (14)

approxim carcinoma case cleft clinic combin current data discuss effect evid lung major associ case cleft clinic dental diagnosi facial genet lip molar patient provid recent rel structur nasal normal palat patient periodont support therapi popul studi teeth tissu tooth

1053: Mandibular Diseases (13) 1054: (40) cell clinic data diagnosi differ case appear contribut effect featur genet includ model number examin present report studi test therapi time extent find indic investig involv later tissu treatment lesser mark multipl observ possibl sclerosi signific sod1 studi suggest survivin

1055: Olfaction Disorders (8) 1056: Mycoses (28) adult analysi base clinic control famili analysi aspergillu associ case caus group human mechan model molecular fungal fungi fungu host normal patient presenc studi human includ isol subject time tissu year young pathogen patient produc product speci spore test wall

132 1057: Peptic Ulcer Perforation (2) 1058: Duodenal Ulcer (19)

affect alter behavior cancer chang cognit aim associ cancer compar control develop

gastrointestin group decreas develop development gastric helicobact infect intestin mucosa patient pylori examin increas lesion liver observ perform gastric respect risk signific stomach studi pylori schizophrenia signific studi

1059: Rhinitis, Allergic, Seasonal (20) 1060: Bronchitis (11) airwai asthma cftr chang compar cell compar control differ diseas effect control cystic differ fibrosi express gene higher increas level lower increas patient plant group model patient protein rate serum respiratori respons sampl signific studi studi system valu time treatment

1061: Esophageal Atresia (11) 1062: Pericarditis, Constrictive (2) dose effect follow-up heart incid irradi associ case caus children congenit defect caus earli gene incid men mortal lead median men month mortal normal preval radiat rat patient preval report role size patient tissu women year studi syndrom women year

1063: Pericardial Effusion (6) 1064: Staphylococcal Infections (50) aeruginosa antibiot antimicrobi aureu bacteri assai case cell clinic bacteria biofilm chain group host detect diagnosi distribut infect isol parasit pathogen patient pneumonia salmonella staphylococcu strain evid includ local mechan virul method patient posit report sensit sever studi support valu

133 1065: Hyperglycemia (42) 1066: Suppuration (3) analys analysi base caus condit dai data adiponectin associ caus control diabet fast glucos increas insulin level mellitu metabol mice obes patient peroxisom ppargamma differ indic infect lead pair resist studi toler patient

perform reveal state studi surgeri surgic test

1067: Epiphyses, Slipped (4) 1068: Legg-Perthes Disease (3) bone chain control diseas evid factor approach assess bmd bone famili gene healthi member mutat children factor famili fractur growth includ measur mechan member patient plai provid reaction risk miner molecular osteoblast parent rang score role studi subject support vitamin

1069: Intracranial Embolism (6) 1070: Hearing Loss (61)

arteri caus children clinic detect abnorm acoust auditori bilater canal caus cochlear deaf differ ear find hair hear impair inner develop effect factor famili gener group hypertens imag month loss middl normal sensorineur vestibular patient protein risk valu variabl year

1071: Skull Fractures (7) 1072: Maxillary Fractures (1) assess clinic impact improv life median assai chain detect develop male mice mous patient pcr polymeras quantit month nucleotid patient physic reaction real-tim revers risk sever structur studi surgeri treatment primari qualiti region research sequenc sever structur symptom technolog year

134 1073: Fractures, Comminuted (2) 1074: Orbital Fractures (3) cancer caus consequ death dog effect extract field approach area case clinic design distribut follow local locat month gastric injuri lead normal patient prevent protect reduc reduct result segment patient persist report research tissu sever strategi structur symptom technolog year

1075: Muscle Weakness (35) 1076: Starvation (21) activ case clinic diseas dystrophi effect exercis adapt associ cell control develop effect express femal gene health fiber group muscl muscular number patient present report sever skelet human improv increas life smooth studi symptom male physic qualiti select studi time

1077: Nail-Patella Syndrome (8) 1078: Williams Syndrome (24) affect associ autosom bone clinic base behavior children cognit congenit control disord domin famili gene genet control deficit develop differ disabl featur group impair learn memori number human inherit mutant mutat protein report risk patient perform syndrom task studi syndrom

1079: Myocarditis (22) 1080: Protozoan Infections, Animal (9) assai base chain cluster data detect analysi cardiac cardiomyocyt cardiomyopathi case caus differ diseas effect differ earli femal genet male morpholog pattern pcr reaction region failur gene heart left mice sensit sequenc speci stage patient rat respons target time ventricular

135 1081: Flavobacteriaceae Infections (2) 1082: Peritoneal Neoplasms (53) analysi assai blot cluster detect diseas analysi cancer case dai dna enhanc fragment gener identifi initi endometri estrogen express marker metastat

isol origin reveal second sensit specif model ovarian patient periton report reveal studi tissu treatment strain western tumor uterin

1083: Leukemia, Monocytic, Acute (18) 1084: Basal Ganglia Diseases (23) acut aml analysi children chronic gene acid affect assess associ clinic diseas disord identifi leukaemia leukemia lymphoblast mds mutat myeloid effect famili level local measur mutat patient process protein sampl screen transplant treatment patient report score studi suggest

treat treatment

1085: Encephalomyelitis, Equine (1) 1086: Xerophthalmia (2)

assess bone care concentr conclusions densiti evalu analys analysi antigen band gene health high hospit level low measur

mice mous scale score blot coli confirm demonstr detect dna patient transgen

examin express immun northern protein

respons reveal segment vaccin western

1087: Osteoarthritis, Hip (14) 1088: Pelvic Neoplasms (7) arthriti assess associ diseas evalu activ case cell clinic compar correl diagnosi diagnost group higher level normal famili function gene genet identifi joint measur patient rate support surgeri surgic pain patient report risk time tissu tumour score screen specif studi

136 1089: Schnitzler Syndrome (1) 1090: Ganglioneuroma (9) articl author avail current data definit case cell clinic delet diagnosi diseas express level

line patient phenotyp posit present discuss inform literatur patient period rare report requir system treatment tumor tumour

point publish report review search

systemat time treat treatment

1091: Lymphoma, Lymphoblastic (8) 1092: Wilms Tumor (48)

associ cancer case chicken children chromosom develop case cell develop differenti individu intratumor malign phenotyp progress solid express genom human larg studi suggest suppressor tumor lymphoma mice mous normal tumorigenesi tumour wt1 patient posit report size studi time tissu treatment

1093: Kearns-Sayer Syndrome (4) 1094: Osteoarthritis, Knee (24) brain case character common dna featur arthriti assess associ clinic control function gene genet data diseas distribut estim evalu group joint local measur pain interact human patient rheumatoid score mitochondri mitochondria mtdna studi treatment patient popul report risk stabil suggest

1095: Carotid Stenosis (13) 1096: Adenocarcinoma, Follicular (32) activ adenoma adren braf carcinoma cortisol ace arteri assess associ blood cardiovascular coronari correl hypertens imag infarct measur differ endocrin express follicular gland group myocardi pressur stroke studi subject time treatment vascular hormon neuroendocrin papillari patient

pituitari ptc ret thyroid

137 1097: Carcinoma, Papillary, Follicular 1098: Mixed Connective Tissue Disease (6) (3) antibodi clinic data diagnosi diseas estim carcinoma cell differ evid genom featur form format identifi incid normal local mean normal patient screen specif system test tissu pattern period point provid sampl trial women year support thyroid time tissu tumour valu

1099: Carcinoma, Basosquamous (1) 1100: Hemolysis (37)

antibodi antigen associ carcinoma case cell character clinic criteria diagnos diagnosi activ anemia blood cell concentr diagnost epitheli express lesion mammari count defect defici effect gene group human increas lymphocyt normal patient specimen stain suggest phenotyp peripher rel studi time

1101: Disease (32) 1102: Fibrocystic (6) approxim breast cancer carcinoma adapt assess develop diseas gene case cell clinic combin compar genom health human measur mechan model new rate regul requir research diagnosi diagnost famili score select sequenc studi group imag major measur normal rel time tissu

1103: Adenoma, Oxyphilic (19) 1104: Diarrhea, Infantile (5) administr analysi children cluster dai analysi cluster diseas express failur cell distribut dose function local method gene genet group kidnei morpholog mutat rcc renal respons sampl studi thyroid neg organ posit presenc primari tumor tumour respons select variabl week year

138 1105: Caliciviridae Infections (11) 1106: Gastroenteritis (22) analysi belong character collect differ divers famili genet analysi associ character children clinic collect differ

genotyp group ident identifi isol relat reveal function genet genotyp group human identifi isol sampl sequenc serotyp strain type sampl sequenc strain test treatment type

1107: Tobacco Use Disorder (27) 1108: Urinary Calculi (14) adjust associ case case-control cigarett cohort compar confid control factor increas interv associ bladder case odd ratio regress risk smoke smoker children clinic control correl studi tobacco examin famili gene increas mobil mutat new signific studi tract treatment urin urinari

1109: Pyelonephritis (4) 1110: Colic (5) bladder caus clinic develop analysi case clinic complic diagnosi earli high imag level low distribut famili follow mobil patient plai popul risk sever role manag member studi tract urinari local patient perform procedur reveal risk sever structur studi surgeri surgic

1111: Multiple Endocrine Neoplasia 1112: Ureteral Calculi (3) Type 1 (22) approach bladder clinic design diagnosi experi gene hospit initi intern larg mutant origin adenoma adren clinic diagnosi diagnost gene genet group hormon multipl patient second size small strategi mutat patient pituitari popul studi surgeri ret role thyroid tumor tumour variabl

139 1113: Kidney Calculi (19) 1114: Androgen-Insensitivity Syn- drome (13) bladder case data activ associ cancer case children femal determin develop effect function function gender group male mate genet includ mobil model mutat normal offspr phenotyp report reproduct gene sex sexual tissu rate renal report structur studi tract urin urinari

1115: Kallmann Syndrome (11) 1116: Hip Dislocation (2) clinic cycl famili follicl high hormon case child children consist direct evid experi follow human level low mutat initi intern light origin parent patient provid report second subsequ support year new patient phenotyp pregnanc product reproduct select steroid subject women

1117: Lower Extremity Deformities, 1118: Pulmonary Fibrosis (44) Congenital (3) adenocarcinoma asthma cancer cell compar acid distal dog experi follow initi intern control develop differ effect gene lung method month network origin nsclc patient phenotyp pulmonari respons studi subject tissu treatment patient predict report second segment site stress syndrom techniqu

1119: Irritable Bowel Syndrome (22) 1120: Colonic Diseases, Functional (2) associ bowel chang chronic clinic diseas acid area assess compar effect function genet inflamm inflammatori control differ enhanc frequenc intestin particip patient respons risk small studi test year function higher increas lower measur potenti rate releas score stimul studi versu

140 1121: Bone Diseases, Metabolic (22) 1122: Malocclusion, Angle Class II (11) chang children cleft clinic dental develop activ alter bmd bone caus chang clinic densiti diagnosi fractur function increas effect facial genet lip molar nasal palat lead miner model osteoblast patient rate studi vitamin patient periodont studi teeth tooth treat treatment

1123: Amino Acid Metabolism, Inborn 1124: Lysosomal Storage Diseases (17) Errors (29) abeta accumul alzheimer amyloid biochem caus character deposit amino analysi associ children clinic acid diseas enzym lead lysosom model patholog control fatti gene identifi increas mechan mutat precursor report storag suggest tissu treatment patient retino screen sever studi symptom treatment

1125: Menkes Kinky Hair Syndrome 1126: Blepharophimosis (7) (15) abnorm anomali characterist chromosom cluster

activ autoimmun case caus children clinic diagnosi

diagnost diseas famili femal gene male common congenit defect delet disord distinct mutat progress report select studi tissu treatment

featur group malform number plai report

retard role syndrom

1127: Mandibulofacial Dysostosis (7) 1128: Limb Deformities, Congenital case children cluster combin congenit differ effect (38) featur gener group identifi mutat abnorm anomali case caus chromosom clinic

patient pattern report requir sampl congenit defect differ disord famili male malform screen studi syndrom

mice mutat patient report retard studi syndrom

141 1129: Foot Deformities, Congenital 1130: Hypertrophy, Left Ventricular (29) (40) abnorm anomali associ case congenit defect diseas famili featur human initi malform cardiac cardiomyocyt member new origin report retard segment cardiomyopathi differ failur function

syndrom year genotyp group heart left level model organ patient polymorph popul risk role subject ventricular

1131: Tyrosinemias (6) 1132: Cadaver (57) alter analysi approach case caus develop differ distal dog donor ethic graft chang children group human method model new organ decreas identif identifi increas mass method patient recipi research sampl segment mutat novel parent report sampl screen treatment stem transplant

1133: Chylothorax (2) 1134: (21) abnorm activ anomali case children clinic arteri cat complic coronari distal congenit defect disord group increas malform dog hand hypertens limb oper mutat parent phenotyp report retard studi postop pressur patient syndrom treatment procedur proxim resect segment surgeri surgic syndrom

1135: Leukemia, Myelomonocytic, 1136: Hernia, Hiatal (2) Chronic (25) alter chang character compar control core acut aml blast children chronic cml encod frame function healthi mean imatinib leukaemia leukem normal open patient read lymphoblast mds leukemia respect subject syndrom tissu valu model myeloid patient rate respons role sampl transplant

142 1137: Cardiovascular Abnormalities 1138: Cutis Laxa (8) (24) abnorm anomali associ bind congenit defect analysi cardiac clinic cluster congenit control

disord express group isol malform mechan defect develop genet heart mechan molecular

model molecular protein report retard site number process rate report risk role studi syndrom studi syndrom

1139: Aortic Diseases (13) 1140: Muscle Hypotonia (35) abnorm analysi anomali associ case children arteri associ complic coronari chromosom clinic congenit defect disord earli function gener hospit hypertens oper featur malform patient report retard sever

patient pressur procedur region syndrom year select sequenc size studi surgeri surgic variabl

1141: Hip Dislocation, Congenital (8) 1142: Wounds, Gunshot (14) case children combin control correl data adult bone children differ earli differ effect larg rat genet mean parent patient patient pattern popul process stage studi surgeri report requir research respons sampl size small studi year syndrom test tumour valu year

1143: Subarachnoid Hemorrhage (27) 1144: Hemangioma, Cavernous, Cen- associ case clinic complic control identifi oper tral Nervous System (5)

patient perform popul postop case develop differ evid featur preoper procedur rate requir resect studi imag larg lesion life mutat number pattern surgeri surgic underw perform qualiti requir size small stain support syndrom

143 1145: Leukemia P388 (10) 1146: Telangiectasia, Hereditary Hem- orrhagic (27) analysi anim blood chang dai cell case clinic data develop famili function develop earli effect growth human inhibit glioblastoma glioma identifi includ malign new mechan mice model structur tumor number patient primari vitro vivo xenograft rate secondari size studi test

1147: Reoviridae Infections (4) 1148: Psoas Abscess (1) analysi assai cell dai detect diseas adolesc autism child childhood dose earli express gene high children clinic diagnosi diagnost frequent gener occur occurr parent incid isol level low report sensit stage patient pediatr report sever studi transmiss year strain studi

1149: Discitis (3) 1150: Tuberculosis, Spinal (2)

children clinic data diagnosi effect enhanc approach case children clinic data design gener includ increas infect patient region diagnosi diagnost gener includ limit sequenc sever studi symptom therapi treat parent rang report specif strategi studi treat treatment tuberculosi treatment year

1151: Hypohidrosis (6) 1152: Abnormali- acid affect autosom case clinic dai diagnosi ties (4) case children correl factor femal form format disord domin dose famili featur femal inherit male member mutat normal human incid larg lung male recess tissu report risk size small syndrom system vivo year

144 1153: Rh Isoimmunization (14) 1154: Erythroblastosis, Fetal (8) analysi birth china chines determin birth blood chain compar differ fetal group human identifi matern pcr differ fetal heterogen includ peripher phenotyp pregnanc product reaction matern observ phenotyp pregnanc respect respect sampl screen valu signific studi subtyp valu weak women

1155: Dermoid Cyst (4) 1156: Cyanosis (8) addit case combin correct demonstr diagnosi effect find kidnei literatur patient present associ case clinic previou rare renal report studi surgeri surgic diagnosi earli effect enzym genet identifi tumor improv life patient present qualiti report sever studi symptom syndrom target

1157: Mobius Syndrome (11) 1158: Rhabdomyoma (10) associ behavior chang children clinic appear cell develop evid examin congenit control develop differ earli featur extent featur find genet human indic investig involv later mark group patient popul process report observ sclerosi studi suggest survivin respons sampl studi syndrom

1159: Pierre Robin Syndrome (6) 1160: Porphyrias (17) children cleft clinic data develop estim evid featur arthriti associ case caus clinic data diseas enzym famili includ joint genet identifi method new patient provid screen select sever support symptom syndrom pain patient rat rate report rheumatoid sever studi treatment

145 1161: Neuroendocrine Tumors (22) 1162: Gastrinoma (3) alter analysi cell chang control correl cell gene imag induc induct islet detect express featur group hormon imag mutat organ pancreat plai patient protein studi receptor region respons role thyroid tissu tumor secret sequenc studi suggest tumor tumour tumour valu

1163: Ileal Neoplasms (10) 1164: Carcinoid Tumor (28) associ cancer case characterist adren analysi associ cell detect gene clinic common diagnosi diagnost hormon human larg mutat number earli featur gene genet methyl patient patient phenotyp size small studi target phenotyp posit report stage tumor tumour thyroid tumor tumour

1165: Carcinoma, Bronchogenic (6) 1166: Prediabetic State (6) cancer carcinoma cell clinic compar decreas differenti express increas level lung mean acid diabet differ glucos individu insulin level linkag map mechan mice model patient prolifer ratio report respect studi pattern period plai point role studi time type tumor valu

1167: Myeloid Metaplasia (15) 1168: Hepatitis (17)

acut aml base chronic clinic control diagnosi adult associ biolog bodi control dai differ group hepat hepatocyt liver gene genet leukemia human method model report signific studi system time tissu year level mds methyl myeloid patient process requir respons transplant

146 1169: Liver Failure, Acute (13) 1170: Bernard-Soulier Syndrome (6) acid anim caus chang clinic develop differ base bind case content control determin differ flow genet healthi larg methods featur hepat hepatocyt level liver model new patient role sever symptom number patient report size test treatment small subject syndrom time

1171: Pregnancy Complications, 1172: Gastritis, Atrophic (5)

Hematologic (35) cancer compar control decreas differ earli gastric group increas length method number case detect birth factor fetal pylori rat repeat respect short signific stage studi gestat group high infant matern mother neonat patient pregnanc prenat protein risk studi week women

1173: Infertility (60) 1174: Gait Disorders, Neurologic (15) cycl data embryo ethic femal adult assess associ clinic correl diseas earli effect evalu function health mean

follicl group hormon increas measur patient product scale score valid valu year male method patient pregnanc

reproduct research select sperm steroid studi women

1175: (57) 1176: Glycogen Storage Disease Type adenoma adren braf endocrin gland group II (14) high hormon identifi level male neuroendocrin papillari pituitari ptc ret screen subject abeta accumul amyloid analysi caus decreas deposit treatment diseas increas thyroid lysosom mice patient precursor process report respons storag studi suggest tissu

147 1177: Dermatofibrosarcoma (10) 1178: Red-Cell Aplasia, Pure (25) analysi c-kit case cell clinic correl abnorm anaemia analysi anemia blood caus common

defect defici disord epo erythrocyt erythroid erythropoietin g6pd hemoglobin normal diagnosi featur growth includ kit gene patient sever sickl malign patient respons reveal sarcoma

stromal studi tumor

1179: Micrognathism (16) 1180: Presbycusis (3) case chang cleft clinic congenit dental facial factor growth increas method model palat associ caus differ lead link loss mechan mice modif modifi molecular observ patient pattern ratio relat risk signific studi suggest patient region report sequenc studi syndrom treatment

1181: Mitral Valve Insufficiency (14) 1182: Intraoperative Complications (38) analysi associ atrial cardiac abdomin aneurysm case chang children cardiomyocyt cardiomyopathi detect dilat complic group manag model oper

express failur group heart patient perform postop preoper hypertrophi left measur method right studi valv ventricular procedur resect surgeri surgic techniqu underw

1183: Cross Infection (43) 1184: Creutzfeldt-Jakob Syndrome bacteri care clinic conclusions design health (23)

alzheimer associ autoimmun common control develop hospit host infect isol main medic number objective pathogen differ diseas famili group high larg low patient number parkinson pathogenesi patient progress size studi risk strain studi year

148 1185: Heart Rupture (2) 1186: Multiple Organ Failure (14) activ analysi block blot case compar activ associ caus clinic differ function group increas lead level number control diseas effect frequenc organ plai risk sever inhibit inhibitori mice produc product patient role report suppress surviv syndrom western studi symptom year

1187: Splenic Diseases (9) 1188: Hip Fractures (15)

associ case combin control data defici disord associ bone care ethic evid follow healthi patient product health hospit inform interv medic provid report sever structur studi subject support time multipl particip patient provid rate ratio research risk studi vitamin year

1189: Mediastinal Neoplasms (23) 1190: Tongue Neoplasms (24) adult b-cell case cell develop express famili analysi case cell compar control gene includ larg lymphocyt lymphoma develop earli express gene model month patient select studi group lesion normal patient surviv tumor year rat stage studi surviv tissu tumor tumour

1191: Nesidioblastosis (1) 1192: Sarcoma, Endometrial Stromal (7) adult analys clinic clone analysi analysi case combin data diagnosi diagnost diseas elderli indic older develop effect express famili genet high level low pancreat perform phenotyp reveal secret studi year young ovarian patient posit role sarcoma stromal studi treatment tumor

149 1193: Factor VII Deficiency (11) 1194: Blood Loss, Surgical (15) blood case complic group human activ analysi bleed blood caus defici differ factor folat gene lead mthfr increas mean model oper patient mutat number patient pattern perform peripher postop procedur resect studi platelet studi subject venou surgeri surgic underw valu

1195: , Hemorrhagic 1196: Lens Subluxation (5) (25) associ case cataract chang acut aml case chronic develop differ correl differ earli famili glaucoma leukaemia mds leukemia implant len level neg normal pattern myeloid normal patient rate requir respons role studi time tissu treatment posit primari report studi tissu

1197: Muscular Atrophy (21) 1198: Fibroma (21) analysi associ children differ dystrophi exercis associ case differ famili gene fiber function growth increas level mechan includ mutat new normal patient provid rare rate report sarcoma stromal studi tissu muscl muscular report role skelet smooth studi subject tumor year

1199: Fibrous Dysplasia, Polyostotic 1200: Leishmaniasis, Cutaneous (14) (7) activ bacteri case concentr effect activ caus children clinic case genom host human infect diagnosi lead length level malign mutat parent mice mutant normal number patient present rare repeat parasit pathogen report studi test report studi tumor tumour tissu treatment

150 1201: Chagas Disease (15) 1202: Tangier Disease (4)

cluster combin compar control cell condit data decreas degre gener differ diseas effect factor famili frequenc genom genotyp increas patient risk select increas larg level lipid mice sequenc studi test treatment mous mutat phenotyp requir resist risk size small temperatur

1203: Whipple Disease (3) 1204: Hypospadias (26) birth case chang combin associ base data error estim fetal gestat increas infant featur form format improv life method male matern neonat pregnanc prenat rate model paramet power ratio risk report risk studi syndrom week women simul statist treat treatment

1205: Hepatoblastoma (17) 1206: (15) adult analysi case cell associ case clinic control diagnosi children effect express diseas express famili function gene liver member mice mutat patient form format hepat famili phenotyp popul report role studi liver new patient report treatment tumor tumour valu year

1207: Leukemia, T-Cell, Acute (29) 1208: Granuloma (22) acut aml analysi cell chronic combin associ case children chronic effect leukaemia leukemia develop differ diseas earli lymphoblast mds myeloid patient protein famili group inflamm inflammatori repeat respons reveal studi target treatment intestin mice number patient pattern rate report respons

151 1209: Ureteral Neoplasms (8) 1210: Porphyria Cutanea Tarda (9)

approxim bladder case data detect arthriti associ attack chronic clinic combin diseas determin effect mobil model fever headach joint knee methods migrain objective patient rel report studi tract pain patient rheumatoid sever transit tumor tumour urin urinari year symptom synovi

1211: Tremor (21) 1212: Rubella Syndrome, Congenital abnorm ataxia atrophi caus chang clinic (2)

adult antibodi child childhood children clinic diseas disord dysfunct earli expand expans huntington motor diagnosi incid mortal parent patient neuron onset patholog progress studi time pediatr presenc preval report studi syndrom women year young

1213: Cerebral Hemorrhage (18) 1214: Vertebrobasilar Insufficiency (3) activ analysi brain case compar control arteri case clinic common diseas differ factor group higher incid featur genotyp hospit imag incid men level mutant mutat identifi mortal patient preval primari patient rate risk serum regul screen women year women year

1215: (33) 1216: Fractures, Bone (37) associ cancer cell compar correl effect endometri estrogen human level analysi bone case cluster combin develop differ femal fractur hospit male miner model ovarian patient periton osteoblast patient report risk studi treatment vitamin year resist signific studi suggest treatment valu

152 1217: Arm Injuries (3) 1218: Emergencies (27) bone care conclusions data design distal dog care case center clinic conclusions hospit inform literatur main medic number design health hospit objective particip report patient increas main medic objective segment structur studi patient practic rate record research studi univers year

1219: Leg Injuries (5) 1220: Cardiomyopathy, Hypertrophic, Familial (13) base clinic combin data design adult cardiac children develop famili gene elderli hospit mean medic model mutat old genet heart identifi left mutant older pair patient state studi year young mutat normal patient ratio risk subject time tissu valu ventricular

1221: Lymphoma, Follicular (67) 1222: Adenomatous Polyps (5) b-cell case cell cll diffus hodgkin immunoglobulin alter associ cancer carrier cell chang larg leukemia lymphocyt lymphoid

malign new nhl lymphoma colorect differ factor genotyp incid increas non-hodgkin patient rate rituximab t-cell

mutat observ pattern polymorph protein rel

repeat risk

1223: Charcot-Marie-Tooth Disease 1224: Lymphoma, Small-Cell (6) (47) data decreas dna estim express featur axon cord demyelin famili fibr follow gene heal gene genet increas larg injuri mutat myelin nerv lymphoma mutat new number protein neuropathi oligodendrocyt peripher regener provid respons size small tumor sensori spinal trauma wound

153 1225: Heredodegenerative Disorders, 1226: Arthropathy, Neurogenic (7) Nervous System (11) adult bone clinic compar control distal caus chang develop diseas gene genom dog effect group high level low high human involv life mechan model measur number patient new process qualiti patient segment test time trial year respons role sequenc studi

1227: Pseudomonas Infections (34) 1228: Botulism (4) aeruginosa antibiot aureu bacteri bacteria assai case chain clinic biofilm control group host infect isol parasit pathogen patient salmonella strain studi subject virul year cluster coli dai detect

diagnosi dna fragment individu

isol method pcr rat reaction

sensit strain subject

1229: Tuberculosis, Female Genital (1) 1230: Lung Diseases, Interstitial (24) amplifi analysi collect data detect dna femal adenocarcinoma associ cancer case cell fragment gener male multipl pcr children clinic develop effect lung mutat primer restrict sampl sex sexual new normal nsclc patient protein singl studi tuberculosi pulmonari sampl studi tissu

1231: Ataxia Telangiectasia (26) 1232: Pharyngitis (11)

analysi associ case clinic compar control differ associ break damag dna factor famili gene growth increas level mutat normal number patient plai repair respons effect gene group infect isol patient rate risk role tissu

report sampl sequenc strain treat treatment

154 1233: Bone Marrow Neoplasms (24) 1234: Adenomyoma (2) assai associ bone cancer cell correl detect adhes breast cancer case cell differ express gene macrophag marrow collagen dynam extracellular integrin matrix

repeat sensit size test patient model molecul ovarian present rare tumor valu year report simul stress surfac women

1235: Myoepithelioma (12) 1236: Esophageal Stenosis (6)

case clinic common esophag featur frequent carcinoma case cell clinic diagnosi includ investig life occur occurr

differ epitheli epithelium patient possibl probabl rare relat report studi transmiss transmit express genet gland human imag mammari number pattern popul report studi tumor

1237: Hernia, Diaphragmatic (17) 1238: Hip Dysplasia, Canine (3) abnorm anomali case clinic congenit defect assess compar data dog estim factor differ find group malform measur model higher incid lower mean measur model patient report retard studi surgeri surgic patient rang rate risk score syndrom year segment valu year

1239: Typhoid Fever (6) 1240: Dyskinesias (3)

american assai bacteri caus detect administr affect associ concentr confid dai dose

effect function interv irradi odd patient distribut ethic ethnic host infect radiat ratio risk smoke studi valu week life local pathogen popul preval primari

research resist sensit test

155 1241: Leukemia, Radiation-Induced 1242: Diabetes Insipidus, Nephrogenic (12) (10) area assess case caus dai differ dose analysi case caus chang concentr control effect factor incid irradi life preval radiat earli express failur femal genet kidnei male manag point rcc risk studi test time women year renal reveal studi time

1243: Skin Diseases, Parasitic (3) 1244: Mite Infestations (5) alter caus chang data diseas evid find data detect effect estim genet high level group identifi infect lead multipl light low model mutant phenotyp provid report screen speci studi new suggest support popul product provid reduc speci

studi treat treatment

1245: Pestivirus Infections (2) 1246: Hemolytic-Uremic Syndrome african american assai cell (13) analysi case defici determin develop earli detect differ ethnic genet enhanc high identifi level model mutat identifi isol popul ratio region risk patient predict rate report risk screen specif sensit sequenc specif stage variabl strain white

1247: Lipodystrophy (13) 1248: Purpura (5) clinic control diabet glucos healthi increas case correl dai decreas donor famili field insight insulin medic mutat new follow increas manag model patient phenotyp protein provid select sever normal patient product specif studi time state studi subject tissu transplant tumour

156 1249: Raynaud Disease (2) 1250: (10) anim case clinic dai diagnosi diseas dose find blood case clinic diagnosi earli gene level model neg patient posit hospit lymphoma new patient present previou report serum sever studi symptom present produc product rare report select specif time treatment tumour

1251: Cellulitis (6) 1252: Skin Diseases (81) adult case combin data effect genet high basal case chang cutan develop epiderm epidermi function gene keratin keratinocyt lesion level local low method model patient present report specif normal patient psoriasi skin studi ultraviolet uvb year studi surgeri surgic year

1253: Cysts (33) 1254: Nevus (27) case clinic complic diagnosi high associ control correl develop differ environment express factor featur gene genet influenc manag oper patient perform melanoma method model polymeras postop present procedur remain report resect rate risk rna studi studi surgeri surgic syndrom underw

1255: Aortic Aneurysm, Thoracic (12) 1256: Thoracic Injuries (3) abdomin case complic group adult avail care case clinic data databas diagnosi genom health includ inform manag normal oper patient larg present program report size small studi perform postop preoper procedur resect year risk surgeri surgic techniqu time tissu underw

157 1257: Aneurysm, Dissecting (18) 1258: Wounds, Nonpenetrating (16) adult arteri case clinic complic group assess case children clinic design form format hospit injuri measur nerv number hypertens imag oper patient perform postop pressur procedur remain patient popul rate report studi surgeri surgic time year respons studi surgeri year

1259: Sarcoma 180 (12) 1260: Anemia, Hemolytic, Congenital (5) activ analysi assai cell combin compar control effect gene group activ anemia area caus cell codon increas inhibit mice number rate data defect defici featur genotyp lead resist sensit treatment tumor vivo mutant mutat new polymorph region sequenc sever subject

1261: Respiratory Distress Syndrome, 1262: Wasting Syndrome (8) Newborn (11) anim associ combin concentr dai differ associ birth care children effect experiment interact model fetal health increas matern new patient pregnanc muscl period point rat role sampl size studi product protein requir role state syndrom time studi treatment women year

1263: Postoperative Nausea and Vom- 1264: Pain, Postoperative (17) iting (3) associ care complic follow group hospit manag administr allel continu copi dai delai dose follow genotyp hour long-term oper particip patient perform postop procedur resect studi surgeri surgic number patient persist time treatment underw polymorph recoveri time treat treatment week

158 1265: Purpura, Schoenlein-Henoch (10) 1266: Nephritis (12)

case children compar control dai develop earli associ biolog cell combin data develop estim effect method month mutat new parent kidnei mechan method model molecular patient protein rate role select normal patient polymorph renal specif year role studi system tissu

1267: Neoplasms, Unknown Primary 1268: Carcinoma, Neuroendocrine (14) (13) carcinoma case cell differ express associ base cancer case chain chang clinic cluster detect diagnosi diagnost differ larg featur gene genom high human larg number patient posit remain mutat number patient posit rate report respons time variabl size small tumor

1269: Metabolic Diseases (12) 1270: Cerebrovascular Disorders (17) caus clinic data diagnosi diseas factor adult associ case diseas elderli gene identifi incid includ increas lead new genet group incid includ number old older patient phenotyp popul risk sampl sever patient report risk studi women year young studi year

1271: Glycogen Storage Disease Type 1272: Heroin Dependence (8) V (3) alcohol assai associ case data associ case children depend detect effect method domin famili femal gene genet inherit male month mutat number oral patient plai rat ratio parent patient report risk sex studi year risk role sensit signific studi year

159 1273: Pregnancy in Diabetics (11) 1274: Nose Diseases (3) acid analysi anim associ birth decreas african american analysi asian develop differ fetal increas level black case caucasian develop matern model predict pregnanc differ ethnic european indian north rat role studi time variabl popul preval race reveal risk south white

1275: Glycogen Storage Disease (4) 1276: Cardiomegaly (35) accumul bind cardiac caus control diseas atrial cardiac cardiomyocyt domin famili gene healthi heart inherit cardiomyopathi develop dilat effect failur muscl mutat protein function gene heart hypertrophi left protein rat respons right role valv ventricular skelet smooth sperm studi subject

1277: Mucopolysaccharidosis VI (8) 1278: Language Disorders (18) behavior behaviour child childhood accumul amyloid case clinic combin correl dai deposit diagnosi diseas children cognit deficit differ group level lysosom normal report disabl genet impair learn memori parent patient perform studi task test year storag studi suggest test tissu

1279: Cytochrome-c Oxidase Defi- 1280: Hypoxia, Brain (6) ciency (3) associ complex concentr defici effect adult condit cultur defect degre delet examin follow group increas initi potenti predict protein rat releas signific develop diseas dna inhibit stimul studi suggest variabl level metabol mitochondri mutant mutat older serum wild-typ year young

160 1281: Diffuse Cerebral Sclerosis of 1282: Dracunculiasis (1) Schilder (7) african american area assai assess clinic concentr develop detect ethnic incid measur men differ effect function imag level method mortal popul min mitochondri mutat new preval produc product patient pattern phenotyp plasma score sensit women year provid select test tumour

1283: Hydronephrosis (10) 1284: Erdheim-Chester Disease (2) case children clinic alzheimer autoimmun case diagnosi diagnosi diagnost diseas effect imag diseas disord kidnei literatur parkinson pathogenesi patholog patient present prognost progress kidnei level parent patient present rare renal report surviv tau rat renal report serum sever studi symptom

1285: Osteosclerosis (7) 1286: Intussusception (5) biolog bone case caus cell clinic diseas associ case caus chronic diseas inflamm inflammatori intestin lead open patient present rare ratio report risk small surgeri surgic syndrom famili includ individu male member mutat new patient popul sever

studi syndrom system

1287: Ileal Diseases (6) 1288: Myotonia (3)

adult associ case abil alter capac chang channel chronic clinic cluster children complex diseas fusion genet increas diagnosi diseas evolut older origin influenc method mice muscl mutat network predict properti stress studi parent patient report sever studi syndrom year young

161 1289: Hyperammonemia (15) 1290: Ornithine Carbamoyltransferase anemia case caus children clinic defect Deficiency Disease (5)

defici effect enzym express case children compar control function high patient reduc report risk dai defici develop effect femal sever studi treatment year growth healthi male manag mean patient protein sex subject transplant valu

1291: Leukoencephalitis, Acute Hemor- 1292: Mucolipidoses (10) rhagic (2) accumul activ case caus analys analysi case characterist clinic deposit diagnosi diseas effect children clinic common degre diagnosi gene genet includ new patient featur function parent patient phenotyp reduc report storag suggest perform present report reveal sever studi test symptom

1293: Mucopolysaccharidoses (6) 1294: Infant, Newborn, Diseases (25) accumul adult analysi correl deposit birth case clinic famili detect diseas function high identifi fetal genet gestat human level low normal organ patient infant matern screen serum specif tissu year identifi neonat patient pregnanc prenat report screen sever treatment women

1295: Immunologic Deficiency Syn- 1296: Galactosemias (20) dromes (46) activ associ cerevisia children compar differ analysi associ cell children group identifi increas model mutat patient rat rate saccharomyc sampl screen clinic differ diseas famili human structur studi yeast infect mutat number patient rate respons select studi syndrom treatment viru

162 1297: Biotinidase Deficiency (4) 1298: Periapical Periodontitis (2) assai case defici detect area assess associ base compar correl differ higher measur observ function genet human group patient popul presenc rate risk score identif identifi novel signific studi treatment patient plai posit regul requir role screen sensit studi test

1299: Tooth, Nonvital (3) 1300: Nephrotic Syndrome (28) assess case control data evalu impact improv associ case chronic clear clinic diseas failur famili glomerular high kidnei mutat nephropathi life literatur measur patient physic publish qualiti report research review patient progress rcc renal risk studi tubular score studi subject

1301: Pancreatic Diseases (15) 1302: Gingivitis (10) area case cell children clinic develop care cell cleft clinic compar control dai diagnosi genet human islet model femal group health higher male manag medic method product rat normal pancrea pancreat patient secret structur studi tissu year rate studi subject

1303: Thyroid Diseases (20) 1304: Diabetic Ketoacidosis (7) analysi associ case chang clinic allel alter case chang clinic combin control develop evid express famili high develop diabet femal frequenc genotyp hormon number patient insulin male patient polymorph product report studi year provid rel report studi support thyroid time

163 1305: Shoulder Dislocation (2) 1306: Optic Nerve Neoplasms (3)

cell clinic cluster compar diagnosi differ hospit activ brain care cost current discuss includ multipl patient pattern perform rang similar follow-up hospit lesion manag median medic structur studi system test tumor type month patient rang recent recurr requir stain year

1307: (13) 1308: Prader-Willi Syndrome (43)

abnorm anomali case children clinic congenit abnorm adult anomali associ clinic congenit defect defect develop famili gener malform normal develop disord featur gene genet group malform

patient report retard select sequenc mental report retard syndrom treatment year syndrom tissu treatment

1309: Jaundice, Neonatal (12) 1310: Nerve Sheath Neoplasms (15) associ broad case develop divers chang clinic correl defici effect gene genet hepat level liver includ larg major mutant mutat mutat patient popul relationship patient rang report repres risk sever signific treatment valu variabl spectrum tissu tumor type varieti wide

1311: Antiphospholipid Syndrome (23) 1312: Abducens Nerve Diseases (2) clinic codon diagnosi diagnost differ analysi antibodi antigen case cell clinic detect develop factor mab mechan monoclon mutat neutral patient platelet process role specif studi experi gener individu

initi injuri intern mean measur origin

ratio respect second substitut syndrom valu

164 1313: Hypesthesia (2) 1314: Dysarthria (6) abnorm adolesc autism boi child childhood assess brain case delet diseas earli enhanc famili gene loss measur normal children congenit disord girl injuri loss nerv parent pediatr report spinal product score stage syndrom wound year patient studi subject time tissu

1315: Brachial Plexus Neuropathies (8) 1316: Thoracic Outlet Syndrome (1)

apoptosi contract cord dystrophi exercis fiber associ chang develop follow includ initi injuri isol nerv origin process implant injuri muscl muscular risk spinal strain studi subject time treat myoblast myopathi nerv regener skelet smc smooth spinal train wound treatment wound

1317: Multiple Sclerosis, Relapsing- 1318: Multiple Sclerosis, Chronic Pro- Remitting (13) gressive (7) data diseas distribut earli examin express behavior case combin compar control extent gene high level local low month correl effect evalu famili human imag number observ patient respons studi suggest year increas measur mice patient

perform produc product signific studi

1319: Hypoxia-Ischemia, Brain (11) 1320: Hypothermia (12) activ adult affect case condit dai degre acid behavior brain central children condit dai data degre estim gener distribut effect famili increas local identifi involv nervou patient process protein member mice model rate subject temperatur patient report studi temperatur year

165 1321: Asphyxia (4) 1322: Hypernatremia (4)

blood clinic condit dai degre differ fetal follow genet alter assess case caus chang group heat patient pregnanc present concentr condit degre express sever shock signific symptom syndrom temperatur increas measur mechan produc product rat repeat risk score temperatur variabl

1323: Miller Fisher Syndrome (4) 1324: Trauma, Nervous System (4) accumul analys analysi antibodi children adapt anim area cell complex develop diseas complex diseas effect experi inhibit initi experiment new plai potenti intern normal origin reduc reveal model provid rat receptor role select state studi second test tissu vivo target

1325: Melanosis (8) 1326: Spinocerebellar Degenerations adult analysi biopsi case (13) abnorm affect analysi ataxia atrophi caus cell develop effect histolog chang clinic differenti immunohistochem includ lesion model diseas disord particip rang report skin specimen stain expand expans gene genet motor varieti wide year patient progress role

1327: Hyponatremia (12) 1328: Scoliosis (21) acut associ caus clinic defici diseas increas abnorm anomali case congenit defect featur lead level manifest mild mutat gene human malform month new patient present sever sign patient rate report retard role select symptom syndrom test treatment syndrom treatment year

166 1329: Ophthalmoplegia (13) 1330: Purpura, Thrombocytopenic, Id- iopathic (19) associ caus differ case children detect develop differ diseas effect diseas disord experi imag express factor folat month increas initi level model mutat patient platelet respect respons sensit studi subtyp time year new origin phenotyp presenc rate second syndrom treatment

1331: Hyperprolactinemia (6) 1332: Machado-Joseph Disease (16) affect case children clinic control design abnorm ataxia atrophi caus clinic effect function diseas disord dysfunct expand group hospit level measur expans express huntington inclus motor patient reduc requir score sever studi neuron onset patholog popul progress repeat subject symptom

1333: von Willebrand Disease (17) 1334: Adrenocortical Adenoma (6)

associ caus cell compar concentr control decreas associ bleed cell coagul factor folat gene imag increas normal homocystein method mthfr mutat new express level patient plasma platelet risk studi patient plasma receptor report serum studi thyroid tissu thrombosi tissu venou

1335: Osteoporosis, Postmenopausal 1336: Cecal Diseases (6) (21) associ case develop evid famili high level local low member number bmd bone care clinic densiti fractur phenotyp present rare report studi suggest health high hip level miner new number treat treatment tumour osteoblast random risk studi treatment trial vitamin

167 1337: Ependymoma (12) 1338: Polycystic Ovary Syndrome (34) children compar control delet differ assist control cycl follicl fsh function express gene glioma month patient pattern posit primari protein secondari studi group hormon ivf ovari ovarian time tumor type year

patient pregnanc progesteron reproduct

steroid stimul studi testosteron women

1339: Esophageal Achalasia (6) 1340: Amniotic Band Syndrome (1)

characterist children common analysi associ behavior blot caus character characterist common core encod distribut effect famili featur featur lead light mechan molecular open relat reveal studi western function genet hormon individu local mechan member molecular parent reduc reduct thyroid treatment

1341: Dwarfism (23) 1342: Uterine Diseases (7) activ analysi chain chang develop factor anim bovin breed case chang clinic compar function gene genet genom growth increas diagnosi differ group higher level mice mous mutant reaction method milk normal number studi syndrom transgen patient pig rate tissu women

1343: Polyps (12) 1344: Abortion, Habitual (26)

adult associ cancer case clinic colon colorect associ birth compar control differ factor diseas famili form gastric member mice mutat fetal gene higher infant matern mutat patient present rare report tumor year neonat patient pregnanc rate risk studi women year

168 1345: Uterine Cervical Incompetence 1346: Needlestick Injuries (3) (2) benefit care children clinic cost decis femal guidelin male manag blood caus clinic criteria data medic month patient practic diagnos diagnost diagnosi random recommend resist safeti trial year evid factor genet lead mechan molecular month patient provid risk support underli

1347: Psychophysiologic Disorders (11) 1348: Hereditary Sensory and Auto- nomic Neuropathies (6) abil adult assess care clinic case character characterist clinic common control develop disord health measur distinct domin famili featur function older particip patient properti risk sampl gene inherit injuri mutat nerv score studi year young patient rel risk sever subject

1349: Gonadal Dysgenesis, 46,XY (9) 1350: Sarcoma, Synovial (21) c-kit case cell gastrointestin giant gist case children clinic correl develop femal

gene gener male mate model offspr group hsp90 imatinib includ kit malign patient process repeat reproduct sex sexual syndrom treatment sampl sarcoma soft stromal

sts studi tissu tumor

1351: Wiskott-Aldrich Syndrome (20) 1352: Labor Pain (1)

abnorm anomali cell children congenit defect chang cours determin differ durat end follow length long diseas express function gene increas malform mutat patient protein report respons select

longer particip period point real repeat short shorter syndrom tumour

start tempor time

169 1353: Duane Retraction Syndrome (5) 1354: Hyperglycinemia, Nonketotic (6) adult case conclusions congenit corneal correct case caus chromosom clinic growth hybrid mean methods normal associ earli gene high level low mutat patient popul presenc report specif patient report residu sever studi syndrom tissu year site structur studi subject syndrom

1355: Cystinuria (43) 1356: Postpartum Hemorrhage (5) alpha-synuclein alzheimer autoimmun caus common analysi case data differ estim group health method organ patient predict presenc dementia diseas disord fabri genet includ neurodegen onset parkin parkinson pathogenesi patholog regress repeat report signific studi treatment patient progress tau variabl variat

1357: Helminthiasis, Animal (4) 1358: Postmortem Changes (33) analysi area complex differ distribut affect analysi associ brain compar evolut fluid group isol local control diseas effect express level method method number pattern produc product gene increas report sampl speci studi suggest patient protein sampl studi subject time tissu

1359: Epilepsy, Absence (13) 1360: Goat Diseases (17) absenc associ attempt condit data eeg epilepsi follow gener head includ indic presenc report anim bovin breed calv respons seizur stress studi suggest suicid cattl cow dai differ effect farm goat

isol lactat milk pig porcin

product respect sheep strain

170 1361: Mastitis (8) 1362: Focal Nodular Hyperplasia (4) adult breast cancer case cluster concentr caus conserv control decreas factor featur function growth health human data effect form format femal increas individu liver mammalian gener isol process sequenc sex male marker mice mous risk sexual strain year studi subject

1363: Joint Diseases (24) 1364: Musculoskeletal Diseases (20) arthriti associ case clinic diseas assess care chain children clinic data express joint mutat new normal design diagnosi health hospit inform pain patient provid rat measur method model particip report rheumatoid select sever patient provid rate reaction studi tissu studi

1365: Ankle Injuries (3) 1366: Gallbladder Diseases (3) assess compar control differ effect affect base case clinic diagnosi differ diseas event evalu higher imag larg measur gastric group hospit involv methods number patient rang rate reduc occur pair patient process report signific studi scale score size small subject

1367: Gastric Outlet Obstruction (1) 1368: Cutaneous Fistula (4) compar control design differ divid evalu activ area associ bladder case clinic diagnosi patient present rare report hospit imag larg larger methods group requir risk structur studi surgeri surgic syndrom month number patient respect signific size small studi tract urinari

171 1369: Bird Diseases (22) 1370: Hepatic Vein Thrombosis (6)

analysi associ chicken cluster differ genet approach case clinic complic decreas factor follow

imprint individu infect isol increas mean mutat patient japanes new organ popul sequenc speci strain persist posit present report sever surgeri surgic studi suggest viru symptom valu

1371: Choledochal Cyst (1) 1372: Cumulative Trauma Disorders african american black data ethnic express (8) adapt area associ chang compar data literatur liver month patient effect group health higher increas model popul publish report review surgeri surgic therapi treatment white year rate risk sampl select studi time treatment year

1373: Dizziness (6) 1374: Opioid-Related Disorders (7) absenc adult case compar detect alcohol consumpt depend drink drug effect ethanol local mechan new high higher human level loss low method model older presenc rate oral patient prefer reduc requir studi subject young year signific studi substanc treatment tumour

1375: Moyamoya Disease (8) 1376: Hypoalbuminemia (3) case clinic defici enhanc gene induc induct analys analysi anim associ level mean mice patient present radiat region report respons sequenc sever children diseas express gene high symptom valu includ individu low model patient

rate region reveal sequenc sever studi

172 1377: Brain Abscess (10) 1378: Heat Stress Disorders (7)

brain case central cultur activ affect cell condit detect develop distribut earli fluid degre effect health measur genet imag local nervou new normal protein provid report patient posit primari region respons risk size studi subject report sequenc test temperatur tissu

1379: Epiretinal Membrane (11) 1380: (6)

case chang cone correl degener activ case chain dai detect earli examin gener group macular estim health identifi patient pcr period point method optic pigment relationship report polymeras quantit retin retina signific studi reaction visual real-tim retin revers screen time

1381: Diabetic Angiopathies (22) 1382: Retinal Drusen (11) cone control degener function compar control diabet earli function glucos incid increas insulin level group high human level low men metabol mortal patient preval risk studi tissu women year macular methods model optic photoreceptor pigment retin retina risk vision visual

1383: Coxsackievirus Infections (14) 1384: Sandhoff Disease (3) bind case combin detect develop diseas factor accumul affect alter approxim caus group growth infect isol method chang clinic deposit diagnosi mice replic sequenc specif treatment viral viru virus diseas enzym gener lung major method mice mutant observ rel suggest

173 1385: Lens Diseases (4) 1386: Hernia, Ventral (2)

affect alter chang children decreas avail case clinic criteria data databas examin express famili implant increas individu len mean member observ parent phenotyp signific deaf diagnos diagnosi syndrom valu diagnost ear hair hear impair inner

laboratori loss patient surviv tool

1387: Hepatitis, Viral, Human (12) 1388: Malocclusion (31)

analysi clinic correl data develop express gene genom hepat identifi infect liver organ case children cleft clinic dental face facial group patient reveal select studi subject viral viru health individu lip molar nasal palat patient periodont studi teeth tooth treatment

1389: Tooth Mobility (6) 1390: Embolism, (2) cleft compar decreas earli effect gene apoptosi blood case cell cohort death event follow incid involv men mortal occur popul preval process rate report women hybrid increas mean measur rat year

ratio reduc rel respect risk stage studi treatment valu

1391: Craniocerebral Trauma (22) 1392: Arnold-Chiari Malformation (6) associ axon caus clinic cord data design heal abnorm adult anomali associ compar congenit control defect frequenc health hospit increas injuri nerv includ malform mechan molecular presenc report neuropathi patient presenc rate retard studi syndrom year regener spinal studi wound

174 1393: Teratocarcinoma (8) 1394: Progeria (17)

acid associ caus cytoplasm export femal local activ analysi associ bind cell differenti male mechan molecular mutat normal evid express function human level line mechan product prolifer provid role sampl nuclear nuclei nucleu protein support treatment syndrom test tissu transloc

1395: Facial Pain (12) 1396: Radiculopathy (2) assess associ base case clinic data carcinoma core data delet encod identif diagnosi effect human incid measur identifi light loss metastasi novel open patient provid report mortal patient popul preval new time treatment variabl women screen treat treatment year tumor

1397: Ovarian Cysts (6) 1398: Hypercalcemia (26) children cluster combin correl differ effect acid bmd bone case caus dai densiti express genet larg local model develop fractur group lead miner multipl ovarian patient popul size studi surgeri osteoblast patient rate singl studi tumour vitamin treat treatment valu

1399: Otitis Externa (4) 1400: Refractive Errors (37) analysi base caus clinic conclusions aberr ablat chang conclusions control cornea corneal design hear hospit individu loss correct evalu examin mean measur methods myopia ocular medic method normal objective perform refract studi thick visual

patient reveal studi subject tissu treatment

175 1401: Aneurysm (17) 1402: Parathyroid Neoplasms (14) arteri case complic develop famili activ carcinoma case hypertens member multipl oper patient common diagnosi featur high perform postop present pressur procedur rare clinic report surgeri surgic treatment hormon human level low mutat patient report role sever specif thyroid time

1403: Measles (7) 1404: Meningocele (4) analysi blot care classif adult case complex differ domin famili gene identifi member new novel cluster data differ organ pattern present provid rare report express form gene gener health screen type year identifi immun pattern phenotyp profil research set viru

1405: Uveitis, Posterior (4) 1406: Conjunctivitis, Allergic (10)

assess compar conclusions control differ effect analysi children conclusions corneal correct data famili healthi hospit measur method methods effect group mean methods month

patient reduc region score sequenc patient perform role sampl studi subject year studi subject tissu treatment year

1407: Radiodermatitis (4) 1408: Sensation Disorders (13)

base compar control differ divid dose effect acid adult amino assess case caus clinic health loss group identifi irradi number patient mean measur patient risk studi therapi pattern radiat rat reduc respect screen signific skin time tissu treatment valu year

176 1409: Spinal Neoplasms (11) 1410: Flaviviridae Infections (2)

analysi cluster data differ express group high american clone correl data differ ethnic express mean method multipl number gene group human liver patient studi surgeri surgic mice popul relationship signific speci surviv treat tumor valu studi treatment surviv vitro vivo

1411: Syphilis (9) 1412: Parotid Neoplasms (13) associ care case dai decreas femal analysi associ carcinoma case group health increas level male model ratio report research risk cell clinic diagnosi epitheli studi test time treatment express featur high month patient phenotyp remain sampl studi tissu tumor tumour

1413: Cerebral Amyloid Angiopathy 1414: Prurigo (2)

(6) anim characterist clinic common dai data

accumul adult allel associ develop development dose correl deposit diseas factor genet experiment featur includ individu model genom genotyp patient month patient sever skin studi symptom polymorph popul risk role structur studi subject year

1415: Keratoacanthoma (7) 1416: Neoplastic Syndromes, Heredi- analysi cell clinic develop diagnosi tary (27) differ express famili femal gene male affect autosom cancer caus clinic control differ disord domin patient phenotyp famili gene genet hereditari protein respons sampl skin studi inherit mutat phenotyp recess risk variabl year test tissu

177 1417: Overdose (13) 1418: Spinal Cord Diseases (19) acid case clinic concentr conclusions dai axon case clinic cord defici high design diagnosi hospit main medic method injuri nerv normal patient present rare report sever spinal syndrom time tissu objective patient present record wound year respons sever studi symptom

1419: Maduromycosis (3) 1420: Ichthyosis (12) analysi associ case clinic associ develop differ distribut

diagnosi differ enhanc human isol famili gene health includ keratinocyt larg local loss member larg popul report reveal size small strain mutat organ patient size skin small syndrom studi test treat treatment

1421: Dermatomyositis (12) 1422: Leg Ulcer (8) alter antibodi case chang clinic compar assess care case clinic concentr correl data error estim evalu health measur control decreas high imag increas method new patient rate report level low method patient score statist variabl respons role studi test treatment

1423: Facial Dermatoses (16) 1424: Warts (6) area case children clinic associ case cervic distribut genet diagnosi famili health human identifi measur parent patient present report skin higher hpv human lesion local studi syndrom time valu year mutat organ plai rate region role select sequenc suggest tumor

178 1425: Epidermal Cyst (6) 1426: Facial Neoplasms (15) analysi chang clinic data diagnosi dynam adapt analys analysi associ base case clinic enhanc form genom high human level differ famili gener includ multipl low map model normal region patient perform rang report sequenc specif tissu reveal select studi syndrom

1427: Sezary Syndrome (7) 1428: Lymphoma, T-Cell, Cutaneous cell clinic condit degre diagnosi express gene (18) b-cell clinic effect gene identifi group lymphoma month patient posit resist target temperatur therapi lymphoma mechan transplant treatment tumour year multipl new patient popul report risk sampl specif studi surviv test time year

1429: Vascular Diseases (22) 1430: Angina, Unstable (10) activ cell clinic develop differ discuss effect analysi arteri clinic compar control diagnosi event factor function health identifi measur differ earli group hypertens increas level patient process rate recent patient pressur select serum studi target treatment signific stage studi time

1431: Rhabdomyolysis (14) 1432: Food Poisoning (6) activ case chang clinic defici diagnosi care compar control differ differ famili function identifi famili frequenc health higher hybrid isol member muscl multipl mutat larg model new pattern process product patient report sever studi rate select size strain symptom valu

179 1433: Hepatitis, Chronic (7) 1434: Anomia (1) assess clinic compar control differ earli approach base bia case data diseas error evalu express frequenc genet hepat liver estim method model power present produc measur normal number patient product rare report set statist treat pattern scale score tissu treatment

1435: Skin Diseases, Metabolic (1) 1436: Dermatitis, Exfoliative (3) articl autosom current discuss domin express case cluster data disord incid insight famili gene genet inherit involv men model mortal mutat new present preval provid rare report skin mechan molecular mutat plai recent syndrom women year research role underli understand

1437: Laryngeal Neoplasms (62) 1438: Carcinoma, Merkel Cell (9) analysi associ cancer carcinoma case cell correl express hcc hepatocellular immunohistochem invas carcinoma case cell delet methods patient respons scc signific squamou studi detect differenti hcc larg local region select test tissu treatment tumor sequenc size specif squamou time tumor

1439: Tonsillar Neoplasms (7) 1440: Skin Diseases, Vesiculobullous absenc activ associ base case cervic correl (2) basal clinic complement cutan defici determin epiderm epidermi gastric keratinocyt lesion data follow increas investig malign measur patient sever skin specif observ patient presenc studi symptom syndrom telomer telomeras uvb

surviv tumor tumour

180 1441: Dacryocystitis (1) 1442: Nonodontogenic Cysts (2)

analysi case clinic collect detect diagnos diagnosi adult case complic elderli mean old older oper patient postop present procedur rare region report sequenc surgeri surgic year young

diagnost evalu hypothesi imag laboratori

patient perform present rare report

sampl studi test

1443: Lip Diseases (3) 1444: Barotrauma (1) analysi case children chronic area associ children clinic effect cleft diseas form format gastric haplotyp locat loss parent patient polymorph prevent inflammatori intestin map predict regress protect random reduc reduct sever signific studi relationship report site surgeri variabl trial variat

1445: Rupture (11) 1446: Opportunistic Infections (26) area arteri combin compar cell chain donor effect gene genet graft

control differ enhanc frequenc gene local mean patient report respons human increas level patient pcr studi subject surgeri time valu year popul reaction recipi respons risk speci stem transplant

1447: Infection (57) 1448: Pharyngeal Neoplasms (4) analysi cell control earli evid express activ cell clinic diagnosi differ healthi identifi level marker diseas effect function gene group health patient radiat reveal screen human patient pattern select studi subject test treatment rate research respons risk role studi tumour

181 1449: Ocular Motility Disorders (17) 1450: Urogenital Abnormalities (21) assess chain clinic differ diseas associ bladder case children clinic earli famili group measur member model new patient pcr diagnosi effect femal polymeras provid rate reaction score year function gene group high

male new patient reduc report

risk studi syndrom

1451: Chondrocalcinosis (3) 1452: Short Bowel Syndrome (3) affect analysi approxim cluster compar adapt assai chronic detect diseas follow genom inflammatori intestin level complex control differ discuss diseas

frequenc genet major natur patient repeat requir select human sensit sequenc serum surgeri surgic mutat recent rel state studi target

1453: Deglutition Disorders (18) 1454: Thiamine Deficiency (5) case caus clinic dai differ earli evid adult anim base bovin breed dai function imag level month activ defici develop differ dose effect patient rate region report sequenc studi surgeri tissu treatment group patient pig region sequenc studi week year

1455: Trichuriasis (1) 1456: Vitamin A Deficiency (13) bacteri broad cell chronic diseas divers epitheli acid amino bodi care children concentr host includ infect inject intestin major develop health level model pathogen rang rat spectrum type process program qualiti respons rice servic studi varieti wide subject time wheat

182 1457: Leukemia, B-Cell (17) 1458: Rhinitis, Allergic, Perennial (12) airwai allerg area asthma cell cftr control abil associ b-cell cell express larg lymphocyt lymphoma mice number cystic dai develop differ dose phenotyp plai properti protein respons role fibrosi genet group high low suggest system time tumor respiratori sampl studi

1459: Autoimmune Diseases of the Ner- 1460: Enterocolitis, Necrotizing (7) vous System (5) anim case chang clinic decreas diagnosi case caus current discuss effect follow improv increas loss plai process recent research role test therapi human increas

treat treatment understand individu model number untreat patient plai protein rat risk role studi surgeri surgic

1461: (3) 1462: Tooth, Impacted (10) case cell clinic copi diagnosi differenti approach associ case cleft clinic event impact improv larg life method control dental detect diagnosi facial hybrid lip manag new palat number patient physic present process qualiti rare report patient report select studi test

1463: Amelogenesis Imperfecta (12) 1464: De Lange Syndrome (7) abnorm anomali associ chromosom clinic affect cleft clinic dental effect facial gene lip molar congenit data defect disord estim evid malform mutat new palat patient periodont protein provid studi mutat patient phenotyp rat teeth tooth tumour report studi support syndrom

183 1465: Hydrops Fetalis (13) 1466: Arteriovenous Malformations (17) birth case caus cell deliveri fetal case caus clinic diagnosi differ discuss fetu gestat infant level matern increas lead light mutant patient present primari rare report sever syndrom target mother neonat newborn treatment year pregnanc pregnant prenat time week women

1467: Brain Diseases, Metabolic (5) 1468: Wallerian Degeneration (10) adult alter associ chang children clinic axon cord differ function heal

larg myelin nerv develop development earli effect injuri famili function includ local male patient neuropathi patient protein regener popul process studi year respons role size small spinal studi wound

1469: Salmonella Infections (16) 1470: Anemia, Aplastic (29) abil activ antibiot bacteri bacteria differ allogen blood case control defect defici function gener host human infect isol new parasit pathogen patient properti detect develop diseas donor graft mutat salmonella strain virul

number patient popul recipi region

sequenc stem transplant

1471: Arterial Occlusive Diseases (16) 1472: Acute-Phase Reaction (5) arteri blood case caus complic coronari analysi caus chain classif clinic cluster diseas high hypertens infarct lead compar differ interact lead measur new patient pressur protein risk number organ patient stroke surgeri surgic vascular year protein rate reaction score valu

184 1473: Carcinoma, Endometrioid (27) 1474: Death, Sudden, Cardiac (45) associ cancer correl endometri epitheli estrogen group number atrial cardiac cardiomyocyt cardiomyopathi case caus death dilat failur ovarian patient periton posit respons signific studi suggest surviv treatment famili genet heart hypertrophi left tumor uterin patient right sudden time valv ventricular

1475: Intracranial Hemorrhages (16) 1476: Stomatitis (25)

associ caus compar case clinic administ administr dai daili dose effect diagnosi differ factor genet higher follow group hour infus intraven level oral patient mutat patient popul receiv studi therapi treat treatment week rate risk sampl sever studi test time

1477: Intestinal Obstruction (21) 1478: Kidney Failure, Acute (40)

analysi case chronic clinic complic diseas clear clinic develop diseas effect failur function genet group kidnei mechan number patient progress intestin new oper patient perform postop procedur rate resect studi rcc renal sever size studi tubular surgeri surgic treatment underw

1479: Parturient Paresis (3) 1480: Meningitis (8) anim bovin breed cluster combin concentr case clinic compar control correl differ dai differ effect enhanc gener genet distribut famili frequenc local loss group influenc milk model pig respect treatment valu member patient pattern rat respons studi treatment tumor year

185 1481: Ciliary Motility Disorders (7) 1482: Uterine Prolapse (6) case cataract event genet glaucoma adult case cohort function group high incid level low

human implant includ involv men methods mortal older patient len marker multipl phenotyp plai popul preval rate women year young process rate report role studi suggest

1483: Diabetes, Gestational (16) 1484: Homocystinuria (16) acid diseas factor famili high identifi associ birth control level low new patient plai plasma data diabet estim fetal platelet respons role screen select serum tissu treatment group incid insulin matern mortal popul pregnanc preval risk size studi women year

1485: Poxviridae Infections (5) 1486: Urethral Neoplasms (2) affect bladder cell determin differenti analysi caus control dai design examin genet high includ level develop factor low mobil prolifer rang signific studi function hospit infect suggest tract urin urinari model objective patient period requir reveal risk studi time viru

1487: Genital Diseases, Female (9) 1488: Urinary Tract Infections (30) acid case children clinic control data case clinic data femal genet male mice normal bladder phenotyp regul report sex determin diagnosi evalu examin excret group studi subject suggest tissu includ mobil report signific studi treatment suggest tract transit urin urinari

186 1489: Chlamydia Infections (19) 1490: Transposition of Great Vessels associ clinic detect diagnosi esophag (15) frequent includ investig method analysi base cardiac combin occur occurr patient possibl effect element failur genom probabl report requir risk studi heart insert integr left mutant test transmiss mutat patient reveal sequenc subject syndrom ventricular

1491: Anoxemia (6) 1492: Endometritis (3) chang data develop evid administr approach case clinic control dai design diagnosi differ dose follow healthi method period point function higher incid level group strategi subject time week mechan method patient process

product provid rate resist support time tumor year

1493: Fetofetal Transfusion (11) 1494: Luteoma (1) birth deliveri develop fetal fetu associ cell combin confid control fetus gestat infant matern model mother neonat newborn placenta differenti effect express increas pregnanc pregnant prenat twin week women interv odd peptid prolifer rat ratio risk

smoke studi treat treatment

1495: Rotavirus Infections (10) 1496: Vulvar Neoplasms (24)

adult case cell children control differ high hospit cancer carcinoma case cell cervic correl develop earli gene hpv human lesion level human isol level mutat patient rate region new posit stage studi sampl sequenc strain type year patient tissu treatment

187 1497: Peripheral Vascular Diseases (10) 1498: Intermittent Claudication (4) analysi associ compar concentr confid adjust adult associ case caus confid control control factor group high interv develop factor interv life odd low odd patient ratio risk signific patient ratio risk smoke smoke studi subject variabl studi subject treatment year

1499: Twins, Conjoined (9) 1500: Death (19) case clinic compon develop diagnosi differ care concern discuss ethic experi effect environ environment factor health inform issu level medic method genet herit high influenc organ paper particip person practic report studi trait treatment twin variat research select social year

1501: Cystitis, Interstitial (2) 1502: Fractures, Spontaneous (13) acid amino bladder care compar associ bmd bone combin correl data control decreas follow frequenc effect fractur includ miner multipl number health hospit increas mobil patient osteoblast patient singl studi therapi renal servic studi tract urin urinari tumour variabl vitamin

1503: Jaw Abnormalities (9) 1504: Nasal Obstruction (7) cleft data discuss case effect adult alter assess associ case chang evid factor growth literatur children clinic develop differ gener number palat provid repeat report requir risk structur patient pattern report requir support treatment trial screen size studi syndrom year

188 1505: Chondrosarcoma, Mesenchymal 1506: Bulimia (11) (5) adhd anxieti associ behavior bipolar cognit approach assess case cell chromosom depress disord identifi memori mental patient perform person psychiatr role differenti human measur neg serotonin sleep studi symptom number posit presenc primari report score studi target treatment tumor variabl

1507: Hair Diseases (21) 1508: Glomerulonephritis, IGA (8)

associ case clinic compar differ effect genet analysi associ caus data distribut genotyp group level new normal domin famili featur function group hear patient polymorph product rate local loss method mutat number renal risk studi tissu patient phenotyp repeat sampl

1509: Mycoplasma Infections (10) 1510: Myositis Ossificans (4) assai character data detect differ divers estim genet bone case children copi earli featur

form format genet larg late individu isol method model patient popul number parent phase present rare report stage syndrom year sensit sequenc strain test tissu type

1511: Legionnaires’ Disease (6) 1512: Carbohydrate-Deficient Glyco- analysi associ compar control differ protein Syndrome (7) famili frequenc gene genom identifi activ caus chang characterist clinic common congenit effect featur lead level mutat isol larg product protein region sequenc size differ specif strain studi patient pattern repeat residu sever site syndrom

189 1513: Skin Ulcer (15) 1514: Drug Toxicity (20) acid case chronic control develop diseas base develop effect effect gastric group intestin data estim exposur gener high level normal number patient low method model new respons signific skin studi tissu treatment variabl patient produc product respons studi time treatment

1515: Essential Tremor (8) 1516: Pneumonia, Pneumocystis (10) clinic diseas disord effect gene genet improv chang children clinic data level life map molecular motor mutat develop diagnosi estim includ patient protein qualiti receptor remain sampl treatment isol method model patient popul process provid rang sampl strain varieti wide

1517: AIDS-Related Opportunistic In- 1518: Obstetric Labor Complications fections (32) (13) assess case chang clinic data differ gener group hiv hiv-1 human infect measur birth dai differ fetal gestat

process score studi test patient incid infant mortal viral viru matern neonat patient pregnanc

prenat preval rate risk studi week women year

1519: Postoperative Hemorrhage (9) 1520: Puerperal Disorders (9) case compar complic develop effect case compar control develop fetal group higher hospit manag oper genom group health hospit incid model mortal mutat popul pregnanc preval risk perform postop procedur patient studi women year rate reduc reduct surgeri surgic year

190 1521: Lewy Body Disease (11) 1522: Vesico-Ureteral Reflux (10)

associ autoimmun base bodi control correl assess associ bladder children clinic diagnosi effect evalu gene measur model parent diseas famili form format gene group human parkinson pathogenesi progress risk studi patient reduc reduct renal report subject treatment score studi year

1523: Respiration Disorders (14) 1524: Xanthomatosis (9) cell characterist common compar control associ case clinic compar control detect gene high human level month decreas differ distinct featur normal report risk patient higher increas level mutat sampl sever studi tissu year normal patient pattern presenc rate similar tissu

1525: (4) 1526: Ecthyma (2) care clinic dai decreas dose affect base bone cell codon combin correl

health increas mutant need patient presenc primari program public effect form format gener marrow observ pair servic sever structur studi treatment trial posit signific studi suggest treat treatment

1527: Gangrene (6) 1528: Pilomatrixoma (3) blood bone case caus cell clinic analysi associ case character characterist common distribut featur gene complic correl diagnosi imag initi isol local map multipl mutat presenc rare report singl studi tumor variabl

patient perform present report sever

surgeri surgic test

191 1529: Folliculitis (3) 1530: Hypophosphatemia, Familial (11) case cell chain compar control differ healthi light mean month patient pattern associ autosom bmd bone clinic decreas domin famili fractur produc product reaction subject increas inherit miner mutat new normal osteoblast target treatment valu year studi tissu treatment vitamin

1531: Osteomalacia (12) 1532: Scabies (6)

adult analysi bmd bone dai fractur level assai case chain detect differ diseas gene genom miner mutat new normal osteoblast group includ microscopi morpholog neg organ popul posit rang reaction risk variabl patient popul repeat size studi tissu vitamin year

1533: Hypereosinophilic Syndrome (10) 1534: Splenic Neoplasms (15) acut aml case clinic detect b-cell case cell chang chromosom clinic cll design gener hospit larg lymphocyt develop diagnosi diagnost lymphoma non-hodgkin genet leukemia level patient process repeat report studi male mechan mutat myeloid patient treatment product risk serum therapi

1535: Jejunal Diseases (6) 1536: Endometrial Hyperplasia (9) affect assai case children concentr dai cancer correl earli express gene detect diseas dose express factor patient present rare rat repeat report risk sensit year group lesion model mutat number ovarian patient protein signific specimen stage stain studi subject system

192 1537: Paraplegia (12) 1538: Ectoparasitic Infestations (7) case differ diseas distribut form format genet activ area caenorhabd differ ecolog genom identifi injuri larg elegan habitat patient popul region report group sampl sea season sequenc sever size local number patient rat report select speci studi year studi test

1539: Ostertagiasis (2) 1540: Amputation, Traumatic (4)

adult anim associ bovin breed cattl approach canin cat design clinic diagnosi differ mean milk pig porcin distal dog earli gener hand posit produc product valu variabl year yield identifi left limb proxim right screen segment select stage strategi time

1541: Finger Injuries (4) 1542: Retinal Vasculitis (3) allow appli applic base describ develop dog identif affect case clinic enhanc hospit median month

identifi mass method model patient phylogenet present recurr procedur protocol rapid screen segment simpl report retin sever speci studi symptom treat standard techniqu treatment year

1543: Eye Infections, Parasitic (2) 1544: Dirofilariasis (3)

area case criteria delet diagnos associ case clinic confid criteria delet clinic diagnos diagnosi diagnost interv isol diagnosi diagnost human incid isol laboratori men mortal patient preval laboratori patient present ratio stimul strain women year report risk smoke strain vivo

193 1545: Prenatal Injuries (7) 1546: Cystadenocarcinoma, Papillary adult birth children ethic fetal (4) gene genet gestat infant issu level adapt adult assess associ cancer cell her-2 matern medic neonat practic pregnanc measur neg normal ovarian prenat research women year posit risk score select statu studi tissu tumor year

1547: Osteolysis (19) 1548: Giant Cell Tumor of Bone (6)

bone cancer case cell correl activ alter cell chang clinic cluster event express form format group human model multipl process report studi target evid function gener genom normal period tissu tumour vitamin

phenotyp point requir support target time

tissu tumor

1549: Giant Cell Tumors (7) 1550: Puerperal Infection (2) data diseas estim ethic evid gene base cell chromosom delet inform isol issu mechan larg lesion local loss marker group mechan method molecular open predict provid research molecular phenotyp plai posit role size set strain support small studi tumor variabl

1551: Fibroma, Desmoplastic (1) 1552: Common Variable Immunodefi-

case conduct data design effect evalu includ investig ciency (16) mutat pathwai pool potenti releas report sarcoma activ analysi clinic control defici differ diseas

signal stimul stromal tumor studi function gene genet human mutat number patient predict regress respons signific variabl variat

194 1553: Trigeminal Nerve Diseases (2) 1554: Leukemia, Lymphocytic (19) base case children corneal acut cell compar control differ express correct delet exposur genet loss mechan molecular observ pair parent present rare flow gene group high larg report syndrom tumor underli leukemia level low number patient protein rate size small

1555: Strongylida Infections (4) 1556: Rodent Diseases (19)

approach clinic dai differ femal anim area control differ effect femal group isol male mice improv infect larg human function model pattern region sequenc speci strain studi test treatment life male method number qualiti rang sex sexual size small speci

1557: Lacrimal Apparatus Diseases 1558: Eye Infections, Bacterial (8) (10) african american asian assess black case clinic control disord children detect differ earli ethnic evalu infect mean measur domin follow famili pattern popul risk score valu white function genet inherit mutat normal patient report sequenc syndrom test therapi time tissu

1559: Eye Injuries, Penetrating (5) 1560: Eye Foreign Bodies (12) case caus clinic dai diagnosi area bodi case cataract clinic diagnosi examin glaucoma diagnost element field improv life implant len method methods number patient method model movement period perform sampl size studi tumor weight point qualiti rat space studi time

195 1561: Farmer’s Lung (2) 1562: Exocrine Pancreatic Insufficiency (10) administr allel case caus compar dai dose adult associ case clinic compar control diagnosi follow function genotyp diagnost healthi increas methods mutat number higher imag interact lead lower organ pancreat patient signific studi polymorph rate versu week subject test year

1563: Hemangioma, Capillary (5) 1564: Eye Infections, Fungal (8) analysi assess case caus clinic correl diagnosi diseas endotheli evalu genet health case children clinic compar control data diagnosi gener includ imag measur patient perform life parent patient produc product report report reveal score vegf sampl studi target variabl year

1565: Dermatomycoses (16) 1566: Onychomycosis (1)

children compar control develop avail benefit care cost decis effect element follow guidelin improv insert manag medic medicin practic recommend therapi treat differ dna fragment gene genom includ number pattern sampl region treatment untreat sequenc similar skin studi treatment type

1567: Depression, Postpartum (9) 1568: Factor X Deficiency (3) assess bipolar case chain chang depress analysi associ blot case chain copi correl detect factor

gene level mutat number detect disord measur pcr person patient popul reaction report serum signific western polymeras quantit reaction real-tim revers risk score studi symptom

196 1569: Factor V Deficiency (5) 1570: Jejunal Neoplasms (3) cell clinic diagnosi express associ case codon dai defici develop case famili gene genet member microarrai dose factor gene mutat plai protein multipl patient present produc product profil report risk role state substitut suggest rare report requir tumor treat treatment

1571: Vascular Neoplasms (10) 1572: Pseudophakia (11) associ base case characterist cataract chang conclusions combin common correl effect express develop differ examin glaucoma group featur larg lymphoma model implant larg len methods rate patient report respons role number patient size small studi time visual size studi tumour

1573: Still’s Disease, Adult-Onset (4) 1574: Neoplasms, Germ Cell and Em- bryonal (25) concentr diseas adult case associ base case cell clinic differ express effect elderli inhibitor old older level group high low normal patient rate patient plasma report serum studi treat report sperm studi tissu young younger tumor treatment year tumour year

1575: Flavivirus Infections (4) 1576: Intracranial Hypertension (6) area case differ diseas dna evolut genet arteri case children complex defici group infect isol method mutant new effect featur hypertens imag includ level organ pcr point provid sequenc time viru mechan mice model molecular present pressur reduc report serum

197 1577: Cholangitis (5) 1578: Liver Abscess (4) adult assess case children clinic case caus follow genet high initi lead level low diagnosi differ earli gene genet month mutant mutat period identifi liver measur model mutat report patient point report target test time year score screen time year

1579: Alagille Syndrome (11) 1580: Aneurysm, Ruptured (9) activ area case chang children develop hepat adult associ case complic imag older oper hepatocyt high higher level liver low mutat patient perform postop preoper patient protein rate report studi procedur resect studi surgeri surgic syndrom techniqu underw year young

1581: Neurofibromatosis 2 (19) 1582: Beckwith-Wiedemann Syndrome associ case clinic diagnosi differ (27) hear includ larg mutat appear avian bird chicken children data determin loss develop differ examin group imprint includ indic

rang rate report size patient individu japanes parent studi studi time tumor wide year suggest syndrom

1583: Vestibular Diseases (11) 1584: Lysosomal Storage Diseases, Ner-

auditori case caus cell deaf ear group hair hear vous System (1) accumul amyloid brain cell defect deposit impair inner loss method model normal patient studi test time tissu develop diseas earli late mice mous mutant mutat phase progress stage storag transgen wild-typ

198 1585: Sigmoid Neoplasms (7) 1586: Choriocarcinoma (9) analysi cell decreas enhanc express factor analys analysi area data differ estim gene group indic model normal fetal growth high increas inhibit patient perform reveal size studi surviv tissu level low new pregnanc protein region sequenc tumor vivo tumor year

1587: Hyperglycemic Hyperosmolar 1588: Pituitary Apoplexy (2) Nonketotic Coma (5) analysi blot bodi case confirm experi initi intern mechan molecular organ origin patient blood case children clinic concentr diagnosi health high interact level low parent present rare report reveal second surgeri western patient present report sever symptom target valu year

1589: Water-Electrolyte Imbalance (4) 1590: Sex Differentiation Disorders (5) case clinic codon diagnosi enhanc combin compar control differ femal function higher identifi frequenc function gender genet group higher interact isol mice patient rate male mate offspr patient rate reproduct report respons screen sever strain sex sexual studi symptom year

1591: Puberty, Delayed (15) 1592: Otorhinolaryngologic Neoplasms adolesc case chain child childhood (3)

analys analysi base cancer clinic data diagnosi children control develop factor diagnost incid mechan molecular mortal pair genom growth high parent pcr pediatr polymeras reaction real-tim revers year patient perform preval reveal tumor women year

199 1593: Choanal Atresia (29) 1594: Liposarcoma, Myxoid (2) abnorm anomali associ case children congenit achiev approach area chain combin defect disord featur gene malform mental multipl parent report retard select studi design effect express gene limit microarrai optim pcr protect reaction reduc syndrom year reduct strategi studi success

1595: Sinusitis (13) 1596: Intracranial Hypotension (5) analysi assess associ case chain children clinic analysi children complic data control differ evalu hospit measur case distribut fluid local normal oper pcr polymeras reaction patient patient perform procedur report reveal repeat score studi subject surgeri surgic syndrom tissu variabl

1597: Hoarseness (5) 1598: Dyspnea (17) acid assess case clinic combin ear earli effect assess case children control

follow function hear impair loss measur effect healthi high includ level low

patient score sever stage treat measur new patient rang

treatment reduc report respons score

studi subject

1599: Achondroplasia (8) 1600: Rhabdomyosarcoma, Alveolar (6) case cell clinic delet differ effect analysi children class correl growth larg mechan molecular mutant includ malign method methyl model

popul posit region rel report select posit produc product requir sarcoma signific specif stromal studi tumor size small time tumour

200 1601: Periapical Diseases (2) 1602: Gram-Negative Bacterial Infec- analysi assai chain codon detect dna factor tions (18) fragment pcr plai primari reaction risk analysi associ bacteri control distribut famili follow group host role sensit sequenc speci studi substitut suggest identifi infect level local model new pathogen risk screen studi time

1603: Dental Pulp Diseases (2) 1604: Spirochaetales Infections (1)

analysi associ bacteri bacteria host analysi approach develop dna famili infect link lung mass method multipl primari relat fragment gel histori identifi mass member rrna sequenc singl speci studi suggest techniqu molecular novel pcr potenti rrna sequenc strategi target therapeut

1605: Myopathies, Structural, Congen- 1606: Giant Lymph Node Hyperplasia ital (13) (3) case develop dystrophi exercis famili fiber area case cell chain clinic diseas effect gene increas member muscl muscular express human lymphoma patient mutat patient phenotyp product regul report reaction reduc reduct regul report sever signal sequenc skelet smooth studi symptom

1607: (8) 1608: Albinism (8) analysi biolog children compar control correl associ case caus children diagnosi femal gener growth individu literatur male patient presenc decreas develop differ femal function gene present rare report studi syndrom therapi treatment increas male mutat patient rat sex studi system

201 1609: Protoporphyria, Erythropoietic 1610: Communicable Diseases, Emerg- (7) ing (10) activ develop differ gene genet care chang diseas evolut genom health high human increas level liver low mice mutat human infect isol new number new pattern phenotyp plai product regul role organ point provid research select servic strain time viru

1611: Eye Diseases (68) 1612: Astigmatism (18) associ case clinic conclusions corneal correct aberr ablat conclusions cornea develop examin genet human identifi includ mean methods number corneal correct design differ equival evalu examin mean patient perform retin studi measur methods myopia ocular visual perform refract thick visual

1613: Dyskinesia, Drug-Induced (15) 1614: Akathisia, Drug-Induced (7)

affect analysi associ control diseas affect assess associ case effect examin group high interact measur children evalu high measur patient rate rel risk schizophrenia signific chain studi suggest treatment patient pcr polymeras reaction real-tim respons revers score studi tissu treatment

1615: Trypanosomiasis, African (6) 1616: Hemangioendothelioma, Epithe-

associ cell compar complet dna earli lioid (1) genom human melanoma method action agent drug effect elicit increas induc induct kit potenti puls record releas respond organ plai popul rna role sequenc structur target test tumour respons sarcoma stimul stromal surfac tumor

202 1617: Night Blindness (18) 1618: Vulvovaginitis (2) concentr control degener famili function associ care clinic diagnosi differ increas macular measur mutat femal health includ larg male number rang size small studi test therapi treat normal optic patient treatment wide respons retin retina select studi tissu tumour visual

1619: Vulvar Diseases (8) 1620: Angiodysplasia (3) care case clinic cost decis effect ethic associ cervic child childhood children evid examin famili femal health hpv male mutat normal parent patient studi guidelin inhibit lesion manag medic support tissu year patient practic recommend report

research therapi treat treatment

1621: Cardiac Output, Low (9) 1622: Mumps (2) associ cardiac cell care case copi health incid increas loss men mortal neg number popul posit chang control effect present preval rate report stress women year femal gene heart high improv increas level life male model qualiti role studi treatment

1623: Varicose Veins (7) 1624: Retrobulbar Hemorrhage (2) adult analysi clinic compar express area clinic complic gene higher base femal human male differ multipl oper pair method model morpholog patient postop procedur resect patient rate repeat sex studi treatment year sever studi surgeri surgic therapi treatment underw vector

203 1625: Rupture, Spontaneous (9) 1626: Myopia, Degenerative (6) activ analysi area case complic area base data databas decreas differ express level mean optic follow method oper patient increas patient regul retin retina site specif perform postop procedur report resect treatment valu visual reveal surgeri surgic techniqu treatment underw

1627: Bronchiolitis, Viral (3) 1628: Abdominal Abscess (3) associ child children diseas gene cancer case clinic complic diagnos haplotyp infect manag new parent diagnosi diagnost gener map oper patient present procedur rare report sever surgeri surgic patient polymorph provid receptor therapi tuberculosi recombin sampl snp studi viru year

1629: Hepatic Encephalopathy (8) 1630: Dyskeratosis Congenita (10) analysi case cell control end genet htert case concentr develop diseas form format gene group hepat human increas length patient respons revers senesc studi syndrom increas liver mitochondri telomer telomeras treatment variabl mutat patient phenotyp process receptor sever subject treatment

1631: Neurocutaneous Syndromes (7) 1632: Gonadoblastoma (5) adult case data differ diseas cell children earli express femal genet group includ influenc individu male marker mate normal literatur number patient pattern phenotyp posit recombin repeat reproduct sex present publish report review search sexual sperm stage tissu studi year

204 1633: Gonadal Dysgenesis, Mixed (3) 1634: Intracranial Thrombosis (6)

case compar data estim femal higher male mate chang clinic differ discuss mutat patient phenotyp produc product rate report reproduct sex sexual sperm evid factor level multipl tumor mutat patient pattern plai recent risk role sever studi system test variabl

1635: Endocrine System Diseases (18) 1636: Failure to Thrive (14) adolesc analysi caus child childhood adult associ cancer clinic develop differ diseas earli children clinic featur function growth human mutat parent effect famili femal identifi male new patient provid studi time treatment year patient pediatr phenotyp report sever syndrom year

1637: Sickle Cell Trait (7) 1638: Radial Neuropathy (2) care children compar differ genotyp health area axon clinic cord diagnosi diagnost high higher increas level low model femal heal injuri male nerv patient polymorph popul protein rate sequenc period point rat segment sex spinal

subject test year time wound

1639: Humeral Fractures (2) 1640: Dysentery, Bacillary (7) bone case dai data dose estim experi follow area associ cluster coli develop

initi injuri method month origin patient differ dna genom high isol level low model patient pattern posit region sequenc

period point remain report second strain type time

205 1641: Spondylitis (3) 1642: Femoral Fractures (7) analysi approach blot bone caus chang approach assess associ bind children combin genet initi lead method chromosom compar control dai model origin patient process diseas effect evalu frequenc respons size small western measur patient reduc scale score surgeri tumor valid

1643: Actinomycosis (3) 1644: Adenofibroma (2)

case children clinic compar control dai diagnos cancer cell compar differenti diagnosi diagnost differ diseas group differ lesion line lung malign observ pattern imag parent patient posit signific state studi treatment phenotyp prolifer similar specimen stain

tumor type vitro vivo

1645: Neuroectodermal Tumors, Prim- 1646: Neuroectodermal Tumors, Prim- itive, Peripheral (10) itive (17) analysi c-kit case children combin effect activ c-kit case cell children dai express famili

genet gist kit malign model new high kit malign method patient report patient report sarcoma soft stromal studi treatment tumor sarcoma soft stromal studi treatment tumor

1647: Spinal Cord Neoplasms (12) 1648: (14) care case children clinic diagnosi effect analysi base cancer clinic cluster data enhanc health number parent decreas develop evid gene patient present primari protein increas initi lung number rare report size studi tumor year patient process respons sever support symptom

206 1649: Giardiasis (4) 1650: Emphysema (5)

anim compar condit control data degre evid frequenc associ caus cell clinic dai diagnosi diagnost form format gener lead lung morpholog gene genet isol model organ human organ regul requir respons studi syndrom valu popul potenti provid speci studi support

1651: Bronchitis, Chronic (4) 1652: Biliary Tract Diseases (6)

adult associ develop differ analysi assess case caus clinic diseas factor gene genet genotyp diagnosi diagnost imag lead measur mechan method multipl mutat patient influenc mice model mutat new provid reveal score sever valu polymorph provid recent risk studi year

1653: Angiomyolipoma (15) 1654: Neoplasms, Complex and Mixed (3) case cell examin famili gener kidnei adult case cell complex normal number observ patient plai posit renal epitheli femal individu report role studi suggest tissu treatment male malign marker mechan tumor molecular report sex sexual studi tumor tumour year young

1655: Smooth Muscle Tumor (2) 1656: Pulmonary Sclerosing Heman- adult affect associ characterist clinic gioma (1) cluster common diagnosi distinct featur find antibodi antigen basi c-kit elucid involv kit mix produc product receptor mechan molecular report sourc studi year yield monoclon poorli provid remain sarcoma stromal transcript tumor underli understand understood

207 1657: Conjunctivitis (11) 1658: Keratoconjunctivitis (5) adult area base cell correl gene higher case children dai health increas isol parent patient product report isol rate region sequenc signific respons sampl sequenc strain strain studi target therapi transfer treatment vector year target therapi time treat treatment year

1659: Fractures, Stress (5) 1660: Alveolar Bone Loss (13) adult base bone data decreas earli cleft clinic compar dental estim experi field forc initi control increas differ facial frequenc mean model normal movement older pair space stage target palat rat report signific studi subject time year young tissu valu

1661: Wolff-Parkinson-White Syn- 1662: Tachycardia, Atrioventricular drome (3) Nodal Reentry (3) adult analysi blot cardiac chain complex activ compar femal higher incid involv lower male mechan molecular month elderli function genet heart mutant mutat patient popul process

human mice old older particip rate specif versu year phenotyp reaction western year young

1663: Gingival Recession (3) 1664: Shock, Septic (23) associ clinic cluster data diseas estim event clinic condit degre develop factor incid normal patient process differ gene genet group heat high level popul respons sever shock risk sever studi symptom patient studi subject temperatur treatment system target tissu treatment

208 1665: Paralysis (22) 1666: Polyendocrinopathies, Autoim- mune (14) area associ caus chang cord adult associ autoimmun case caus cell combin genet high injuri isol lead diseas express mechan model mutat new mechan model nerv popul rate spinal progress protein report structur studi subject year studi subject test wound

1667: Sjogren’s Syndrome (28) 1668: Encephalomyelitis, Autoimmune, associ biolog case cell clinic develop diagnosi Experimental (30) diseas gene gener glioma includ increas axon cell cord effect genom group heal patient primari sampl secondari injuri model myelin nerv studi syndrom system neuropathi peripher rat regener respons spinal studi treatment wound

1669: Retrognathism (6) 1670: Fibromatosis, Gingival (5) analysi base case children case cell chang children chromosom cleft complet dai dental clinic decreas differenti earli develop fusion includ method gene pair palat provid report new genet increas inhibit map studi variabl morpholog new normal report

requir studi tissu

1671: Hepatitis D (4) 1672: Gastroenteritis, Transmissible, of

core correl develop encod frame health identifi Swine (2) adult clone correl dna fragment infect isol marker open patient read identif novel replic signific strain test viral viru virus gene identifi model pcr plant recombin region report screen sequenc speci studi year

209 1673: Newcastle Disease (5) 1674: Fetal Nutrition Disorders (1) area chicken combin compar control core determin differ encod genet genom associ compon differ effect environ environment factor group imprint individu genet japanes mechan molecular open signific studi herit individu induc induct influenc pair respons risk studi trait twin variat

1675: Prognathism (8) 1676: Sarcoma, Granulocytic (12) alter associ case chang cleft dental develop acut aml blood bone case cell children facial genet group identifi initi origin diagnosi differenti enhanc kit leukemia marrow myeloid patient rare report sarcoma palat patient popul role signific studi treatment stromal tumor

1677: Articulation Disorders (5) 1678: Tachycardia (12) analysi assess behavior chang cardiac caus chang clinic children cognit deficit disabl combin dai effect failur evalu famili group impair learn heart measur memori parent perform score human identifi left mutat task treatment patient risk role screen stimul treatment ventricular

1679: Malaria, Vivax (12) 1680: Nails, Malformed (7) combin compar differ evalu human hypothesi isol case caus clinic common delai diseas

famili featur follow function malaria mutat perform plasmodium posit region sampl

gene genet influenc mutat patient sequenc signific statist strain studi test persist report sever studi syndrom

210 1681: Adrenocortical Carcinoma (7) 1682: Peanut Hypersensitivity (6) adult carcinoma earli express femal form airwai assai asthma case cell clinic cystic format genotyp human identifi male mice mutat detect diagnosi estim normal resist screen stage thyroid develop event fibrosi individu involv tissu year process respiratori sensit specif valu

1683: Telangiectasis (11) 1684: Retinal Vein Occlusion (19) acuiti amd conclusions cone degener detach alter chang delet earli effect includ examin famili macular methods optic new observ patient provid rang retin photoreceptor pigment retin retina sampl structur studi syndrom test risk rod time vision visual treat treatment visual

1685: Pneumonia, Pneumococcal (5) 1686: Port-Wine Stain (7) adult assess children clinic compar design area assess case congenit correl effect higher improv differ group genet larg measur method pattern produc infect patient requir specif studi rate product score size skin small studi subject treatment trial year syndrom treatment

1687: Cardiomyopathy, Restrictive (6) 1688: Septo-Optic Dysplasia (3) autosom cardiac case caus cell brain children clinic common compar characterist common concentr diseas domin control design evolut featur famili featur gene heart inherit level mechan frequenc genet hospit mechan molecular mutat report select multipl mutat patient predict studi surviv

211 1689: Neurotoxicity Syndromes (10) 1690: Infarction (5) analysi caus differ effect event exposur alter case cell chang diagnosi factor growth imag increas lesion literatur magnet method genet increas involv lead mechan organ present rare report risk techniqu volum molecular normal organ process rat remain respons studi tissu

1691: Plant Poisoning (4) 1692: Sphenoid Sinusitis (3) analysi case classif clinic cluster collect adult analysi anim bovin data distal dog hand patient present proxim rare breed cattl dai effect expos report right sampl segment set sever exposur indic milk pig plant porcin presenc reveal studi subject year

1693: Lymphangiectasis (2) 1694: Diaphragmatic Eventration (4) affect autosom biolog case disord domin adolesc approach associ autism boi case caus famili find identifi inherit mutat novel present child childhood featur previou rare recess screen studi children report form format lead parent pediatr report studi system syndrom year

1695: Choristoma (16) 1696: Hypothalamic Diseases (8) associ cancer case cell children express famili associ case epilepsi health includ increas

gastric model patient phenotyp mechan model mutat patient presenc region regul report role studi suggest phenotyp posit report seizur stress syndrom year studi suicid syndrom time treatment

212 1697: Craniosynostoses (38) 1698: Lymphoma, Small Lymphocytic chain chang congenit detect develop distal (6) b-cell base case cll event involv larg level dog gene hand mutat new patient reaction report segment studi surgeri lymphocyt lymphoma microscopi morpholog non-hodgkin pair patient syndrom time treatment process report structur treat treatment

1699: Tooth Injuries (4) 1700: Child Nutrition Disorders (14) associ case caus children data effect associ bodi care clinic incid inhibit injuri lead normal reduc children develop diagnosi earli function health reduct report structur tissu treat identifi parent patient plai risk role screen stage studi year treatment women year

1701: Status Epilepticus (14) 1702: Epilepsy, Reflex (9) associ attempt clinic condit epilepsi express associ attempt case chang condit epilepsi gener group high includ level low rat report function gener includ involv normal patient respons seizur stress studi suggest report respons seizur stress studi suicid suggest suicid tissu

1703: Epilepsy, Tonic-Clonic (10) 1704: Dental Leakage (2) absenc attempt case chang condit dai blue captur color composit concentr differ

epilepsi gener includ indic patient dye effect intens laser light min observ presenc report respons seizur presenc red report shed studi trial tumour stress studi suggest suicid year

213 1705: (8) 1706: Vaginal Neoplasms (10) affect case correl dai follow gene incid initi light cancer case cell children control data

local month patient phenotyp process region report sequenc suggest women year diagnosi individu initi new origin patient

present report risk studi time treat

treatment tumor

1707: Hepatic Veno-Occlusive Disease 1708: Lung Diseases, Parasitic (1) (6) care case chain complement host infect clinic cluster cours data diagnosi diseas donor inform particip pathogen pcr person end enhanc includ liver patient period point polymeras reaction real-tim report research

region risk sequenc test time revers specif technolog transplant transplant

1709: Encephalitozoonosis (2) 1710: Chest Pain (12) antibodi approxim case caus clinic assai case cell clinic detect develop diagnosi diagnosi includ individu induc lead major factor genet high level normal mice mous rang rel report patient popul risk select sensit test tissu year respons state system transplant

1711: Respiratory Tract Diseases (18) 1712: Hypersplenism (2)

activ area associ asthma anim associ case caus characterist care children data develop differ common diseas distinct experi featur initi lead model origin patient report second genet health rate ratio specif studi therapi report research respons risk role studi time

214 1713: Mast-Cell Sarcoma (2) 1714: Leukemia, Mast-Cell (4)

activ cell data effect enhanc activ analysi categori cell classif evid express increas inhibit line month cluster correl diseas health inhibit kinas mice overexpress profil rat recombin set morpholog multipl patient provid studi structur subgroup transform suggest support suppress tumor

1715: Carbon Tetrachloride Poisoning 1716: Myelitis, Transverse (3) (7) analys analysi assai blot case children activ cell chang compar control effect gene clinic codon detect diagnosi express gene genom liver mean model plai protein rat normal patient protein reveal respect role studi subject time valu sensit sever substitut tissu

1717: Thyroid (16) 1718: Pneumatosis Cystoides Intesti- adenoma adren braf endocrin estim hormon nalis (2) imag incid increas new normal papillari bodi case distribut diverg duplic evolut evolutionari find local mice phenotyp pituitari ptc ret thyroid microscopi morpholog observ organ origin treatment tumor tissu previou report site studi suggest

1719: Fatigue Syndrome, Chronic (8) 1720: Impetigo (2) analysi base class clinic compar control area case chain child childhood

diagnosi differ disord express gene children dai distribut isol local parent patient pcr polymeras reaction skin group human patient strain studi system year pattern pcr sampl signific time type

215 1721: Mercury Poisoning (6) 1722: Carcinoma, Large Cell (17) area associ care caus concentr analysi associ case cell detect express function gene larg lung number effect gener health higher hybrid lead model posit product rat rate reduc patient posit rate report size studi time valu small studi tumor tumour

1723: Aortic Rupture (11) 1724: Laryngostenosis (5) analysi case complic famili incid mortal avail combin correl data databas design evid group hospit local month oper patient perform postop preval procedur rate risk surgeri surgic patient provid respons tissu variabl women year sampl studi support surgeri surgic year

1725: Latex Hypersensitivity (3) 1726: Malignant Hyperthermia (17) antibodi area caus compar care case clinic condit degre famili gener genet health heat identifi muscl mutant control differ diseas extract mutat respons select fraction frequenc genet high influenc patient temperatur time tumor inhibit lead level locat low research studi

1727: Keloid (7) 1728: Hemosiderosis (6) chromosom compar earli effect express factor gene growth higher interact level adult associ blood case caus combin effect femal gap identifi iron measur number plai rate junction lead male patient posit role score subject valu variabl screen studi suggest year

216 1729: Oral Fistula (2) 1730: Epilepsies, Partial (22) cleft dental duplic effect evolut facial factor absenc analysi associ attempt condit data effect increas lip loss manag medic palat patient epilepsi gener group includ indic presenc

potenti releas risk stimul surgeri report respons seizur stress studi surgic suggest suicid

1731: Myxedema (1) 1732: Heartwater Disease (1) cardiac failur follow-up heart left long-term mean analysi copi determin differ evolut gene median month patient rang genom larg length long number popul predict regress remain repeat sequenc short receiv recurr relaps therapi time treat tumor variabl variat ventricular year

1733: Mesenteric Vascular Occlusion 1734: Gigantism (5) (3) american character common countri european

adapt clinic data develop factor featur function growth marker medic mice nation earli enhanc imag incid late method natur organ patient phase progress organ phenotyp predict research signal state syndrom select sever stage studi treatment

1735: Surgical Wound Dehiscence (7) 1736: Poisoning (18) approach clinic complic data literatur analysi care children clinic control mechan molecular mutat oper differ effect expos exposur group health human individu level medic patient perform postop risk size studi treatment procedur publish repeat review risk patient surgeri surgic trial

217 1737: Ichthyosis, X-Linked (4) 1738: Tooth Fractures (2) acid amino children chromosom compar brain case color compar composit core differ delet differ famili gene loss group intens laser light mean mechan model molecular method open ratio red report respect studi valu patient pattern rate region sequenc syndrom target

1739: Hypoventilation (5) 1740: Shy-Drager Syndrome (1) caus cell combin earli effect evid affect alter chang clinic control gener genet imag famili identifi decreas differ distribut form format healthi increas member plai presenc process protein increas local observ patient sever signific studi role screen state subject symptom

1741: Dwarfism, Pituitary (4) 1742: Hematoma (10) associ case cluster function case clinic complic detect diagnos diagnosi diagnost experi follow initi oper organ growth initi isol level mice normal patient process product ratio patient present procedur rare report studi surgeri surgic report risk strain tissu treatment valu

1743: Afibrinogenemia (7) 1744: Cystadenocarcinoma, Mucinous (8) associ case clinic combin diagnosi diseas enhanc factor function mutat analysi cancer cell correl data posit presenc produc product protein detect differ express featur gener report risk studi suggest time methyl model normal patient pattern reveal studi test tissu year

218 1745: Duodenal Diseases (9) 1746: Prosthesis-Related Infections (5) area cancer clinic cluster diseas case cell develop earli express gene gastric male marker pancreat patient identifi infect isol mechan model product remain report secret studi surgeri surgic treatment tumour patient produc product protein rat repeat risk screen specif strain

1747: Hearing Loss, Noise-Induced (8) 1748: Paraneoplastic Syndromes, Ner- activ adult base caus chang children ear vous System (5) follow gener hair hear human impair individu associ case clinic diagnosi loss popul respons studi test year identifi larg loss mechan present rare report screen select size small studi treatment tumor tumour valu

1749: Spinal Cord Compression (12) 1750: Gonorrhea (9) approach associ caus data design dose effect group african american area differ ethnic genet human

injuri irradi method nerv patient isol phenotyp popul protein region risk select radiat respons size strategi time treatment tumor sequenc strain studi test type white

1751: Neoplasms, Connective Tissue 1752: Hemangioblastoma (11)

(5) angiogenesi case cell clinic differ diseas endotheli express factor growth identifi month analysi cell cluster compar complex develop differ express featur gene group identifi mechan patient pattern rate report studi tumor vascular vegf normal phenotyp risk screen tissu tumour variabl

219 1753: Hemangiopericytoma (8) 1754: Ovarian Diseases (9) cell combin compar express famili base case correl differ express larg lesion normal function higher hormon interact lower ovarian process number observ pair receptor rate sequenc studi report signific size small studi tissu respons treatment tumor valu women tumor year

1755: Arsenic Poisoning (6) 1756: Skin Diseases, Vascular (8) activ area assai case concentr correl detect effect expos exposur high low activ case clinic correl data differ discuss includ multipl mutat patient pattern process product recent resist normal primari region sensit studi subject tissu treatment studi syndrom treatment type

1757: Sneddon Syndrome (1) 1758: Anorexia (11) associ biolog case character clinic diagnosi activ bodi caus depress diet disord factor includ literatur mild patient phenotyp present rare report sever studi symptom effect famili lead mass member syndrom system normal obes patient remain select studi tissu trial weight

1759: Sexually Transmitted Diseases 1760: Testicular Diseases (3) (15) bodi breast cancer case condit degre elegan factor femal fusion male determin develop differ femal gender morpholog observ partial report risk group health increas male mate offspr sex speci sperm temperatur patern rate ratio reproduct risk sex sexual steril studi

220 1761: Laryngismus (3) 1762: Enterocolitis, Pseudomembra- nous (3) biolog brain clinic compar control analys analysi character clinic coli differ escherichia diagnosi differ effect factor frequenc genet increas patient potenti produc product releas method neg perform phenotyp popul risk stimul system isol posit recombin reveal strain studi subtyp type

1763: Polyneuropathies (13) 1764: Subdural Effusion (4) activ associ axon clinic cord diagnosi famili gene heal high includ injuri interact nerv acid children complic data differ distribut extract genet incid rang spinal treatment patient local oper parent patient perform wide wound procedur studi surgeri surgic women year

1765: Spinal Osteophytosis (2) 1766: Fistula (5) associ case caus clinic complic distribut approxim associ correl data famili form format imag lead local member determin distribut incid local patient report specif suggest major observ ratio regress rel surgeri surgic syndrom relationship risk signific specif variabl women year

1767: Deficiency Diseases (11) 1768: Respiratory Hypersensitivity activ area bodi caus chang defect (16)

defici develop earli airwai asthma control cystic genotyp increas individu lead model new effect fibrosi local mean measur patient polymorph popul sever studi normal number patient ratio respiratori sampl studi subject test tissu valu

221 1769: Retinal Artery Occlusion (4) 1770: Fuchs’ Endothelial Dystrophy (6) affect analys analysi arteri dai aberr conclusions control dose featur hypertens imag light perform cornea pressur retin reveal structur studi tumour corneal visual volum week correct electron examin featur identifi mean measur methods microscopi morpholog ocular perform screen surfac visual

1771: Chediak-Higashi Syndrome (6) 1772: Bunyaviridae Infections (2)

activ analysi anim area base alter approach base chang clinic control diagnosi diseas complex decreas design famili donor earli mice model patient increas member observ occur pair sever stage studi syndrom system phenotyp residu resist site state transplant strategi vector

1773: Lyme Neuroborreliosis (2) 1774: Parasitic Diseases, Animal (7) anim control differ effect genet activ adapt assai cell complement detect high human increas determin develop development highli larg level low model kinas line major natur plai remain role select number organ signific size speci sensit specif time treatment variabl

1775: Facial Hemiatrophy (3) 1776: Liver Failure (16) case caus common diseas earli assess associ chang children combin effect environment factor famili featur genet function hepat hepatocyt liver measur influenc lead member patient report stage trait tumour variabl variat mice mutat patient reduc role score subject treatment year

222 1777: Gout (5) 1778: Abdomen, Acute (7) care caus clinic data diagnosi diseas case clinic complic diagnosi diagnost earli gener mean method mutat famili genet health includ member multipl mutat pain patient region oper organ patient postop procedur research sequenc studi treatment report surgeri surgic time valu

1779: Staphylococcal Skin Infections 1780: Blood Coagulation Disorders, In- (3) herited (11) adult anim develop differ experiment care case caus code codon effect individu infect isol mice model factor famili folat health patient pattern recombin region mutant mutat patient platelet sequenc strain studi type year young process receptor requir role size substitut

1781: Magnesium Deficiency (9) 1782: Pregnancy Complications, Para- associ clinic compar detect higher includ sitic (3) increas level mutat normal antibodi area assai detect

patient rang rate role select develop development ethic health serum sever studi tissu wide infect issu live locat organ presenc region requir research sensit studi syndrom

1783: Toxoplasmosis, Congenital (1) 1784: Pneumoconiosis (2) abnorm anomali bacteri congenit critic defect analys analysi associ

develop diseas factor genet demonstr depend deplet essenti establish host influenc interact plai popul ratio regul reveal risk role stimul studi tumor variat infect maintain mainten necessari pathogen

requir suffici syndrom

223 1785: Brain Concussion (1) 1786: Cystinosis (10) acut clinic complic control cours diseas activ blood care data differ health dysfunct increas manifest mild moder neurolog injuri larg larger literatur microscopi morpholog number patient peripher public servic sever size patient phenotyp present small sever sign symptom symptomat syndrom

1787: Bartter Syndrome (4) 1788: Paratuberculosis (7) autosom case character characterist clinic common anim assai data detect estim decreas domin famili featur genet hospit includ gener isol method model neg posit rate sampl increas inherit mutat patient rat sensit specif strain studi test tissu valu report treatment

1789: Cocaine-Related Disorders (11) 1790: Poland Syndrome (7) alcohol associ chang consumpt control case characterist combin common data depend effect ethanol increas congenit distal distinct dog featur frequent includ multipl occur occurr presenc oral plai risk role sampl signific report segment studi studi substanc test treatment syndrom transmiss

1791: Respiratory Insufficiency (30) 1792: Spinal Muscular Atrophies of asthma case clinic data evid fibrosi Childhood (13) caus children clinic diseas disord famili gene group health hospit includ muscl identifi includ member motor muscl patient process provid sever number patient phenotyp popul progress risk subject tumour studi syndrom time treatment year

224 1793: Anus Neoplasms (9) 1794: Mucopolysaccharidosis II (4) activ cancer carcinoma cell cervic delet accumul acid caus clinic diseas famili detect express famili genet identifi femal high identifi level low male interact lesion patient rate role mutant mutat patient screen sampl screen studi therapi sever structur studi syndrom

1795: Dysautonomia, Familial (8) 1796: Disorders of Excessive Somno-

cell clinic compar control differ famili frequenc lence (8) higher human increas lower member month adult assess associ chang clinic disord patient protein rate sever test time versu evalu famili identifi measur member mutat patient popul scale score studi time treatment year

1797: Intestinal Perforation (8) 1798: Syphilis, Congenital (2) cancer case cluster complic data adult autosom codon distal dog oper patient perform popul postop domin elderli factor famili imag inherit loss procedur report resect respons risk mutat older proxim risk segment structur surgeri surgic treatment underw substitut year young

1799: Ulcer (8) 1800: Hypokalemia (6) adult case cell clinic detect diagnosi diseas earli featur gener month new activ adult case caus patient present rare report stage children differ diseas form format test tumor year gene genet identifi lead

mutat patient repeat screen

studi subtyp year

225 1801: Colonic Pseudo-Obstruction (2) 1802: Chickenpox (9) adult assai associ case concentr data activ area clinic compar concentr detect differ distribut effect individu local differ high higher individu level low model patient protein sensit lower pancreat patient secret sever rate test tissu year studi symptom syndrom studi

1803: Presbyopia (7) 1804: Hemoglobinopathies (18) abnorm analysi anemia caus defect analysi cataract correl defici epo erythrocyt erythroid data detect estim examin glaucoma erythropoietin genom hemoglobin high normal patient popul posit sever studi year implant intraocular len method methods perform requir reveal risk signific studi variabl

1805: Flatulence (3) 1806: Funnel Chest (1) bladder care children data character characterist classic common

function health length congenit distinct esophag featur need patient public repeat report servic short frequent includ occur occurr probabl report studi surgeri surgic syndrom urinari year repres similar studi syndrom transmiss typic

1807: Penile Neoplasms (11) 1808: Lead Poisoning (6) carcinoma case cell correl current adult assess caus children concentr data discuss express literatur control effect expos normal patient exposur genet high lead product recent phenotyp level low measur model report size subject tissu treatment multipl organ process year tumor

226 1809: Superior Vena Cava Syndrome 1810: Intracranial Arteriosclerosis (7) (1) acid adult alter chang compar arteri case china chines cost determin diagnosi differ heterogen literatur manag medic control gene healthi high practic present rare report respect reveal studi subtyp increas new patient ratio risk signific studi

subject test treatment year

1811: Aortitis (1) 1812: Graft Occlusion, Vascular (9) approach area arteri base cell characterist clinic bodi correl express gene genet identifi index isol mice microarrai molecular combin diagnosi earli effect featur hypertens mous pathwai profil relat relationship signal signific strain weight patient requir stage strategi therapi treat treatment

1813: Hypertension, Malignant (2) 1814: Hyperparathyroidism, Secondary chain compar control differ examin experi (8) frequenc gene initi intern observ organ analysi bone densiti differ effect high origin patient possibl reaction second studi subsequ subtyp higher increas level low new normal patient process respons serum subject test tissu treatment

1815: Preleukemia (2) 1816: Wolfram Syndrome (6) cell chromosom clone delai environment factor follow gene case differ earli famili function express identifi includ mechan member mutat patient influenc marker molecular neg pattern rang rel report respons risk screen genet syndrom test new persist posit promot provid transcript

227 1817: Spastic Paraplegia, Hereditary 1818: Dystonia (17) (9) abnorm anim ataxia atrophi caus chang affect analysi autosom caus clinic diseas disord domin famili gene genom identifi cluster diseas disord expand expans gener includ member inherit interact motor mutat famili phenotyp product protein recess model motor patient popul progress

1819: Urinary Incontinence, Stress (10) 1820: Hematuria (14) bladder determin evalu examin adult bladder case children clinic control diagnosi differ famili excret group includ life mobil new group kidnei mutat patient perform qualiti signific studi surgeri renal studi tract treatment urinari year young tract transit treatment urin urinari

1821: Glanders (1) 1822: Spondylarthropathies (7)

activ addit combin complet associ compar control differ effect enzym field fusion isol median month diseas distribut frequenc movement partial patient result space strain famili stress substrat year group increas level local member pain patient rel report risk studi treatment

1823: Uveitis, Anterior (7) 1824: Urinary Retention (6) associ clinic data earli evid associ bladder case complic develop famili featur health larg manag oper

perform procedur report hospit map patient group increas size small studi surgeri surgic year

mutat patient phenotyp polymorph

region risk sequenc specif studi treatment

228 1825: Mixed Tumor, Malignant (1) 1826: Clostridium Infections (7)

analys analysi carcinoma cell coli combin compar condit control compar data indic mean measur neg correl data degre detect develop normal perform phenotyp posit effect isol model phenotyp reduc ratio respect reveal studi valu tissu strain studi subject test year

1827: Liver Cirrhosis, Biliary (21) 1828: Fibromatosis, Aggressive (7) bile chronic compar control genet genotyp group analysi cancer case clinic diagnosi diseas enhanc factor famili member normal hepat hepatocyt level liver number patient polymorph protein risk role studi subject patient popul report reveal risk time studi tissu tumor tumour

1829: Cholestasis (22) 1830: Bronchopneumonia (2)

analysi bile biliari case chronic cirrhosi clinic combin administr clinic densiti diagnosi diseas diagnosi effect gene genet hepat hepatocyt dai dose effect genotyp high isol level liver model patient rat reduc time low mean patient strain treat treatment valu week

1831: Pityriasis Rubra Pilaris (1) 1832: Echinostomiasis (2)

biolog disord effect follow follow-up improv includ analysi clone collect data decreas epitheli evid median month patient recurr skin stress studi system therapi treat famili host increas induc induct treatment untreat year infect level member protein provid respons sampl support

229 1833: Schistosomiasis mansoni (5) 1834: Elliptocytosis, Hereditary (3)

compar dai decreas differ effect alter assai caus chang control express growth health higher defect defici detect genet increas modifi mutat peptid rat rate reduc region select identifi lead organ patient risk sequenc studi sampl screen sensit studi subject test

1835: Arthritis, Infectious (6) 1836: Klebsiella Infections (7) activ children clinic data enhanc evid health higher includ infect level patient process rang adult clinic host infect isol local new pathogen patient provid rate specif studi subject support repeat tumour rate region sequenc sever strain studi test variabl year

1837: Gyrate Atrophy (1) 1838: Diabetes Insipidus, Neurogenic acid amino cell children effect examin (6) adult area autosom caus cell chang children higher mean measur parent plasma level correl diseas domin express famili femal ratio respect serum target therapeut treat inherit male mutat patient studi treatment valu test year

1839: Hemorrhagic Fever with Renal 1840: Environmental Illness (4) Syndrome (5) adult area blood divers evid factor genet adult analysi area blot dai data genom health human increas interact model differ human isol level popul risk specif studi subject variat year patient pattern rat risk select

strain studi subtyp time year

230 1841: Fused Teeth (6) 1842: Maxillofacial Abnormalities (6) adult case cleft dental facial form african american asian black format fusion individu lip multipl caucasian clinic differ earli ethnic palat patient number european individu male method periodont studi teeth time tooth year organ popul preval race south variabl white

1843: Meningococcal Infections (10) 1844: Blood Platelet Disorders (8)

analysi base case chain clinic diagnosi differ group blood cell chang diseas factor gene identifi interact mechan method increas isol level life method patient qualiti normal novel organ rate studi techniqu type mutat strain peripher receptor screen tissu treatment tumour

1845: Platelet Storage Pool Deficiency 1846: Uterine Cervical Dysplasia (14) (2) assai cancer cell cervic cytolog child childhood children clinic complex compon group increas condit copi degre factor increas larg number detect hpv human lesion neoplasia papillomaviru sampl sensit parent patient risk state subunit signific studi test tumour type system year

1847: Nephrocalcinosis (7) 1848: Hyperostosis (6) adult analysi associ case caus earli bone children compar control famili function kidnei male develop effect express member mutat renal report human individu length level long loss model reveal studi test treatment tumour year normal reduc repeat sampl short tissu

231 1849: Stuttering (5) 1850: Thoracic Neoplasms (8) assess caus children control evalu health case caus chang combin correl data healthi hear imag individu loss measur new patient rel research score human imag lead normal patient presenc

treatment studi subject present report sequenc size studi surviv

tissu tumor

1851: Lichen Planus (5) 1852: Cachexia (22) cell concentr differenti discuss distribut adult associ bodi cancer diet dietari fat group increas intak mass model express group level new obes patient studi time tissu weight year local measur patient recent

respons score serum skin studi

subject treat treatment

1853: Pruritus (8) 1854: Adenoma, Pleomorphic (14)

activ analysi chang carcinoma case cell chromosom children clinic control data delet epitheli evid express loss diseas estim famili method new normal receptor respons reveal malign mammari provid region regul report sampl test tissu treatment requir role support tumor tumour

1855: Lactose Intolerance (4) 1856: Bloom Syndrome (6) adult associ effect environment factor associ cell dna famili form format genet genotyp influenc model includ level mechan mice mous phenotyp recombin repeat replic requir select specif phenotyp polymorph popul ratio risk studi suggest tumour test trait twin variat year

232 1857: Branchio-Oto-Renal Syndrome 1858: Malocclusion, Angle Class III (9) (3) adult children cleft clinic dental facial form format group lip molar case chain compar differ control palat periodont plai role studi subject evid frequenc gene higher loss mutat patient pcr polymeras provid reaction remain report teeth tooth year support syndrom

1859: Microstomia (3) 1860: Coagulation Protein Disorders african american approxim cell cluster (1)

caus code codon conform dose effect exon factor gene data ethnic famili initi major manag member minor observ origin popul identifi irradi mutat nucleotid posit radiat radiotherapi receptor sequenc structur rel report set syndrom substitut

1861: Hernia, Inguinal (13) 1862: Brain Death (27) abdomin adult aneurysm case children brain concept concern consid discuss ethic experi famili gene health issu natur order complic group manag oper organ patient possibl process preoper patient perform postop research view wai procedur resect surgeri surgic techniqu underw year

1863: Pouchitis (3) 1864: Optic Atrophy (9) chronic dai delai diseas featur analysi chain clinic detect develop find flow follow gener genet diagnosi hospit mutat new inflammatori intestin long-term patient pcr polymeras quantit month patient persist reaction real-tim retin revers sever studi visual popul report studi year

233 1865: Scotoma (6) 1866: Osteitis Deformans (7)

assess clinic compar develop diagnosi function bone chang compar control densiti higher measur method mutat normal diseas famili form format patient rate retin score therapi genet high level low member normal tissu treatment visual year patient product subject tissu vitamin

1867: Delirium (6) 1868: Hypotrichosis (6)

affect associ chang dai affect alter autosom caus chang domin famili gene genet high inherit level loss develop effect evid famili follow low map morpholog mutat region repeat sequenc group patient plai rate respons role schizophrenia signific studi suggest year

1869: Dermatitis, Atopic (40) 1870: Corneal Ulcer (10) airwai allerg assess associ asthma cftr aberr cell conclusions control cornea corneal correct design diseas cystic differ diseas fibrosi gene includ evalu group mean measur methods

ocular perform sampl keratinocyt measur patient patient studi time

pulmonari respiratori score skin studi

1871: Thrombasthenia (8) 1872: Alopecia Areata (9) acid analysi base blot case caus clinic express factor adult area assai associ cutan detect examin flow form gene gener human level measur model form gener genet keratinocyt normal risk

mutat report patient sensit skin specif studi tissu treatment year

234 1873: Molluscum Contagiosum (1) 1874: Scleroderma, Diffuse (3)

administr case continu dai delai dose effect allel codon compar control decreas diseas form follow hour improv long-term persist receiv report format gene genotyp healthi skin speci therapi treat

level mice observ patient treatment week increas polymorph recombin studi subject

1875: Yersinia pseudotuberculosis In- 1876: Hypoprothrombinemias (3) fections (2) adapt antibiot bacteri dai delet densiti dose brain diseas earli effect factor gene genet mean mechan molecular mutat point host infect level low progress reduc region risk sequenc stage high time valu natur parasit pathogen select speci state vitro vivo

1877: Central Nervous System Vascular 1878: Pregnancy, Prolonged (2) Malformations (2) affect associ birth fetal genet case caus clinic data diagnosi gestat infant matern neonat period point diagnost estim imag lead method new pregnanc prenat ratio regress risk stimul patient present produc time variabl women product provid report sever specif syndrom

1879: Osteochondroma (6) 1880: Foreign-Body Reaction (6) area case clinic diagnosi diagnost activ area blood cell children dai distribut differ earli individu larg lesion multipl posit report size small stain studi treat elev follow lesion level local normal plasma presenc product serum stain studi variabl treatment tissu

235 1881: Virilism (8) 1882: Gonadal Dysgenesis, 46,XX (4)

analysi blood case data develop express famili case chang clinic famili femal gene femal gender gener hospit genet high identifi male mate member mutat offspr patient reproduct screen sex male mate offspr reproduct reveal sex tissu sexual sexual studi target

1883: Pseudohermaphroditism (10) 1884: Sexual Dysfunction, Physiologi- cal (6) case caus clinic diagnosi express femal care cost differ effect femal gender genet growth male mate offspr patient product reproduct sampl sex sexual test treatment guidelin health male manag measur

medic method pattern practic reduc

reduct score sperm treat treatment

1885: (3) 1886: (7) case caus cell compar control correl analysi assess birth correl effect dai differ dose frequenc lead group evalu fetal human imag index matern length repeat report respons signific measur pregnanc relationship risk signific specif studi week syndrom valu variabl women

1887: (5) 1888: Dystocia (6)

birth compar control data differ earli effect enhanc case clinic correl detect differ fetal fetal group matern neonat normal hospit identifi local matern phenotyp pregnanc ratio risk sampl signific studi tissu pregnanc relationship report sampl screen signific studi syndrom variabl

236 1889: Hyperopia (15) 1890: Optic Atrophies, Hereditary (3) aberr ablat conclusions cornea associ case caus chromosom corneal correct common diseas disord featur develop evalu examin mean measur famili identifi includ map member methods ocular perform refract gene respons studi thick visual year mutat novel report respons screen specif

1891: Carbohydrate Metabolism, In- 1892: Mental Retardation, X-Linked born Errors (14) (18) cleavag clinic combin data disord function gene genet abnorm anomali case clinic congenit defect identifi mutat patient popul proteas residu sampl select sever site symptom syndrom differ disord famili gene identifi local malform

member mutat number patient report screen syndrom

1893: Angelman Syndrome (25) 1894: Nose Deformities, Acquired (3) abnorm analysi anomali associ congenit defect analysi approach classif cleft cluster dental gener imag method normal palat patient procedur site strategi surgeri surgic develop differ featur function gene genet techniqu tissu transplant

genom human individu malform report retard

sequenc syndrom

1895: Synostosis (11) 1896: Ankylosis (5) activ analysi case cat distal dog african american characterist children express famili hand high larg limb mutat proxim report right segment clinic common ethnic famili size small syndrom featur gene hospit individu medic member mutat patient popul product treatment white

237 1897: Encephalocele (7) 1898: Knee Injuries (7) adult associ case children compar case clinic correl data detect diagnosi estim gene group imag method control frequenc function high imag increas level local low number patient posit report mutat normal patient syndrom tissu year risk role studi test vector

1899: Persian Gulf Syndrome (2) 1900: Ileus (7) algorithm approach base disord effect level clinic compar data develop differ effect mean method methyl network normal group higher identifi increas isol pair peptid predict receptor reduc serum set lower patient phenotyp rate report tissu valu respect studi test valu

1901: Pancreatic Cyst (5) 1902: Neurofibroma, Plexiform (4) broad divers includ individu larg major alter chang correl identifi improv includ life marker mechan observ pancreat malign microscopi morpholog normal patient phenotyp posit qualiti rang screen studi treatment tumour wide rang repres spectrum studi tissu tumour type varieti wide

1903: Microsporidiosis (4) 1904: Hyperalgesia (17)

adult aggreg area associ data differ analysi anim control dai effect express human increas induc inject injuri interact mechan drosophila estim form model nerv plai rat respons role week format interact male method model popul specif statist studi test year

238 1905: Muscular Disorders, Atrophic (9) 1906: Abscess (15) ataxia caus control diseas disord case caus cell clinic diagnosi effect group host infect isol number pathogen

effect gene group increas patient rate report sampl strain tissu treatment year male motor muscl mutat potenti process

receptor reduc releas repeat stimul

1907: Thrombophlebitis (3) 1908: LEOPARD Syndrome (4) analysi annot avail clinic combin data databas diagnosi effect http inform organ analysi case chromosom famili genet identifi includ linkag loci locu map patient presenc program provid marker member mutat qtl quantit region search softwar tool web report syndrom trait

1909: Osteogenesis Imperfecta (20) 1910: Leprosy, Borderline (1) allel analysi blot differ ethnic gener activ bmd case chang children bone genotyp isol length long polymorph popul cluster densiti develop format fractur gene hip increas miner normal osteoblast osteoporosi repeat reveal short strain tandem tissu vitamin termin unit western

1911: Leprosy, Tuberculoid (2) 1912: Lymphoma, Large-Cell, Im- munoblastic (3) abil assai cell detect distribut gener abil character characterist children common dai genet high includ induc level local low distinct express featur gene includ

patient popul properti rang lymphoma patient phenotyp respons sensit wide presenc properti regul similar studi system

239 1913: Bulbar Palsy, Progressive (3) 1914: Circoviridae Infections (10) case cours data databas diseas evolut femal analysi bind collect differ effect famili human infect isol new patient genotyp injuri male nerv new reduc replic sampl specif studi subtyp test viral viru patient period plai point provid

report role time

1915: Pregnancy, Tubal (4) 1916: Sclerosis (9) affect assai case concentr detect diagnosi analysi blot brain case compar control embryo follow hormon literatur patient pregnanc develop differ effect express famili frequenc present rare report reproduct sensit steroid studi women group human new patient report signific studi tumor

1917: Mediastinal Diseases (5) 1918: Gestational Trophoblastic Neo- cancer case caus children clinic diagnosi experi plasms (6) gener initi metastasi metastat node origin analysi assess birth correl design diseas fetal health patient present rare report second express treatment tumor hospit matern measur neonat patient pregnanc rate studi time treatment tumour

1919: Hydatidiform Mole (11) 1920: Abdominal Neoplasms (23) birth control correl deliveri fetal gene analysi assess case control evalu group genet gestat infant map matern mother human imag magnet malign measur neonat patient pregnanc number patient perform report studi prenat signific subject week women treatment tumor tumour volum

240 1921: Hyperkalemia (4) 1922: Hematoma, Subdural, Chronic arteri caus concentr decreas effect essenti (3) case caus clinic compar decreas diagnosi hypertens increas inhibit lead mutat new pressur provid differ flow increas lead mean measur multipl patient pattern report surgeri random renal requir resist risk surgic type valu trial

1923: Hearing Loss, Sudden (21) 1924: Hearing Loss, Unilateral (4)

abnorm acoust auditori bilater canal caus cochlear adapt auditori compar control deaf differ ear deaf ear find hair hear impair increas inner enhanc femal frequenc hair hear impair increas

loss middl normal sensorineur vestibular individu inner loss male multipl select

1925: Infarction, Anterior Cerebral 1926: Trichinosis (9)

Artery (2) analysi assai bovin cell collect data decreas detect determin distribut gene health increas approxim case caus compar copi data differ group hear includ individu larg lead local organ popul sampl sensit test tissu loss major number patient rel report sever

1927: Tachycardia, Sinus (1) 1928: Iris Diseases (13) algorithm analysi associ data independ case cataract clinic examin find interv liver method network patient glaucoma implant len methods predict ratio regress relationship microscopi morpholog patient perform risk sever signific studi primari report select studi syndrom treatment visual variabl variat

241 1929: Hypoparathyroidism (10) 1930: Thymoma (21) alter base cell chang control bone caus evid famili femal health high lead low male member method develop effect famili gap mutat product recombin report studi human iron junction member model support syndrom time patient phenotyp rate studi treatment tumor

1931: Acidosis, Renal Tubular (7) 1932: Cafe-au-Lait Spots (7) case cell clinic diagnosi diseas genet broad case develop divers earli gener

growth initi kidnei loss membran mutant includ larg limit major

patient presenc report patient renal report rang repres spectrum stage type varieti wide respons risk studi treat treatment

1933: Goiter, Nodular (11) 1934: Mucopolysaccharidosis III (5)

adenoma adren analysi case caus clinic compar accumul activ adult higher hormon lower marker mutat papillari analysi caus earli enhanc femal patient pituitari protein rate ret reveal thyroid health lead male mechan mice mous mutat normal reveal studi tissu year

1935: Muscular Dystrophies, Limb- 1936: Sick Sinus Syndrome (4) Girdle (23) bind cardiac care caus combin effect clinic contract develop diagnosi dystrophi exercis famili genet health heart lead member multipl mutat popul program express fiber gene muscl muscular mutat myoblast myopathi phenotyp skelet smc provid reduc servic specif smooth strength train

242 1937: Clubfoot (13) 1938: Astroviridae Infections (3) children compar differ distal dog african american assai compar gene group hand health higher control data incid patient preval proxim rate detect differ ethnic isol literatur popul publish segment studi treatment women year rate report search sensit strain time white

1939: Catalepsy (2) 1940: Vitamin E Deficiency (10) adult bodi caus clinic defici diseas effect evid affect alter assai chang dai gene group lead mutat detect dose enhanc femal increas male mechan protein provid rat normal schizophrenia sensit studi patient suggest tissu treatment tumour specif support trial year

1941: Unverricht-Lundborg Syndrome 1942: Arthritis, Psoriatic (21) (3) arthriti associ clinic control diseas adult alter approach gene genet haplotyp joint pain chang children clinic design patient polymorph popul report diagnosi diseas event limit map risk sever snp studi test time new optim organ process provid strategi therapi year

1943: Anthrax (15) 1944: Otitis Media (18) auditori dai data deaf develop ear error estim care coli distribut effect escherichia genet health high isol gene hair hear impair inner isol loss method model normal number statist level local low model mutat research sampl select strain studi toxin

243 1945: Stomach Ulcer (22) 1946: Exostoses (4) activ analysi cancer case compar control case cell chain enhanc evid featur follow function includ light loss data effect gastric increas method new patient provid pylori reduc patient plai provid rang reaction role respons role studi test suggest support syndrom

1947: Multiple Trauma (5) 1948: Eye Hemorrhage (2) activ analysi assess bodi caus cluster data differ arteri bodi cataract conclusions human measur morpholog group electron examin famili organ patient rat report research glaucoma implant score studi weight intraocular len methods microscopi morpholog observ perform pressur studi syndrom weight

1949: Embolism, Fat (1) 1950: Medullary Sponge Kidney (1) arteri bmi bodi diet dietari factor fat critic differ function gener indic kei larg larger number plai proport rel fed feed food hypertens index intak leptin mass

segment smaller nutrit obes supplement syndrom role size small weight structur suggest vari

1951: Open Bite (9) 1952: Neck Injuries (1)

case children cleft case compar control differ experi frequenc higher increas lower observ organ possibl clinic combin dental differ process report residu respect rice signific site wheat effect facial individu lip palat pattern periodont report risk studi teeth tooth treatment

244 1953: Ovarian Hyperstimulation Syn- 1954: Tay-Sachs Disease (5) drome (13) affect case clinic data assist clinic control cycl follicl develop diagnosi diseas famili genet hormon ivf ovari ovarian identifi level male model mutat rel risk screen studi test time patient pregnanc protein

reproduct risk sever steroid stimul

studi testosteron women

1955: Trypanosomiasis (7) 1956: Neuroaxonal Dystrophies (2) analys analysi control detect health anim chines clone differ follow gene heterogen induc induct level mice model multipl human isol method mice new organ phylogenet provid reveal sampl sequenc respons sequenc serum stress strain techniqu tree speci studi subtyp therapi

1957: Adenoma, Chromophobe (1) 1958: Fecal Impaction (4) analys analysi cell chines compar care case data effect evid growth health

control differ differenti dna individu inform insight new present frequenc pattern perform prolifer reveal signific similar studi subtyp tumor type provid report studi support target therapi

treat treatment

1959: Tooth Demineralization (7) 1960: Alcoholic Neuropathy (1) assess children cleft data develop differ effect assess clinic disord distal dog extract hand impact improv life patient physic plai form format group measur model number popul predict radiat score signific proxim segment target variabl qualiti role sever suggest symptom

245 1961: Takayasu’s Arteritis (3) 1962: Purpura, Thrombotic Thrombo- cytopenic (15) addit combin dai dose activ associ bleed coagul defici factor effect evolut express factor hybrid folat homocystein mthfr mutat patient level multipl potenti reduc reduct serum singl plasma platelet product risk sequenc sever stimul studi tumor tumour studi thrombosi venou

1963: Carcinoma, Islet Cell (3) 1964: Serum Sickness (2)

case clinic compar diagnosi differ chain continu declin delai express imag malign marker clinic mean measur organ pancreat pattern secret studi diagnosi diagnost follow tumor tumour type valu level long-term patient pcr persist polymeras reaction recoveri remain serum sever spontan

1965: Head Injuries, Closed (6) 1966: Cherubism (5)

character characterist classic clinic common absenc behavior concentr control diagnosi distinct featur genet higher month mutat dai head isol develop imag new patient rate share similar syndrom typic uniqu level organ perform presenc process requir serum specif strain studi test

1967: Jaw Diseases (7) 1968: Cholecystolithiasis (5) care case cell clinic genet base case chang complic control correl estim health hospit includ medic model femal imag male oper patient perform postop procedur report studi surgeri multipl need patient surgic underw provid public report servic singl studi therapi

246 1969: Subcutaneous Emphysema (2) 1970: Opisthorchiasis (3) case caus children clinic dai delai cell combin effect factor follow growth isol line diagnosi event follow infect lead long-term occur parent patient persist presenc process liver marker median month patient presenc recurr requir stimul strain surviv year respons surgeri

1971: Monkey Diseases (9) 1972: Exanthema (15)

assai blood chang dai detect develop differ form format activ analysi case caus chemotherapi clinic data design diseas express famili hospit includ marker high human isol low monkei primat sensit speci strain studi tumor patient popul report risk studi system

1973: Respiratory Paralysis (1) 1974: Myositis, Inclusion Body (9) continu delai differ experi accumul cluster data develop diseas gene genet follow group method muscl new normal gener initi intern larg long-term number origin patient persist patient plai process role skelet smooth tissu treatment recoveri second sever size small subsequ

1975: Ellis-Van Creveld Syndrome (5) 1976: Migraine with Aura (12)

abnorm analysi anomali associ blot congenit arthriti associ chang diseas defect disord experi featur gene initi malform mental origin report retard second famili fever gene group high human joint map member mutant mutat syndrom western pain patient process rheumatoid sever

247 1977: Migraine without Aura (4) 1978: Eczema (9) analysi anim arthriti associ caus chromosom associ case chang combin effect famili diseas genet human joint linkag loci find gener group high improv life member locu map model organ pain patient previou qualiti report qtl studi patient risk studi treatment

1979: Mucopolysaccharidosis I (15) 1980: Adenoma, Islet Cell (2)

case clinic criteria densiti diagnos diagnosi abeta accumul amyloid caus defici deposit diseas famili high level low lysosom diagnost distribut gene high imag level

number patient precursor report local low mutat neg pancreat storag suggest transplant treatment posit test tumour

1981: Myoclonic Epilepsy, Juvenile (7) 1982: Cholesterol Ester Storage Disease adult attempt condit control epilepsi famili (1) gener genet includ involv mutant accumul apoe case cholesterol deposit patient process report respons seizur diseas electron layer lipid lipoprotein liver microscop microscopi morpholog observ present rare report reveal surfac stress studi suicid year

1983: Multiple Endocrine Neoplasia 1984: Digestive System Abnormalities Type 2b (10) (5) anim assai chang detect differ american area case children express gene genet hormon identifi method clinic diagnosi diagnost discuss imag liver new multipl mutat role model organ patient popul recent report sensit sequenc specif studi risk specif studi surgeri thyroid

248 1985: Aortic Valve Stenosis (13) 1986: Actinobacillus Infections (3) approach cardiac compar associ cell cleft collect compar control correl differ diseas epitheli gene control differ earli failur frequenc group model pattern ratio risk gene heart left method model sampl signific studi type patient studi subject surgeri test vector ventricular

1987: Glomerulonephritis, Membra- 1988: Bacteroidaceae Infections (3) nous (5) analysi assai cell chain clone detect differenti analysi blot caus control diseas featur express gene genet human identifi incid individu kidnei lead patient phylogenet popul popul preval renal report requir reaction region sensit sequenc speci tumour risk screen studi subject

1989: Guillain-Barre Syndrome (12) 1990: Yersinia Infections (3) analysi associ caus clinic cord injuri isol adult bovin caus children clinic diagnosi differ diseas group incid individu men nerv patient popul respons risk mortal mutat pig preval resist test women sever spinal strain studi subject time treatment wound year

1991: Peroxisomal Disorders (9) 1992: Dermatitis, Contact (10) acid cell chang children cluster diabet assai cell chain compar control detect differenti diseas disord genet high individu low mechan mutat normal patient enhanc function healthi phenotyp process tissu human increas level mechan

reaction regul respons skin structur

studi subject

249 1993: Kidney Tubular Necrosis, Acute 1994: Hepatitis, Autoimmune (20)

(2) associ bile blood case chronic clinic diseas

chain children clinic defici diagnosi diagnost elev distribut function hepat hepatocyt liver

level morpholog organ patient local number patient rate role plasma possibl produc product rat reaction serum sampl system test state studi

1995: Epidermolysis Bullosa, Junc- 1996: Burkholderia Infections (2) tional (6) analysi classif cluster differ distinct dna analysi case caus children clinic develop fragment identifi isol organ diagnosi featur genet identifi lead mutat new mutat

pattern produc patient popul screen skin target patient transplant tumour product profil set similar strain type

1997: Anemia, Hemolytic, Autoim- 1998: Salmonella Infections, Animal mune (11) (19) analysi case chang clinic defect anim antibiot bacteri bacteria bovin breed defici develop diseas differ host infect isol number parasit pathogen pig region sampl sequenc strain treatment virul effect function human mice mutat patient popul report select studi time treatment

1999: Rhabdoid Tumor (17) 2000: Collagen Diseases (2)

adult carcinoma case cell antibodi antigen autoantibodi clinic differ differenti express hcc hepatocellular invas malign model normal patient squamou tissu tumor year young direct elisa epitop hypothesi igg immunoglobulin mab

monoclon neutral polyclon reactiv recogn sera serum

specif surfac test

250 2001: Neurocysticercosis (3) 2002: Amebiasis (3) antibodi assai chromosom clinic collect conserv acid american case clinic concentr diagnosi detect determin develop diagnosi diagnost differ effect growth isol individu level patient peptid organ pattern popul presenc reduc resist popul protein sampl sensit serum specif sampl speci type

2003: Central Nervous System Proto- 2004: Leishmaniasis, Visceral (5) zoal Infections (2) analysi area assai clinic control chain clinic demonstr diagnosi distribut detect infect larg month mutat neg

number patient plai posit find genet length local normal pcr protein role sensit size small

polymeras previou reaction repeat

report studi suggest test tissu

2005: (2) 2006: Lice Infestations (4)

allel biolog birth chain clinic concentr fetal absenc approach characterist child children

genotyp isol matern neonat patient pcr common drosophila featur human polymorph pregnanc reaction sever improv larg life parent presenc qualiti size small speci studi year strain system viru

2007: Arthritis, Gouty (1) 2008: Maxillary Sinusitis (3) administr bind cell dai demonstr dose assess cell control diseas evalu find isol mice mous observ previou report strain studi health impact improv life suggest transgen vitro vivo week measur patient perform physic

qualiti score studi

subject system test treatment

251 2009: Pharyngeal Diseases (3) 2010: Thyroiditis (2) bodi clinic conclusions design diseas evalu hospit clinic compar control diagnosi includ initi level main mean multipl objective origin diagnost differ follow-up frequenc imag lesion median month patient perform studi surgeri valu group patient recurr signific stain test tumor year

2011: Fever of Unknown Origin (9) 2012: Penile Diseases (1) associ case caus children effect care clinic commun continu delai educ identifi imag model multipl normal follow inform long-term patient report risk screen studi subject health time tissu treatment year need nurs particip patient persist servic sever skin survei symptom

2013: Rickets (8) 2014: Leukemia, Myeloid, Aggressive- bind bone case chain Phase (1) acut aml arm baselin chronic clinic children clinic detect diagnosi high level parent patient pcr compar diseas effect efficaci improv polymeras rate reaction revers time tissu treatment leukemia mds myeloid

patient placebo random studi

treatment trial

2015: Hypopharyngeal Neoplasms (10) 2016: Cholestasis, Intrahepatic (14) case combin compar bile chang chronic express famili function hepat hepatocyt human individu express control effect level liver mechan member molecular mutat patient posit process serum healthi higher patient presenc radiat rate report sampl signific specif studi subject surviv test

252 2017: Enophthalmos (1) 2018: Paranasal Sinus Diseases (4) associ case caus concentr diseas case compar comparison differ electron distal dog follow genet hand lead evalu imag magnet microscopi morpholog mri observ pattern perform report reson scan similar patient present proxim rare remain type volum report segment studi tumor

2019: Headache Disorders (5) 2020: Supranuclear Palsy, Progressive care gene health high identifi imag (12) alzheimer autoimmun case clinic diagnosi level low mechan method number diseas disord earli famili genom includ organ patient phenotyp onset parkinson pathogenesi patholog patient phenotyp progress report tau receptor sampl screen serum servic studi

2021: Lentivirus Infections (10) 2022: Osteoma (3) adult blood care case elderli analysi cell differ earli famili gene examin health macular old older optic present hiv hiv-1 infect isol level model normal rare report retin retina tumor visual year pattern role sequenc strain studi tissu young viru

2023: Respiratory Tract Fistula (1) 2024: Esophageal Fistula (2)

b-cell cardiac clinic complic conclusions diseas exercis heart lymphoma methods muscl oper pain associ case clinic criteria diagnos diagnosi diagnost follow-up interv patient perform skelet smooth surgeri surgic ventricular lesion median month patient ratio recurr risk stain surgeri surgic year

253 2025: Pyloric Stenosis, Hypertrophic 2026: Epidural Abscess (2) (3) code codon complic dai dose femal approxim cancer clinic diagnosi gastric male oper patient gastric identif identifi kinet perform postop preoper procedur resect major multipl novel observ patient rel screen state surgeri surgic sex substitut surgeri surgic syndrom transit underw

2027: Spinal Dysraphism (21) 2028: Urticaria (9) abnorm anomali area assess care clinic complex adult case clinic differ human improv level life multipl congenit gene genet health measur patient patient physic qualiti respons serum singl skin studi trial valu year popul rate risk score sever studi syndrom

2029: Endodermal Sinus Tumor (4) 2030: Pseudohypoaldosteronism (5) adult cell compar delet fetal higher loss month alter case chang children clinic new patient phenotyp plai pregnanc produc diagnosi express product protein rate role tumor develop year famili function gene higher member mutat patient rate regul report requir structur

2031: Adenocarcinoma, Scirrhous (8) 2032: Hirsutism (9) anim assai cancer case cluster combin associ case children clinic control famili detect effect experiment gastric gene genom high level low member mutat

model normal patient patient phenotyp report resist role sequenc serum syndrom sensit studi surviv tissu tumor valu

254 2033: Gas Poisoning (1) 2034: Cestode Infections (3) centuri countri center conclusions design genet hospit incid infect main medic methods objective european franc french patient popul record retrospect german germani institut studi test unit univers year internat medic medicin meet nation research societi state unite univers work world

2035: Aniridia (7) 2036: RNA Virus Infections (5) base case cataract caus detect accuraci algorithm approach base cell data earli method network plai glaucoma high implant lead predict problem propos region role sampl sequenc set techniqu time len level low model mutat patient product studi subject

surgeri syndrom

2037: Spondylolisthesis (3) 2038: Kyphosis (10) adapt approach case children environ evolut characterist clinic common famili featur factor fit growth manag multipl mutant natur find larg member new normal number

parent releas report stimul select report role sever size strategi syndrom patient studi syndrom tissu treatment

2039: Spondylolysis (1) 2040: Albinism, Oculocutaneous (14)

addit associ biolog contribut demonstr determin bone clinic defect defici distal dog famili hand histori identifi member mutant mutat patient proxim segment sever symptom syndrom wild-typ develop diseas gene includ involv lupu mutat

patient provid pten relev sle studi system

255 2041: Enteritis (9) 2042: Sturge-Weber Syndrome (2)

assai caus chain chang compar avail compar data differ estim genet higher

control detect develop incid inform lower method rate remain respect studi subtyp syndrom versu women year diseas effect group higher isol patient rate reaction role sensit strain studi

2043: Cholesteatoma, Middle Ear (6) 2044: Colitis, Ischemic (1) adult associ case children clinic ear evid hair hear larg concentr copi determin follow loss methods patient size small studi higher increas larg mean measur microg subject support surgeri year microm min number persist plasma rang ratio respect total valu

2045: Animal Diseases (11) 2046: Anaphylaxis (15) analysi care clinic countri develop activ analysi associ case chain clinic diagnosi enhanc ethic growth dai diagnosi differ identifi number health inform isol medic patient pcr product method model nation process research servic strain reaction respons sampl studi time treatment

2047: Encephalomalacia (1) 2048: Pressure Ulcer (11) anim blood bovin breed clinic control assess care cluster correl cost diagnosi diagnost differ examin healthi health high impact improv incid men mortal pig preval studi life manag measur medic need subject women year physic practic qualiti risk score select

256 2049: Adenoma, Liver Cell (6) 2050: Dentinogenesis Imperfecta (4) analysi blot carcinoma cluster activ caus common differ featur gene genet lead mice mous mutant express famili flow gene human increas model mutat normal risk mutat patient protein regul specif structur studi subtyp syndrom role set studi tissu tumor year

2051: (13) 2052: Foot Diseases (9) airwai asthma base case cftr clinic analysi associ base case compar control cystic diagnosi data differ diseas evid famili diseas fibrosi frequenc gener identifi isol featur gener model mutat number patient respiratori studi pattern product provid report role support tumour

2053: Cholecystitis (7) 2054: Carcinoma, Adenosquamous (8) carcinoma case caus children decreas associ case combin correl express form format increas liver develop express model marker organ parent patient posit report sever specif support year patient posit protein rate risk role

specif structur studi subject test tumor tumour

2055: Hemifacial Spasm (3) 2056: Fetal Membranes, Premature

case compar demonstr featur find higher imag Rupture (6) includ lower patient previou rate birth caus control deliveri fetal fetu gestat infant report specif stimul stress studi surgeri group surgic versu matern mother neonat newborn pregnanc pregnant prenat sampl subject week women

257 2057: Conjunctivitis, Viral (4) 2058: Mucocutaneous Lymph Node adult clinic detect diagnosi effect Syndrome (6) genom isol larg method case diseas gene genet genotyp group mice patient sensit sequenc size small specif strain therapi vector year high level low multipl pain patient plai polymorph report role serum syndrom

treat treatment

2059: Arteritis (3) 2060: Congenital Hypothyroidism (20) activ adren analysi associ chang concentr arthriti continu delai diseas develop function gene hormon identif donor femal follow joint identifi new novel patient long-term male map neg pain pituitari risk screen thyroid time patient persist posit receptor recoveri sex transplant

2061: Convalescence (2) 2062: Ectropion (3) adapt antibodi area compar data differ distribut effect evid follow higher inhibit associ case cataract corneal correct examin glaucoma implant len link methods observ popul relat report requir studi suggest syndrom system local lower provid rat rate select support versu

2063: Ichthyosis, Lamellar (9) 2064: Polycythemia (19) analysi caus common differ diseas express famili anemia case caus defect featur function gene human map defici express function gene lead member member model mutat new pattern report skin famili studi mutat normal patient plai report role studi suggest test

258 2065: Mucocele (2) 2066: Cytomegalovirus Retinitis (14) cleft clinic dental diagnosi diagnost effect activ address assess case cmv despit human major measur patient possibl facial fish fluoresc hybrid microscopi morpholog question rais rate remain risk score studi test unknown palat patient probe situ studi surgeri treat treatment

2067: Choline Deficiency (3) 2068: Scleral Diseases (5) cell cluster compar decreas differenti express assai case clinic detect diagnosi diagnost

gener mean method patient gene growth higher human present region report sensit sequenc structur studi system tumour valu increas level liver mice normal profil

protein rate resist tissu

2069: Emaciation (2) 2070: Vasospasm, Intracranial (4)

abil case caus concentr activ arteri assess brain caus concentr discuss effect growth hospit increas lead data effect evalu hypertens imag lead mean microg microm min patient potenti properti measur patient rat reduc risk score valu releas report stimul studi

2071: Synovitis (7) 2072: Mucopolysaccharidosis IV (4)

accumul affect assai chines clinic detect differ adult associ blood children earli heterogen late microscopi morpholog correl differ earli enhanc form increas patient phase progress sensit normal organ parent patient stage studi subtyp syndrom pattern produc product sequenc tissu year

259 2073: Hot Flashes (6) 2074: Hereditary Central Nervous Sys- tem Demyelinating Diseases (3) area dai effect field group hospit autosom caus clinic diagnosi improv life patient plai qualiti reduc reduct diagnost disord domin famili identifi imag inherit injuri mutat repeat risk role studi therapi treat patient recess risk screen sever studi tumour treatment

2075: Gliosis (8) 2076: Pelizaeus-Merzbacher Disease (8) assai axon chang clinic cord detect diseas combin compar control form gene heal injuri diseas effect evid develop mechan mutat nerv neuropathi number examin includ individu injuri mechan role sensit spinal wound mutat normal phenotyp product rat regul support tissu

2077: Lentigo (3) 2078: Mucormycosis (3) characterist clinic common diagnosi environment evid factor featur gener assai cell chain dai detect differ differenti diseas elegan pattern pcr genet influenc linkag locu map new provid select support trait variat polymeras quantit reaction real-tim revers rt-pcr speci stimul type

2079: Mouth Breathing (1) 2080: Loiasis (1) approach character characterist common cohort develop development drosophila exposur factor incid includ increas men design distinct featur imag improv length mortal popul possibl preval question rate remain risk women year

long repeat short similar stabil strategi

target therapeut treat treatment

260 2081: HELLP Syndrome (6) 2082: Duodenal Neoplasms (13) analysi associ blood case caus clinic factor associ cancer case children gene hospit interv level measur colon colorect correl famili function group member model mutat mutat patient ratio reveal risk patient posit sampl studi subject target score serum studi tumour

2083: Stomatitis, Denture (1) 2084: Babesiosis (6)

care case clinic follow-up gener inform interview acid american bladder combin compar median methods month nurs particip concentr determin differ ethnic infect method pattern popul posit rate respect patient person present recurr report sever symptom year studi tract urinari valu

2085: Aortic Valve Insufficiency (9) 2086: Duodenitis (2)

analysi cardiac case clinic data effect evid acid amino anim blood children depend develop establish experiment human infect mice function heart individu left level mechan method organ provid patient mous oral patient peripher reveal support transplant model requir sever studi

2087: Paget’s Disease, Extramammary 2088: Rectal Fistula (3) (5) assai assess case chromosom area breast cancer carcinoma case data clinic detect diagnosi evalu diseas evid express malign imag initi measur model month overexpress patient posit progress new perform report scale score provid studi support tumour sensit surgeri valid volum

261 2089: Adenolymphoma (3) 2090: Lymphoma, T-Cell, Peripheral (11) associ blood case clinic diagnosi epitheli inhibit lymphocyt lymphoma malign b-cell blood case cell clinic cluster densiti

patient peripher present rare relat report sever factor growth high larg level low studi symptom tumour lymphocyt lymphoma patient phenotyp surviv therapi treatment

2091: Multiple Endocrine Neoplasia 2092: Factor XI Deficiency (11) (12) analysi associ data defect defici factor adren analysi associ complex diseas famili gene high low model mutant genet hormon incid mice model mutat new phenotyp rate requir mutat patient pituitari popul risk sampl sequenc

protein rate studi thyroid time women

2093: Hemorrhagic Fever, Ebola (1) 2094: (16) bind contain demonstr element essenti alter caus cell chang congenit differ effect famili femal genet group male mutat function gene genom impair infect insert integr known physiolog plasmid protein recombin site structur viru patient pattern report role sex

syndrom tissu

2095: Fetal Macrosomia (8) 2096: Hyperlysinemias (1)

birth case children develop earli fetal cell clinic concentr diseas effect elev higher increas increas infant level matern neonat lower measur microm min patient normal pregnanc prenat report studi level plasma serum sever symptom treat treatment syndrom tissu women year

262 2097: Laron Syndrome (4) 2098: Hypertrophy, Right Ventricular

bind children clinic correl factor femal (4)

growth human male mechan analysi assess cardiac caus clinic normal patient predict product target time tissu treatment variabl year differ femal heart level male measur pattern plai process rat respons reveal role score structur

2099: Uveomeningoencephalitic Syn- 2100: Sialadenitis (2) drome (4) allel case criteria diagnos approxim clinic compar differ clinic diagnost genotyp diseas earli model new diagnosi imag isol linkag loci locu map pattern provid random mice patient mous patient polymorph strain transgen rat rel risk stage system therapi treatment trial

2101: Ciguatera Poisoning (2) 2102: Immune Complex Diseases (4) area behavior clinic combin decreas diseas effect administr antibodi children condit dai factor fish human hybrid increas damag degre dna dose multipl mutat level locat patient risk sever site studi symptom patient plai rat renal repair replic role transplant week

2103: Feline Infectious Peritonitis (2) 2104: Anisakiasis (2) analysi assai case clinic detect diagnosi cancer case chines class clinic differ

dna featur fragment infect differ form format gastric heterogen hybrid pattern pcr report restrict sampl sensit similar speci type mild patient present report

sever studi subtyp symptom test

263 2105: Polycystic Kidney, Autosomal 2106: Ureteral Obstruction (7) Recessive (12) approach care case chang clinic control analysi chromosom differ diseas failur gene effect femal function health kidnei male genet kidnei larg map model mutat month particip patient protein renal sampl state year new rate rcc renal risk size small studi

2107: Lymphatic Abnormalities (1) 2108: Plagiocephaly, Nonsynostotic (3)

clinic compar comparison criteria current data care child children cluster differ effect follow gene health hospit mean medic parent persist diagnos diagnosi diagnost differ discuss observ patient pattern present recent sever similar ratio repeat treat treatment syndrom type valu year

2109: Hartnup Disease (2) 2110: Central Nervous System Viral Diseases (6) associ cell condit degre delet differ compar control dna diseas gene heat individu investig light mutat assai detect observ relat renal resist studi temperatur tumour effect express factor function

gene higher human

individu mutant mutat popul rate risk sensit subject

2111: Diabetes Mellitus, Lipoatrophic 2112: Tick-Borne Diseases (2) (4) advanc applic biologi care challeng develop drosophila factor follow health infect adult autosom case children clinic domin famili gene gener inherit mechan molecular new mutat normal nuclear older organ provid research risk technolog underli protein report tissu year young understand

264 2113: Insulinoma (16) 2114: Glucagonoma (3) bodi case cell distribut fusion islet lesion analysi associ children differ cell liver local malign normal pancrea gene high identifi increas pancreat primari secret stain islet level low number studi suggest tissu tumour pancreat posit rate respons screen secret studi

2115: Scalp Dermatoses (12) 2116: Granuloma, Giant Cell (4) absenc case cell children blood case caus cell gene genet lead clinic congenit correl incid larg lesion parent lesion model patient plai present rang presenc report size skin small studi rare report role specimen stain target tumor

syndrom women year

2117: Holoprosencephaly (24) 2118: Lymphoma, Large-Cell, Ki-1 (3)

abnorm alter analysi anomali associ case chang alter analysi blot chain chang characterist data databas detect distribut chromosom clinic congenit defect disord featur includ featur increas local lymphoma pcr polymeras reaction revers stimul western

malform mental new report retard syndrom

2119: Feline Acquired Immunodefi- 2120: Leukemia, Feline (1) ciency Syndrome (5) area case chines differ heterogen high analys analysi area blood carcinoma carrier data factor identifi indic live locat perform peripher region resid reveal risk studi tumor identifi includ infect isol level low remain risk screen strain studi subtyp

treat treatment

265 2121: Infectious Mononucleosis (5) 2122: Exanthema Subitum (1) associ case character clinic complex dai diagnosi differ case chimpanze clinic criteria demonstr diagnos

diagnosi diagnost exposur human laboratori macaqu monkei patient potenti primat rhesu function hypothesi patient phenotyp rodent routin suspect

popul regul repeat risk sever suggest symptom test

2123: Roseolovirus Infections (9) 2124: Eye Infections, Viral (9) analysi associ collect compar detect differ assai cell chain clinic compar control data detect diagnosi gene infect genom human infect method pattern process rate regul remain sampl patient pcr polymeras reaction sequenc test transplant viru subject test therapi vector viru

2125: Lingual Goiter (1) 2126: Thyroid Hormone Resistance assess case clinic concentr impact Syndrome (8) improv life neg normal patient physic activ autosom clinic combin domin famili posit present qualiti random report sever gene genet inherit level mutant

studi tissu trial mutat new phenotyp process region respons sequenc thyroid treatment

2127: Goiter (13) 2128: Lymphangioma, Cystic (6) adren analysi base case detect express gene birth caus complex effect evid fetal hormon initi loss method mutat genom gestat identifi infant matern measur normal pituitari report sampl studi neonat patient pregnanc thyroid tissu valu prenat score screen structur women

266 2129: Thyrotoxicosis (5) 2130: Cranial Nerve Diseases (5)

alter approach caus chang concentr gene clinic compar dai differ diseas featur group injuri mechan molecular mutat increas initi lead month patient nerv patient posit rat sever signific syndrom phenotyp point rat syndrom thyroid time treat transplant trial treatment viru

2131: Parkinson Disease, Secondary (7) 2132: Meningitis, Bacterial (14) adult assai base cell detect bacteri base clinic data differ differ diseas enhanc distribut enhanc host function gene interact neuron infect local method pattern product receptor risk sensit studi model organ pathogen patient test year sampl strain studi time treatment

2133: Breast Cyst (1) 2134: Soft Tissue Infections (3) adjust associ cancer case confid control factor assess associ genet increas interv odd period point popul clinic diagnosi diagnost earli evalu ratio risk smoke studi surviv time gene health interv late measur phase plai ratio risk role scale score stage

2135: Dipetalonema Infections (1) 2136: Pneumonia, Mycoplasma (4) associ base compar condit confid analysi anim caus differ effect experiment lead mean measur control degre differ infect model neg posit predict rat interv isol observ pair process ratio reduc reduct regress valu variabl variat risk smoke strain studi temperatur

267 2137: Neoplasms, Adnexal and Skin 2138: Colonic Diseases (15) Appendage (1) cancer case colon biopsi cancer cell clinic e-cadherin epitheli epithelium colorect develop diseas earli effect express gland immunohistochem lesion mammari famili group includ new patient process methods ovarian patient skin specimen provid rat report treat treatment stain tissu tumor year

2139: Hypotension, Orthostatic (2) 2140: Pelvic Pain (5)

elderli field improv life base compar control data differ adult environment estim factor genet movement old older patient period physic point qualiti receptor resist space target group influenc patient pattern risk signific studi subject trait variat year time year young

2141: Gingival Neoplasms (8) 2142: Leydig Cell Tumor (4) analysi carcinoma case cell data activ bind cell effect hormon human kinas express imag larg number line patient period point regul thyroid time treat differ treatment tumour vitro vivo women observ patient pattern presenc rel reveal size small studi tumor

2143: Sciatic Neuropathy (10) 2144: Nephrosis, Lipoid (8) axon cord effect enhanc follow group heal associ compar control differ injuri model myelin nerv frequenc group high higher level low neuropathi number peripher rat regener select spinal trauma wound lower patient rate renal role serum signific studi treatment year

268 2145: Meningitis, Cryptococcal (7) 2146: Glomerulonephritis, Membra-

adult case distribut enhanc fungal human noproliferative (9) isol larg local model mutat pathogen case correl dai data diseas evid express patient phenotyp protein report size small strain year human kidnei model

patient provid renal

report studi support test transplant

treat treatment

2147: Ichthyosiform Erythroderma, 2148: Hand Deformities (5) Congenital (5) adult cat chromosom dai delet distal area caus compar control differ domin dog earli hand left limb multipl ethnic famili frequenc gene genet genotyp process proxim respons right member mutant mutat segment stage syndrom year patient polymorph popul skin studi

2149: Sigmoid Diseases (5) 2150: Multiple Endocrine Neoplasia adult case chain children detect diseas high level low Type 2a (22) adenoma adren braf famili function gene number patient pcr polymeras quantit reaction real-tim revers risk studi year genet high hormon level low member method

mutat papillari patient pituitari ret

studi thyroid

2151: Esophageal Cyst (1) 2152: Actinomycetales Infections (3)

complic delai distribut electron analysi cluster concentr differ dna fragment gene genet isol fluid follow layer long-term group local method pattern pcr primer restrict sequenc method microscopi speci strain target time morpholog observ oper patient persist procedur surgeri surgic techniqu

269 2153: Diphtheria (4) 2154: Mycobacterium Infections, Atyp- acid adult area case children dai ical (6) case data human indic isol length data estim factor field gener isol locat gener long mechan method molecular mycobacterium repeat report short speci specif strain studi tuberculosi organ patient posit risk strain studi year

2155: Empty Sella Syndrome (2) 2156: Auditory Perceptual Disorders

bodi case corneal correct critic defect factor form (1) format involv mechan molecular mutant aberr caus corneal correct defect delet exon factor function gene methods mutant mutat plai report role suggest transcript wild-typ mutat phenotyp reduc regul transcript visual wild wild-typ

2157: Eyelid Neoplasms (11) 2158: Mycobacterium avium- analysi associ carcinoma case cell intracellulare Infection (2) conclusions corneal correct express mean methods month analysi assai associ case patient perform report role select studi detect electrophoresi treatment year function gel gener hospit hybrid identifi induc mass remain report respons sensit specif studi

2159: Avitaminosis (2) 2160: Mesenchymoma (5) adult analysi case categori classif acid dai data develop dose factor incid level liver period point preval rat classifi cluster distinct gene risk serum structur time week women year identifi lesion mutat new profil report set stain subgroup tumour year

270 2161: Bacteroides Infections (4) 2162: Lung Diseases, Fungal (12)

adult clinic combin compar diagnosi diagnost chang children clinic determin fungal fungi effect higher human method popul fungu human isol pathogen promot rate region repeat sequenc speci patient produc remain respons sampl speci subject treatment year strain studi treatment valu

2163: Burns, Electric (1) 2164: Adrenal Rest Tumor (1) approxim consist differ experi follow initi analysi differ duplic effect essenti evolut independ injuri intern larg larger major nerv lesion measur patient predict rat regress relationship releas requir signific stimul number observ origin rel second variabl variat size small suggest

2165: Adenocarcinoma, Bronchiolo- 2166: Bronchiolitis Obliterans (4) Alveolar (23) analysi clinic cluster compar dai data

cancer case cell characterist clinic diagnosi differ donor earli cluster common compar differ featur gene develop higher human level genom group human increas lung group mutat rate stage transplant variabl mutat number sequenc studi

2167: Felty’s Syndrome (1) 2168: Agranulocytosis (3)

abnorm anomali associ case caus clinic congenit advanc base care chemotherapi congenit demonstr find health observ pair regimen defect delai development disord featur hypoplasia patient previou report respons servic studi surviv

malform mental rare report retard sever syndrom toxic syndrom

271 2169: Heart Septal Defects (6) 2170: Granuloma, (8) bladder case cell clinic cluster correl associ cardiac determin diagnosi lesion normal patient present children chromosom differ factor failur report signific specif stain studi time tissu tumor famili heart left member method mice multipl repeat risk studi syndrom time ventricular

2171: Maxillary Sinus Neoplasms (2) 2172: Bronchopulmonary Dysplasia adult analys analysi bodi chain collect data (13) detect malign mass older pcr reaction remain birth chang compar control research sampl studi develop fetal gestat tumour year young group infant matern mother neonat number patient pregnanc prenat rate studi week women

2173: Focal Infection, Dental (4) 2174: Paramyxoviridae Infections (8) care differ earli educ evid analysi assai cluster combin detect develop differ effect high identifi health isol method pattern program provid public repeat servic specif level low new patient strain studi subject support test phenotyp protein respons sensit studi subtyp

2175: Corneal Neovascularization (9) 2176: Food Hypersensitivity (16) activ assess cell control effect gene airwai assai asthma bodi caus cell children clinic cystic genet inhibit measur model detect fibrosi new provid reduc sampl score studi gene subject suppress time vector human level product protein respiratori sensit specif studi

272 2177: Carcinoma, Embryonal (10) 2178: Sea-Blue Histiocyte Syndrome (1) acid activ associ case cell case direct diseas distanc divers field forc develop differenti domain enhanc genet intens laser light motion movement neg express gene high human level low report space time model organ presenc studi tumor popul posit variat

2179: Methemoglobinemia (6) 2180: Trypanosomiasis, Bovine (1) activ case clinic defici diagnosi diagnost analysi cdna chain chromosom clone detect dna extract fragment gene librari pcr enzym express famili genet life member particip patient popul posit requir polymeras protein quantit sever studi substrat reaction real-tim resist revers sequenc

2181: Gait Ataxia (6) 2182: Root Caries (2) affect chang combin data alcohol area bodi effect estim field level method model adult caus clinic elderli extract factor lead movement new normal patient older oral patient risk sever posit space studi subject tissu treatment studi symptom transplant year young

2183: Bruxism (2) 2184: Optic Neuropathy, Ischemic (8) content determin differ earli enhanc flow care depress disord form format associ genom inform larg loss particip health impact improv life particip new provid size small patient person physic qualiti ratio patient specif stage test valu relat risk state studi

273 2185: Lip Neoplasms (5) 2186: Ischemic Attack, Transient (18) blood case cell children clinic clone activ arteri blood caus compar coronari diseas concentr diagnosi diagnost earli famili effect function higher hypertens femal interact male member patient pressur rate reduc risk mutant posit report stage tumour sampl stroke subject vascular

2187: Rickettsiaceae Infections (1) 2188: Leg Length Inequality (3) clone data event evid experi femal follow adolesc approach autism base boi child childhood

hypothesi initi intern involv male origin children data girl length literatur method pair parent pediatr problem repeat report process protein provid year second sex support tumour

2189: Klippel-Trenaunay-Weber Syn- 2190: Fractures, Closed (1) drome (9) articl author avail current data definit associ case differ environment factor genet electron includ inform imag influenc level mechan molecular develop layer literatur microscopi morpholog paper patient process repeat report publish report review search systemat serum studi syndrom trait variat

2191: Fractures, Open (3) 2192: Xanthomatosis, Cerebrotendi- nous (3) analysi associ blot bone cluster data differ earli estim high inform level life low case compar control differ effect frequenc healthi incid liver mutat normal patient qualiti stage structur studi tumour patient reduc regul signific studi subject tissu treatment year

274 2193: Neurofibrosarcoma (2) 2194: Hearing Loss, Bilateral (16) adult analysi blot broad detect hybrid abnorm auditori canal caus cochlear deaf ear famili

hair hear impair inner loss middl normal patient studi subject vestibular year incid includ individu mechan

molecular mortal rang treat treatment varieti western

wide women year

2195: Neoplasms, Neuroepithelial (10) 2196: Tularemia (5) case cell children detect diagnosi adult approach caus data detect genet differenti express gener growth malign number identifi includ individu infect lead literatur patient present primari protein rare method repeat risk screen report stress tumor tumour strategi techniqu time year

2197: Reflex Sympathetic Dystrophy 2198: Leukoencephalopathy, Progres- (4) sive Multifocal (9) affect care chain event form format inform brain case clinic develop follow genom interview involv new nurs particip human model new patient person posit process patient random rate rat reaction risk time respons select sequenc studi treatment trial tumour viru

2199: Whooping Cough (6) 2200: Metal Metabolism, Inborn Errors adult care case chain children (1) clinic detect diagnosi diagnost absenc affect defici head indic intermedi kinet linkag loci locu map genom health method model pcr period mitochondri peptid presenc point reaction risk time year schizophrenia state studi suggest switch transit

275 2201: Sarcoidosis, Pulmonary (10) 2202: Iatrogenic Disease (14) associ case chronic compar control decreas area clinic complic factor famili human improv diseas earli gene identifi imag improv life manag oper patient perform procedur qualiti risk studi surgeri surgic treat increas intestin life patient qualiti report screen stage treatment

2203: Tuberculosis, Lymph Node (2) 2204: Cat-Scratch Disease (5) assess case clinic data evalu arthriti case child children clinic lymph measur metastas diagnosi diseas function larg pain parent gener patient present rare report risk size small metastasi metastat node patient present tumor year primari region report score sequenc tumor

2205: Toxoplasmosis (7) 2206: Herpes Labialis (3) anim detect effect form host differ consist csf data determin differ distribut individu infect mechan mice model pathogen pattern plai posit presenc fluid hiv-1 infect local mechan molecular observ pattern point sampl spatial suggest time viru role sampl studi suggest

2207: Infant Nutrition Disorders (3) 2208: Anaplasia (4)

african american bodi caus children clinic adolesc associ child childhood diagnosi differ enhanc ethnic group children compar correl effect life month parent patient popul qualiti test white year famili group higher level model parent pediatr process rate rel studi year

276 2209: Bronchopulmonary Sequestra- 2210: Rothmund-Thomson Syndrome tion (1) (6)

adolesc autism care case child childhood adult case clinic diagnosi dna enhanc famili featur function gene interact member mutat children frequent gener inform occur occurr parent particip pediatr patient phenotyp popul protein report studi syndrom transmiss year report syndrom year

2211: Aneurysm, Infected (3) 2212: Shock, Traumatic (4) complic decreas delet dose drosophila element anim associ avail children condit increas insert irradi level oper data databas degre genom inform patient perform postop procedur radiat resect surgeri surgic underw level model new plasma provid report sequenc serum studi subject

2213: Myotonia Congenita (2) 2214: Muscle Rigidity (2) caus chain dystrophi exercis fiber find gene chain detect discuss gene genotyp lead level muscl muscular muscl mutat organ pcr previou reaction report patient pcr polymeras polymorph mutat serum skelet smooth studi quantit reaction real-tim recent revers sever skelet syndrom

2215: Hepatitis, Infectious Canine (1) 2216: Phenylketonuria, Maternal (3)

candid children control detect earli fetal identif administr appear brain confoc dai dose granul layer microscop electron identifi known late newborn novel phase pregnanc program sampl screen microscopi stage women year

morpholog observ reveal shape structur surfac ultrastructur wall week

277 2217: Ebstein’s Anomaly (5) 2218: Serotonin Syndrome (3) anim case caus dai depress atrial cardiac cardiomyocyt cardiomyopathi case clinic diagnosi dilat failur disord effect includ lead hospit hybrid hypertrophi imag interact mechan model heart molecular multipl organ rang receptor left report right site valv ventricular reduc studi symptom

2219: Fluorosis, Dental (1) 2220: Alcohol-Related Disorders (2) activ alcohol chines depend affect allel area associ cluster data differ disord differ effect end gastric gene genotyp incid patient polymorph popul preval specif studi tumour heterogen human infect inhibit women year oral respect senesc signific studi subtyp telomer telomeras

2221: Varicose Ulcer (6) 2222: Bacteremia (17) activ assess distribut effect genet analysi bacteri correl detect differ improv incid induc inhibit life local qualiti function genom host hybrid respons risk studi system identifi normal time treatment trial women infect pathogen posit risk screen strain studi tissu tumor

2223: Anemia, Refractory (11) 2224: Anemia, Refractory, with Excess

activ acut associ cluster dai data detect form of Blasts (9) group high leukemia low myeloid normal acut analysi case clinic decreas gener

patient phenotyp studi subject increas leukemia mice multipl normal tissu treatment number patient select state studi tissu transplant treatment tumor

278 2225: Haemonchiasis (1) 2226: Foreign Bodies (17)

anim bovin breed cattl cow differ elegan bodi case children clinic element hybrid insert mean

famili identifi includ indic member new occur occurr patient report milk phenotyp pig porcin sea season sheep studi suggest surgeri treatment valu weight year speci

2227: Tick Infestations (3) 2228: Spasm (4) african american anim data develop differ ethnic experiment gene genet incid acid analys analysi

model polymorph popul children clinic compar preval specif state studi valu white control diagnosi diagnost featur frequenc gene genet health origin parent rat reveal sampl syndrom

2229: Klippel-Feil Syndrome (4) 2230: Gonadal Dysgenesis (4) abnorm anomali case children clinic case femal larg male normal congenit diagnosi evid genet patient popul present provid rare report sever stimul number organ origin plai posit support syndrom year

product risk role sex size small syndrom

tissu treatment tumor

2231: Iron Metabolism Disorders (9) 2232: Goiter, Endemic (2) associ clinic children behavior defici discuss effect evolut featur follow genet control gene factor high level low marker prevent increas iron junction mutat new parent protect recent reduc reduct region research patient phenotyp protein studi subject target risk sequenc test

279 2233: Protein-Losing Enteropathies (5) 2234: Pyoderma (2) adult analysi case cell clinic human character characterist common compar control differ distinct featur group improv includ life level method patient perform plasma qualiti regress relationship signific speci stress studi variabl protein reveal serum sever studi test transplant treatment year

2235: Leukemia L1210 (7) 2236: Athletic Injuries (9) anim cell combin dai effect enhanc gene high increas induc induct level low mice model area caus chain dai detect multipl product respons vitro form format gene health pcr vivo polymeras quantit rat reaction real-tim region revers sampl select studi

2237: Thymus Neoplasms (30) 2238: Nasopharyngeal Diseases (2) approach base blood data delai differ exposur activ analysi base case cell follow human long-term mean compar control correl differ method pair persist ratio recoveri strategi techniqu test valu express famili featur human mice

patient pattern signific studi surviv tumor

2239: Tuberculosis, Osteoarticular (2) 2240: Coronary Vessel Anomalies (11) affect children clinic control diagnosi differ ace behavior blood distribut event gener arteri group cardiovascular case coronari includ involv local occur patient process regul control report specif studi diseas hypertens infarct ischem ischemia myocardi new popul pressur provid stroke vascular

280 2241: Hemothorax (3) 2242: Secernentea Infections (1) adult alter case chang child compar conclusions control decreas detect children dna parent patient period point present report risk surgeri time differ fish fluoresc group healthi hybrid transplant tumor year young increas level mean methods probe signific

situ studi subject

2243: Osteitis Fibrosa Cystica (1) 2244: Radiation Pneumonitis (15) analysi associ base cancer cell develop assess associ bone clinic design diagnosi diagnost evalu hospit measur mild distribut dose effect fluid irradi patient present scale score sever sign local lung observ patient studi symptom valid radiat radiotherapi respons studi surviv

2245: Hyperostosis, Diffuse Idiopathic 2246: Scleroderma, Limited (3) Skeletal (1) allel approach biolog class common esophag find frequent distribut examin includ investig italian mesothelioma incid indic involv muscl occur occurr genotyp possibl probabl relat report stress local mortal observ studi suggest transmiss polymorph preval studi transmit suggest system women year

2247: Craniopharyngioma (7) 2248: Ectopia Lentis (4) children clinic codon detect develop differ anterior cataract chamber disc examin gene includ parent patient famili gene glaucoma pattern plai process product report role includ intraocular iop len studi test time treatment implant member methods perform requir studi surgeri syndrom

281 2249: Bone Cysts, Aneurysmal (5) 2250: Mastocytosis, Systemic (10)

activ case caus complic experi activ biolog cell develop function includ involv larg mechan method model molecular initi interact local oper method number phenotyp role size small studi organ origin patient procedur process system time second surgeri surgic techniqu treatment

2251: (2) 2252: Tendon Injuries (4) analys analysi case clinic canin cat dai distal dog dose conclusions control design hospit level gene hand higher left limb lower medic objective patient perform patient proxim rabbit rate right present reveal sever state studi subject symptom segment therapi year

2253: Narcolepsy (5) 2254: Gingival Diseases (5) area behavior caus clinic cluster depress accumul area diseas gene high detect differ disord identifi lead incid individu level low mechan men loss patient phenotyp remain model mortal mutat phenotyp screen select studi symptom valu popul preval tumour women year

2255: Lymphoma, Small Cleaved-Cell, 2256: Lymphoma, Mixed-Cell, Follicu- Follicular (1) lar (1) analysi blot chain detect express imag chain chromosom clinic dna dynam fragment induc induct marker month patient outcom pcr polymeras prognosi model patient pcr polymeras random reaction prognost protein reaction recombin stage respons sever trial year surviv target therapeut western

282 2257: Mycobacterium Infections (10) 2258: Distal Myopathies (2) case data detect differ gener genet analysi blot case cell clinic detect differenti earli electron express microscopi morpholog human identif identifi includ method model mutat new number report screen select studi protein report reveal stage treatment patient stain studi western

2259: Chlamydophila Infections (5) 2260: Vaccinia (10) activ cell chang dai differenti gener analysi caus children genom increas infect level mice new number process product prolifer resist content differ flow hybrid identif respons viral viru identifi individu lead normal organ pattern rat respons reveal screen speci tissu

2261: Vestibulocochlear Nerve Diseases 2262: Neuroma, Acoustic (25)

(1) auditori canal case caus chang cochlear deaf ear bone case cell diagnos diagnosi donor european literatur man marrow nation patient present gene hair hear impair inner loss middl patient rate sensorineur studi vestibular rare report surgeri surgic transplant tumor woman

2263: Facial Nerve Diseases (3) 2264: Spinal Fractures (8) abil assai base care case detect adult bone case chang clinic compar data higher imag incid level measur month genet health mechan method molecular pair patient present properti remain report patient rate size treatment sensit servic tumor valu women year

283 2265: Nystagmus, Congenital (6) 2266: Albinism, Ocular (3)

activ biolog case children affect assess biolog differ distribut famili genom identifi increas interact male enhanc local measur neg observ pattern posit regul score state studi suggest neg parent patient posit tumour type respons screen studi subject system system year

2267: Corneal Edema (3) 2268: Insomnia, Fatal Familial (2) autosom case clinic diseas disord domin alter approxim case chang famili gene genom incid inherit corneal correct correl electron effect map men mortal preval report examin major microscopi morpholog mutat observ reduc rel report signific specif sequenc women year surfac

2269: Vitreous Detachment (4) 2270: Neuroectodermal Tumors (3) approach blood care cell children express approach associ cone degener examin form format improv life macular factor famili function health histori includ member parent patient rang risk methods optic photoreceptor pigment qualiti strategi tumor wide retin retina studi vision visual

2271: Glycogen Storage Disease Type 2272: Fucosidosis (1) IV (2) compar decreas differ higher accumul clinic cours find level marker normal organ patient period phenotyp point previou increas level mean report serum sever studi suggest time tissu measur normal paramet patient

period point rang ratio respect serum time tissu valu

284 2273: Hypertension, Portal (8) 2274: Maple Syrup Urine Disease (9)

case clinic combin acid amino analysi base blot clinic control earli enzym extract fatti identifi mutat control correl effect genotyp hepat patient repeat retino reveal screen sever structur level liver mechan molecular mutat patient polymorph sever studi subject system year

2275: Retinitis (4) 2276: Rheumatic Fever (2) allel associ children class combin decreas associ compar conclusions control design differ healthi hospit local effect factor frequenc gene genet genotyp normal patient pattern plai product increas influenc mhc patient role studi subject tissu treatment variabl polymorph ratio risk studi

2277: Duodenal Obstruction (4) 2278: Shock (6) case children complic differ distribut gastric growth initi literatur local origin patient activ analysi case condit phenotyp present rare report studi surgeri surgic syndrom degre distribut earli effect genotyp local mechan reduc report requir respons reveal stage temperatur tumor valu

2279: Nasal Polyps (12) 2280: Ossification, Heterotopic (6) cancer case clinic control correl diagnosi disord affect associ case clinic dai diagnosi effect group level patient present find gastric human includ loss report respons serum signific size studi test year mice mous patient rang report segment studi suggest tumour

285 2281: Metrorrhagia (3) 2282: Submandibular Gland Neo-

associ breast cancer case children endometri plasms (6) estrogen factor gener growth interv ovarian adult case cell clinic diagnosi epitheli epithelium express gland patient present rare ratio report risk group studi tumor human imag mammari normal present rare report tissu tumor year

2283: Nephritis, Interstitial (13) 2284: Arrhythmogenic Right Ventricu- cluster differ diseas failur famili femal kidnei lar Dysplasia (8) male mutat normal patient product rcc analysi associ cardiac caus diseas renal risk specif studi test tissu tubular failur femal gene group heart high left level low male new plai provid role ventricular

2285: Tachycardia, Ectopic Junctional 2286: Tachycardia, Paroxysmal (2) (2) cardiac case chines clinic develop cardiac characterist clinic development differ diseas heart heterogen includ common distinct environment factor failur observ patient report seizur sever stress studi subtyp syndrom featur genet heart influenc left patient sever stress syndrom trait variat ventricular

2287: Melorheostosis (1) 2288: Nephritis, Hereditary (12) adult case chain dai dose elderli form adult autosom case chang control domin format normal old older pcr polymeras famili inherit kidnei method mutat rare reaction report tissu week year number patient region renal young report sequenc studi treatment year

286 2289: Cerebral Arterial Diseases (4) 2290: Encephalitis, Japanese (3) acid area care chicken cluster dai differ affect alter anim arteri chang dai genet genotyp health hybrid immun decreas diseas dose effect enhanc gene hypertens increas model patient pressur reduc individu inject multipl produc signific studi product rat studi viru

2291: Hypoproteinemia (2) 2292: Synovial Cyst (1)

cell complic dynam effect epitheli improv associ caus clinic collect data diagnosi diagnost differ group investig lead marker month patient sampl sever signific model oper paramet patient postop studi syndrom tumour predict procedur resect simul surgeri surgic

therapi treat treatment

2293: (5) 2294: Leukodystrophy, Globoid Cell caus complex enhanc examin (10)

express extent find growth activ alter base chang data distribut estim form gene health indic mice interact method model mutant number new observ phenotyp posit observ patient protein region studi suggest target treatment studi time vector

2295: Hematocolpos (1) 2296: Retroperitoneal Fibrosis (1)

analysi blot associ blood epilepsi find gener link method peripher procedur protocol relat respons seizur simpl standard stress studi suggest suicid children classif techniqu cluster data detect differ examin imag individu magnet parent patient set sever studi syndrom volum western

287 2297: , Infectious (2) 2298: Hypophosphatemia (4) acid adapt amino dai differ dose infect inhibit analysi bone clinic compar control design diagnosi differ growth higher hospit larg larger marker number plai role identifi lower patient rate screen select size small viral viru vivo select studi subject variabl

2299: Leukodystrophy, Metachromatic 2300: Carcinoma, Giant Cell (3) (11) avail clinic dai data databas diagnosi express accumul activ axon cord diseas gene group identifi inhibit patient earli function heal identifi plai regul role screen therapi treatment trial tumour injuri mechan nerv neuropathi patient phase phenotyp role spinal stage wound

2301: Churg-Strauss Syndrome (4) 2302: Spinal Cord Ischemia (2) case children clinic current diagnosi differ analysi chain classif discuss featur group new patient cluster complic content differ effect flow gene plai present recent report role sever studi therapi treatment inhibit injuri oper patient pcr rat reaction surgeri surgic vector

2303: Aneurysm, False (5) 2304: Intervertebral Disk Displacement (12) case caus clinic complic diagnosi evid lead mutant oper patient procedur provid report select state support surgeri surgic analysi associ blot chang complic treatment tumour detect differ express increas oper patient perform procedur role sampl studi surgeri surgic time western

288 2305: Hernia, Umbilical (9) 2306: Rubella (3) base children chromosom combin compar complex control differ effect function assai blood data detect find identifi mutant neg open group higher method new patient mutat provid rate risk structur syndrom organ posit previou region rel report sensit sequenc studi suggest

2307: Lymphoma, Diffuse (2) 2308: Anal Gland Neoplasms (1) cancer cell colorect compar differ epitheli lesion arm cell clinic combin compar mean measur p53 pancreat paramet predict

cultur effect efficaci factor improv multipl protein rang ratio respect stain standard valu patient prognost random singl studi surviv treatment trial tumor

2309: Photophobia (5) 2310: Hypertelorism (6) adult assess case caus clinic chain chromosom clinic congenit control correl effect evalu identifi individu detect famili identifi mutat patient pcr phenotyp polymeras quantit reaction life loss measur patient plai reduc real-tim revers screen syndrom role score screen studi year

2311: Dandy-Walker Syndrome (15) 2312: Nerve Compression Syndromes abnorm adult anomali associ case clinic complex (7) congenit defect disord featur gene malform patient adult analysi case children report retard sever studi syndrom correl evid form format hospit year clinic injuri model patient process report reveal segment sever studi year

289 2313: Impotence, Vasculogenic (2) 2314: XYY Karyotype (5) case cohort combin diagnos effect alter associ chang children group incid increas men mortal patient popul present preval rare rate report chromosom compar factor synthesi women year genet growth higher includ method rang rate repeat research risk syndrom tumor wide

2315: Neurofibromatoses (11) 2316: Purine-Pyrimidine Metabolism, associ broad case clinic common diagnosi Inborn Errors (1) analysi case chromatographi determin enzym divers includ larg limit major patient extract fraction independ liquid predict

rang repres spectrum tissu type vari prepar produc product regress relationship report signific variabl variat varieti wide yield

2317: Actinomycosis, Cervicofacial (1) 2318: Vasculitis, Central Nervous Sys- tem (2) arteri case data discuss experi follow hypertens initi intern literatur organ origin possibl present publish rare report adapt adolesc associ autism brain review second subsequ case central child childhood children parent pediatr period point present report select studi time year

2319: Spasms, Infantile (11) 2320: Pain, Intractable (4) attempt chang children condit control data care case ethic group develop epilepsi famili gener group includ health improv incid inform life report respons seizur stress studi medic nurs person physic suicid syndrom treatment particip practic qualiti research studi support survei

290 2321: Tension-Type Headache (2) 2322: Pneumocystis Infections (3) action affect area children cluster differ diseas effect absenc anim assai case combin detect examin gener imag increas isol parent includ model multipl mutat plai patient potenti releas stimul strain studi presenc rang rate region role sensit sequenc studi wide

2323: Histoplasmosis (4) 2324: Lymphangiectasis, Intestinal (2) case chronic clinic criteria diagnos assess compar data differ estim diagnosi diagnost diseas genom inflammatori evid featur gener identifi isol measur intestin lesion literatur patient present rare report sequenc sever symptom pattern protein random risk score screen studi support trial

2325: Cecal Neoplasms (6) 2326: Neoplasms, Basal Cell (2) cancer case clinic concentr dai cancer character characterist chromosom clinic differ enhanc femal express common correl delet diagnosi featur index phenotyp reduc gene male mice mous remain effect report studi system therapi transgen reduct relat relationship signific skin tumour treatment

2327: Rectal Prolapse (3) 2328: Immunoblastic Lymphadenopa- anim compar differ earli higher lower thy (3) model patient period point rate approxim case cell content determin region sequenc size small studi time tumour valu variabl distribut flow health local lymphoma

major malign number observ

plai rel report role specif tumour

291 2329: Thecoma (1) 2330: Choledocholithiasis (4) adult caus children compar content alter case chromosom control delet dna function gain gene involv loss modul control decreas elderli flow genet peptid region regul regulatori role hepat increas liver model observ old older young sarcoma skin tumor time year

2331: Anemia, Pernicious (2) 2332: Cerebral Ventricle Neoplasms (3)

adult analys analysi clinic concentr data defici analysi area assai blot brain diagnosi diagnost gene individu model month children detect larg patient perform reveal sever studi year young parent phenotyp plai primari region role sensit sequenc size small studi tumor

2333: Paget’s Disease, Mammary (1) 2334: Granuloma, Foreign-Body (5)

acid approach case design diseas effect event breast cancer express expression gap iron junction level lymph malign metastas metastasi metastat mrna node pattern primari tissu tumor women follow hybrid improv interact involv lesion occur

process recombin report state treat treatment

2335: Meningoencephalitis (4) 2336: Brain Stem Neoplasms (6) case data diagnosi distribut earli clinic analysi carcinoma case children estim form format gener higher clinic correl distribut famili form identifi hospit local mechan patient process rate sever stage studi local mutat parent patient report reveal screen surviv trial tumor

292 2337: Polyradiculoneuropathy, Chronic 2338: Parathyroid Diseases (1) Inflammatory Demyelinating (4) clinic diagnosi diagnost evalu area cell clinic decreas earli featur genet imag magnet measur increas injuri patient plai mri patient perform region repeat role sampl sequenc specif method procedur reson scan surgeri surgic techniqu stage studi treatment vitro vivo volum

2339: Esophagitis (11) 2340: Leiomyomatosis (5) case cell characterist clinic common chang dose characterist cluster common data distinct featur function group includ irradi lung new associ enzym factor featur genet human patient radiat studi therapi model mutat overexpress popul presenc risk studi transform tumor treatment trial

2341: Ketosis (3) 2342: Schistosomiasis (6)

adolesc autism boi child childhood area assess compar control differ children follow-up median medic earli follow month mutant organ parent patient famili group pediatr rang recurr stress studi year increas measur member modifi persist phenotyp risk select studi subject time

2343: Osteopoikilosis (4) 2344: Syringomyelia (4) associ bone case data diagnosi diseas disord analysi case caus differ extract genet fractur literatur miner model osteoblast patient group larg level local mechan present rare ratio report risk studi vitamin model patient reveal sever signific size small subject variabl

293 2345: Cri-du-Chat Syndrome (7) 2346: (2) abnorm alter case chang chromosom clinic base case common dai diseas featur combin congenit delet diagnosi genet genom larg find genet model pair patient period point present previou report state studi patient report size small studi subject syndrom time tumor

2347: Somatosensory Disorders (5) 2348: Ganglion Cysts (1) assess behavior caus compar control field healthi canin case cat diagnos diagnosi distal dog higher life measur movement hand left limb literatur neuron present proxim rabbit rare report right segment skin patient perform posit presenc rate score space studi subject

2349: Musculoskeletal Abnormalities 2350: Coma (10)

(13) area case clinic data ethic examin follow individu issu analysi associ chang cluster data detect locat patient remain research sever effect famili hybrid differ group studi surviv symptom test time year identifi incid mutat popul process syndrom tissu variabl women

2351: Chills (2) 2352: Pulmonary Atresia (5) adult care children clinic defect delet assess associ blood confid degre follow genet high initi interv level diagnosi diagnost genet low measur odd peripher process health heart hybrid identifi inform ratio risk score smoke mutant nurs particip screen syndrom year

294 2353: Peritonitis, Tuberculous (2) 2354: Pulmonary Subvalvular Stenosis cancer case chain complic data dna evid (1) follow fragment ovarian patient pcr persist absenc character characterist classic provid reaction report studi support common congenit distinct featur surgeri surgic head includ lesion neck presenc repres share similar stain

syndrom typic uniqu

2355: Coronary Aneurysm (7) 2356: Cranial Nerve Injuries (3) behavior cleft concentr dai dose effect hospit arteri case clinic decreas diagnos diagnosi discuss dose increas irradi induc induct injuri month normal particip patient presenc present radiat rare recent report surgeri syndrom therapi patient potenti respons stimul

surviv target tissu

2357: Lymphoma, High-Grade (6) 2358: Tuberculosis, Bovine (6) b-cell cell clinic condit control data degre anim assai assess associ bovin cell data detect earli gener health high low measur model pig score sensit stage studi diagnosi estim follow health healthi

lymphocyt lymphoma

month patient remain respons

structur subject

2359: Dementia, Multi-Infarct (4) 2360: Gliosarcoma (4)

care case children diseas earli estim experi anim associ cell develop earli establish experiment gene human identifi imag gene inform initi medic mutat nurs particip person physician report resist stage model rat screen stage studi system variabl target tumor vivo

295 2361: Mallory-Weiss Syndrome (1) 2362: Cluster Headache (2) care clinic concentr dai diagnosi discuss bladder cancer defect defici effect examin gastric mobil mucosa prevent protect pylori reduc reduct signific studi syndrom tract urin urinari effect genet health improv isol life malign

qualiti rang rat recent state strain tumour

2363: Toothache (3) 2364: Vascular Headaches (2) care case clinic commun diagnosi educ advanc articl base clinic featur includ inform medic health current data discuss focu focus need nurs practic program provid public rang literatur pair patient primari servic wide recent research review sever summar therapi understand

2365: Burning Mouth Syndrome (1) 2366: Placental Insufficiency (1)

case clinic condit criteria degre apoptosi birth brain central clinic express fetal gestat demonstr diagnos diagnosi diagnost infant matern mother mrna neonat patient find previou report speci studi suggest pregnanc prenat sever symptom week women target temperatur therapeut treat treatment

2367: Epidural Neoplasms (1) 2368: Spondylarthritis (1)

beam biolog damag dose effect expos exposur assess effect evalu imag improv magnet fraction gamma ion ioniz irradi particl measur mri perform random releas reson scan stimul studi tomographi treat radiat radiation-induc radiosensit radiotherapi rai surviv x-rai treatment trial volum

296 2369: Hypopigmentation (12) 2370: Berylliosis (1) african allel american associ class code codon activ analysi associ case chang decreas differ ethnic genotyp clinic effect develop increas level phenotyp group includ light model polymorph popul substitut target therapeut white patient rang report respons sampl skin studi tissu

2371: Rheumatic Heart Disease (4) 2372: Heart Valve Diseases (14) allel chines clinic control correl differ cardiomyopathi case genotyp normal cardiac group compar control diseas express failur gene patient polymorph respect incid left normal patient respons sever signific studi subject heart report risk select tissu ventricular year subtyp symptom tissu

2373: Vomiting, Anticipatory (3) 2374: Panniculitis (7)

advanc cancer chemotherapi combin cycl dai chang clinic concentr diagnos docetaxel grade hospit median month case diagnosi differ evolut function level literatur origin patient pattern present rare report sever studi patient phase receiv regimen respons system studi surviv toxic treatment

2375: Aphakia, Postcataract (5) 2376: Dystonic Disorders (13) affect ataxia autosom caus clinic associ base cataract children chromosom correl develop earli disord domin famili famili growth implant len linkag loci locu diseas map parent studi surgeri variabl function gene gener genet inherit

motor mutat new

patient recess respons

297 2377: Blepharospasm (2) 2378: Leukemia, Mixed-Cell (1)

acut apoptosi clinic compar comparison behavior cognit deficit disabl ethic famili genet histori identifi impair learn member memori differ examin express leukemia mix new patient perform popul provid research task observ pattern produc product similar sourc therapi treatment type yield

2379: Syphilis, Cardiovascular (1) 2380: Retroperitoneal Neoplasms (7) african american asian associ case caus cell clinic detect differ evalu imag normal black differ european diseas ethnic patient perform product report sensit studi subtyp surgeri surgic tissu tumor femal interv male popul ratio risk sex smoke south studi white

2381: Leukemia, Myeloid, 2382: Mydriasis (2) Philadelphia-Negative (2) bone cell chines compar control administr cell chang corneal correct dai dose energi epitheli evalu imag kinet measur develop differ earli healthi methods modifi perform state studi visual larg number pattern similar size small stage week studi subject subtyp type

2383: Myoclonic Epilepsies, Progres- 2384: Disseminated Intravascular Co- sive (2) agulation (14) associ bleed clinic coagul compar control case clinic compar control diagnosi factor folat frequenc develop diagnosi earli evolut frequenc growth homocystein marker mthfr platelet risk late length patient phase progress repeat role studi thrombosi venou report sever stage stress target

298 2385: Tetralogy of Fallot (27) 2386: Histiocytosis (4) adult affect case caus characterist atrial cardiac cardiomyocyt children common discuss distinct featur find cardiomyopathi caus death differ dilat failur imag includ lesion patient recent heart hypertrophi left patient right sever sudden syndrom treatment valv report studi tumour year ventricular

2387: Histiocytic Disorders, Malignant 2388: Anemia, Dyserythropoietic, Con- (1) genital (4) broad case characterist adult bind cell clinic complex defect defici diagnosi differenti disord express featur children common disord gene mutant mutat normal distinct divers featur includ patient tissu tumour year lesion major parent rang report

repres spectrum stain varieti wide

2389: Hemangioendothelioma (4) 2390: Coronary Thrombosis (10) anim associ case clinic control arteri case chain detect discuss healthi human literatur model patient present rare report sever stress studi genet human hypertens mechan subject symptom year molecular mutat patient pcr polymeras pressur quantit reaction real-tim report revers specif

2391: Prostatic Diseases (6) 2392: Fetomaternal Transfusion (3) assess cancer compar control analysi base blood determin diseas flow individu level measur mice model organ cluster content determin follow patient prostat sampl score differ flow serum specif stain genom high level low method plai popul role studi subtyp tumour

299 2393: Hemoglobin C Disease (1) 2394: Macroglossia (2)

care commun diseas distribut educ care chain clinic content determin evalu flow health

health identifi incid local nation individu methods month patient pcr need nurs program public research screen reaction sever specif surgeri syndrom vector year servic student women year

2395: Primate Diseases (3) 2396: Venous Insufficiency (4)

area assai data detect dna duplic evid evolut avail characterist clinic common data databas effect enhanc factor featur form fragment human hypothesi pcr provid region restrict sampl sensit sequenc support format growth includ inform organ reduc test requir studi treatment

2397: Antithrombin III Deficiency (4) 2398: Megacolon (2) acid approxim blood control case analysi anim cluster core defect defici healthi inhibit major high mechan molecular mutant neg posit rel isol level low model open report sever subject syndrom plai predict produc product report role strain studi suggest variabl

2399: Jaundice (9) 2400: Fissure in Ano (5) analysi case differ diseas group complic correl effect improv manag new oper patient perform postop preoper procedur hepat liver mice normal patient reduc resect surgeri surgic techniqu regress report signific state studi subject test tissu treatment variabl treat treatment underw

300 2401: Salivary Gland Diseases (3) 2402: Intestinal Polyposis (7) assai associ chromosom compar detect associ cancer colon colorect develop evid differ follow group higher initi lower hospit human larg level mechan molecular patient phenotyp rate process ratio rel resist risk size risk sensit tumor versu patient small studi support

2403: Rhabdoviridae Infections (12) 2404: Femoral Neck Fractures (3) bone case caus disord experi acid assai chain detect follow initi intern lead organ gene infect measur effect genom origin patient possibl presenc report model pcr polymeras protein quantit second seri subsequ surgeri surgic reaction reduc region sensit sequenc viru

2405: Pneumonia, Aspiration (5) 2406: Tetanus (3) adult asthma clinic compar adult assai caus data detect concentr differ fibrosi imag develop distribut famili higher local member older presenc produc mean measur month patient product rate resist sensit year young ratio respect risk sever studi therapi valu year

2407: Arteriovenous Fistula (4) 2408: Optic Disk Drusen (5) adult analysi blot case clinic complic develop alter analysi anim chang concentr imag interact model patient control correl decreas experiment healthi increas present report sever surgeri surgic symptom treat model observ rel retin reveal signific treatment year studi subject visual

301 2409: Angioneurotic Edema (6) 2410: Retinal Necrosis Syndrome, alter associ chang clinic defect defici Acute (4) adapt case clinic compar control effect function genet health interact level frequenc gene hiv hiv-1 immunodefici infect patient report select sever therapi treatment tumour viral viru patient popul select sever structur therapi

treat treatment

2411: Granuloma, Lethal Midline (2) 2412: Mediastinal Emphysema (2) associ case clinic differ fusion gene individu case characterist clinic common densiti

isol mutat observ patient pattern develop diagnosi distribut relat report sever similar strain studi symptom type featur high imag level local low patient report surgeri surgic treat treatment

2413: (2) 2414: Rhinorrhea

associ children correl data discuss famili (1) induc induct marker member model popul ratio case code codon distribut event fluid relat report respond respons risk signific studi involv local normal nucleotid occur posit

present process rare report step substitut

suggest tissu

2415: Lacerations (6) 2416: Anisometropia (4) adult analysi case children densiti examin adult african american case clinic data diagnosi ethnic hospit includ health high level low older older patient popul report studi parent patient report retin sampl studi visual year young surgeri surgic white year young

302 2417: Extravasation of Diagnostic and 2418: Esotropia (5)

Therapeutic Materials (2) algorithm associ children compar data differ group improv life method neg network absenc associ examin experi follow patient posit predict report signific studi surgeri genotyp head indic initi intern investig light trial observ origin persist polymorph presenc second studi suggest

2419: Endolymphatic Hydrops (3) 2420: Labyrinthitis (5) alter chang characterist common complex anim area associ auditori canal caus clinic cochlear deaf diagnosi ear hair hear impair inner control distinct ear featur follow hair healthi

middl model studi vestibular hear impair length loss regul repeat loss sever subject

2421: Uveal Diseases (4) 2422: Monsters (1) alter area case chang clinic adjust associ avail confid data databas factor fetal inform interv odd compar diagnosi differ control patient pregnanc program ratio risk diseas frequenc higher implant incid life smoke studi surviv tool patient qualiti rate report studi

2423: Spinal Stenosis (4) 2424: Moraxellaceae Infections (1) case clinic complic diagnosi function improv analysi analyz area categori children classif cluster collect data detect determin differ infect isol parent isol life patient perform present qualiti rare report requir sever strain surgeri profil sampl set strain studi surgic symptom

303 2425: Morphine Dependence (4) 2426: Respirovirus Infections (3) alcohol approxim behavior chang caus correl data evid human incid decreas depend effect increas initi lead mutat origin patient popul preval provid studi support viru inhibit major mice mous vitro vivo women number oral receptor rel requir studi test time

2427: Tics (7) 2428: Hemianopsia (2) associ base behavior bipolar chang children birth blood case effect factor fetal field matern movement peripher pregnanc report control depress disord includ retin risk space stress treat individu method number patient person process psychiatr respons studi symptom treatment visual women

2429: Asbestosis (2) 2430: Leigh Disease (10) adjust antibodi associ confid case caus complex dna exon gene develop earli evid exposur genet identifi mitochondri interv marker neg odd posit provid ratio risk mitochondria mtdna mutat novel smoke stage studi support process protein report screen syndrom tumour variant

2431: Acidosis, Lactic (8) 2432: Pyruvate Dehydrogenase Com- plex Deficiency Disease (2) case caus children clinic defici diagnosi autosom caus children chines control defici differ domin famili heterogen inherit high increas lead lead mutat parent plai region role sequenc studi subtyp trial level low mechan mitochondri number patient region sequenc test treatment

304 2433: Hemangioma, Cavernous (6) 2434: Subacute Sclerosing Panen- cephalitis (2) approach chromosom decreas delet case clinic diseas evalu exposur follow-up imag famili gene imag increas larg lesion median month patient loss member phenotyp present rang rare recurr report sever stain symptom year report sampl size small specif strategi studi syndrom

2435: Leukemia, Subleukemic (1) 2436: Hematemesis (4)

acut bind center clinic conclusions design cancer caus children clinic delai diseas follow gastric gene initi lead long-term multipl origin develop development hospit includ leukemia patient persist report sever studi main medic methods objective patient tumour record site studi syndrom

2437: Endocarditis (6) 2438: Mitral Valve Prolapse (3) associ case children clinic diagnosi diseas effect featur gener interv isol associ behavior cardiac control

earli failur healthi patient ratio report risk smoke function left month phase plant specif strain surviv treatment heart patient stage studi subject surgeri ventricular year

2439: Otitis Media with Effusion (12) 2440: Laryngitis (2) analysi case caus children deaf develop differ assai clinic data detect ear effect hair hear impair inner loss diagnosi diagnost evalu evid medic method monitor patient risk studi time trial year occurr patient provid report sensit specif studi support test

305 2441: Papilloma, Inverted (3) 2442: Ileitis (3) analysi assess base correl data associ children chronic diseas earli express gene dna evalu hybrid lesion measur neg perform genet genotyp haplotyp intestin level parent plai polymorph posit rat posit protein region reveal score role snp stage

sequenc signific studi

2443: Meniere’s Disease (7) 2444: Hutchinson’s Melanotic Freckle (1) clinic compar control differ diseas ear bladder determin extract fraction gene follow frequenc genet hair hear increas loss concentr glioma melanoma microg microm min

signific specif studi subject patient mutat plasma primari respect rna treatment tumour secondari studi tract urinari

2445: Ape Diseases (6) 2446: Heart Block (14)

area detect develop differ cardiac case clinic combin diagnosi differ failur famili health diverg duplic evolut evolutionari evolv gener human heart identifi larg left member number patient remain risk studi model number origin pattern ventricular popul posit select speci studi

2447: Gallstones (14) 2448: Truncus Arteriosus, Persistent approxim bladder determin evolut factor gene (6) genet hepat hepatocyt human incid influenc adult cardiac care case caus level liver patient rel sampl studi chromosom suggest surgeri children clinic delet diagnosi failur health heart left loss parent report select ventricular year

306 2449: Sick Building Syndrome (1) 2450: Colitis, Collagenous (4) address adolesc autism boi child childhood associ blood bowel caus chronic common

children differ girl larg larger diseas famili featur includ number parent pediatr plant question remain inflamm inflammatori intestin lead member size small year patient small studi treat treatment

2451: Persistent Hyperinsulinemia Hy- 2452: Cystadenoma, Mucinous (3) poglycemia of Infancy (7) adult cancer case collect data experi initi literatur organ origin present rare renal report children chines clinic differ earli femal sampl second studi tumor year young form genet group male mutat pancreat parent patient secret select sequenc sever studi subtyp

2453: Prostatitis (6) 2454: Optic Atrophy, Autosomal Dom- base cancer cdna clone compar control differ inant (2) effect gene group higher hospit analys analysi clinic compar diseas famili genet high higher level low lower member mutat model patient rate report sequenc studi treatment year patient perform rate reveal sever versu

2455: Cysticercosis (4) 2456: Bell Palsy (2)

antibodi area assai case caus absenc associ case chain clinic factor

clinic combin detect diagnosi famili member mutat patient pcr presenc random reaction report risk sever studi suggest trial famili health lead member

popul report research risk sensit specif studi

307 2457: Gingival Overgrowth (5) 2458: (9) cleft clinic dental effect experi facial follow analysi anim area case complic develop genet initi intern lip origin palat patient random reduc second treat experiment femal male model oper treatment trial patient perform procedur reveal role sampl studi surgeri surgic

2459: Urinary Fistula (2) 2460: Urethral Diseases (3)

approach associ case compar associ bladder case collect complic mobil oper patient perform presenc control correl dai design earli frequenc hospit multipl patient relat remain procedur report sampl studi surgeri report signific stage studi syndrom surgic syndrom tract urin urinari

2461: Pinealoma (4) 2462: Lung Diseases, Obstructive (2) articl associ confid data donor interv literatur associ case correl delet differ odd patient publish ratio report express gene human identifi review risk search smoke studi systemat isol loss normal organ pattern region transplant trial select sequenc target tissu tumor

2463: Dysplastic Nevus Syndrome (9) 2464: Hematoma, Subdural, Acute (3) compar control correl detect express gene brain central clinic complic copi dai diagnosi diseas dose larg method month genet higher lesion melanoma phenotyp polymeras posit protein rate rna role number patient specimen stain tumor procedur sever surgeri surgic symptom techniqu

308 2465: Burns, Chemical (5) 2466: Eye Burns (5)

acid area assess case correct dai differ factor associ children cord data enhanc gene injuri life measur methods mice group health increas injuri light mice model multipl nerv qualiti risk score studi target time ratio risk spinal studi test wound

2467: Silicosis (3) 2468: Shoulder Fractures (1) behavior biopsi brain child associ compar control differ earli frequenc health larg mean measur number children clinic cognit histolog immunohistochem impair lesion memori patient ratio respect respons parent patient perform sever specimen size small stage structur valu stain symptom year

2469: Radius Fractures (6) 2470: Alcohol-Induced Disorders (2) approach bone canin cat children alcohol analys analysi distal earli hand left life limb dog associ care depend effect genotyp health indic oral predict regress relat model normal proxim rabbit right relationship reveal signific studi variabl variat segment structur tissu

2471: Wrist Injuries (3) 2472: Ulna Fractures (2) bone case clinic diagnosi diagnost distal adult assai assess detect dog ethic examin field issu modifi patient report research segment surviv treat differ gene genet measur older patient pattern plai popul posit role treatment vitamin score sensit studi year young

309 2473: Alkaptonuria (8) 2474: Ochronosis (6) acid amino bladder case chang case clinic diagnos diagnosi diseas effect enzym literatur new normal organ patient present earli enzym heart mechan new differ product rare reduc report select tissu treatment patient pattern present provid rare report studi treatment type

2475: Polymyalgia Rheumatica (4) 2476: Marijuana Abuse (6)

cell clinic dai diagnosi dose evid health lesion alcohol assai data depend detect

normal number patient produc product provid requir stain support tissu develop effect ethanol factor genet treatment year

individu influenc interact

oral phenotyp specif studi suggest treat treatment

2477: Drowning (3) 2478: Soft Tissue Injuries (4) analys analysi caus clinic defect diagnosi alter approxim case chang combin compar diagnost function imag indic lead data evid increas injuri level major mechan molecular mutant mutat perform requir reveal target wild-typ normal observ organ provid rel subject

support tissu

2479: Glomus Tumor (2) 2480: Paraparesis, Spastic (3)

analys case chromosom clinic correl distribut fluid hospit investig local malign observ activ affect clinic copi diagnosi factor femal identifi male marker patient present rare report signific famili studi suggest tumour member mutant mutat number organ plai risk role screen

310 2481: Ventricular Premature Com- 2482: Orofaciodigital Syndromes (6) plexes (1) abnorm analysi anomali approxim brain adapt analysi caus compar differ group lead mean measur multipl predict ratio regress congenit defect featur gel gene identifi major relationship respect select signific valu variabl variat

malform mass protein rel report requir

retard syndrom

2483: Steroid Metabolism, Inborn Er- 2484: Sexually Transmitted Diseases, rors (5) Bacterial (3) caus children clinic defect defici design domain analysi area care differ health incid larg live effect femal function gene growth locat men mortal particip patient preval respons size studi treatment women hospit male multipl mutant mutat year patient reduc treatment

2485: Sexually Transmitted Diseases, 2486: Menopause, Premature (4) Viral (3) associ chain decreas effect factor approxim data featur children group high increas larg level low genotyp health incid level men mortal normal number reaction reduc rel risk size small tissu polymorph popul preval rate rel risk studi target women year

2487: Sialic Acid Storage Disease (4) 2488: Epistaxis (11) assess chang clinic compar control acid amino analys analysi blot differ genet glioma group life measur case differ diseas distribut femal indic individu local male patient protein reveal patient popul primari qualiti sever studi subtyp score secondari select studi subject

311 2489: Mineralocorticoid Excess Syn- 2490: Alkalosis (4) drome, Apparent (1) adult alter case caus chang clinic concentr bodi caus chang condit environment diagnosi femal function genet inhibit exposur factor genet influenc intermedi kinet male mutant mutat patient lead occur rapid slow state switch transit variat weight sever sex subject year

2491: Fallopian Tube Diseases (6) 2492: Adrenal Cortex Diseases (2) caus compar enhanc follow form format adren antibodi autosom group higher hormon identifi initi lead complex compon diseas domin lower persist pregnanc rate reproduct famili hormon inherit mitochondri mutat pain patient pituitari skin subunit syndrom screen steroid women thyroid tumor

2493: Mastocytosis (4) 2494: Hemoglobinuria (3)

case cell chain clinic codon defect defici mutant anim assai assess cell correl dai detect diseas evalu gene level measur model mutat mutat patient popul present rare patient rat scale score sensit test reaction report sever state stress substitut symptom

2495: Lymphocytosis (5) 2496: Psychoses, Substance-Induced case chromosom clinic develop diagnosi (5)

affect associ condit control degre distribut earli investig level local malign differ function genotyp group influenc interact involv modif microscopi morpholog patient progress regul modifi polymorph schizophrenia signific studi suggest treatment stage state studi tumour

312 2497: Pasteurella Infections (3) 2498: Alcohol-Induced Disorders, Ner-

character characterist common condit dai degre differ vous System (3) assai chang dai detect effect express dose featur individu isol month new high length level long low mutat oral patient provid region sequenc strain target type rat region repeat risk sensit sequenc short

2499: Malaria, Avian (2) 2500: Proctitis (2)

base clinic dai design differ dose earli gener associ chain compar differ dna fragment genet higher individu lower multipl group hospit late observ pair patient pcr reaction similar pattern popul rate phase progress radiat sever stage studi studi test type

2501: Leishmaniasis (3) 2502: Amphetamine-Related Disorders analys analysi antibodi blot detect express (10) factor infect investig malign mice normal affect alcohol allel associ chang protein reveal risk segment studi tissu compar correl depend western control tumour differ effect gene genotyp human oral polymorph select signific studi subject

2503: Central Nervous System Cysts 2504: Holocarboxylase Synthetase De- (5) ficiency (2) adult base case clinic complex defici differ activ cellular control defect defici enzym

factor gene genet larg mutat function fusion human hybrid number popul risk size small variabl variat year involv isol mechan modul regul regulatori role specif strain substrat

313 2505: Peritoneal Diseases (4) 2506: Lupus (2) approxim cell character chromosom differenti cancer caus chain detect diseas identifi linkag loci locu major map mechan mice molecular develop famili genotyp regul rel suggest group member mutat ovarian phenotyp system patient pcr polymeras quantit reaction real-tim revers risk rt-pcr

2507: Liver Abscess, Amebic (4) 2508: Biliary Fistula (1) activ base caus develop extract articl base clinic core current data diagnosi diagnost discuss encod identifi follow gene health includ larg new number product rang rat size small studi varieti wide literatur manag open pair patient read recent review vector

2509: Neuromyelitis Optica (2) 2510: Li-Fraumeni Syndrome (8) activ adult approxim case children clinic delet case describ diagnos diagnosi dna find includ injuri literatur man occur present rang rare report reveal unusu varieti wide woman famili gene major mechan member mutat p53 patient rel report syndrom test year

2511: Jaw Neoplasms (6) 2512: Tooth Erosion (6) associ biolog cell discuss diseas evid acid case children cleft clinic concentr data dental diagnosi estim evid facial gener express includ lesion normal protein palat patient studi support syndrom provid rat recent support studi test treatment syndrom system tissu tumor

314 2513: Osteoradionecrosis (2) 2514: Alexander Disease (5) care dai data design evid hospit inform manag analys analysi case chang clinic concentr data diseas enhanc famili increas level mutant mutat medic particip practic produc product patient perform protein reveal provid studi support target therapi sever stress treat treatment

2515: Neoplasm Seeding (5) 2516: Gastritis, Hypertrophic (3)

base cell compar control differ distribut earli adult cancer case clinic decreas differ diseas featur gastric health increas lesion mice mous higher hospit human local patient period plant point rate stage studi time patient pattern stain structur tumor therapi year

2517: Death, Sudden (13) 2518: (5) cardiac caus chain children detect develop famili group heart identifi lead new caus cell children complex

patient pcr polymeras quantit diabet enhanc evid factor genet reaction revers screen studi growth increas insulin lead

phenotyp protein rat

risk specif support treatment

2519: Adrenocortical Hyperfunction 2520: Tracheoesophageal Fistula (13) (3) abnorm anomali associ case congenit defect analysi blot cell clinic densiti diagnosi differenti gene genet high low malform model normal patient report retard studi surgeri dose health high irradi level low organ point radiat resist respons time syndrom tissu tumor

315 2521: Tongue Diseases (5) 2522: Job’s Syndrome (4) adolesc base case child childhood case chain clinic domin express famili gene infect inherit microarrai mutat number children combin earli effect follow increas parent pediatr repeat report studi test time treatment year patient pcr polymeras profil reaction report syndrom system

2523: Tooth Attrition (3) 2524: Tooth Abrasion (1) area assai compar detect differ genet benign biopsi brain case cleft dental dysplasia higher imag influenc lesion lower popul evalu facial histolog immunohistochem immunohistochemistri immunostain rate sensit stain studi surviv treat treatment versu lesion ovarian palat section specimen stain tissu

2525: Osteochondritis (1) 2526: Pancreatitis, Acute Necrotizing (8) biopsi compar comparison control differ clinic differ effect fish gene genet group histolog immunohistochem lesion group human hybrid interact methods patient pattern rat section new pancreat patient probe secret sever specif signific similar specimen stain tissu type studi treat treatment

2527: Supratentorial Neoplasms (8) 2528: alpha-Mannosidosis (2) acid analysi associ base combin compar dai accumul affect case caus cell clinic core diagnosi diagnost disord encod dose develop differ group genotyp lead line open patient polymorph new pair patient pattern respons studi present report sever subject tumor year

316 2529: Refsum Disease (2) 2530: Embryo Loss (18)

acid amino caus chang combin effect caus cell control function enzym famili fatti hybrid intermedi kinet lead member nucleic retino slow state switch transit gene genet lead mice mous multipl mutant normal patient process rate requir role tissu treatment wild-typ

2531: Colitis, Microscopic (1) 2532: Colitis, Lymphocytic (2)

bowel chronic depress diabet diseas disord effect case caus clinic conclusions data design diseas estim efficaci follow improv inflamm inflammatori intestin hospit incid lead method methods mortal objective pretreat reduc small therapi treat patient preval therapi women year treatment untreat

2533: Hemorrhoids (3) 2534: Epilepsy, Rolandic (2)

bladder clinic compar data differ evalu area assess behavior children cognit

includ month multipl patient group environment factor genet influenc measur memori perform popul pattern perform random signific studi surgeri treatment trial year score stress studi trait twin variabl variat

2535: Oculomotor Nerve Diseases (5) 2536: (3) adult ataxia case caus decreas affect associ autosom caus clinic diseas disord earli congenit diseas disord domin effect famili gene increas model motor hereditari inherit inhibit mutat rat recess mutat normal progress report syndrom report stage studi subject tissu year

317 2537: Dysentery, Amebic (2) 2538: Fibrous Dysplasia of Bone (6) allel american carcinoma clinic diagnosi assess bone correl evalu health improv lesion life measur method patient diagnost dna ethnic fragment genotyp infect physic qualiti recent research scale score specimen stain valid isol map multipl polymorph popul

produc product remain strain

2539: Dysgammaglobulinemia (1) 2540: Porphyria, Erythropoietic (6) activ alpha cell consist data direct domain arthriti case caus clinic diagnosi diseas enzym group joint lead ethic evid find hypothesi issu kinas mechan molecular pain patient present rare report rheumatoid sever symptom protein provid receptor research

signal suggest support

2541: Oral Ulcer (4) 2542: Urogenital Neoplasms (6) administr case children clinic dai dose assai detect differ gener high earli human initi literatur parent patient present radiat rare report sever stage test week human level low marker model patient pattern phenotyp popul posit sampl sensit specif studi tumor

2543: Kernicterus (6) 2544: Dermatitis, Photoallergic (3) area case caus control diseas extract care enhanc gene children healthi induc induct lead patient present rare health hepat high level liver low manag mechan medic model parent patient research report respons site skin studi subject risk studi year test

318 2545: Dermatitis, Phototoxic (2) 2546: Vesicovaginal Fistula (1) acid amino anim approxim chemic develop bladder complic construct contain domain gene effect experiment expos exposur extract growth homolog human mice oper patient fraction major model observ rel skin stabil studi toxic plasmid procedur recombin

surgeri surgic transplant vitro vivo

2547: Onchocerciasis, Ocular (1) 2548: Dental Occlusion, Traumatic (2)

analys analysi approach control cours differ chines compar comparison differ genet heterogen high isol level low observ pattern plai popul role similar strain studi subtyp type function larg method month patient period

point regul reveal size small studi subject time

2549: Lambert-Eaton Myasthenic Syn- 2550: Renal Artery Obstruction (6) drome (4) arteri blood cluster concentr correl approach cancer clinic form format identifi lung data distribut estim mean measur normal patient function imag level local predict ratio respect screen sever tissu tumour valu variabl method model rat sampl statist test treatment variabl

2551: Genital Diseases, Male (8) 2552: Pituitary ACTH Hypersecretion acid associ case clinic diagnosi effect (3) featur femal gener incid male mortal clinic concentr diseas environment factor form format genet genom induc induct influenc preval respons sequenc patient patient receptor respons sever sex studi women year symptom thyroid trait variat

319 2553: Peptic Ulcer Hemorrhage (5) 2554: Nevus, Intradermal (1) analysi case children chromosom determin activ cancer combin diseas effect evid gastric high identifi inhibitor famili independ member microscopi intestin level low patient provid screen state morpholog parent predict regress relationship studi support therapi report resist signific structur variabl variat

2555: Angiomyoma (2) 2556: Urethral Stricture (2)

adult base case cluster design differ elderli bladder case children end follow human month patient remain hospit mean normal old older pair patient group report signific studi target telomer telomeras splice studi tissu variant year young tract trial urinari year

2557: Erythema Nodosum (4) 2558: Hypothalamic Neoplasms (4)

affect area case cell characterist brain case characterist common distinct enhanc factor featur growth includ initi month new origin

provid rang report specif dai diagnost patient clinic diagnosi year

differenti featur patient promot

report studi system therapi transcript

treat treatment

2559: Furunculosis (2) 2560: Vibrio Infections (4) case cdna clinic clone differ enhanc evid form format genet group high hybrid infect isol condit dai degre diagnosi level low new pattern provid requir specif strain support evid gene includ patient provid rang sequenc sever support temperatur varieti wide

320 2561: (1) 2562: Arbovirus Infections (2) cancer chromosom correl endometri diseas drosophila effect european estrogen grade index length long ovarian identif month posit receptor relat relationship identifi method nation novel patient protect reduc reduct repeat short signific studi tandem remain screen speci techniqu vector year termin

2563: Ganglioneuroblastoma (1) 2564: Epilepsy, Complex Partial (2)

biopsi cell deriv differenti express analys analysi area brain case control data distribut healthi imag indic histolog human immunohistochem induc iron junction local multipl perform produc lesion line malign peptid prolifer specimen stain product reveal stress studi subject tissu tumor

2565: Eclampsia (3) 2566: (6) allel analysi associ case cluster acut blood cell children clinic decreas confid control genotyp high interv level low diagnosi gene increas initi leukemia method patient sever state patient polymorph ratio reveal symptom therapi treat risk smoke studi subject treatment tumour

2567: Fallopian Tube Neoplasms (4) 2568: Premenstrual Syndrome (5) approxim cancer chemotherapi data demonstr assess clinic compar control data differ design find hospit major objective observ disord higher length measur phenotyp ovarian patient previou rel report random rate repeat role score studi suggest target tumor size studi subject trial

321 2569: Anencephaly (11) 2570: Vaginosis, Bacterial (3) associ case children combin dai associ confid dai dose fish hybrid effect high incid low men mortal organ increas interv number odd probe ratio pregnanc preval reduc report studi syndrom risk situ smoke studi test treat women year treatment women

2571: Hamartoma Syndrome, Multiple 2572: Horner Syndrome (6) (10) case earli identif identifi includ malign affect case clinic congenit develop novel patient present rang rare report screen segment sever stage studi syndrom tumour wide diagnosi famili genet high low

member model mutat number patient

report role syndrom test treatment

2573: Torsion (7) 2574: Shoulder Pain (3)

adult caus direct distanc earli experi activ clinic compar control diagnosi differ group patient period point sever forc lead mean measur field signific studi test therapi time treat treatment motion movement orient space trial variabl studi subject time valu year

2575: Shoulder Impingement Syndrome 2576: Hyperphagia (3) (3) analysi assai blot brain chain control detect adult associ clinic diagnosi direct distanc diabet genet glucos healthi individu influenc experi field forc group initi motion insulin patient reaction sensit movement orient patient posit studi subject western space studi time year

322 2577: Siderosis (2) 2578: Tympanic Membrane Perforation bladder bodi brain case central effect light (3) mobil report rice splice structur studi tract approxim blood core encod frame hear treat treatment urinari variant weight wheat identifi indic loss major open orf put read rel report state studi suggest therapi

2579: Gagging (1) 2580: Liver Diseases, Alcoholic (7) alcohol anim chang compar control action children compar control differ effect frequenc higher increas microscopi depend diseas effect enhanc higher morpholog observ parent patient potenti puls releas respons signific stimul increas liver model oral patient protein rat rate studi subject

2581: Muscle Cramp (2) 2582: Prolactinoma (6) absenc affect autosom caus clinic diseas adult bind case cluster disord domin effect famili head develop gene high inherit mutat muscl patient level low mice multipl presenc product presenc reduc reduct sever report studi test thyroid tumor vector symptom year

2583: Hypovolemia (1) 2584: Esthesioneuroblastoma, Olfac- tory (3) adult associ case confid elderli examin interv mean old older ratio relat report adult case clinic combin correl diagnos risk smoke speci studi year young younger diagnosi earli effect genet life morpholog organ popul present qualiti rare report stage year

323 2585: Dysgerminoma (2) 2586: Ear Deformities, Acquired (2)

blood cancer diseas earli femal identif identifi case clinic control criteria diagnos male neg novel patient phase posit progress prostat screen sex sperm stage tumor diagnosi diagnost fusion healthi hospit laboratori loss month organ patient studi subject test therapi year

2587: Bartonella Infections (4) 2588: Lacrimal Duct Obstruction (6) dai design enhanc group hospit imag initi assai caus clinic detect effect genet identifi infect interact lead mechan normal patient perform method normal posit prevent reduc process rat report requir studi surgeri surgic tissu treatment reduct screen sensit tissu tumour

2589: Enzootic Bovine Leukosis (6) 2590: Dextrocardia (5) anim area assai bovin breed cell chang collect associ cardiac case caus clinic growth detect differ isol method milk model pig heart identifi lead mechan molecular polymorph respons sampl sensit test normal patient posit report

screen sever studi syndrom tissu

2591: Pleural Diseases (3) 2592: Infratentorial Neoplasms (3) caus combin compar complex assess case decreas evalu featur gener decreas determin effect identifi imag health increas marker measur number plai popul increas lead mean measur primari role scale score treatment tumor valid number occur occurr screen studi subject valu

324 2593: Leukemia L5178 (5) 2594: Liver Diseases, Parasitic (1) acid analysi cell cluster combin compar analys analysi chromosom data concentr control differ effect gene genet identifi indic linkag loci locu frequenc genet posit rat requir resist reveal map marker perform qtl quantit region studi tumor valu reveal studi trait

2595: Forearm Injuries (1) 2596: Jaw, Edentulous (3) bone caus center children conclusions care cost earli flow health imag decreas densiti design high hospit interact manag medic multipl new popul practic protein provid stage studi increas lead level low main subject test treatment medic objective patient record studi

2597: Dentin Sensitivity (2) 2598: Nevus, Epithelioid and Spindle

compar concentr control data develop differ Cell (3) group identif identifi inform insight light amino analys new novel presenc provid screen signific studi acid analysi understand approxim compar data demonstr express indic major melanocyt melanoma mutat perform polymeras rel reveal rna studi

2599: Menstruation Disturbances (6) 2600: Mouth, Edentulous (1) cohort data diagnos epidemiolog estim evid cdna children clinic increas men methods clone evid femal form format incid gene genet hospit level male parent period popul rate patient popul sequenc studi variabl mortal preval year registri support trend women year

325 2601: Blindness, Cortical (3) 2602: Tumor Lysis Syndrome (5) associ chemotherapi children clinic brain clinic current develop diagnosi diagnost discuss express gene mice particip phenotyp protein recent releas cluster concentr current length manag patient research rna stimul tumor understand

repeat resist risk sever studi syndrom telomer

therapi treatment tumor

2603: Hypertensive Encephalopathy 2604: Staphylococcal Food Poisoning (3) (2)

analys analysi bacteri element gene genom brain chain clinic detect follow inform particip patient pcr polymeras host human indic infect insert quantit reaction real-tim integr isol map mutat pathogen perform report resist revers sever studi recombin reveal strain syndrom transplant

2605: Esophagitis, Peptic (3) 2606: Heartburn (7) data develop evid frequent incid includ analysi care clinic data men mortal occur occurr patient health manag medic method preval protein rang studi support transmiss valu women year model new number occur occurr patient provid rate select studi test valu

2607: Ethmoid Sinusitis (2) 2608: Feminization (2)

acut case clinic complic delai diagnosi diagnost area caus clone data databas femal gender follow function imag leukemia long-term oper gene lead level male mate offspr patient perform persist procedur organ reproduct sequenc serum sex sexual syndrom recoveri surgeri surgic

326 2609: Neuritis, Autoimmune, Experi- 2610: Hemoglobinuria, Paroxysmal (7) mental (2) blood bone case chang develop biopsi dai data distribut dose find cell differ differenti earli express individu mutat immunohistochem lesion local multipl patient plai previou protein report role specimen stain patient pattern phenotyp report score seizur specif stress studi suggest

2611: Sarcocystosis (2) 2612: Encephalomyelitis, Eastern antibodi chain clinic detect evolut genet isol Equine (1)

adult anim bovin breed clinic marker patient pcr polymeras popul previou core criteria diagnos diagnosi diagnost elderli encod milk older open pig reaction report sever speci strain studi porcin read year young test

2613: Arachnidism (2) 2614: Dental Fistula (1) adult conserv drosophila factor form adult biopsi bladder effect elderli examin lesion mean month old older patient specimen format function high highli human stain studi therapi treat level low mammalian mous older risk treatment year young suggest surviv year young

2615: Optic Nerve Injuries (2) 2616: Jaundice, Chronic Idiopathic (1) absenc analysi apoptosi bind analys analysi chromosom experi indic initi intern level median month origin particip blot cell confirm cultur demonstr detect patient perform reveal second serum enhanc express increas methyl studi test year neuron presenc protein reveal suggest western

327 2617: Neoplasms, Adipose Tissue (2) 2618: Meningitis, Escherichia coli (1)

activ bacteri bacteria coli cytokin defect epilepsi abnorm case cell factor host infect mutat clinic criteria mutant chromosom nf-kappab pathogen respons seizur strain stress densiti diagnos diagnosi diagnost suggest wild-typ high incid infect level low men mortal preval women year

2619: Keratoderma, Palmoplantar, Dif- 2620: Bronchial Neoplasms (4) fuse (3) cancer case caus compar follow higher incid

cell children clinic delet diagnosi factor function lower lung men mortal persist preval genet individu induc line mutat rate respect select state versu women year patient protein respons risk skin structur treat treatment

2621: Catastrophic Illness (2) 2622: Bone Cysts (1)

complic follow-up mean median mix month oper care commun educ featur health manag medic method model need nurs practic patient perform postop procedur program provid public requir research servic state student produc product rang recurr surgeri surgic underw year yield

2623: Leukostasis (2) 2624: Salmonella Food Poisoning (1) blood cancer caus clinic decreas experi alcohol bodi case consumpt depend effect ethanol extract fraction infect lesion oral increas initi intern lead level prefer present rare report stain studi substanc lung origin patient peripher requir second weight sever symptom therapi

328 2625: Paraganglioma, Extra-Adrenal 2626: Vipoma (1) (2) achiev approach caus design absenc delet head hybrid identif identifi initi malign environment ethic factor genet influenc lead

mutat novel origin patient presenc limit multipl myeloma research region screen second sequenc studi thyroid tumour singl strategi studi thyroid trait variat

2627: Hepatitis D, Chronic (3) 2628: Epilepsy, Partial, Sensory (2)

acid analysi assess blot cluster differ femal affect autosom disord distribut domin express function genom genotyp liver male famili fluid genet histori identifi inherit local member mutat novel recess report screen measur patient polymorph region stress score sequenc variabl western

2629: Anus Diseases (5) 2630: Vitamin B Deficiency (1) adult case earli famili femal male member particip patient present question acid amino carrier chicken ethic factor remain report respons risk stage surgeri fatti high imprint individu japanes mix surgic year young produc product research

resist risk sourc studi yield

2631: Overnutrition (2) 2632: Birnaviridae Infections (4) analysi blot bodi cancer code codon densiti acid amino analysi chain chicken differ genet group growth hybrid individu detect express high inform level isol nucleotid reaction region remain reveal low particip protein receptor reveal substitut sequenc strain studi weight western

329 2633: Erysipelas (1) 2634: Krukenberg Tumor (2) agent breast cancer cell cervic clinic effect adult bone carcinoma cell clinic compar diagnosi efficaci follow hpv human improv prostat tamoxifen therapeut therapi treat diagnost gastric higher lower month normal

treatment untreat women older patient rate tissu versu year young

2635: Hepadnaviridae Infections (1) 2636: Echinococcosis, Hepatic (4)

analysi blot compar control detect differ divid express anim area case children clinic discuss

higher infect primari protein group estim organ plai recent respect reveal signific statist studi viru western model region rel role sequenc studi target test therapeut year

2637: Eosinophilic Granuloma (4) 2638: Pregnancy, Ectopic (8) adult characterist chronic cleft associ compar control differ fetal frequenc group higher human imag lower diseas featur form patient pregnanc rate ratio risk signific studi versu women

format includ inflammatori intestin multipl organ patient

possibl remain studi surviv tumour year

2639: Wolman Disease (2) 2640: Coffin-Lowry Syndrome (2) acid bodi case clinic compar base bone cell clinic differ domain extens gene kinas kinet loss mutat observ p53 control diagnosi differ diseas pair patient sever state symptom syndrom frequenc imag mice mous patient report signific surviv test transgen weight

330 2641: Encephalitis, Herpes Simplex (8) 2642: Anemia, Neonatal (2) behavior case children clinic children china chines clinic determin diagnosi cognit develop earli impair infect learn differ heterogen improv incid life manag memori patient perform present report role sever subject task viru observ patient qualiti respect studi subtyp women year

2643: Meconium Aspiration Syndrome 2644: Rocky Mountain Spotted Fever (3) (1) anim asthma dai differ express follow approach case center conclusions design group induc induct larg lesion hospit main medic objective patient present rare record report retrospect setting strategi studi unit univers model number patient respons size small studi treat treatment

2645: Facial Injuries (6) 2646: Ectromelia (3)

associ clinic combin diagnosi diagnost differ earli activ approach behavior case cognit combin differ discuss effect gener imag pattern effect ethic group human late perform presenc present recent report research medic mutant mutat phase research stage studi respons studi syndrom

2647: Acanthoma (1) 2648: Retinal Dysplasia (2) activ alcohol bladder brain case cell clinic critic cycl delet differenti essenti femal diseas effect inhibit melanoma mobil oral present rare report rna skin studi isol male mutant necessari patient suppress tract urinari prolifer requir sever sex strain suffici syndrom

331 2649: Gait Apraxia (2) 2650: Carcinoma 256, Walker (2) area base brain case clinic copi activ cell dai decreas dna dose effect develop genet larg enzym increas inhibit level mutant plai rat reduc role treat treatment number pair patient possibl present produc product remain report sever tumor week symptom

2651: Phyllodes Tumor (8) 2652: Thyroglossal Cyst (2) breast cancer case cell correl articl carcinoma care case current data discuss essenti examin extent health indic differenti increas level malign phenotyp literatur present rare recent report requir research syndrom prolifer protein report sampl sarcoma

signific size studi tumor tumour

2653: Syncope, Vasovagal (2) 2654: Appendiceal Neoplasms (2) anim delet develop experiment gene genotyp affect analysi associ blot control differ environment factor famili gener loss methyl model month new patient polymorph promot provid studi genet influenc larg member signific size small studi subject test therapi treat treatment vivo

2655: Tarsal Tunnel Syndrome (1) 2656: HIV Wasting Syndrome (2)

assess clinic dai data diagnosi evalu factor acut case clinic diagnosi diseas distal dog famili manifest mild patient present rare report research segment sever sign symptom technolog growth human literatur measur publish recombin report review scale score search trial valid

332 2657: Cystadenocarcinoma (3) 2658: Proctocolitis (1)

compar control cox-2 critic differ extract fraction abil area behavior capac case clinic cell group inhibit inhibitor involv kei modul correl diagnosi effect mean method plai regul regulatori respect role signific suggest potenti properti reduc regul report select signific valu

2659: Fasciitis (4) 2660: Neoplasms, Post-Traumatic (1)

aim analys carcinoma centr characteris design edit biopsi breast cancer case clinic

criteria diagnos diagnosi endogen enhanc hospit increas investig malign diagnost laboratori lesion patient predict

present report specimen stain treat treatment objective patient potenti progress studi tumor tumor tumour

2661: Jaw Fractures (1) 2662: Fractures, Ununited (1) accumul analys caus consequ death diverg analysi analyz bone china chines

dose duplic effect evolut evolutionari infect content cytometri determin differ

irradi lead malign origin radiat field flow heterogen investig load

radiotherapi result tumour observ respect signific space studi subtyp

2663: Listeria Infections (14) 2664: Self Mutilation (3) antibiot bacteri cell control event gene gener affect associ case cell compar host infect mice mous mutat differenti earli featur pathogen patient phenotyp process control respons subject time transgen frequenc progress report segment stage stress studi treat treatment tumor tumour

333 2665: Pasteurellaceae Infections (1) 2666: Patellar Dislocation (1) achiev approach case clinic design diagnosi anim antibodi bind bovin brain activ improv limit literatur optim oral present random rare breed cattl cell complet cow fusion interact milk studi success treatment partial pig porcin protein sheep site report strategi trial

2667: Adie Syndrome (1) 2668: (2)

addit alcohol allel associ combin complex clinic complet criteria diagnos depend effect ethanol exposur frequenc gene diagnosi diagnost fusion imag loop loss magnet novel partial potenti segment genotyp human loss oral polymorph stress studi syndrom stress suggest target therapeut volum

2669: Tonic Pupil (1) 2670: Ehrlichiosis (4)

addit axon clinic combin cord activ assai circadian clinic criteria diagnos diagnosi diagnost distal dog diagnosi dna form format effect hand injuri nerv segment spinal syndrom detect synergist wound fragment genet higher loop method new patient pcr rate sensit suggest

2671: Bladder Exstrophy (6) 2672: Decerebrate State (1) action amplitud conserv durat effect electr bladder case chromosom increas mammalian month patient potenti puls record releas respons rest determin express function stimul threshold wave year genom includ initi mobil normal origin patient report second studi tissu tract urin urinari

334 2673: Encephalomyelitis, Acute Dis- 2674: Cataplexy (2) seminated (3) assess clinic compar control differ analysi blot brain case children clinic dai imag parent patient present group healthi hospit mean measur rare sever state symptom primari report patient pattern score signific syndrom western year model popul studi subject valu variabl

2675: Leukemia, Neutrophilic, Chronic 2676: Tracheal Stenosis (5) (3) analysi case children data develop assess case dai delai evalu femal follow function group model new long-term measur persist male plai patient perform process product report requir reveal specif studi time year recoveri report requir role scale score sex system

2677: Hernia (1) 2678: Ranula (1) case complic gastric injuri occur occurr alcohol case cell depend direct effect oper patient perform postop present epitheli field forc motion movement procedur rare report resect stress studi oper oral orient patient report space studi surgeri surgic underw surgeri surgic

2679: Adenoma, Villous (2) 2680: Avian Leukosis (1)

adult analysi blood cancer collect colon colorect bird cell chicken differ differenti effect copi data databas detect determin factor lesion imprint individu japanes light number risk patient line prevent produc product prolifer protect reduc reduct studi suggest sampl specimen year

335 2681: Hyperbilirubinemia, Hereditary 2682: Crigler-Najjar Syndrome (7) (1) children concentr domin effect famili gene elev elicit hepat higher induc induct level liver mix genet hepat level liver measur mutat plasma produc product respond respons serum sourc stimuli syndrom phenotyp rat remain report score serum transplant yield studi valu

2683: Amnesia, Transient Global (2) 2684: Head Injuries, Penetrating (3) acut behavior case clinic glioblastoma glioma manifest mild assai chain detect discuss featur gener method neg organ patient pcr patient present primari polymeras posit quantit rare releas report secondari sever sign stimul symptom viru reaction real-tim research revers rt-pcr techniqu

2685: Leg Dermatoses (5) 2686: Anaplasmosis (2) analysi case categori classif clinic blood bone cell core delai diseas cluster compar dai differ dose drosophila encod follow frame infect marrow occur occurr open patient persist higher new profil random rate report read sever suggest set skin studi trial

2687: Sweet’s Syndrome (1) 2688: Oculocerebrorenal Syndrome (6)

blood case chain core encod frame clinic differ discuss gene high human lesion open pcr peripher polymeras present put question rare reaction read level low male normal patient remain report phenotyp protein recent region sequenc studi syndrom tissu tumour variabl

336 2689: Anemia, Hypochromic (8) 2690: Keratosis, Seborrheic (4) analysi anemia associ decreas defect carcinoma compar decreas flow higher defici diseas effect gene human increas human increas keratinocyt mutat normal patient product lesion lower melanoma mutat neg posit reduc reveal time tissu treatment rate receptor requir rna skin versu

2691: Nutrition Disorders (3) 2692: Myocardial Stunning (2) adult analysi bodi dai data acut agent clinic compar drug

higher impair lesion lower estim femal health function develop mild nuclear patient present rate respect sever sign includ male new organ provid report reveal symptom versu studi valu weight year

2693: Asthma, Exercise-Induced (1) 2694: Periodontal Pocket (4) chang cours cultur determin differ durat end follow allel case cleft data effect evid genotyp isol level mean patient polymorph provid induc induct long longer muscl period point real reduc strain studi support treat respond respons start time treatment valu

2695: Carcinoma, Verrucous (3) 2696: Hematoma, Subdural (2) apoptosi approach approxim assess absenc brain case disord experi follow form format indic initi intern manag carcinoma cell compar differ origin presenc report second signal evalu flow major measur observ pattern subsequ suggest variant posit region rel score sequenc type

337 2697: Abortion, Missed (1) 2698: Chorioretinitis (1) behavior bodi cognit compar control data alter assess chang clinic decreas evalu dynam enhanc exposur healthi increas increas induc induct measur patient respond literatur manag medic model respons scale score sever symptom treat treatment valid publish simul studi subject weight

2699: Cystadenoma (2) 2700: Pruritus Vulvae (1)

activ clinic decreas develop associ cancer cervic cytolog degrad development examin factor growth detect hpv human intraepitheli lesion increas kinas level manag mice mous observ neoplasia papillomaviru patient posit patient sever signal symptom therapi prognost protein signific studi surviv type

2701: Fasciitis, Necrotizing (4) 2702: Waardenburg’s Syndrome (1) assess case caus clinic dai altern cell clinic diagnosi diagnost dynam exon express form gene diagnosi dose effect measur insight intron isoform model new normal patient rat reduc regul provid simul splice stabil variant repeat risk score sever tissu treatment

2703: Mastocytosis, Cutaneous (2) 2704: Angiomatosis (1)

adult chain clinic compar femal higher improv administr basi current dai detect discuss dose fish

life lower male mutat new patient fluoresc genet hybrid molecular probe recent situ suscept telomer transcript understand week provid qualiti rate reaction sever stimul year

338 2705: Infectious Bovine Rhinotracheitis 2706: Nephroma, Mesoblastic (2)

(2) adjac allel case clinic compar diagnosi diagnost distribut genotyp kidnei local mutat neg anim assai bovin breed cluster detect differ featur gene induc induct milk period pig point normal organ polymorph posit renal sampl sensit test time respons tissu tumor

2707: Lymphoma, Intermediate-Grade 2708: Keratoconjunctivitis Sicca (3) (2) clinic cohort concentr dai data incid anim degre diseas experiment follow follow-up initi men methods mortal origin long-term median model month patient popul preval rate second multipl patient period point recurr therapi time treat treatment year studi therapi women year

2709: Rift Valley Fever (1) 2710: Phantom Limb (1) case center conclusions design basi case chromosom clinic dose earli hospit late main medic genet involv irradi mechan molecular pancreat patient present neg objective patient phase posit radiat report sever symptom underli progress record report stage studi univers understand understood

2711: Dystonia Musculorum Defor- 2712: Bronchial Diseases (2) mans (5) case caus clinic complic diagnosi larg lead activ associ caus diseas disord neg number oper patient posit postop presenc procedur size distribut effect field gene gener respons small surgeri surgic human local measur mutant mutat reduc reduct rel score wild-typ

339 2713: Bronchial Fistula (2) 2714: Hernia, Abdominal (3)

affect case effect imag incid men mortal oral abil children clinic compar complic diagnosi higher lower mass mutant oper patient present preval rare report patient postop procedur properti speci studi surviv treat treatment women year rate surgeri surgic versu year

2715: Laryngeal Diseases (5) 2716: Stomatitis, Herpetic (3) abil behavior case cell complex correl diseas approach case compar current differ discuss dna higher hybrid laser light lower mechan earli epitheli late marker method molecular rate recent number patient perform phase speci understand viru progress properti research stage treatment

2717: Borna Disease (1) 2718: Picornaviridae Infections (3) associ base chines delai differ follow caus compar differ evid heterogen infect long-term observ organ pair persist possibl region relat sequenc studi express famili form format subtyp viru gene higher mechan method molecular new pattern provid rate rel requir support

2719: Common Cold (3) 2720: Salivary Gland Fistula (1) affect case chain degre differ express factor absenc case head indic investig muscl neck observ occur occurr patient presenc present gene includ mechan group rare report studi suggest surgeri surgic syndrom microarrai molecular rang reaction report risk studi subtyp wide

340 2721: Intestinal Volvulus (6) 2722: Ganglioglioma (2)

adult case chain children detect brain clinic criteria current data improv life pancreat patient function diagnos diagnost discuss pcr polymeras qualiti quantit diagnosi gener inhibit primari produc reaction real-tim repeat report revers year product random recent specif studi trial tumor

2723: Acantholysis (3) 2724: Skin Diseases, Papulosquamous analysi blot carcinoma case children (4) control determin distribut healthi lesion local base case children clinic decreas new number presenc provid diagnosi famili gener identifi increas report stain studi subject western interact number patient plai region report role screen sequenc skin

2725: Myofibromatosis (2) 2726: Brain Injury, Chronic (1) autosom case cell congenit disord adolesc autism bladder boi child childhood domin famili inherit line mean measur mutat children diabet dna girl infant present rare ratio report respect stress metabol mother pancreat parent pediatr problem syndrom valu report studi year

2727: Tooth Migration (2) 2728: Pulmonary Alveolar Proteinosis broad children clinic condit current data (3) degre diagnosi diagnost discuss includ activ associ control diseas major plai rang recent report role genet healthi identif identifi mechan spectrum varieti wide membran method mice molecular presenc screen specif studi subject understand vivo

341 2729: Dysmenorrhea (4) 2730: Lymphoma, Large-Cell, Follicu- adult cancer case dai follow lar (1) mechan molecular new ovarian area case character characterist patient popul produc product common conserv differ distinct divers featur provid report respons studi genet live locat lymphoma popul region report resid studi zone surgeri treatment year

2731: Granuloma, Plasma Cell, Orbital 2732: Pyloric Stenosis (1)

(2) bone canin cat clinic congenit deform distal dog hand

activ aggreg case children coloni later left limb methods patient proxim convers demonstr endogen enhanc form rabbit report right segment syndrom format imag increas indic isol light report result strain suggest

2733: Intracranial Embolism and 2734: Erythema Multiforme (2) Thrombosis (1) caus dai differ effect behavior brain central clinic cognit base dose enhanc follow genotyp increas irradi lead disabl disord impair isol learn memori observ pair patient radiat site skin patient perform primari sever therapi week strain stress studi symptom task

2735: Epidermal Necrolysis, Toxic (3) 2736: Toxoplasmosis, Animal (3)

assess associ base case compar activ analysi avail base dai control dai differ dose frequenc irradi measur data databas discuss estim health observ pair radiat rat report score studi tumour inform method mice model multipl program recent reveal select simul

342 2737: Odontogenic Tumors (3) 2738: Hyphema (2) analys case cell follow identifi lesion case cataract chamber examin glaucoma implant intraocular iop len malign mutat novel potenti present rare region methods microscopi morpholog neg observ regul report screen sequenc stain target perform posit primari report studi surgeri tumour

2739: Prolapse (3) 2740: Parotid Diseases (1) case center conclusions design addit chimer complet confirm consist environment factor femal gener genet demonstr diseas find fusion indic observ partial previou replac higher hospit influenc main male report result segment studi medic objective patient rate suggest syndrom record studi

2741: Border Disease (1) 2742: Neuroaspergillosis (1)

address case conduct data design evalu gene includ anim bovin breed calv investig perform pool possibl question remain report cattl conserv cow differ diseas studi syndrom transfer transplant effect farm goat herd lactat lymphoma vector mammalian milk pig porcin sheep

2743: Dermatitis, Perioral (2) 2744: Hypertension, Pregnancy- articl assess control data includ literatur Induced (6) measur patient plai publish repeat report birth clinic compar design fetal genet gestat hospit infant level matern review role score search skin studi subject systemat neonat patient pregnanc prenat rate risk specif studi women

343 2745: Fasciitis, Plantar (1) 2746: Heel Spur (1) associ compound data dose effect extract abil abl addit capac fraction gene haplotyp irradi literatur combin demonstr displai dose effect element exhibit plasmid polymorph publish radiat insert integr irradi method potenti properti protocol radiat techniqu radiotherapi recombin report search snp

2747: Respiratory Sounds (9) 2748: Brain Stem Infarctions (2) arteri brain central clinic compar design field asthma caus children clinic coli develop higher hospit hypertens injuri lower movement development diseas earli factor femal fibrosi high objective patient pressur rate sever space identifi low male patient risk screen versu specif

2749: Intestinal Atresia (4) 2750: Lymphangioma (2)

case clinic femal impact improv life male month area associ case cell chronic diseas event gener intestin involv multipl patient present physic qualiti report sex process rare report studi surgeri surgic syndrom patient surgeri surgic syndrom therapi treat treatment year

2751: Pseudarthrosis (2) 2752: Foot Ulcer (2) adult bone case cat distal dog hand includ limb associ care chromosom clinic commun educ femal health male manag medic need nurs older patient proxim rang report patient practic program public right segment varieti wide year young research servic student

344 2753: Diabetic Foot (8) 2754: Skin Diseases, Bacterial (3) case chang clinic detect differ distal dog factor hospit anim area assess develop establish experiment form format human live locat measur method normal patient pattern risk sampl segment studi test time tissu year model month patient resid score studi treatment

2755: Anemia, Macrocytic (2) 2756: Pilonidal Sinus (1) caus center conclusions dai design dose acid amino assai base clinic hospit lead main median medic month defici design detect diagnosi mutant objective patient record diagnost hospit method pair releas stimul studi year patient region requir sensit sequenc studi techniqu

2757: Pseudomyxoma Peritonei (3) 2758: Q Fever (5) case clinic diagnosi diseas individu level activ antibodi area assai chain compar

marker median month patient control copi detect dna fragment recurr remain report serum studi surviv treat frequenc genet number pcr treatment tumour year polymeras popul reaction respons sampl

2759: Eye Infections (2) 2760: Optic Nerve Glioma (1)

clinic compar criteria diagnos diagnosi diagnost behavior case cognit conserv densiti effect differ greater higher lower mild patient present high includ level low present rang rare report retin treat treatment varieti visual primari rate respect sever sign symptom wide versu

345 2761: Gingival Hypertrophy (1) 2762: Cystic Adenomatoid Malforma- tion of Lung, Congenital (1) alcohol assess case cell clinic defici depend evalu measur oral patient present rare reliabl report scale score sever altern asthma cervic exon femal symptom valid includ intron isoform male mate multipl myeloma offspr reproduct sex sexual singl splice syndrom variant

2763: Central Nervous System Fungal 2764: Multicystic Dysplastic Kidney Infections (1) (2)

allogen cell core dai donor dose effect encod base bladder children clinic compar dai follow frame graft line open read recipi stem diagnosi differ ethic express transplant treat function higher lower pair parent treatment week patient rate research studi versu

2765: Acidosis, Respiratory (1) 2766: Bowen’s Disease (6)

anim cancer compar develop experiment fish fluoresc higher hybrid injuri lower lung membran adult affect case cell cluster diseas effect enhanc femal keratinocyt lesion male marker report probe respect situ studi model rate skin studi therapi treat treatment year versu

2767: Dental Pulp Calcification (4) 2768: Colles’ Fracture (1)

case cleft clinic famili impact allel bone compar control densiti improv life member new patient differ frequenc genotyp high higher incid physic presenc provid qualiti report requir risk level low men mortal polymorph popul preval women year studi therapi treatment

346 2769: Osteomyelitis (6) 2770: Melena (3)

base cancer case children clinic collect data acut adolesc affect autism cancer case child diagnosi femal follow local male method childhood children factor gastric leukemia

patient report sampl sex studi parent patient pediatr report studi treatment tumour syndrom tumor year

2771: Porphyrias, Hepatic (3) 2772: Ear Neoplasms (3) care caus cost data estim examin extent alter analysi approach assai chang data genet health lead liver manag medic detect develop estim featur genet includ loss mechan molecular method neg observ posit practic rang suggest patient phenotyp sensit studi tumor

2773: Epispadias (4) 2774: Demyelinating Autoimmune Dis- associ bladder case determin evalu examin eases, CNS (3)

includ method mobil patient cell combin compar control perform presenc report risk studi suggest tract urin urinari variant dai diseas earli effect frequenc mice

normal organ popul posit stage studi target test tissu treatment

2775: Pneumothorax (6) 2776: Rheumatoid Nodule (1) anim area assess clinic conclusions children clinic diagnosi event famili control evalu experiment healthi hospit imag lesion lung magnet member mutat patient process region rel sequenc sever stain treatment volum measur methods model objective patient scale score studi subject surviv

347 2777: Embolism, Air (5) 2778: Decompression Sickness (4) alter assai case chang clinic activ assai compar control copi detect earli field frequenc function increas measur data detect develop diagnosi error estim featur method patient model normal number patient present report sensit sever surgeri surgic process sensit space tissu

2779: Epilepsy, Benign Neonatal (7) 2780: IgA Deficiency (3) attempt children condit epilepsi antibodi children differ fusion gener famili follow gener histori includ member mutat patient recent report respons human individu initi mice mutat origin parent pattern primari requir second seizur stress studi suggest suicid state studi trial type

2781: Otitis Media, Suppurative (4) 2782: Hemorrhagic Disorders (5) dai design ear famili genet group activ associ bleed factor hair hear hospit loss marker medic member famili folat fusion homocystein inherit mthfr neg platelet point posit ratio risk studi normal patient popul specif studi tissu treatment thrombosi time venou

2783: Pneumonia, Staphylococcal (1) 2784: Pseudotumor Cerebri (1) aeruginosa antibiot antimicrobi aureu bacteri case clinic diagnos diagnosi involv literatur mechan molecular patient poorli present rare bacteria biofilm caus defens host infect report sever surgeri symptom syndrom underli understand understood parasit pathogen pneumonia pseudomona salmonella staphylococcu strain suscept virul

348 2785: Vitamin K Deficiency (2) 2786: Polyarteritis Nodosa (5)

associ avail brca1 carrier clinic data databas arthriti case clinic delai differ develop diseas factor growth diseas follow joint model multipl pain patient pattern persist present radiat rat report rheumatoid surgeri increas inform pancreat patient prevent risk secret sever surviv

2787: Median Neuropathy (1) 2788: Angioid Streaks (2) acut clinic complic diseas includ injuri manifest anim bladder case data develop establish experiment famili human includ individu median mild month neurolog patient present rang sever sign symptom varieti member model mutat provid report wide year structur studi tract urinari

2789: Hepatitis, Chronic, Drug- 2790: Gonadal Disorders (1) Induced (1) clinic control criteria diagnos abil anim capac caus demonstr develop diagnosi diagnost earli domain earli experiment late lead marker femal healthi late male model new phase potenti mate particip phase reproduct sex sexual properti provid stage studi stage subject syndrom

2791: Aortic Stenosis, Supravalvular 2792: Otorhinolaryngologic Diseases (2) (5) affect autosom caus delet disord domin adult cell chang children clinic current famili gene inherit lead length long loss diagnosi discuss earli hear loss organ

membran mice mutat recess patient progress rat recent sever repeat short syndrom stage treatment year

349 2793: Visceral Prolapse (1) 2794: Esophageal Motility Disorders acut clinic compar complic cours diseas lesion (1) manifest mild neurolog normal assess compar differ good group impact patient present random sever improv life month mutant normal patient physic qualiti sever signific span studi tissu year sign symptom syndrom tissu trial

2795: Argyria (2) 2796: Abortion, Septic (1) case confoc electron gener granul articl caus condit consequ data death definit degre induc induct inform lead literatur layer microscop microscopi month publish report respons review morpholog observ oral patient search state systemat report reveal shape structur surfac ultrastructur wall

2797: Entamoebiasis (2) 2798: Status Asthmaticus (1) adapt compar control differ diseas higher includ mechan molecular adult alcohol correl dai depend dose effect elderli neg old older oral number plai rang rate region repeat role select sequenc posit relat relationship signific subject variabl studi week year young

2799: Lipomatosis (1) 2800: Diverticulitis, Colonic (2) addit brain child childhood children adult approxim case demonstr find insight new parent famili previou provid question recent remain hospit includ major member normal report studi suggest syndrom year observ patient rang region rel report

sequenc state tissu wide year

350 2801: Papillon-Lefevre Disease (6) 2802: Helminthiasis (3) activ analysi case code adult children famili genet codon famili gene genom high incid influenc level low mortal parent larg level nucleotid region repeat reveal sequenc size small substitut syndrom popul preval region risk sequenc variabl tumor variat women year

2803: Diabetic Coma (1) 2804: Meningitis, Pneumococcal (2)

associ behavior case chain collect compar control absenc alter case cours chang differ examin group isol loss patient rat decreas follow-up increas median month observ reaction sampl sever signific strain studi patient period point presenc recurr

report sever time year

2805: Nevus, Blue (1) 2806: Alcohol Withdrawal Seizures (1) adult allel children collect control genotyp character composit differ includ isol laser light healthi mean older parent patient polymorph melanoma multipl myeloma red rna sarcoma sequenc sampl sever studi subject singl strain studi syndrom tumor type vitro vivo year young

2807: Nasopharyngitis (1) 2808: Achlorhydria (1)

addit carcinoma confirm consist data demonstr actin cancer cell cellular cerevisia cytoskeleton endotheli filament function gastric membran migrat earlier fail find gene indic mutat npc mucosa polar protein pylori regul observ previou recent report studi saccharomyc transport yeast suggest work

351 2809: Tic Disorders (3) 2810: Bronchial Spasm (2)

approxim current data discuss effect evid famili analys anim approach base improv major member model provid recent rel analysi support test therapi treat classif cluster data estim form format treatment understand human method model perform reveal set strategi studi tumour

2811: Hyperlipoproteinemia Type IV 2812: Hajdu-Cheney Syndrome (2)

(2) affect autosom clinic develop disord domin famili inform inherit insight mutat new patient activ analys analysi autosom blot provid random recess sever syndrom trial clinic confirm data domin famili flow gene indic inherit understand mutat patient perform reveal studi western

2813: Angiolymphoid Hyperplasia with 2814: Ocular Hypotension (2) Eosinophilia (1) analysi bodi cataract classif cluster

analysi case cost depress disord effect follow-up glaucoma electrophoresi examin extent find gel lesion combin implant len light median month lung manag mass medic practic proteom report stain studi patient recurr studi treat treatment year

2815: Neoplastic Processes (2) 2816: Mastoiditis (3) countri data estim european event hospit approach case child childhood involv medic method nation novel potenti children design diseas femal initi process regul research target male origin parent patient pediatr report therapeut therapi tumour univers second surgeri treat treatment year

352 2817: Lateral Sinus Thrombosis (1) 2818: Onchocerciasis (2)

children conclusions dai delai design dose element care caus cluster correl divers evid famili genet follow hospit insert long-term parent inform loci member particip popul patient persist studi surgeri target provid treat therapeut week year structur support treatment valu variat

2819: Hyperlipoproteinemia Type III 2820: Leiomyoma, Epithelioid (1)

(3) case clinic collect criteria design detect diagnos diagnosi diagnost hospit laboratori allel base chain detect develop featur genotyp mutat patient pcr lesion objective patient sampl specimen polymeras polymorph quantit studi target therapeut tumor reaction real-tim revers rt-pcr specif subject valu

2821: Carbon Monoxide Poisoning (3) 2822: Brachial Plexus Neuritis (2) area case caus chicken differ examin articl associ avail current data databas discuss imag link multipl organ particular possibl exposur imprint improv individu recent regul relat research studi suggest understand japanes lead life live locat qualiti region resid studi system

2823: Schistosomiasis haematobia (3) 2824: Labyrinth Diseases (2) adult area case differ diseas examin affect assess conclusions design evalu event level live locat polymorph popul region state function hospit initi involv loss studi test therapi time treat measur origin patient process score second treatment year stimul studi target

353 2825: Autolysis (1) 2826: Piebaldism (1) carcinogen chemic diverg dose duplic effect candid cell delai design follow hospit identif embryo evolut evolutionari expos includ long-term month exposur fertil genotox irradi identifi novel objective patient persist program recoveri mutagen origin radiat speci sperm toxic screen studi year

2827: Polymyositis (5) 2828: Odontodysplasia (4)

activ alter analysi chang classif adapt case children diseas distribut gene gener genet high iron junction level classifi clinic cluster local low presenc regul report diagnosi diagnost differ mutat select studi express higher level mechan muscl observ patient rate set

2829: Renal Osteodystrophy (5) 2830: Myoclonus (5) acid bone clinic cluster compar affect analysi case chang differ effect higher level lower mean control differ epilepsi high measur patient phenotyp level low mutat new patient reduc respect subject vitamin rate valu pattern phenotyp report reveal seizur stress studi

2831: Dourine (1) 2832: Hematoma, Epidural, Spinal (1) address articl current data discuss experi brca1 carrier complic dai develop diseas dose factor identif identifi increas novel oper patient initi intern isol issu origin peptid

prevent procedur screen surgeri surgic question recent remain report risk research rna second strain

354 2833: Protozoan Infections (1) 2834: Sinoatrial Block (3)

adolesc autism bacteri boi child childhood base clinic differ diseas gener heart identif identifi

larg larger novel number pair patient children data girl host infect literatur mother parent pathogen pediatr publish report search year rel screen size small smaller syndrom

2835: Menorrhagia (5) 2836: Leukoplakia (1)

affect clinic design diseas distribut famili hospit activ adjust associ confid endogen

local measur medic patient rang enhanc factor increas interv repeat report score studi treat treatment women year kinas mechan molecular odd phosphoryl promot ratio risk smoke studi underli

2837: Hemorrhagic , Viral (3) 2838: Osteoarthropathy, Secondary Hypertrophic (2) accuraci algorithm american affect autosom cancer cleft colon colorect domin approach base comput data ethnic evid famili growth histori inherit member mutat palat plant report stress syndrom tgf-beta gene inform method transform network origin popul predict problem propos set support

2839: Hyperbilirubinemia (8) 2840: Osteitis (2) algorithm bone case cell characterist common differ dose express dai famili data evolut featur lesion method neg network patient posit predict sever stain function identifi individu level liver metabol method mutat studi techniqu normal number patient rat screen tissu variabl

355 2841: Carotid-Cavernous Sinus Fistula 2842: Malabsorption Syndromes (4) (3) adult case caus chronic diseas gener approxim arteri case clinic complic identif identifi intestin mutat novel older plai role delai effect follow identifi respons major patient persist reduc rel screen system target year young report screen sever surgeri surgic syndrom

2843: Hepatopulmonary Syndrome (2) 2844: Gardner Syndrome (3)

biolog clinic cohort data decreas diagnosi behavior cancer clinic colon colorect combin

incid increas level liver effect famili femal histori identif identifi male member novel patient screen men mortal popul preval rat rate serum sever sex syndrom system women year

2845: Corynebacterium Infections (1) 2846: Trichostrongyloidiasis (2)

analysi caus china chines determin differ distal dog analysi assai correl data heterogen human isol lead loss major respect segment strain studi subtyp type detect distribut error estim form format local method model point resist reveal select sensit statist time

2847: Reflex, Abnormal (8) 2848: Bronchiolitis (3) case combin correl develop differ diseas earli approxim chain children conclusions data design express hospit major effect genet identifi new patient provid sampl screen signific studi subject time mechan molecular number treatment objective patient popul reaction rel studi test year

356 2849: Foot Deformities, Acquired (3) 2850: Foot Injuries (2)

assess correl distal dog evalu featur imag approach child childhood children clinic level life measur method normal develop development imag new number patient qualiti parent patient pediatr provid sever state strategi studi symptom system year region score segment sequenc tissu

2851: Paralyses, Familial Periodic (3) 2852: Ureaplasma Infections (1) acid blood differ famili gene gener assai biopsi bladder case detect genet identifi member mutat open patient pattern previou produc product remain report evalu histolog immunohistochem studi type isol lesion phylogenet section sensit speci specif specimen stain strain test tissu

2853: Laboratory Infection (1) 2854: Chondrodysplasia Punctata (5) associ case clinic compar criteria diagnos diagnosi diagnost diseas gener higher abnorm analys analysi brain caus chromosom dai includ lead length interv isol lower particip rate ratio risk strain versu loss mutat rang repeat reveal short stress studi syndrom trial

2855: Asphyxia Neonatorum (6) 2856: Central Nervous System Bacte-

adult affect associ children compar control differ rial Infections (1)

growth identifi measur patient group antibiot bacteri bacteria brain central pregnanc respect sequenc signific studi subject women year cerebr clinic cns cortex host infect nervou parasit pathogen plant salmonella strain therapi treatment virul

357 2857: Endotoxemia (5) 2858: DNA Virus Infections (3) alter cancer chang effect elev function high caus cluster diseas effect gene

higher increas larg low mice genom genotyp isol lead mechan molecular level plant polymorph protein reduc resist sequenc plasma rat reduc serum size small treatment speci strain system

2859: Encephalomyelitis (1) 2860: Coronary Vasospasm (4) analysi case caus dai dose elev includ inhibit administr case combin interact lead level measur patient dai dose effect experi follow initi plasma rang sampl serum stress variabl intern month origin patient receiv report week second transplant vector week year

2861: Erythromelalgia (1) 2862: Strongyloidiasis (4) caus code conserv critic encod exon gene adult care case caus

identifi involv kei missens mutat chain health improv infect lead life nucleotid plai primari receptor region role sequenc suggest manag medic practic qualiti regul report research speci studi year

2863: Myoglobinuria (2) 2864: Altitude Sickness (2)

acid assai case clinic compar concentr activ allel care compar content decreas control detect differ frequenc higher min determin flow follow genet genotyp patient period point present report increas inform level mean measur sensit specif time particip polymorph popul valu

358 2865: Calculi (1) 2866: Marek Disease (3) antigen associ chicken class compar control applic biologi case cell develop differ enhanc extract frequenc haplotyp imprint diseas element epitheli express genom insert integr mammari new present rare report research stem technolog individu japanes mhc polymorph protein studi suggest valu

2867: Esophageal Diseases (4) 2868: Muscle Hypertonia (3)

adult alter cancer case caus chang characterist clinic combin common diagnosi differ effect bladder case children clinic featur femal male patient pattern coli diagnosi diagnost report year effect flow follow genet identifi patient reduc reduct remain report screen studi urinari

2869: Ureteral Diseases (5) 2870: Meningitis, Fungal (1) analysi analyz chines chromosom content anim base case clinic diagnosi cytometri determin differ diseas kidnei member famili flow fluid heterogen model pair patient plai renal report distribut role select studi syndrom tumor investig isol local mass observ strain studi subtyp

2871: Pancreatic Pseudocyst (2) 2872: Breech Presentation (3) american clinic complic condit degre differ birth care commun diseas distribut ethnic fluid develop fetal gestat health infant inform interact isol local patient matern medic neonat nurs organ particip pregnanc prenat risk women popul sever strain surgeri surgic surviv symptom

359 2873: Stiff-Person Syndrome (3) 2874: Lecithin Acyltransferase Defi- acid affect decreas design diseas dna earli ciency (1)

alpha-synuclein alzheimer apoe autoimmun caus effect fragment gene hospit human

initi reduc region cholesterol common dementia diseas increas mutat disord gene lipid lipoprotein mutat onset parkinson sequenc stage studi pathogenesi patholog progress tau

2875: Angiomatosis, Bacillary (1) 2876: Toxocariasis (1) approach chines data design differ assai biolog chain clinic detect

direct evid heterogen hypothesi develop includ patient pcr polymeras

infect isol modifi primari provid pten quantit reaction real-tim

revers rt-pcr sever studi symptom strain strategi studi subtyp system suggest support

2877: Leukemoid Reaction (1) 2878: Cor Triatriatum (3) biolog chain copi data includ literatur adult assess cardiac case copi data earli group heart literatur measur model number patient pcr polymeras publish quantit reaction real-tim number patient present report revers review search system publish rare report score stage year

2879: Hepatitis, Alcoholic (2) 2880: Yin Deficiency (1) adolesc alcohol area autism child childhood cancer cell chines determin differ express gastric heterogen lesion mrna observ oncogen children dai depend dose effect ethanol examin oral parent patient pediatr overexpress protein pylori respect sever studi year stain studi subtyp transform

360 2881: Egg Hypersensitivity (1) 2882: Tuberculoma (2) absenc african american asian black cancer cell ethnic extract gastric head month patient case clinic criteria diagnos diagnosi diagnost distribut dna popul presenc protein resist hospit induc induct studi white year gener genom local patient produc product regul respons sequenc

2883: Iris Neoplasms (3) 2884: Factor XII Deficiency (3) anterior case cataract chamber alter bodi codon decreas data disc examin glaucoma chang defici factor form format gene increas includ intraocular iop month observ patient platelet requir substitut implant therapi tumor variant len methods perform primari report studi surgeri tumor

2885: Trophoblastic Neoplasms (2) 2886: Monoclonal Gammopathies, Be-

cag cell contain cultur fibroblast length long nign (1) longer number patient peptid region algorithm cancer data differ identif repeat sequenc short surgeri surgic tandem termin unit identifi includ

individu mean measur

method multipl network novel predict

ratio respect screen surviv valu

2887: Tooth Eruption, Ectopic (5) 2888: Blepharitis (4)

case clinic combin compar control dai differ earli analysi approach associ effect frequenc methods patient posit cleft compar control design presenc rat report respons sever stage studi differ femal higher larg male model popul rate reveal size small strategi studi

361 2889: Sweat Gland Diseases (3) 2890: Korsakoff Syndrome (1) blue case color composit differ effect area attent behavior behaviour cognit data deficit differ disabl group impair gastric intens laser length light inform learn memori particip perform social studi target task mechan molecular number red repeat report stimul studi tumour

2891: Ecthyma, Contagious (1) 2892: Sweat Gland Neoplasms (5) care commun contain core case chicken describ diagnos diagnosi diseas hiv hiv-1 individu infect lesion literatur man present encod frame health rare receptor report reveal viru woman identifi inform medic nurs open orf particip person physician practic put read research

2893: Bone Diseases, Infectious (1) 2894: Milk Hypersensitivity (1)

approach care data design evalu hospit includ biopsi case chronic develop diseas inflamm isol limit manag medic need objective patient inflammatori insight intestin lesion new present provid rare renal report small specimen stain understand perform signal strain strategi studi success

2895: Peritonsillar Abscess (4) 2896: Hemoperitoneum (2)

adolesc autism boi case child childhood affect allogen complic domin donor famili differ evid children group graft histori hospit identifi includ member patient parent pediatr phenotyp product report studi procedur recipi requir stem surgeri surgic transplant support treat treatment year

362 2897: Penile Induration (1) 2898: Oral Submucous Fibrosis (2) accuraci algorithm approach base axon case caus clinic cord diagnosi diseas disord injuri motor nerv patient cell comput data death degre inform present progress rare report sever spinal symptom wound machin method network optim paper perform predict problem propos set

2899: Cardiovirus Infections (2) 2900: Inappropriate ADH Syndrome

abil cell current discuss diseas evolut high hospit (3) human induc induct level low mice mous caus clinic consequ death event excess properti recent respond respons experi failur initi interact lead mechan transgen mutat organ patient prevent process result sever tumour

2901: Paraneoplastic Endocrine Syn- 2902: ACTH Syndrome, Ectopic (2) dromes (1) approach caus correl experi identif

algorithm children develop development discuss experi follow initi intern identifi initi intern lead malign new malign method methyl network origin parent predict recent second subsequ tumour novel origin provid recent screen second

signific strategi tumour

2903: Diabetes Insipidus (3) 2904: Paracoccidioidomycosis (1)

case clinic defici disord experi gene genet allel caus condit death degre excess express expression genotyp heat influenc initi new origin patient lead lesion level lung mrna polymorph shock stain present provid receptor report second sever symptom temperatur tissu system

363 2905: Ventricular Septal Rupture (1) 2906: Mixed Tumor, Mesodermal (1)

cardiac chromosom complic cost articl clinic combin compar

function heart involv manag control current data differ effect mechan medic molecular oper patient procedur frequenc inform literatur phenotyp publish provid surgeri surgic underli understand understood report review search systemat therapi treatment

2907: Uterine Cervical Diseases (3) 2908: Lateral Medullary Syndrome (1) case cervic compar detect differ form bladder brain case distal dog examin format higher hpv human lower find imag later magnet observ present rare report segment studi suggest tract urinari volum organ popul possibl rate report sampl studi subtyp tumor

2909: Acatalasia (2) 2910: Diffuse Axonal Injury (1)

altern approach copi diseas earli enzym exon apoptosi arthriti axon biopsi brain cell clinic cord death diseas injuri lesion methods nerv pain gene high increas level low patient specimen spinal stain wound mutat number plai role splice stage strategi variant

2911: Polyradiculoneuropathy (1) 2912: Dysgeusia (2) care case coli commun design educ affect alter anim chang control cord dai decreas effect increas induc inject injuri nerv health hospit medic need nurs observ signific spinal week wound rat patient program public rat regul servic student

treat treatment

364 2913: Sertoli Cell Tumor (1) 2914: Leukoaraiosis (1) arteri assess brain central comput diseas evalu analys analysi blot breast cancer case confirm demonstr detect express inhibitor hypertens imag magnet measur northern present protein rare renal report reveal motor mri perform pressur reson scan techniqu syndrom western tomographi volum

2915: Sciatica (1) 2916: Tuberculosis, Central Nervous allel associ control data differ direct evid exon factor System (2) gene genotyp hypothesi mutat group associ case data effect gener indic polymorph provid risk signific support variant mycobacterium patient present ratio reduc reduct report risk specif studi test treat treatment tuberculosi

2917: Porcine Reproductive and Respi- 2918: Chronobiology Disorders (3) ratory Syndrome (4) alter bind caus chang assai chang detect diseas enhanc disord express includ lead loop mean mice new period point provid rang femal form format high isol level regul suggest time valu

low male new organ region sensit sequenc strain studi

2919: Hallux Valgus (2) 2920: Agraphia (1) behavior care cognit commun adult associ case elderli enhanc examin incid increas link mortal old older preval relat segment studi suggest women year young disabl ethic health impair inform learn memori nurs particip perform practic public research servic social task

365 2921: Bronchiolitis Obliterans Organiz- 2922: Fibrous Dysplasia, Monostotic ing Pneumonia (3) (1) abil case caus clinic event evid involv biopsi bone c-kit case dysplasia histolog immunohistochem lead patient present process properti provid rare recombin report sever state support system immunohistochemistri kit lesion malign sarcoma section soft specimen stain stromal syndrom tissu tumor

2923: Calciphylaxis (2) 2924: (1) clinic diagnosi differ donor includ induc induct larg month number patient rang avail chain data databas recipi respons size small therapi transplant varieti wide delet detect inform lymphoma malign pcr

polymeras potenti quantit

reaction real-tim revers search

target therapeut tumour

2925: Parapsoriasis (1) 2926: Urethral Obstruction (3)

blood cell chain content count associ data effect evid detect determin flow identif identifi line genet incid kidnei model lymphocyt neg novel pcr peripher polymeras posit reaction screen mortal patient popul provid ratio reduc renal risk support system women year

2927: Lichenoid Eruptions (3) 2928: Histiocytosis, Langerhans-Cell (4) affect alter cell data disord chang address analysi anim biopsi diseas earli evid increas induc induct late lesion phase provid receptor respons independ lesion model possibl skin stage support predict question regress relationship remain signific specimen stain tumor variabl variat

366 2929: Thoracic Diseases (2) 2930: Nephrosis (4) diseas distribut evid evolut find adult alter chang concentr copi includ local magnet imag decreas evolut famili identifi increas patient perform provid rang level local model mutat report studi suggest support surgeri number protein respons tumor volum screen serum year

2931: Tinea (1) 2932: Cardiac Output, High (1)

care clinic cost decis dose factor guidelin activ apoe associ character cholesterol complic imag irradi manag medic medicin practic effect exhibit inhibit lipid lipoprotein mice

primari radiat recommend risk mous patient phenotyp secondari therapi treatment suggest suppress surgeri surgic transgen

2933: Hyperthyroxinemia (2) 2934: Anemia, Megaloblastic (4)

affect assai belong bind detect domin defect defici event experi femal induc induct

level male marker organ famili histori identifi includ initi level patient member origin report sensit serum specif subfamili superfamili possibl process requir respons serum sever sex state

2935: Femur Head Necrosis (5) 2936: Phencyclidine Abuse (1)

absenc associ autosom case clinic diseas domin famili abil abl capac data demonstr displai effect gene genom genotyp group inherit mutat

exhibit identif identifi neuron novel period patient polymorph presenc risk studi time point potenti properti screen

time treat treatment

367 2937: Aspergillosis, Allergic Bron- 2938: Pulmonary Eosinophilia (2) chopulmonary (3) allel associ content distribut domain flow identif induc demonstr diseas essenti high induc induct level gene genotyp haplotyp identifi low method mice mous necessari peptid protein induct local mice novel polymorph screen snp requir respond respons speci respons specif transgen

2939: Respiratory Tract Neoplasms (2) 2940: Fructose Intolerance (1) caus cohort data death express alter chromosom code codon condit conform crystal degre delet form loop loss mutant mutat region isol lead men mortal incid residu structur substitut temperatur wild-typ period popul preval rate registri strain studi trend women year

2941: Psittacosis (2) 2942: Theileriasis (2) adult allel analysi blot develop differ addit assess base combin divers genet genotyp group infect copi differ effect enhanc evalu increas isol polymorph resist signific lymphoma measur number observ popul test variat western year pair possibl score singl strain studi

2943: Carotid Artery, Internal, Dissec- 2944: Monkeypox (1) tion (2) antigen develop differ earli immun isol case data differ event group involv larg larger late number phase progress rel larg model number patient predict process regress report signific size small studi respons size small smaller system variabl stage strain vaccin

368 2945: Meningitis, Listeria (1) 2946: Histiocytosis, Malignant (1)

alter case cell chromosom delet frequent gain gene brain case cell central cns cortex

loh loss lymphoma malign membran present rare region data direct evid find host hypothesi

report sperm transport infect modif modifi nervou provid report tumor

suggest support

2947: Angiolipoma (1) 2948: Fournier Gangrene (1) adren biopsi case diagnos diagnosi histolog hormon lesion literatur man pituitari present primari adult bovin clinic elderli examin rare report reveal specimen stain thyroid woman infect liver loss mean nuclear old older pig skin studi therapi treatment year young younger

2949: Renal Tubular Transport, Inborn 2950: Equine Infectious Anemia (2)

Errors (3) antigen chromosom dose encod endogen enhanc analysi associ clinic dai enhanc gene immun increas indic kinet mutat neg posit radiat respons state suggest transit vaccin

famili femal gene genet includ male

member mice mutant mutat

number region report sequenc studi

2951: Atelectasis (1) 2952: Ventricular Dysfunction (1)

addit airwai asthma cftr combin cystic effect administr american compar control dai decreas differ domain dose effect ethnic fibrosi function involv lung mechan molecular provid respiratori studi synergist healthi underli understand understood increas individu inhibit level popul studi subject week

369 2953: Adenoma, Acidophil (1) 2954: Trichomonas Infections (1) analysi base categori classif classifi cluster cell characterist common cultur complex data differ distinct group demonstr distinct electron extract identifi isol featur fibroblast find light human microscopi morpholog observ patient profil set speci strain subgroup previou report studi vitro vivo

2955: Pemphigoid, Bullous (2) 2956: Blood Protein Disorders (1) approxim bind brain cell clinic diseas major mice caus chromosom compound death defici delet elev

excess exon gene higher lead loss lower observ patient plai rat rel level measur mutat plasma renal serum role sever splice suggest symptom variant vivo

2957: Equinus Deformity (1) 2958: Endomyocardial Fibrosis (1) analysi assess clinic determin evalu adhes cell compar complement decreas demonstr determin domain express growth highli independ measur patient predict regress relationship scale increas level mrna ovarian overexpress score segment sever signific surviv protein reduc specif transform valid variabl variat

2959: Nails, Ingrown (1) 2960: Periodontitis, Juvenile (2) base compar differ group higher analysi children chines collect detect differ field find lower month pair patient random rate respect gene heterogen month mutat patient signific similar studi surgeri surgic trial versu year previou report sampl site studi subtyp year

370 2961: Chondroma (1) 2962: Granuloma, Respiratory Tract (1) adjuv aromatas breast analys analysi case determin differ diseas cancer dcis ductal endocrin estrogen enzym independ linear measur patient predict hormon invas mammographi mcf-7 mda-mb-231 predictor regress relat relationship signific postmenopaus progesteron receptor statu tam tamoxifen women test variabl variat

2963: Bites, Human (1) 2964: Choroiditis (2) children critic demonstr densiti essenti fish adult age-rel case degener elderli examin lesion macular old older optic pigment present genet high hybrid level low rare report retin retina visual year young maintain mainten necessari parent popul

probe requir situ suffici

2965: Glycogen Storage Disease Type 2966: Immersion Foot (1) III (2) bind caenorhabd cell dispers ecolog care characterist common condit case elegan forest fungal fungi habitat isol lesion degre disord featur find genet health patient nematod pathogen sea season segment site peptid popul present previou rare recent speci stain report studi

2967: Hypokinesia (1) 2968: Adiposis Dolorosa (1) blood condit copi cultur dai decreas degre dose administ administr bladder case clinic

increas larg level loss mechan complic dai daili dose follow hour patient present receiv report sever molecular number peripher surgeri surgic symptom week temperatur total underli week

371 2969: Facial Nerve Injuries (2) 2970: Panuveitis (1) caus cell correl differenti factor index affect associ compar comparison defect defici injuri lead lesion plai posit prolifer receptor differ distinct inhibitor liver methods observ

relationship risk role signific specimen patient pattern schizophrenia stain suggest signific similar studi suggest type

2971: Myofibroma (2) 2972: Ecchymosis (1) adolesc autism case characterist child african american asian black childhood children clinic caucasian differ elegan diagnosi evid featur parent pediatr provid ethnic recent report support tumor tumour year european fusion indian loss north popul preval race season south speci white

2973: Prune Belly Syndrome (1) 2974: Pregnancy, Abdominal (1) chromosom experi fish fluoresc follow complic concentr design embryo hospit main matur medic microg hybrid initi intern linkag loci locu microm min objective oocyt oper patient procedur studi surgeri surgic women

malign map origin probe remain

second situ subsequ tumour

2975: Unconsciousness (1) 2976: Balkan Nephropathy (1)

address anim clinic current develop discuss drug ethic allel associ clinic compar control correl differ diseas experiment issu methods model frequenc gene genotyp higher index metabol methods

patient question recent remain observ patient polymorph research studi surviv understand relationship signific

372 2977: Patellofemoral Pain Syndrome 2978: Brain Damage, Chronic (7) (1) analys analysi associ blood case chang

achiev approach bone design effect element children combin develop effect ethic function group level phenotyp regul genom improv insert integr limit muscl optim report research reveal studi

segment strategi structur success therapi treat treatment

2979: Adenosarcoma (1) 2980: Mixed Tumor, Mullerian (3)

adhes bodi cancer cell cultur degrad diet fibroblast analys analysi carcinoma characterist lymph mass metastasi metastat node obes ovarian primari prostat protein tumor weight cluster common correl differ distinct express featur gene index indic properti relationship reveal signific studi tumor

2981: Splenic Infarction (1) 2982: Typhus, Endemic Flea-Borne (1) base cours decreas determin differ experi follow area case differ genet incid influenc mean men mice mortal imag increas initi intern level observ origin pair mous preval ratio respect studi valu vitro vivo women year period point second system time

2983: Mercury Poisoning, Nervous Sys- 2984: Optic Neuritis (3) tem (1) clinic compar control dai diagnosi differ applic biologi bodi develop exposur involv diseas femal genet group mechan molecular new higher lower male mean popul posit rate organ poorli possibl process provid remain respect subject valu research technolog underli understand understood

373 2985: Sphincter of Oddi Dysfunction 2986: Fibromatosis, Abdominal (2)

(1) cell character characterist clinic common diagnosi abdomin cardiac case clinic complic diseas diagnost differenti distinct express famili featur gene histori identifi includ member prolifer heart manag oper patient share tumor perform postop preoper procedur resect sever surgeri surgic symptom underw

2987: Ascariasis (1) 2988: Neurosyphilis (2) asthma caus character characterist affect behavior bipolar case depress develop common complet cystic distinct elegan diseas disord earli late modifi fibrosi fusion lead partial featur onset phase progress provid report pattern result season similar speci typic new stage studi test

2989: Condylomata Acuminata (3) 2990: Coproporphyria, Hereditary (1)

area cervic design affect case character characterist associ correl clinic common diagnos diagnosi diagnost distribut featur hospit individu local distinct featur pain patient present rare report schizophrenia skin studi typic median month patient popul relat relationship signific studi tumor year

2991: Freemartinism (2) 2992: Adenoma, Sweat Gland (2)

case compar concentr differ greater high higher cell determin differ femal gender initi lesion lower new present provid rate report respect similar stain tumor tumour versu male mate mean new offspr origin provid ratio reproduct second sex sexual tumour valu

374 2993: Brown-Sequard Syndrome (1) 2994: POEMS Syndrome (3)

case consid criteria data associ color composit congenit examin clinic find independ intens investig laser light link muscl observ red relat signific studi suggest syndrom develop diagnos diagnosi diagnost

discuss includ laboratori literatur organ

patient possibl present report review studi

2995: Myelitis (2) 2996: Joint Deformities, Acquired (1)

anim condit degre develop donor effect cat distal dog event hand initi involv left limb establish experiment genet heat human membran occur patient process proxim right segment step surgeri surgic model popul protect provid reduc reduct studi temperatur transplant transport

2997: Meningitis, Aseptic (2) 2998: Conjunctivitis, Bacterial (1) adult case clinic diagnos diagnosi diagnost biolog case clinic develop includ involv differ earli incid isol men mortal macular optic present pten rare report retin retina studi system therapi thyroid pattern preval stage patient treatment visual strain type women year

2999: Torticollis (1) 3000: Alveolitis, Extrinsic Allergic (3)

children conclusions copi design determin field approach area clinic diagnosi diagnost diseas hospit includ increas larg movement field forc form format function gener induc induct movement space number objective parent patient respons space specif studi total year structur studi therapi

375 3001: Vascular Fistula (2) 3002: Dysostoses (1)

adult antibodi chromosom clinic compar base caus clinic complic comparison differ elderli imag old older diagnosi imag incid lead patient pattern sever similar symptom syndrom type year young magnet men mortal pair patient perform preval surgeri surgic volum women year

3003: Enterocolitis, Neutropenic (2) 3004: Carotid Body Tumor (2) care case chemotherapi chronic commun activ alter analys characteris chromosom diseas educ health inflammatori delet frequent gene genet hormon investig loss intestin need nurs patient program public report research servic student transplant malign patient progress region studi test thyroid tumour

3005: Taste Disorders (2) 3006: Glomus Jugulare Tumor (1)

affect behavior care chain compar conclusions alter chromosom clinic delet detect fish fluoresc frequent gain gene hormon hybrid loss methods mutat

probe region situ thyroid control duplic evolut famili healthi patient

hospit inform marker medic member particip

reaction studi subject

3007: Glomus Tympanicum Tumor (1) 3008: Iridocyclitis (1) cataract chain complic alter amplif chromosom case delet glaucoma implant len oper patient pcr detect dna enzym fish fluoresc fragment perform polymeras procedur quantit gain gene hormon hybrid loss pcr probe reaction real-tim report revers surgeri region situ thyroid surgic

376 3009: Pulmonary Valve Insufficiency 3010: Noma (1)

(2) antibodi bladder children class compar control differ adult clinic conserv diseas effect essenti evolut environment factor genet group influenc improv older patient requir sever symptom parent pathwai signal signific studi trait twin variat syndrom therapi treat

treatment untreat year young

3011: Mucopolysaccharidosis VII (1) 3012: Parotitis (1)

analys analysi anim base data demonstr associ current discuss epitheli examin disord enhanc experiment form format gene gene lesion link median month increas indic model pair perform reveal mutat pancreat patient recent relat secret stain studi suggest year studi suggest

3013: Cholesteatoma (2) 3014: Heart Injuries (5) cell chain compar content cultur decreas case compar control enhanc express determin elev flow hear increas individu gene genom higher mechan mice new level loss plasma reaction serum patient posit provid rat rate specif treat treatment regul risk subject treatment

3015: Weil Disease (1) 3016: (3)

aggreg case clinic coloni convers criteria critic defect anim approxim birth decreas fetal gestat

defici develop development diagnos high increas infant diagnosi diagnost earli form format includ present report level low matern model neonat pregnanc prenat rel studi vivo women

377 3017: Chagas Cardiomyopathy (1) 3018: Syphilis, Cutaneous (1)

cancer cohort data embryo epidemiolog incid includ allel associ clinic compar control investig iron junction lung men mortal pool popul differ divers frequenc gene genet preval rate women year genotyp higher individu patient studi polymorph popul random sever signific trial

3019: Postphlebitic Syndrome (1) 3020: Arterio-Arterial Fistula (2)

center compar conclusions design differ greater anim arteri blood coronari develop experiment higher hospit lower main medic objective patient heart hypertens imag model patient record remain respect similar studi versu rate pressur primari secondari stroke structur studi surviv syndrom vascular

3021: Putaminal Hemorrhage (1) 3022: Focal Dermal Hypoplasia (1) assess brain case caus design diseas adjust associ character characterist hospit impact improv lead life main common confid congenit distinct elegan objective patient physic present qualiti rare report studi featur interv odd pattern ratio risk smoke speci studi syndrom typic

3023: Miosis (1) 3024: Pyoderma Gangrenosum (2) case dai diagnos diagnosi dose form format blastocyst develop egg embryo literatur man method network new patient predict present provid rare report vector woman endogen enhanc event fertil increas initi involv matur occur oocyt process somat stage step transfer vitro

378 3025: Sweating, Gustatory (1) 3026: Stomatognathic Diseases (1)

affect alter care chang commun analys analysi behavior clinic decreas educ health increas mice mous mutant need nurs observ program public servic signific student complement criteria data demonstr determin

diagnos diagnosi diagnost highli indic

normal perform reveal specif

studi tissu

3027: Euthyroid Sick Syndromes (2) 3028: Spinal Curvatures (1) adjust associ confid dog effect imag interv odd activ analysi associ blot detect

event examin implic involv link genet patient perform ratio risk segment smoke studi molecular process relat stress studi suggest suscept understand western

surgeri surgic test treat treatment

3029: Cerebral Hemorrhage, Traumatic 3030: Cardiac Tamponade (3) (2) case caus clinic diagnos diagnosi brca1 carrier complic environment factor gene diagnost express lead major period point genet identifi influenc molecular possibl present rare remain report specif syndrom time tumour mutat oper patient postop primari procedur risk studi surgeri surgic

3031: Hypertension, Renovascular (2) 3032: Hemoptysis (2) arteri biolog blood case coronari arteri associ confid enhanc factor effect factor field hypertens peripher potenti present pressur rare releas report space stimul function increas interv odd rat ratio system vascular receptor relat renal risk segment smoke structur studi suggest

379 3033: Neoplasms, Connective and Soft 3034: Metatarsalgia (1) Tissue (2) adult case decreas demonstr discuss case center clinic conclusions copi design elderli find increas level old older present previou rare recent report studi suggest year diagnosi express hospit includ main medic young

normal number objective patient signal specif studi tissu

3035: Neuroma (2) 3036: Empyema, Pleural (1)

adult case clinic diagnosi diagnost discuss distal analysi analyz base categori classif classifi cluster collect damag data detect dna gene dog elderli old older patient recent identifi profil repair report segment studi surgeri year young younger mutat sampl set subgroup

3037: Bacteriuria (5) 3038: Pyuria (1) analysi bladder clinic collect combin african american anim area develop differ determin diagnosi effect level method mobil ethnic experiment light live locat method

patient perform sampl studi test model multipl popul region singl time tract urin urinari studi techniqu white

3039: Olivopontocerebellar Atrophies 3040: Kluver-Bucy Syndrome (1) (2) care associ case chain core diseas disord encod factor adult caus clinic fusion includ morpholog motor open diagnosi diagnost experi patient pcr reaction report risk follow health initi intern lead studi syndrom older origin presenc second studi subsequ year young

380 3041: Spermatocele (1) 3042: Chondrodysplasia Punctata, Rhizomelic (1) area case cell differ epitheli express lesion live locat mammari membran present rare autosom bladder bone clinic criteria region report resid specimen stain studi zone case diagnos diagnosi diagnost domin famili inherit literatur mutat present rare report telomer telomeras urinari

3043: Coin Lesion, Pulmonary (1) 3044: Intracranial Hemorrhage, Hyper-

averag calcul compar concentr curv determin differ tensive (2)

higher lower mean measur paramet area care case caus compar data decreas

patient predict rang ratio refer elev health imag increas lead respect standard valu

level literatur normal present report

serum studi tissu

3045: Spina Bifida Cystica (1) 3046: Herpes Zoster Ophthalmicus (1)

base cleft compar control correspond differ divid abil abl capac clinic color complex composit extens group loop match observ pair intens laser potenti possibl propos respect signific similar structur effect light syndrom prevent properti protect red reduc reduct therapi treatment

3047: Atrial Flutter (2) 3048: Nocturnal Myoclonus Syndrome assess associ cardiac carrier confid factor health (1) heart improv increas interv life mutat odd character characterist classic common patient qualiti ratio risk smoke studi depress disord distinct featur includ patient rang repres sever share similar symptom typic uniqu varieti wide

381 3049: Mitral Valve Stenosis (1) 3050: Histiocytic Necrotizing Lym- altern character core defici encod exon phadenitis (2) absenc biopsi case dna domain follow-up fragment lesion lymphoma median month frame identifi intron isoform novel open patient presenc rang receptor recurr report specimen stain year patient put read splice surgeri surgic

syndrom variant

3051: Neuritis (1) 3052: Tooth Discoloration (5)

acid activ amino cell divers gene genet induc activ analysi assai case induct inhibitor loci popul promot respond caus clinic data detect respons structur telomer telomeras differ transcript variat effect estim evid method pattern popul reduc reveal select sensit support

3053: Candidiasis, Oral (6) 3054: Lactation Disorders (1) area care cell clinic cluster combin differ effect associ care data error estim health inhibit isol marker requir experi factor gener genet health influenc initi method origin power risk second set statist servic specif strain studi subject test studi therapi

3055: Filariasis (3) 3056: Alphavirus Infections (1)

antibodi critic develop diseas disord genet kei area cluster differ distinct distribut famili featur local member new patient knockout model molecular mous pattern protein provid risk sever similar mice target test type murin pathogenesi plai role suggest surgeri transgen wild-typ

382 3057: Lymphadenitis (3) 3058: Urticaria Pigmentosa (1) adult chain cours follow improv level life mean month adult children core experi patient period point qualiti reaction femal improv initi life male serum studi time tumor valu year older open origin physic qualiti second sex speci studi year young

3059: Mastocytoma (3) 3060: Fowlpox (1) complet contain continu core delai encod analysi blood case children compar follow frame identifi long-term mutant develop famili femal higher open orf persist produc individu male member patient presenc product put read recoveri rate repeat reveal studi surviv tumor remain

3061: Tetany (2) 3062: Trench Fever (1)

bone coli compar concentr decreas field analysi correl gel human index isol mass method modif modifi phylogenet posit relat increas kidnei level mass microm min relationship sequenc signific speci strain studi movement multipl renal singl space structur techniqu syndrom transplant

3063: Lipomatosis, Multiple Symmetri- 3064: Pasteurellosis, Pneumonic (1) cal (2) activ blood cell coli count cultur diseas absenc case decreas event head imag enzym fibroblast gener increas indic lymphocyt oxid peripher studi substrat synthas indic involv magnet neck observ increas synthesi tuberculosi presenc present process rare report studi suggest volum

383 3065: Snake Bites (1) 3066: Malocclusion, Angle Class I (1)

adult assess behavior class differ evalu administr adult care dai dna dose group mean measur month older elderli gene health old older program patient scale score studi treat treatment valid year young public servic specif transfer vector week year young

3067: Hydropneumothorax (1) 3068: Lymphogranuloma Venereum (2)

case clinic criteria diagnos diagnosi diagnost duplic evalu evolut evolutionari follow-up imag care chain commun detect educ laboratori magnet median month ethic health level need pcr patient recurr volum year polymeras program public quantit reaction real-tim research revers rt-pcr servic

3069: Hypoaldosteronism (1) 3070: Splenosis (1)

activ clinic defici effect enzym improv increas nitric analysi assai chain confirm detect determin heavi method multiplex pcr

novel oxid potenti reduc strategi synthas synthesi polymeras primer quantit reaction real-tim revers rt-pcr sampl transcriptase-polymeras transcription-polymeras target therapeut therapi treat treatment

3071: Splenic Rupture (1) 3072: Erythroplasia (1)

analysi assai chain confirm detect administ administr carcinoma clinic dai determin heavi method multiplex pcr daili dose follow hour infus inject intraven invas polymeras primer quantit oral patient receiv sever skin symptom week reaction real-tim revers rt-pcr sampl transcriptase-polymeras transcription-polymeras

384 3073: Uterine Cervicitis (1) 3074: Meningitis, Haemophilus (1) cervic common esophag frequent blood chain children consist determin differ includ investig italian loss mesothelioma distribut dna fluid length observ occur occurr possibl local long observ pattern pcr peptid probabl relat report studi reaction repeat short suggest suggest transmiss transmit

3075: Leukemia, T-Cell, Chronic (1) 3076: Ophthalmia Neonatorum (1) acut allogen autolog case caus algorithm care caus commun data educ follow health inform lead method consequ death donor excess failur graft lead need network nurs particip predict problem program servic set

leukemia patient recipi reject report result

stem transplant

3077: Neuroectodermal Tumor, Melan- 3078: Anemia, Hypoplastic, Congenital otic (1) (1) allogen continu defect defici delai donor aberr abnorm analys analysi cell chromosom confirm cytogenet data elegan identifi indic karyotyp perform protein follow graft long-term patient persist rearrang reveal speci studi transloc

recipi recoveri reject remain spontan stem

sustain syndrom transplant

3079: Borrelia Infections (1) 3080: Femoral Neuropathy (1) absenc case clinic criteria diagnos adult clinic core dai delai diagnosi diagnost head kinet laboratori design diagnosi diagnost dose encod mechan molecular patient presenc present follow hospit older open patient persist read studi young rare report state test underli year

385 3081: Spirurida Infections (1) 3082: Central Nervous System Helminthiasis (1) activ applic cell china chines determin brain chines clinic diagnosi diagnost differ drosophila differ evalu heterogen imag magnet heterogen imag invas magnet measur mri perform reson respect scan studi subtyp tomographi volum matrix new research respect studi subtyp technolog volum

3083: Spermatic Cord Torsion (2) 3084: Myopathy, Central Core (2) area case data earli estim case caus clinic core diagnosi diagnost field forc late locat method movement oper phase present remain report space stage surgeri time discuss express gene lead morpholog muscl

open overexpress patient present rat receptor

report studi

3085: Myotonic Disorders (3) 3086: Paralysis, Obstetric (1)

assai assess clinic compar concentr correl axon birth cord critic fetal gestat infant inhibitor detect famili genotyp higher injuri matern neonat nerv plai pregnanc prenat

human measur member model role spinal suggest women wound phenotyp polymorph rate score sensit test

3087: Tricuspid Atresia (1) 3088: Liver Abscess, Pyogenic (2)

anim develop experiment genet case children clinic control critic diagnosi diagnost healthi infect kei phenotyp plai report human identif identifi known loss major model novel plai question remain role studi subject suggest therapi treat screen studi suggest syndrom role treatment

386 3089: Amaurosis Fugax (2) 3090: Rickettsia Infections (1) applic chain cultur develop factor absenc case clinic criteria diagnos diagnosi diagnost inform manag new particip genet infect method molecular pcr patient presenc present provid rare report polymeras quantit reaction real-tim research revers sever symptom test risk techniqu technolog understand

3091: Epididymitis (1) 3092: Tuberculosis, Ocular (1) case demonstr design dna find fish fluoresc case center chain conclusions design dna fragment hospit hybrid patient gener gener hospit main medic neg objective patient pcr polymeras posit reaction previou probe produc product record report studi report situ studi suggest

3093: Gastric Dilatation (1) 3094: Gerstmann-Straussler-Scheinker abnorm anemia anomali associ basal cancer caus Disease (2) analysi anim blot cell detect diseas experiment congenit cutan defect defici epiderm express gene marker mitochondri model morpholog mutant mutat protein gastric keratinocyt lesion normal report sever resist reveal studi western skin syndrom

3095: Infarction, Posterior Cerebral 3096: Diverticulosis, Colonic (1) Artery (2) care diseas experi incid affect aim area arteri brain clinic compar conclusions famili conserv control differ healthi locat methods inform larg member mortal number nurs organ particip person size small patient peptid stress studi subject suggest specif survei women year

387 3097: Mushroom Poisoning (1) 3098: Lupus Erythematosus, Discoid cancer character characterist chines common (3) compar control determin differ distinct biolog case caus characterist featur healthi heterogen includ respect clinic common diagnos diagnosi signific similar studi subject diagnost featur includ month normal subtyp patient report studi system tissu treatment year

3099: Jervell-Lange Nielsen Syndrome 3100: Protein Deficiency (1) (2) avail bodi care content data databas event ca2+ calcium channel child children current develop field flow health inform involv mechan molecular function hear heart impair insight loss mice mous mutat new parent provid process program provid rat transgen resist step

3101: Scimitar Syndrome (2) 3102: Thanatophoric Dysplasia (2) absenc complic delai follow head indic associ birth case decreas fetal incid long-term lung neck observ oper patient increas interv matern men persist postop procedur presenc model mortal neonat pregnanc preval ratio studi suggest surgeri surgic remain risk women year

3103: Cholestasis, Extrahepatic (1) 3104: Lordosis (1)

cancer chemotherapi clinic conclusions cours arm case chromosom clinic criteria diagnos diagnosi diagnost dna electron design dna end fragment hospit main medic famili laboratori microscopi morpholog muscl patient random studi treatment trial objective patient pcr period point studi surviv time

388 3105: Melioidosis (1) 3106: Leishmaniasis, Mucocutaneous african algorithm american antibodi black cell (1) data ethnic factor immun method network abil abl activ avail capac cell data popul predict respons risk set stress databas demonstr design displai exhibit includ inform vaccin white pool potenti program properti studi tool

3107: Tinea Capitis (1) 3108: Bluetongue (1) brain continu delai exposur factor follow follow-up african american differ discuss earli ethnic long-term malign median month patient kinet late phase popul progress persist rang recoveri recurr risk time isol protein recent stage state tumor year strain transit type white

3109: Crush Syndrome (2) 3110: Chromoblastomycosis (2) caus clinic conclusions design assess chines differ evalu heterogen imag lesion magnet manag measur hospit incid lead main mri perform reson scan skin studi subtyp therapi tomographi volum marker medic men mortal

objective patient preval

record studi system women year

3111: beta-Mannosidosis (1) 3112: Deltaretrovirus Infections (2) acid amino anim blood cell cohort data accumul activ adolesc autism case child childhood children diagnos diagnosi disord literatur health incid level men parent patient pediatr present rare renal report year model mortal popul preval

rate target trend women year

389 3113: Mongolian Spot (2) 3114: Stomatognathic System Abnor- adult analysi chines clinic data differ malities (1) estim femal follow heterogen initi male adult care children clinic delai design diagnosi mass method patient report sever diagnost differ follow group health hospit older parent patient persist studi year young studi subtyp year

3115: Choroideremia (1) 3116: Melanoma, Amelanotic (1)

associ code codon condit degre gene cancer degrad electron genet human layer melanoma microscop microscopi molecular monkei heat link nucleotid observ posit morpholog observ p53 prostat protein reveal rna mutat structur surfac relat sequenc shock singl studi substitut suggest temperatur

3117: Epiglottitis (1) 3118: Retropharyngeal Abscess (2)

adolesc adult autism boi child childhood adolesc adult autism boi child childhood

children earli father girl infant children earli girl infant mother mother parent pediatr problem report school studi parent pediatr presenc problem recombin report year young school studi year

3119: Yang Deficiency (1) 3120: Legionellosis (3) clone compar control detect differ express fish adult antibodi area assai case clinic collect detect diseas enhanc high level low new

fluoresc function healthi sampl sensit specif studi year young hybrid mean methods modifi mrna probe signific

situ studi subject

390 3121: Shaken Baby Syndrome (1) 3122: Vertebral Artery Dissection (1) aggreg case chromosom coloni case chines clinic design diagnos diagnosi diagnost differ heterogen hospit complement convers demonstr ethic form inhibit isol objective patient present rare format linkag loci locu map present rare report strain studi subtyp report research specif stress

3123: Bile Duct Diseases (1) 3124: HIV-Associated Lipodystrophy Syndrome (1) clinic criteria diagnos diagnosi achiev alter analysi approach diagnost evalu hepat imag infect chang design express laboratori liver magnet measur mri perform gene limit mechan molecular predict provid reson scan segment studi volum regress signific strategi success system variabl variat

3125: Chlamydiaceae Infections (1) 3126: Fasciculation (1) antibodi assess associ confid antibodi case chromosom conduct data delet dna environment evalu factor genet infect influenc interv measur gene includ investig loss methyl muscl pool present organ ratio risk scale score smoke studi valid promot rare region report studi

3127: Hallux Rigidus (1) 3128: Pulmonary Heart Disease (1) clinic delai distal dog donor bone case clinic criteria diagnos follow hand includ long-term diagnosi diagnost diseas field forc gene

persist proxim movement muscl mutat patient patient present sever skelet space symptom rang recoveri segment sever symptom transplant varieti wide

391 3129: Glossopharyngeal Nerve Diseases 3130: Pityriasis (1) (1) base case character characterist classic adult children cohort data estim incid common distinct evid featur men method mortal older popul preval pair popul provid repres share similar rate remain treat treatment trend support treat treatment typic uniqu women year young

3131: Leukocyte-Adhesion Deficiency 3132: Nelson Syndrome (1) Syndrome (2) alter behavior behaviour chang case cell children clinic codon cognit deficit disabl ethic impair increas induc diseas incid men mortal patient preval induct issu learn memori perform research report sever site substitut symptom respons social task therapi treatment women year

3133: Granuloma, Plasma Cell, Pul- 3134: Echinococcosis, Pulmonary (1) monary (1) african american black cancer chines

cell chronic clinic diagnosi diseas case determin ethnic donor graft invas metastasi patient present rare differ femal recipi report sever stem symptom transplant tumor heterogen lung male popul reproduct respect sex sexual studi subtyp white

3135: Isaacs Syndrome (1) 3136: Myokymia (1)

canin cat clinic distal distribut dog fluid hand continu delai dog experi follow initi intern length long long-term left limb local normal patient proxim origin persist recoveri remain repeat second segment short right segment sever suggest symptom spontan subsequ tissu

392 3137: Wounds, Stab (1) 3138: Entropion (1) aberr ablat conclusions cornea clinic diagnos diagnosi corneal correct diagnost effect form format evalu examin gastric mean measur hospit incid mechan medic men methods myopia ocular perform refract molecular mortal patient preval reduc segment syndrom thick visual reduct women year

3139: (1) 3140: Neoplasms, Cystic, Mucinous,

chain character chromosom contain core encod frame and Serous (1) absenc analysi cell content cycl cytometri identifi loss open orf pcr patient determin evalu flow head indic load nuclear polymeras put reaction read real-tim revers syndrom observ patient percentag presenc

protein signific surviv

3141: Cystadenoma, Papillary (1) 3142: Neuroleptic Malignant Syndrome cancer densiti endometri estrogen field (1)

high level low mice movement affect allel associ chain delet novel ovarian potenti space studi target detect disord dna examin fragment gene therapeut tumor vitro vivo genotyp loss pcr polymeras polymorph reaction schizophrenia studi suggest

3143: Choriocarcinoma, Non- 3144: Thalamic Diseases (2) gestational (1) acut caus children clinic complex duplic

case cell complex detect diverg duplic evolut evolut imag lead leukemia mild month parent patient present sever sign syndrom year evolutionari fish fluoresc genet hybrid lung symptom

normal origin probe report situ stress tissu

393 3145: Parakeratosis (1) 3146: Stevens-Johnson Syndrome (1)

differ achiev approach cell clinic design effect efficaci follow area carcinoma cell improv limit optim patient sever strategi success epitheli examin express immunohistochem lesion live locat mammari region resid skin syndrom therapi treat treatment untreat specimen stain studi tumor zone

3147: Dermatitis, Irritant (2) 3148: Superior Mesenteric Artery Syn- assai clinic detect diagnosi drome (1) algorithm allow appli applic approach data develop inform insight method multipl network diagnost differ genet health identifi new predict provid set singl techniqu technolog understand

mean measur popul ratio resist respect

screen sensit specif test valu

3149: Chondroblastoma (1) 3150: Hiccup (1)

angiogenesi cellular control element endotheli african american asian associ black caucasian factor function genom growth insert integr invas differ ethnic european gene pattern mechan modul regul regulatori role test popul preval race ratio risk south therapi type vascular vegf white

3151: Tuberculosis, Gastrointestinal 3152: Tuberculosis, Pleural (1)

(2) behavior cognit compound disabl esophag frequent gener impair includ learn memori occur alter case chang chronic data diseas occurr perform probabl report studi task gener hospit includ increas indic isol transmiss mycobacterium patient popul report specif strain studi test tuberculosi

394 3153: Mesothelioma, Cystic (1) 3154: Cholecystitis, Acute (1) assess chicken differ diseas evalu cancer compar complic differ gastric greater higher lower oper patient perform postop procedur femal individu isol rate resect respect surgeri surgic underw loss male mate measur versu reliabl scale score sex sexual strain studi valid

3155: Fibroma, Ossifying (2) 3156: Scleredema Adultorum (1) adult develop event find individu insight involv addit case confirm consist demonstr find indic model mutat older previou process new kinet observ patient present previou provid report studi tumor understand year young rare report skin state studi suggest switch transit

3157: Short Rib-Polydactyly Syndrome 3158: Thyroiditis, Subacute (1) (1) associ autosom clinic domin famili follow-up adren autoimmun chronic common diseas esophag frequent hormon includ injuri intestin investig gene haplotyp inherit median month mutat occur occurr pituitari probabl progress studi thyroid transmiss patient polymorph prognost recurr snp surviv syndrom year

3159: Hepatitis, Animal (2) 3160: Hyperostosis, Cortical, Congeni-

blood demonstr densiti discuss distribut essenti tal (2) autosom bone chain differ distribut domin fluid function high level local low mice mous recent requir suggest famili function gene inherit transgen vitro vivo larg local mutat number produc product reaction remain size small

395 3161: Pelger-Huet Anomaly (1) 3162: Skull Fracture, Depressed (1)

acid amino bone cell defici electron essenti induc complic disord elev imag level measur new oper patient perform plasma procedur research serum surgeri surgic syndrom induct insight marrow microscopi morpholog techniqu technolog volum

necessari new provid receptor requir respond respons

3163: Tooth Ankylosis (1) 3164: Henipavirus Infections (1)

assess associ case clinic confid diagnosi diagnost evalu interv marker measur ratio report chines confirm demonstr differ find heterogen isol observ pattern popul previou risk scale score smoke studi valid test report respect signific similar strain studi subtyp suggest type

3165: Schistosomiasis japonica (1) 3166: Pityriasis Rosea (1) cdna cell clone detect differenti dna anim develop diverg duplic effect evolut evolutionari experiment gene human

origin plant skin studi express fish form format fragment gene model therapi transfer treat treatment vector hybrid librari normal probe prolifer

recombin sequenc tissu

3167: Candidiasis, Chronic Mucocuta- 3168: (2) neous (1) acid caus dai develop dose effect adhes analysi categori classif classifi cluster condit evid genet group incid lead mutant degre differ elev higher level oxid mutat provid rat reduc support treat treatment women patient plasma profil serum set subgroup temperatur

396 3169: Gastroschisis (3) 3170: African Swine Fever (1)

adapt analys analysi associ care anim bovin breed immun infect involv isol data design earli group health hospit mechan molecular pig poorli provid indic mutant patient perform reveal risk respons strain type underli understand select stage studi understood vaccin viru

3171: Vasculitis, Hypersensitivity (1) 3172: Angiokeratoma (2)

base cancer case clinic correspond develop development differ extens includ lung match methods biolog clinic develop development multipl observ pair patient possibl diseas femal fusion includ male mass method sever sexual techniqu report singl patient sex system therapi transplant treatment

3173: Bezoars (1) 3174: Staphylococcal Scalded Skin Syn- drome (1) analysi approxim blot compar detect complet contain femal greater half hear known loss major analysi chines core differ encod frame fusion genet male minor observ rel sex suggest syndrom western heterogen identifi infect mass open partial read skin studi subtyp

3175: IgG Deficiency (1) 3176: Central Nervous System Venous (1) addit caus combin demonstr densiti brain center clinic conclusions congenit design domin earli effect find high late lead famili hospit inherit main medic methods mutat

level low patient phase previou objective patient record studi syndrom tumor report stage studi suggest

397 3177: Serratia Infections (1) 3178: Motion Sickness (1) anim cell data differ direct epitheli evid assai caus clinic compar detect experiment induc induct larg larger diagnosi diagnost earli isol differ model number provid lead mice pattern sensit specif stage state strain test type respons size small smaller support

3179: Ureterocele (1) 3180: Microvascular Angina (1)

acid amino chain elev genet increas level metabol articl case compar control molecular oxid patient pcr plasma current data discuss famili frequenc polymeras reaction real-tim revers serum synthas identifi literatur member present publish recent synthesi remain report review search systemat

3181: Gingival Pocket (1) 3182: T-Lymphocytopenia, Idiopathic CD4-Positive (3) bind bladder cervic chain abil blood cell decreas densiti diseas event detect clinic diagnosi follow high incid increas diagnost dna epitheli fragment gene hpv level low mutant peripher process human pcr polymeras reaction properti stress tumour women revers studi vector

3183: Blastomycosis (1) 3184: Sialorrhea (1)

amplif amplifi analysi clinic detect diagnosi affect compar control differ earli group healthi higher late lower mean methods phase diagnost dna fragment interact length respect signific stage studi normal pcr primer protein rate subject versu restrict sequenc therapi tissu treatment

398 3185: Pelvic Infection (2) 3186: Factor XIII Deficiency (1)

delai effect follow group associ chronic dimer diseas factor identifi incid long-term mortal fold form gene outcom patient platelet patient persist preval prevent protect rat reduc reduct screen signific women prognosi prognost protein skin solubl stabil year stabl surviv transcript

3187: Hand, Foot and Mouth Disease 3188: Burns, Inhalation (1) (1) african american area black cultur develop earli experi extern characterist chines common final follow initi intern late light onset origin phase progress second seri skin differ ethnic featur stage subsequ heterogen identifi includ isol popul screen strain studi subtyp white

3189: Anisocoria (1) 3190: Uveoparotid Fever (1) confirm consist defin determin establish experi congenit consist determin establish experi

extern final follow independ initi extern final follow initi intern intern minim origin propos report minim mitochondri mtdna origin report second seri subsequ second seri subsequ syndrom syndrom translat

3191: Lead Poisoning, Nervous System, 3192: Rectovaginal Fistula (1) Childhood (1) cancer colon colorect complet continu delai diverg duplic evolut evolutionari follow care children commun educ health fusion genom long-term occur manag medic nation need nurs plan practic profession program provid public research origin persist recoveri sequenc spontan servic student trial

399 3193: Acrospiroma, Eccrine (2) 3194: Sarcoma, Avian (2) assai chicken detect determin analysi case compar control determin differ diseas distribut frequenc hiv-1 individu infect local predict regress report develop differ dna imprint includ signific variabl variat viru individu japanes nucleotid region sensit sequenc specif structur suggest target test

3195: Mycotoxicosis (1) 3196: Scheuermann’s Disease (1) antibodi antigen cell chicken compar control differ divid adult case diseas dynam elderli factor group immun imprint individu japanes pathogen respect respons signific studi vaccin viru mean model month old older patient predict present report risk simul studi year young

3197: Pulmonary Blastoma (1) 3198: Embolism, Paradoxical (1) cancer case continu delai domain effect brain clinic compar control copi criteria data diagnosi follow length long long-term loss lung diagnost differ group includ increas larg persist potenti recoveri releas literatur number publish review signific total repeat report short stimul

3199: Porokeratosis (2) 3200: Dermatitis Herpetiformis (1) analysi base case data differ genet literatur mean measur mutat pair predict adolesc assai associ case child present rare regress report syndrom valu childhood children decreas variabl variat detect diseas increas level parent pediatr report sensit specif studi test year

400 3201: Papilloma, Choroid Plexus (1) 3202: Glossalgia (1)

adapt associ bladder caus consequ analys analysi assess avail data evolut examin fit infect lead link natur nuclear relat databas evalu extract genom measur select studi suggest tumor viral viru perform remain reveal scale score sequenc tool treat treatment valid

3203: Sarcoma, Alveolar Soft Part (1) 3204: Rhabditida Infections (1) affect case cohort data evid gene bacteri develop development incid men mortal period popul drosophila earli elegan host includ infect initi late loop melanoma onset pathogen phase progress rna preval provid rate registri report support speci stage

trend women year

3205: Skin Diseases, Infectious (1) 3206: Glucose Metabolism Disorders (1) access annot avail data administr allel associ dai diabet domain dose databas http infect inform integr program provid resourc search set softwar femal gender gene genotyp tool user visual web www male mate methyl offspr polymorph reproduct sex sexual week

3207: Furcation Defects (1) 3208: Hand Deformities, Acquired (1)

child childhood assess biolog bone correl evalu grade adult children diseas elderli mean old higher index invers ki-67 neg observ paramet posit chromosom clinic older parent sever studi symptom relat relationship signific statist studi system patient syndrom year young younger

401 3209: Intertrigo (1) 3210: Flatfoot (1)

algorithm avail data databas design differ affect autosom case caus clinic group hospit inform level method criteria diagnos diagnosi diagnost network patient predict remain serum set signific studi tool diseas disord domin famili inherit laboratori mutat patient recess skin tumor

3211: Bone Malalignment (1) 3212: Spina Bifida Occulta (1)

canin case cat deform distal dog factor abnorm associ case congenit defect defici examin find her-2 her2 link neg neu posit relat report function growth hand igf-i later left limb present proxim rabbit report right segment studi suggest syndrom segment

3213: Adenomatosis, Pulmonary (1) 3214: Aleutian Mink Disease (1)

analysi associ character classif cluster compar base caus compar control differ extens find control differ distinct ebv exhibit frequenc group higher lead level mutant observ pair previou report serum signific studi test identifi mice mous phenotyp set similar suggest transgen

3215: Polyuria (3) 3216: Favism (2)

adult alter case chang compar concentr adult african american area asian black case data differ estim ethnic initi origin decreas express find increas level observ patient phenotyp reduc renal report patient popul preval report studi suggest year south white year

402 3217: Choroid Hemorrhage (1) 3218: Contusions (1) analysi analyz approxim bodi capillari cleft cours durat dynam end experiment field median diet electrophoresi gel identif identifi model month movement paramet patient major mass minor observ proteom period point predict simul space time rel separ spectrometri spot weight year

3219: Calcium Metabolism Disorders 3220: Gingivitis, Necrotizing Ulcerative (1) (1)

analysi cdna chain clone detect diseas express fish alter chang chines decreas differ fluoresc gene hybrid interact microarrai express heterogen increas inhibit mechan mice molecular mous mrna observ remain patient pcr polymeras probe profil signific studi subtyp underli reaction situ

3221: Tuberculosis, Meningeal (1) 3222: Hypervitaminosis A (1) case clinic design distribut hospit bodi compar concentr control differ dose gene group mice min mous mutat plasmid incid men mortal local patient radiat recombin respect signific transgen vector weight present preval random report sever studi symptom trial women year

3223: Fetal Hypoxia (1) 3224: Tricuspid Valve Insufficiency (1) analysi differ heart incid independ measur affect assess associ case compar control evalu healthi mean measur methods patient men mortal normal predict preval report scale schizophrenia score signific studi regress relationship signific stimul subject suggest tissu variabl variat women year

403 3225: Leukomalacia, Periventricular 3226: Cementoma (1)

(2) belong chromosom clinic data direct diseas evid adult alter caus chang elderli famili histori hypothesi identifi includ member patient provid sever suggest superfamili hospit identifi includ lead mean old older support symptom patient remain screen studi valu year young younger

3227: Eczema, Dyshidrotic (1) 3228: Neoplasms, Nerve Tissue (1) character characterist classic common abnorm anemia caus defect defici dna epigenet follow-up gene inactiv median cord distinct express featur metabol methyl month normal injuri mice mous mrna nerv p53 patient promot recurr sever year similar spinal transgen typic uniqu wound

3229: Papilloma, Intraductal (1) 3230: Aortic Stenosis, Subvalvular (1) analys characteris chromosom delet distribut fluid abnorm cardiac cardiomyocyt cardiomyopathi caus clinic congenit defect frequent investig light local loss malign observ dysfunct failur heart hypertrophi left mild patient present sever symptom plai progress region role studi suggest syndrom ventricular tumour

3231: Peste-des-Petits-Ruminants (1) 3232: Epidermolysis Bullosa Acquisita analysi anim antibodi base categori classif (1)

cluster code codon data differ experiment adolesc autism base boi child childhood

model patient phylogenet set sever children differ girl infant inhibit speci studi substitut mother observ pair parent pediatr primari skin studi year

404 3233: Abruptio Placentae (1) 3234: Melkersson-Rosenthal Syndrome (1) associ clinic compar control arteri case clinic compar comparison

differ find frequenc develop differ diseas distinct observ patient genet genotyp interv patient polymorph pattern present pressur rare report sever similar previou ratio report risk sever studi symptom symptom syndrom type

3235: Carbamoyl-Phosphate Synthase 3236: Oliguria (1) I Deficiency Disease (1) analysi chang compound defici experi fusion intermedi kinet clinic dai diagnosi organ partial plai possibl process residu diagnost differ distribut dose hospit local patient predict role site state suggest switch telomer transit region regress relationship sequenc sever symptom variabl variat

3237: Follicular Cyst (1) 3238: Macrostomia (1)

case clinic diagnosi diagnost addit associ caus combin content cytometri determin effect evalu flow increas lead link load mate femal male methods observ patient relat signific method month studi patient procedur recurr resist sex sexual structur surgeri surgic techniqu year

3239: Arterivirus Infections (1) 3240: Hernia, Diaphragmatic, Trau- acid amino analysi classif matic (1) compar complic dai design dose higher hospit data differ identifi cluster isol lower month oper patient perform postop predict radiat region regress procedur rate respect surgeri surgic relationship sequenc set signific versu year strain variabl variat

405 3241: Hearing Loss, High-Frequency 3242: Odontoma (1)

(1) adolesc adult autism boi child childhood assai assess compar conclusions control detect evalu healthi loss mean measur children earli father girl infant methods reliabl requir scale score sensit mother parent pediatr problem report school studi therapi year studi subject valid

3243: Vascular Hemostatic Disorders 3244: Amino Acid Transport Disorders, (1) Inborn (1) concentr convent elev higher includ brain caus cell chronic clinic depress

increas level lipid lower measur diseas disord intestin membran microg microm min multipl motor muscl neurolog myeloma plasma serum singl studi patient present sever sign skelet sperm stem symptom

406